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Abstract
The primary aim of the present study was to develop a scale which assesses self-
efficacy of partners of drug and alcohol users and to determine the scale’s psychometric
properties. Given that there are approximately one million partners of drug and alcohol
users in Australia alone and there is currently no validated standardized scale available
in the literature which assesses coping self-efficacy in partners of drug and alcohol users
such as scale is expected to fill a large void.
The 24 item Partner Coping Self-Efficacy Scale (PCSES) was developed using
Bandura’s recommendations for devising self-efficacy scales and was reviewed by an
expert panel and piloted on a small group of partners. In the first phase of this research
(Study 1) the PCSES was administered to 83 partners of patients attending outpatient
treatment at the Western Sydney Area Health Service Drug and Alcohol Service. Internal
consistency (coefficient alpha = 0.882) and test-retest reliability results (r = 0.89) were
found to be promising for a newly devised scale. The PCSES was subjected to factor
analysis and the results revealed the presence of 4 clear factors labeled :
“Comprehensive Care”, “Reinforcing Abstinence”, “Resilience” and “Negative Affect”,
which accounted for 51% of the total variance.
Evidence for the PCSES’s construct validity was obtained from strong relationships
between the PCSES and coping style as assessed by the Ways of Coping
Questionnaire. Higher partner self-efficacy on the PCSES was associated with more
effective forms of coping in partners, namely reported use of Problem-Focused coping
strategies when dealing with the patient’s substance use problem. Further evidence of
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the PCSES’s construct validity was obtained from significant relationships between the
PCSES and self-reported depression and anxiety in partners as assessed by the
Hospital Anxiety and Depression Scale. More specifically, partners reporting lower self-
efficacy on the PCSES were significantly more likely to report greater levels of
depression and anxiety on the Hospital Anxiety and Depression Scale. The results from
Study 1 failed to provide evidence for the PCSES’s predictive validity in that PCSES
scores were unable to predict relapse in patients 6 months following treatment.
In order to determine whether the 4 factor structure of the PCSES could be replicated
the PCSES was administered to 183 partners of drug and alcohol users who were
accessing information about addictions from the internet in phase 2 of this research
(Study 2). The same 4 factor structure obtained in Study 1 was also confirmed in this
second sample of partners. Internal consistency for the PCSES and its factors was
found to be adequate to good (coefficient alpha 0.692 to 0.893). Although this second
sample of partners failed to provide evidence for the PCSES’s construct validity based
on scores on the Hospital Anxiety and Depression Scale, this may in part be due to
sampling differences between Study 1 and Study 2 partners.
Overall the results from both Study 1 and Study 2, despite being preliminary, suggest
that the PCSES has acceptable psychometric properties with a stable and clear 4 factor
structure. The psychometric properties of the PCSES were verified in two different
populations of partners using two different modes of scale administration (i.e. face to
face and online). Despite this future research needs to be conducted using the PCSES
in order to assess the scale’s psychometric properties further. It is expected that the
PCSES will greatly assist clinicians when treating partners of drug and alcohol patients.
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1Introduction
It is widely accepted that addictive behaviours are difficult to treat and pose huge
economic and social costs to society (Australian Institute of Health and Welfare
(AIHW), 2011). Drug and alcohol misuse is a widespread problem in Australia and
around the world. In Australia in 2010 one in five people over the age of 14 years
were at risk of lifetime alcohol-related harm (Australian Institute of Health and
Welfare (AIHW), 2012). In 2011-2012 almost 20% (19.5%) of Australians reported
consuming more than 2 standard drinks per day on average, which exceeds the
lifetime risk guidelines set by the National Health and Medical Research Council
(AIHW, 2012). Almost half of the Australian population over the age of 14 years
reported exceeding the single occasion risk threshold by consuming in excess of 4
standard drinks at least once in the previous 12 months between the years 2011 and
2012 (AIHW, 2012).
Drug use in Australia is also alarmingly high. Approximately 7.3 million people in
Australia over the age of 14 years reported ever having used illicit drugs, with 15%
reporting using illicit drugs in the previous 12 months (AIHW, 2012). From this study
cannabis was the most widely used drug in Australia followed by ecstasy and
hallucinogens (AIHW, 2012). Australia and New Zealand combined have the highest
rate of cannabis use in the world, with almost 15% of the population reporting using
cannabis (United Nations Office on Drugs & Crime (UNODC), 2012). In 2012 there
were 1790 deaths due to drugs in Australia, with 40% of deaths due to the use of
opioids and almost 15% due to the use of benzodiazepines (AIHW, 2012).
2Equally high rates of drug and alcohol use have been reported in America.
Approximately 58.3 million Americans aged over the age of 12 years reported binge
drinking at least once in the last 30 days during 2011, which equates to 23% of the
population (Substance Abuse and Mental Health Services Administration (SAMHSA),
2012). Approximately 7% of the American population, that is 16.7 million people,
were dependent on or abused alcohol in 2011 (SAMHSA, 2012). Furthermore, 8% of
the American population (20.6 million people) over the age of 12 years were
dependent on a substance or abused a substance in 2011 (SAMHSA, 2012). Five
million Americans used cannabis on a daily or almost daily basis in 2011 (SAMHSA,
2012). In 2011 1.5% of the American population, that is 3.8 million people, received
drug and alcohol treatment, which included inpatient rehabilitation, outpatient
rehabilitation, attendance to Alcoholics Anonymous/Narcotics Anonymous, hospital
treatment or treatment by a general practitioner (SAMHSA, 2012).
There is no data available on how many Australians are living with a partner who has
a drug or alcohol problem. A conservative estimate can be obtained from the AIHW
(2012) data and data from the Australian Bureau of Statistics (2010 - 2011) which
suggests that 71% of Australians were living with their partner in 2011. From these
data one would estimate that there were approximately one million Australians who
were living with a partner who had a drug and alcohol problem in 2011. Thus there
are currently approximately one million Australians whose lives are affected by living
with the stress and strain associated with having a partner with a drug or alcohol
problem. If children and other immediate family were included in the number of
persons immediately affected by the drug and alcohol problem this number would be
significantly greater. Given this alarming figure it is surprising to see that partners of
persons with a drug and alcohol use problem have been largely ignored in the
literature.
3Drug and alcohol problems can often be a life-long debilitating condition not just for
the patient but their partner and family as well. The number of published papers
examining how partners of drug and alcohol users cope with the chronic burden and
stress of living with a partner with an addiction are sparse. As a consequence there is
an absence of well-validated instruments which can be used in a clinical setting to
assess the needs and coping of partners of drug and alcohol users. Furthermore
most treatment programs do no tend to include the partner in treatment at all with
some residential rehabilitation programs even placing strict exclusions on partner
involvement during rehabilitation. The available literature has found that partners of
drug and alcohol users have been shown to display greater levels of depression,
anxiety, somatic concerns, as well as physical and emotional abuse compared to
partners without a spouse with an addiction (E.g. Dawson et al., 2007 ; Kishor, Pandit
& Raguram, 2013 ; Rognmo, Torvik, Roysamb & Tambs, 2013 ; Tempier et al.,
2006).
Despite the paucity of work conducted on partners of drug and alcohol users a great
deal of work has focused instead on patients. Relapse rates for drug and alcohol
users are high, with approximately two thirds relapsing within the first three months
following treatment (E.g. Charney, Zikos & Gill, 2010 ; Fals-Stewart, O’Farrell &
Hooley, 2001 ; Penick et al., 2010). Two factors which have been found to have a
significant impact on relapse prevention are patient self-efficacy (E.g. Dolan, Martin &
Rohsenow, 2008 ; Ilgen, McKellar & Tiet, 2005) and partner support (E.g. Nattala et
al., 2010 ; Sobell et al., 1993).
Most of the research on self-efficacy in the addictions field has focused on self-
efficacy in the patient. Although there is ample research conducted on the self-
efficacy of patients there is a paucity of research conducted on partner self-efficacy in
the addictions field. Even though the self-efficacy model has been studied a great
4deal in research on stress and coping relatively little attention has been paid to the
self-efficacy of partners of people with substance use problems. However, more
recent research in areas outside the addictions field, such as dementia and chronic
medical illness, have focused on partner coping self-efficacy. Such research has
consistently shown that self-efficacy in the partner plays a significant role in
accounting for the functioning and long-term outcome in both the patient and the
partner (E.g. Rohrbaugh et al., 2004).
Self-Efficacy
Self-efficacy has been defined as “one’s belief in their ability to engage in a course of
action sufficient to attain a desired outcome” (Bandura, 1977). Self-efficacy is
concerned with a person’s perceived ability to successfully perform a coping
response to deal with a high-risk situation. Self-efficacy is distinct from motivation,
self-esteem, locus of control, or willpower. Self-efficacy beliefs are not an indication
of the level of skill one possesses, rather they are a judgment made about what one
can do with the skills they possess (Bandura, 1995). If one has high self-efficacy for a
particular coping skill it is more likely that they will implement that coping skill.
Self-efficacy beliefs influence whether or not one chooses to change their behaviour,
whether one is successful in changing their behaviour and whether the change in
behaviour is maintained over time (Bandura, 1992). Furthermore, self-efficacy affects
the amount of effort one puts into achieving their desired goal and one’s emotional
reactions when encountering a situation (Bandura, 1997). Self-efficacy varies with
respect to the specific situation the person is confronted with. Furthermore, self-
efficacy is a state measure as opposed to a trait measure such as self-esteem and it
is not static. Self-efficacy is distinct from outcome expectancy in that outcome
expectancy is one’s anticipation of the results that one’s behaviour will achieve
5whereas self-efficacy on the other hand is a judgment made regarding one’s
capability to execute a behaviour (Bandura, 1977).
Self-efficacy can be measured along three dimensions: level, strength and generality.
Level is concerned with whether or not the person believes he/she can perform a
certain task. Strength is concerned with the degree of confidence the person has in
that judgment whereas generality is concerned with the similarity of this self-efficacy
rating across similar situations. Self-efficacy does not include an assessment of what
the person will actually do to cope in the particular situation, as this is an assessment
of coping skill. Instead, self-efficacy is a measure of how confident they are that they
can cope in a particular situation.
According to Bandura’s self-efficacy theory (Bandura, 1997), one’s perceived self-
efficacy in a particular situation is influenced by four things:
1. one’s past performance in that situation : with past success likely to result in
continued success.
2. vicarious observation of the performance of others in a similar situation : that is
modeling. Although not as powerful as past performance, modeling can demonstrate
that a particular challenging situation can be handled and the person can obtain
ideas about how they too can deal with the difficult situation.
3. external/social influences from partners or friends (e.g. advice or encouragement) :
usually not as effective when used alone than when used in conjunction with past
performance.
4. altering physiological states of emotional arousal : based on the assumption that
challenging situations induce anxiety and people rely on their assessment of their
anxiety level to determine their level of self-efficacy in facing that particular situation.
6According to Bandura’s theory it is unlikely that these four sources operate
independently. Any one of these four sources is likely to influence one’s judgments of
perceived self-efficacy.
Self-efficacy has been widely examined in patients attempting to stop using drugs
and alcohol, in those attempting to quit smoking or lose weight and in assessing
sexual risk behaviour. Perceived self-efficacy influences whether one initiates
changing their substance use behaviour, achieves changes to their behaviour and
maintains these changes (Bandura, 1997). According to Bandura (1997) there are
two main types of perceived self-efficacy, namely “self-change efficacy” and
“recovery self-efficacy”. Self-change efficacy is defined as one’s belief in their ability
to carry out a therapeutic task which will influence personal change. This type of self-
efficacy is important at the commencement of change. Clinicians can utilize a variety
of tools such as motivational enhancement techniques if the patient’s self-change
efficacy is low. Furthermore, the clinician will need to focus early on in treatment on
fostering the patient’s efficacy and identifying any positive changes made by the
patient. It is just as important for the clinician to ensure that patients do not drop out
of treatment prematurely or become discouraged from attempting to change as a
result of their low efficacy. Research has shown that patients who are low in self-
efficacy are unlikely to seek treatment or even attempt to change their drinking
behaviour (E.g. DiClemente & Hughes, 1990 ; Heller & Krauss, 1991).
The second type of self-efficacy identified by Bandura (1997) is recovery self-efficacy
and has been defined as the belief in one’s ability to reinstate control following a
lapse or relapse. This particular type of self-efficacy plays an important role in
maintaining gains following treatment. In the drug and alcohol field it is widely
accepted that if a coping response is successfully implemented by the patient when
faced with a high-risk situation, the patient’s self-efficacy will be strengthened,
7lessening the chance of a lapse or relapse (Marlatt & Gordon, 1985). Self-efficacy
has been repeatedly found to be predictive of relapse following treatment, even after
controlling for other factors such as degree of drug/alcohol dependence and
sociodemographic variables. For instance there is ample research to suggest that
low self-efficacy in drug and alcohol patients is highly predictive of relapse and that
coping skills training can increase one’s self-efficacy (E.g. Condiotte & Lichenstein,
1981; Feeney et al., 2006 ; Hser, 2007 ; Kavanagh, Sitharthan & Sayer, 1996 ; Martin
et al., 2011; Mattoo, Chakrabarti & Anjaiah, 2009 ; Rychtarik, Prue, Rapp &
King,1992 ; Sitharthan & Kavanagh, 1990). There are, however, a few studies which
have found that self-efficacy does not influence relapse (E.g. Demmel, Nicolai &
Jenko, 2006).
Global measures of self-efficacy are inconsistent with self-efficacy theory (Bandura,
1997). It has been recommended that measures of self-efficacy should assess
beliefs, behaviours and circumstances (Forsyth & Carey, 1998). Furthermore,
measures of self-efficacy should contain items that reflect subject’s beliefs about their
capacity to perform certain behaviours under circumstances of increasing difficulty
(Bandura, 1997). Bandura (1977) argues that self-efficacy needs to be assessed
separately to performance as although self-efficacy can affect performance other
factors also influence performance.
Measures of self-efficacy in the addictions field typically aim to identify situations
where the patient is likely to experience difficulty controlling or abstaining from using
drugs or alcohol. It is the clinician’s role to identify such high risk situations with the
patient and focus on those in which the patient feels least able to control or abstain
from using drugs or drinking. It is also the clinician’s role to teach the patient skills to
effectively refrain from using drugs/drinking when faced with high risk situations in
which the patient expresses low self-efficacy. Numerous validated patient self-
8efficacy scales are available in the literature, some of which assess self-efficacy for
particular substances such as amphetamines (Feeney et al., 2006), benzodiazepines
(Parr et al., 2009), and cannabis (Young et al., 2012). Some self-efficacy scales
assess confidence in achieving the patient’s specific treatment goal, such as alcohol
abstinence (McKiernan et al., 2011), a controlled drinking goal (Kraus et al., 2012 ;
Sitharthan et al., 2003) and confidence in engaging in harm minimisation behaviours
in intravenous drug users (Phillips & Rosenberg, 2008).
Partner Coping Self-Efficacy
Most of the research conducted in the addictions field has focused on the patient’s
self-efficacy. Even though the self-efficacy theory had been studied at length in
research on stress and coping relatively little attention has been paid to partners of
people with drug and alcohol problems. A number of partner coping self-efficacy
scales have been devised in areas outside of the addictions field. Research in areas
outside of the addictions field, such as with partners of dementia sufferers and
partners of people with chronic illnesses, have shown that partner self-efficacy plays
an important role in the functioning and long-term outcome of both the partner and
the patient (E.g. Rohrbaugh et al., 2004).
Partner coping self-efficacy can be defined as a subjective appraisal of whether or
not one’s coping efforts were successful in meeting their goals within a particular
context. Partner coping self-efficacy is situation-specific in that one partner can have
high self-efficacy for a particular coping situation but not another. Self-efficacy can
determine whether coping behaviors will be initiated, how much effort will be
expended, and how long they will be sustained when faced with obstacles or
aversive outcomes, such as one’s partner relapsing.
9According to Bandura’s theory, partners with low self-efficacy when faced with
difficult tasks will focus on their personal deficiencies, the negative aspects of the
task at hand and the disadvantages of failing the task (Bandura, 1997). Partners who
are low in coping self-efficacy may know how to assist their partner but they may not
feel confident in their ability to offer the correct kind of support. In turn such low self-
efficacy will limit the partner’s ability to effectively assist the patient or their own
coping. As a consequence, this will reduce the partner’s drive to engage in any
effective coping activity, causing depression, anger and anxiety (Bandura, 1997;
Billings & Moos, 1983). A strong relationship between care giving self-efficacy and
depression has been frequently cited in the literature, particularly in carers of
dementia sufferers (E.g. Gilliam & Steffen, 2006 ; Zeiss et al., 1999). On the other
hand, those partners displaying high care giving efficacy focus on what they are
accomplishing rather than their failures thus leading them to focus on what they can
do to change their situation. According to Bandura (1997) partners displaying high
care giving self-efficacy are resilient and this helps them to “endure hardships and
persevere against great odds” usually associated with care giving (Bandura, 1997,
p22).
Bandura’s (1997) self-efficacy theory also states that efficacy beliefs are closely
associated with one’s emotion regulation. More specifically, the greater a partner’s
self-efficacy for controlling their own upsetting thoughts the more likely they are to
consistently be able to manage their upsetting thoughts, leading to affect regulation
through behaviour modification. Conversely, the lower a partner’s confidence in being
able to control their anger or unpleasant thoughts the less likely they are to be able to
manage their anger and related behaviour. This has important implications for
partners given the stress and anger they must often endure in their role as a partner.
If partners are unable to manage their anger or other unpleasant emotions which
may often be elicited by the patient’s drug/alcohol use behaviour then this will limit
10
their ability to effectively assist their partner or even in assisting their own coping
behaviour. Bandura (1997) has recommended that self-efficacy scales need to
include an assessment of one’s ability to manage their anger when exposed to
challenging situations, such as care giving.
There is a complete absence of any published well-validated scales assessing
partner self-efficacy in the addictions field. The only published research in the drug
and alcohol field on partner coping self-efficacy to my knowledge is that by Hurcom,
Copello & Orford (1999). Hurcom and her colleagues interviewed 29 female partners
of heavy drinkers and administered a scale which they devised which assessed
partner’s beliefs in their ability to engage, tolerate or withdraw from their partner’s
drinking behavior based on Orford et al’s (1998) work describing the three main
coping styles used by partners of drug and alcohol patients. This “Coping Self-
Efficacy Scale” devised by Hurcom, Copello & Orford (1999) consisted of 18 items
which asked partners to rate how much they agreed with a series of beliefs in their
ability to use various coping strategies (e.g. “I can..”) on a 5 point Likert-type scale
ranging from “strongly disagree” (rated 1) to “strongly agree” (rated 5). There is no
information available regarding the wording of the items or the instructions for using
this particular scale. Results from this Coping Self-Efficacy Scale were compared to
scores on a scale designed solely for the purpose of this study called the Coping
Self-Demands Scale which assessed partner’s beliefs about the extent to which they
“should” use each of the three coping types. The results suggest that this particular
sample of partners felt more able to withdraw from their partner’s drinking behaviour
than to engage or tolerate the behaviour. Unfortunately the researchers also failed to
examine whether self-efficacy in the partner was related at all to the patient’s
outcome following treatment. Other than internal reliability checks on this scale which
proved to be adequate (0.8 to 0.84 on the three subscales) no other psychometric
properties of the scale were examined. The authors claim that the scale had 3
11
subscales however it does not seem likely that these 3 subscales were derived
through factor analysis, instead it seems they were based on a previous theory put
forward by Orford et al (1998). Due to the small sample size (N=29) and the fact that
the self-efficacy scale devised by Hurcom et al has not been adequately validated,
the results must be considered as purely preliminary. The authors did stress however
that they found it extremely difficult to recruit partners for this study despite using a
drug and alcohol treatment service to recruit subjects. They blame this difficulty in
recruiting suitable subjects on the shame and stigma partners of drug and alcohol
users face. The scale itself appears problematic as it does not provide a measure of
the strength of confidence, instead it assesses degree of agreement with a
statement. Further research needs to be conducted using this scale as it has not to
my knowledge been used in any other published research.
Despite the paucity of validated measures of partner coping self-efficacy in the field
of addictions, limited research has been conducted in partners of patients with
chronic medical illnesses (E.g. Freund et al., 2013), such as dementia (E.g.
Mackenzie & Peragine, 2003 ; Rabinowitz et al., 2007 ; Steffen et al., 2002 ; Zeiss et
al., 1999), partners of patients with cancer (E.g. Ugalde, Krishnasamy & Schofield,
2013), partners of patients with chronic pain (E.g. Rejeski et al., 1996), partners of
patients with heart disease (E.g. Schroder, Schwarzer & Endler, 1997) and parents of
pediatric palliative care patients (E.g. Bingen, Kupst & Himelstein, 2011). Such
research has focused on the cognitive appraisal processes of partners and whether
this can predict psychological distress. Generally, such research has found that
partners low in coping self-efficacy often report feeling depressed, anxious, angry,
and have difficulties motivating themselves to deal with challenging care-giving
behaviors. Partners who are low in coping self-efficacy tend to focus on the negative
aspects of coping when faced with demanding situations and thus fail to use effective
coping strategies. It is unclear whether this failure to use effective coping strategies is
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a result of feeling depressed & hopeless or vice versa. Furthermore, such research
has generally found that if the partner is low in self-efficacy it can have a detrimental
impact on the patient’s general functioning as well as the partner’s general
functioning. Research has found that positive partner self-efficacy can improve one’s
chance of recovering from chronic illnesses such as heart disease (Schroder et
al.,1997).
One well-validated partner self-efficacy scale with excellent psychometric properties
is that developed by Steffen and her colleagues (2002) to examine the coping self-
efficacy of partners of patients with dementia. The Revised Scale for Caregiving Self-
Efficacy is a fifteen item scale assessing confidence in a variety of challenging
caregiving situations which asks partners of dementia sufferers to rate their
confidence in being able to deal with these challenging situations on a scale of 0%
(“cannot do at all”) to 100% (“certain can do”) in 10% increments. For instance one
item of Steffen et al’s scale states : “When your partner asks you 4 times in the first
one hour after lunch when lunch is, can you answer him/her without raising your
voice?”. The main strength of this scale is its ability to measure care giving
competence across a wide range of areas of patient functioning as opposed to a
global measure of perceived competence which is often the case when assessing
partner coping self-efficacy. The authors of this scale hypothesized that there are
three main care giving domains, namely, 1. partner self-care and obtaining respite, 2.
responding to disruptive patient behaviors and 3. controlling upsetting thoughts
activated by care giving activities. The scale devised by Steffen et al (2002) appears
to have adequate psychometric properties and has been validated on relatively large
samples (Gilliam & Steffen, 2006). The main criticism of this self-report scale is that a
large number of subjects reported difficulties following the complex instructions. The
authors have subsequently recommended that the scale be administered in an
interview format rather than as a self-report instrument.
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Unfortunately most of the published partner coping self-efficacy scales have been
plagued with methodological flaws and scale construction problems, such as item-
response formats which are less than ideal. The main problem with the already
limited number of published partner coping self-efficacy scales is that they tend to
assess global self-efficacy beliefs as opposed to specific coping beliefs.
The first published study to examine caregiver coping self-efficacy was conducted by
Zeiss, Gallagher-Thompson, Lovett, Rose & McKibbin (1999). Zeiss and her
colleagues developed two caregiver coping self-efficacy scales for carers of
cognitively impaired and/or frail elderly patients. Their pioneering work in the
partner/carer self-efficacy field led to the development of two self-efficacy scales, one
of which consisted of 10 items assessing confidence on a scale from 0% to 100% in
10% increments on items relating to caregiver self-care, thus named the “Caregiver
Self-Care Self-Efficacy Scale”. Items on this particular scale assessed confidence in
being able to initiate or take part in activities which would reduce stress in the
caregiver, such as making time for one’s own hobbies, getting adequate sleep, and
getting out of the house without the patient. Most of the items centered around
obtaining respite from the patient except for one item which assessed confidence in
taking part in enjoyable activities with the patient. The second scale developed by
Zeiss and her coworkers (1999), the “Problem-Solving Self-Efficacy Scale”, assessed
the care giver’s ability to specify a problem, brainstorm possible solutions, choose a
solution and apply it to deal with the problem. This particular scale consisted of four
items and used an identical response format to that used in the Caregiver Self-Care
Self-Efficacy Scale. Both scales were administered to a sample of 217 mostly female
caregivers, half of which were partners of the patient and the other half of the care
givers were the children of the patient. From this study it appears that the Caregiver
Self-Care Self-Efficacy Scale assessed confidence in the care giver being able to
14
obtain social support whereas the Problem-Solving Self-Efficacy Scale appeared to
assess confidence in applying problem-solving skills. Unfortunately the Problem-
Solving Self-Efficacy Scale did not specify the type of problem participants were to
rate their confidence on which is problematic as participants may have responded to
items on this scale taking into account situations not specific to care giving per se. As
a consequence this particular scale may have been assessing general problem
solving self-efficacy as opposed to care giving problem self-efficacy which is not
ideal.
Kuijer and colleagues (2000) constructed the Partner’s Self-Efficacy in Providing
Support Scale and asked 106 partners to rate their self-efficacy for providing support
to their partner who was suffering from various forms of cancer on a self-report
measure. Partners were asked to rate how strongly they agreed with 11 coping
statements, such as “I feel powerless because I can’t do much for my partner”, on a
four point Likert-type scale. Kuijer et al (2000) found that partners high in self-efficacy
for providing support were more likely to report using more effective coping
behaviours, such as active engagement, which was also confirmed by the patient. It
was also found that patients whose partners were high in self-efficacy were less
distressed and reported greater improvements in their relationship since being
diagnosed with cancer. Partner coping self-efficacy did not however appear to impact
on the patient’s prognosis or illness characteristics. The main problem with Kuijer’s
partner coping self-efficacy scale is that it does not appear to measure self-efficacy
per se. Instead it appears to assess global beliefs and fails to assess coping self-
efficacy in a variety of different problematic situations specific to caregiving.
Furthermore the items on the scale are rather negatively loaded and self-efficacy
should instead be assessed on a percentage scale rather than a Likert-type scale as
recommended by Bandura (2005). Also problematic is the fact that this scale was not
subjected to factor analysis.
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Schroder, Schwarzer and Endler (1997) found that partner’s perceived self-efficacy
from the 10 item Generalized Self-Efficacy Scale could predict recovery from cardiac
surgery better than patient characteristics up to 6 months following surgery. The
researchers have proposed a “resource transfer hypothesis” to explain their findings
which states that the partner influences the patient whereby his/her strength is
transferred through social interaction in that the partner acts as a coping model for
the patient. More specifically, if the patient’s partner is optimistic the patient will in
turn feel confident and cope in an adaptive way with their rehabilitation. Bandura
(1997) has explained this phenomenon by suggesting that a partner’s
encouragement and ongoing support can influence the patient’s self-efficacy
resulting in better health outcomes for the patient. Schroder et al (1997) used the
Generalized Self-Efficacy Scale which appeared to assess partner self-efficacy along
a global personality /dispositional dimension rather than assessing situation-specific
self-efficacy which is highly problematic. For instance one item from this scale was  “I
can always manage to solve difficult problems if I try hard enough” which appears to
assess dispositional optimism rather than coping self-efficacy.
Rohrbaugh et al (2004) examined self-efficacy in 191 heart failure patients and their
partners and assessed patient survival rates over 4 years. Self-efficacy was
assessed by asking partners and patients how confident they were on a scale from 1
(“not at all confident”) to 10 (“completely confident”) in being able to deal with 11
specific challenging situations associated with managing congestive heart failure,
such as medication compliance, managing strong emotions and adhering to dietary
restrictions. The researchers found that when the partner and patient’s self-efficacy
scores were combined their total self-efficacy score significantly predicted patient
survival in that greater combined self-efficacy scores (that is greater confidence)
increased the patent’s chance of survival 4 years following heart failure. Surprisingly
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when partner and patient self-efficacy scores were assessed separately only partner
self-efficacy was able to predict patient survival. Rohrbaugh and his colleagues
(2004) concluded from these findings that partner coping self-efficacy is a risk-
protective factor for long-term survival from heart failure.
Ugalde, Krishnasamy & Schofield (2013) developed a 21 item Caregiver Self-Efficacy
Scale to assess self-efficacy in care givers of people with advanced cancer. Carers
were required to rate how they feel right now and rate their responses on a 4 point
scale (“not at all confident”, “a little confident”, “quite confident”, and “very confident”).
The scale was administered to a sample of 94 care givers, of which 75% were the
partners of the patient. Factor analysis of the scale produced evidence of 4 distinct
factors  which accounted for 69% of the total variance. The factors were:
1. “Resilience” - e.g. “I can continue to provide care when I feel angry”.
2. “Self-Maintenance” – e.g. “I have some time to myself”.
3. “Emotional Connectivity” – e.g. “I know my care giving is making a difference”.
4. “Instrumental Care giving” – e.g. “Assist the person I care for with everyday
activities”.
The scale had excellent psychometric properties however there are a number of
limitations of Ugalde and her colleague’s (2013) study including the small sample
size and the fact that the factor structure needs to be confirmed using a larger
sample of carers. Furthermore the response format of the scale items is not in the
format recommended by Bandura (2005) for self-efficacy scales. Also problematic is
the fact that some of the items on the scale appeared to be assessing global
constructs rather than self-efficacy for specific challenging care giving situations. For
instance, “I can be positive when I need to be” and “I can be my own person” do not
relate to care giving per se and appear to be assessing global personality constructs
instead.
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Clinical Application of Partner Coping Self-Efficacy : Partner Coping Skills
Training
Partners play a significant role in not only encouraging their partner to seek help for
their drug or alcohol problem but in actively helping them to change their substance
use problem. Partners can also assist their partner by helping them manage lapses
and relapses and maintaining their treatment goals over time. It has been well
documented that partners experience a great deal of stress as a result of living with a
drug and alcohol user (E.g. Rognmo et al., 2013). Despite this relatively few partners
actually seek treatment for themselves due to a number of possible barriers, such as
stigma, embarrassment, fear of their partner’s reaction, cost of treatment, and the
competing work or childcare demands that this largely female population are faced
with. Fortunately the rising popularity of internet-based treatments for a variety of
conditions including drug and alcohol problems has helped improve access to
treatment. One would hope that future work will focus on delivery of internet-based
treatments for partners of drug and alcohol users.
Treatments for partners of drug and alcohol users in the 1970s until the late 1980s
tended to focus on the “family disease” model of addiction and thus consisted
primarily of family therapy with partners. The popularity of this model faded due to the
lack of empirical support for this model and the absence of standardized controlled
trials examining the efficacy of family therapy for partners of drug and alcohol users.
More recently the Stress-Strain-Coping-Support (SSCS) model originally proposed
by Orford (1987) has taken over in popularity. The SSCS model states that the drug
and alcohol user’s behaviour causes stress and strain in the family, such as physical
and psychological discomfort, and the level of stress and strain experienced is
mediated by how the family member copes and the type and quantity of social
support the family member receives.
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For those partners able to access treatment it is expected that information obtained
from assessing partner coping self-efficacy will provide valuable information on the
relative strengths and skill deficits of partners of substance users which may assist in
future treatment planning. Self-efficacy theory implies that those partners who are
low in care giving self-efficacy can achieve personal mastery of specific care giving
skills through psycho-educational strategies such as coping skills training. Therefore
partners can be taught effective coping skills which in turn will result in improved
partner functioning and consequently result in reductions in the patient’s drug and
alcohol use. Treatments vary in terms of their focus with some treatments teaching
the partner how to change the patient’s drug and alcohol use behaviour whereas
others solely focus on the partner’s well-being without involving the patient directly in
treatment (E.g. Al Anon). Coping skills training (CST) focuses on introducing the
stress and coping model to the partner, explaining the relationship between thoughts,
feelings and behaviour, and finally introducing the problem-solving approach and
applying this to high risk situations where the patient is likely to use drugs or drink. It
is the therapist’s role to teach the partner specific skills to cope in high risk situations
and this is best achieved through modeling of effective responses through role-play
and regular feedback and monitoring of the use of such skills through guided
homework tasks.
A review of 38 controlled studies conducted prior to 2002 by O’Farrell and Fals-
Stewart (2003) found that CST as part of couples treatment is more effective than
individual treatment alone in increasing the chance of abstinence and improving the
partner-patient relationship. This review also found that patients who were not ready
to seek treatment for their substance use problem actually achieved a better patient
outcome when their partner attended Al-Anon instead of CST. A more recent review
of the treatment outcome literature from the years 2002 to 2010 by O’Farrell and
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Clements (2012) provides further support for CST. More specifically this review found
that CST resulted not only in improvements in the patient’s drinking but the partner’s
functioning and relationship quality, regardless of the patient’s readiness to change
or the patient’s attendance to treatment.
Similar support for CST has been found from recent studies treating partners in
same-sex gay or lesbian relationships where one partner has a drinking problem
(Fals-Stewart, O’Farrell & Lam, 2009). Pioneering work examining the outcome of
CST on the children of alcoholic fathers by Kelley & Fals-Stewart (2002) found that
the children of fathers undergoing behavioural couples therapy functioned better
post-treatment when compared to controls. Furthermore the children displayed fewer
clinical impairments without themselves being treated directly or being actively
involved in treatment.
Despite the general support for the efficacy of CST there have been some mixed
results obtained in the literature. For instance, Halford, Price, Kelly, Bouma & Young
(2001) randomly assigned 61 female partners of heavy drinkers not currently in
treatment to supportive counseling, stress management or alcohol-focused couples
therapy with stress management. Unfortunately Halford et al (2001) failed to find
significant improvements in the patient’s drinking or the couple’s relationship as a
result of any of the three treatments. The lack of significant findings may be due to
the small sample size and other methodological problems, such as the fact that not
all of the patients attended couples therapy.
A similar lack of significant effect of CST on patient drinking was found when
comparing  group-delivered CST with Al-Anon and waiting list controls by Rychtarik &
McGillicuddy (2005) in 171 female partners of untreated alcoholics. However, CST
and Al-Anon both resulted in equally reduced levels of depression in partners post-
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treatment compared to waiting list controls. CST was however superior to all other
treatments in terms of reducing the incidence of self-reported partner violence given
that one part of the CST focused on teaching partner’s specific skills to deal with
alcohol-related domestic violence.
Copello and his colleagues (2009) trained primary health care workers such as
general practitioners and compared training in the delivery of brief intervention versus
full intervention (5 face to face sessions) for partners of heavy drinkers who refused
to change their drinking behaviour. Copello et al (2009) failed to find the full
intervention to be more effective than the brief intervention in altering partner’s
coping behaviours or the partner’s symptoms, as assessed by the Symptom Rating
Test. This finding suggests that briefer forms of intervention for partners may be
more cost-effective in a population where the drinker resists treatment.
A recent review of the literature examining treatment for families of alcoholics has
stressed that the field is still in its infancy and is plagued by a lack of adequate
randomized controlled trials with a strong tendency for treatments to focus more on
the person with the alcohol problem than the partner and family (Templeton,
Velleman & Russell, 2010).
Partner Support
In addition to self efficacy, another factor which can influence alcohol or substance
use behaviour in the patient is support from their partner. Although a great deal of
work has examined the relationship between partner support and its impact on drug
and alcohol use in the patient, the relationship between partner support and partner
self-efficacy is yet to be examined. The present study will be the first to examine the
impact, if any, that both partner support and partner self-efficacy have on treatment
outcome in patients. One might expect to see a relationship between partner support
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and partner self-efficacy despite the lack of research conducted in this particular
area. According to social learning theory one would expect to see a relationship
between the level of support offered by the partner and the patient’s subsequent drug
and alcohol use behaviour. It is expected that partner behaviours which reinforce
abstinence or continued substance use will influence future abstinence or continued
substance use. An alternative though equally accepted model is the stress buffering
hypothesis (Cobb, 1976) which states that support from one’s partner protects
patients from the potentially adverse effects and stress of attempting to change one’s
substance use behaviour. Furthermore, the more frequent social contact one has, the
fewer symptoms of distress they display and the greater their ability to cope with
stress (Cobb, 1976). The presence of effective social support is likely to assist the
patient with meeting their goals by providing support to deal with stressful events
which may lead to relapse.
Research has shown that the more social support patients receive the less likely they
are to relapse and the more likely they are to achieve their goals in a shorter period
of time (E.g. Nattala et al., 2010 ; Sobell, Sobell, Toneatto & Leo, 1993). Research
has found that just having a partner helps lessen the chance of relapsing in that
patents with partners are less likely to relapse than those who are single (E.g.
Cronkite & Moos, 1984 ; Havassy, Hall & Wasserman, 1991). Sobell et al (1993)
asked 120 subjects what they believed helped them to avoid relapsing back to heavy
alcohol use. Spousal support was reported by the greatest number of subjects as
having helped them to remain abstinent from alcohol without treatment. Billings and
Moos (1983) examined 113 alcoholics and their families 2 years following treatment
and compared them to a community-matched control group. Patients who had
relapsed at the 2 year follow-up period reported significantly less positive social
support and less family cohesion in comparison to patients who had remained
abstinent. Those who had remained abstinent following treatment reported levels of
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social and family support which were comparable to that of the control group. Similar
results were obtained by Klingemann (1991) in a sample of 60 Swiss substance
users who had not received formal treatment.
Global support has been found to be quite distinct from alcohol-specific support
(Love et al., 1993). Love and his colleagues (1993) reviewed a modified version of
the Significant-Other Behaviour Questionnaire (SBQ) originally devised by Orford et
al (1975). The SBQ is unique in that it measures alcohol-specific support from the
perspective of both the patient and the partner which has obvious clinical
advantages. Research by Love and his colleagues (1993) found that alcohol-specific
support, as assessed by the SBQ, is only slightly correlated with global support which
suggests that it may be quite distinct from it. The SBQ needs to be researched
further as there is no information available on the scale’s predictive validity and the
internal consistency for one of the four factors of the scale is rather low (coefficient
alpha=0.54). Furthermore the factor structure of the SBQ needs to be confirmed in a
larger sample. Also the length of the SBQ (62 items for each version) may deter
clinicians from using the scale given the time taken to administer and score it. The
results from the SBQ may not apply to partners per se given that the study included a
large number of significant others who were not partners.
The relationship between the person giving the support and the recipient has also
been shown to influence how effective the support is in producing change (Billings &
Moos, 1982). The patient’s perspective of how “supportive” the type of support being
provided by the partner is also of importance given that at times patients may not
classify certain types of support as helpful (Love et al., 1993). For instance, a partner
may restrict the patient’s access to money in order to assist the patient with
abstaining from alcohol. However the patient may not perceive this to be helpful.
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Instead, the patient may feel angry and resent this level of unnecessary control which
could in turn increase his/her drinking rather than promoting abstinence.
It appears that the type of substance the patient is dependent on also influences to
what extent they attribute partner support to their abstinence. A study by Best et al
(2010) found that patients who had been abstinent for approximately 10 years from
alcohol were more likely to attribute their lengthy abstinence to their partner’s support
compared to heroin users who had been abstinent for 10 years or those previously
addicted to both heroin and alcohol. The partner’s gender has also been found to
play a role in partner support and the amount of pressure they place on the patient to
change their drinking behaviour (Raitasalo & Holmila, 2005). Male partners tend to
place less pressure on their female patients to change than female partners of male
patients do after controlling for drinking level (Raitasalo & Holmila, 2005).
It has been found that the quality of support provided by the partner is more
important than the quantity of support received. Much research has been conducted
on “Expressed Emotion” (EE) in families of patients with schizophrenia, bipolar
disorder and depression. Research in this field has generally found that patients are
more likely to relapse if their partners or families are high in EE (E.g. Butzlaff &
Hooley, 1998). High EE families or partners tend to be highly critical of the patient
and frequently express negative emotions towards them, such as hostility and
emotional over-involvement.
Given the previous findings from research conducted on EE in mental health one
would expect that drug and alcohol patients are more likely to relapse if their partners
are high in EE. To date only two published studies have been conducted examining
EE in partners of substance users. O’Farrell, Hooley, Fals-Stewart & Cutter (1998)
examined EE in spouses of 86 alcoholic patients using the Camberwell Family
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Interview and found that patients with partners high in EE were more likely to relapse
in the first 12 months following behavioral marital treatment compared to patients
with low EE partners. Furthermore, patients with high EE partners were found to be
more likely to relapse sooner and to drink more during their relapse following
treatment. The results are consistent with those which were found by Fichter et al
(1997). The results from O’Farrell et al’s (1998) study should be interpreted with
caution as the sample may be biased as it consisted of patients and their partners
who were actively seeking treatment in order to improve their relationship and to
assist the patient in achieving abstinence. Furthermore, the Camberwell Family
Interview was administered prior to commencement of behavioral marital therapy.
Given that most behavioral marital therapy programs include teaching the partner
strategies to minimize hostility and criticism towards the patient, this may have
influenced the strength of the association between EE and relapse. Biases in the
sample could have been minimized if EE was assessed following completion of
behavioral marital therapy or in a sample not currently seeking treatment. The
presence of comorbid psychiatric illness was not assessed by the investigators,
which also may have influenced the findings. In addition, the conclusion that high EE
leads to relapse was based on relatively weak correlational data (r=0.36).
Although EE appears to be an important construct to measure when assessing
partner support, most researchers have avoided assessing EE due to the cost and
time required to assess it (i.e. 1-2 hours to complete the Camberwell Family
Interview). Perceived criticism (PC) has been found to be a cheaper and less time
consuming alternative to measuring EE. Perceived criticism has typically been
assessed by asking patients how critical they perceive their partner to be on a Likert-
type scale. Early work on PC was conducted in the field of depression, with most
research showing that PC was predictive of relapse to depression (E.g. Riso, Klein,
Anderson, Ouimette & Lizardi, 1996). One such study found that PC accounted for
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more variance in relapse rates than EE, as measured by the Camberwell Family
Interview, in depressed patients (Hooley & Teasdale, 1989). Unfortunately the data
on PC is limited and it is not exactly clear how PC is related to EE.
Maisto, McKay & O’Farrell (1995) found that perceived criticism from one’s partner
was found to significantly contribute to relapse in a group of 74 male alcoholics. Forty
percent of subjects attributed their relapse to their partner compared to other possible
relapse precipitants such as mood states or the presence of alcohol. Furthermore
half of all subjects attributed their reasons for terminating relapses to marital or family
problems. The main problem with this particular study is that PC from one’s partner
was measured using a single item. A more thorough measure of PC, possibly
assessing PC in a variety of situations or circumstances may have provided a more
accurate measure of PC.
Similarly, Fals-Stewart, O’Farrell & Hooley (2001) assessed PC in a sample of 106
substance abusers and their partners and found that PC predicted relapse even after
controlling for other variables, such as relationship satisfaction and substance use
severity. The results from this study should be interpreted with caution as there are a
number of methodological flaws with the study. Firstly, as with all available research
on PC, only a single item was used to assess PC. As a consequence the results
cannot be readily generalized to the general substance-using population.
Furthermore, not all patients were living with their partner (e.g. some were living with
their parents), which may have confounded the results obtained. The generalizability
of the results is limited due to the fact that the sample consisted of only male patients
who voluntarily sought treatment for their substance use.
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An 8 year American study which was funded $27 million by the National Institute on
Alcohol Abuse and Alcoholism (Project MATCH) was conducted in order to
determine which type of drinker responds best to which form of treatment. Three
treatment types were evaluated : cognitive-behavioural coping skills treatment,
motivational enhancement treatment, and 12 Step Alcoholics Anonymous meetings.
Results from the Project MATCH study revealed that clients who reported that the
main factor attributing to their relapse was “family” tended to have more severe
relapses compared to those whose relapses were triggered by social pressures to
drink or cravings or alcohol cues (Zywiak et al., 2006).
There is a paucity of standardized measures which assess support in substance
abusers and those few scales which are available tend to have poor psychometric
properties. The conceptual vagueness of the topic of ‘partner support’ and how it is
measured continue to plague the literature. Although there is research examining
support received by patients very little research has examined the level of support
received by the partner caring for the substance user. Only recently has a scale been
developed which assesses perceived support from the perspective of the partner or
family member of the drug and alcohol patient. More specifically, Toner and
Velleman (2014) have devised a 25 item scale which assesses the quality of support
the partner/family member receives when coping with their partner or family
member’s drug and alcohol use problem. The scale appears to examine three
support types : positively perceived functional support received by the partner/family
member from their support network, negatively perceived addiction-specific support
provided by the support network to the partner as well as the patient, and finally
positively perceived addiction-specific support provided by the support network to the
partner and the patient. Although the results are promising this field is still in its
infancy and more work needs to be conducted examining support in partners.
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Partner Coping Style
Although there is an absence of research examining partner coping self-efficacy in
the addictions field some advances have been made in the literature examining
coping styles used by partners of drug and alcohol users. Early research in this field
in the 1950s and 1960s concluded that partners of substance abusers tended to
have “dysfunctional personalities” and this contributed to the patient’s poor
prognosis. Similar research that followed in the 1960s and 1970s concluded that the
partner was “codependent” suggesting that there were deficiencies in the partner
which contributed to or directly caused the patient’s drug or alcohol problem. There is
no definitive evidence to suggest that a partner’s personality or behaviour can cause
a substance use problem or lead to relapse. More recent research has focused
instead on stress and coping in the partner rather than blaming the partner.
Examination of the coping styles used by partners has important implications for
treatment. More specifically, training partners in the use of effective coping strategies
is likely to improve the patient’s outcome and minimise to some extent the distress
associated with caring for a partner with an addiction.
Partners providing support to patients with substance abuse problems are faced with
a number of stressful demands. The commitment of caring for a partner with a
substance use problem often takes its toll on the partner’s emotional well-being. Most
partners of patients abusing substances report feeling anxious, fearful, hopeless and
depressed (E.g. Kishor, Pandit & Raguram 2013 ; Rognmo, Torvik, Roysamb &
Tambs, 2013 ; Tempier et al., 2006). Furthermore, partners of substance abusers are
more likely to experience relationship problems, are more likely to be separated or
divorced and are more likely to experience domestic violence (Copello, Templeton &
Powell, 2010). Women with a substance abusing partner have been found to have
severely compromised social adjustment compared to women without a substance
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abusing partner (Hudson et al., 2014). Such reported symptoms associated with
coping would in turn compromise the quality of care provided to the patient.
Coping has been conceptualised as a cognitive and behavioural response which
aims to minimise, tolerate or master external and internal demands (E.g. Lazarus &
Folkman, 1984). Coping can help prevent a stressful situation and can also be
implemented to manage the stress symptoms associated with a situation. According
to Lazarus & Folkman (1984) coping is fluid in that it changes over time and coping
influences neurochemical stress responses, such as immune system functioning.
Lazarus and Folkman developed the Ways of Coping Questionnaire (WOCQ) which
is based upon Lazarus’s transactional theory of stress and coping (Lazarus &
Folkman, 1984). Lazarus & Folkman have conducted a great deal of research in this
area and they have identified “Problem-Focused Coping” and “Emotion-Focused
Coping” as the two main means of coping with a stressor. Emotion-Focused Coping,
such as denial or avoidance, prevents the person from finding solutions to the
problem and is thus an ineffective way of dealing with the problem. Emotion-Focused
Coping involves the person putting effort into regulating emotional distress for
instance by using avoidance, drug and alcohol use, or venting anger. Some of these
Emotion-Focused Coping strategies actually increase distress levels. Problem-
Focused Coping involves the person defining the problem, generating and
implementing potential solutions to the problem. Which of the two coping types is
used depends on the type of stressful situation the person is confronted with.
Emotion-Focused Coping is typically implemented in situations where one has less
control over the stressor e.g. in a terrorist attack. Conversely, Problem-Focused
Coping tends to be used in situations perceived to be controllable e.g. work problem.
Problem-Focused Coping is more effective when the person has a realistic chance of
changing the stressor.
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 A large body of work on coping in the addictions field has focused on the patient’s
coping rather than the partner’s coping. A common finding is that problem drinkers
tend to use more avoidant coping, a component of Emotion-Focused Coping, when
compared to non-problem drinkers (E.g. Moos et al., 1990). Garrity et al (2006)
administered the WOCQ to 500 clients of the Kentucky Drug Court Program and
examined correlates of subjective stress in this population. Garrity et al (2006) found
that escape avoidant coping, a component of Emotion-Focused Coping, was
associated with greater reported levels of stress whereas patients using Problem-
Focused Coping strategies reported less stress. During a 28 day inpatient treatment
program for alcoholism, patients reported decreased use of avoidant coping in
response to stressful situations (Finney et al., 1998). However, a study by Moos,
Finney & Chan (1981) found that even when in remission 2 years post-treatment,
alcoholic patients still displayed greater use of avoidant coping compared to controls
and reliance on avoidant coping was associated with greater levels of depression
and lower self-confidence in patients. Simons et al (2003) assessed 112 females
receiving inpatient and outpatient treatment and found that those patients with a
history of emotional abuse were more likely to engage in avoidant coping, as
assessed by the Ways of Coping Questionnaire, than those patients without a history
of abuse. The researchers concluded that alcohol and drug abuse is one form of
emotion-focused coping used to avoid thoughts associated with past traumatic
experiences. Tapert et al (2004) assessed 43 male veterans hospitalised for alcohol
treatment and made the unexpected finding that Problem-Focused Coping was
significantly positively related to drinking outcome 12 months post-treatment, in that
patients reporting using problem-focused coping were more likely to have relapsed
following treatment. These unexpected results may be due to the unique nature of
the population being examined.
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Although the WOCQ is yet to be examined in partner’s of drug and alcohol users, a
study of the partners of women with breast cancer has found that Emotion-Focused
Coping in husbands of patients is associated with more patient distress and poorer
quality of life in both partners and patients (Ben-Zur, Gilbar & Lev, 2001; Wagner et
al., 2006). Furthermore, husbands of breast cancer patients are less likely to use
Problem-Focused Coping strategies when compared to partners of women without
cancer (Wagner et al., 2006). In a study of carers of patients with Alzheimer’s
disease the use of Emotion-Focused Coping strategies in carers was positively
associated with symptoms of depression (Mausbach et al., 2006).
Although the theory behind the WOCQ is not specific to partners of patients with a
drug or alcohol problem, work conducted by Orford identified eight key coping styles
which apparently are specific to partners of drug and alcohol users. The eight coping
styles identified are : controlling, emotional, avoidance (withdrawal), inaction,
tolerance, support for the user/drinker, confrontation (assertion), and independence
(Orford et al., 1992; Velleman & Orford, 1993). Orford based his theory of 8 coping
styles solely from qualitative data, usually obtained from open-ended interviews with
partners of patients which is problematic. Orford later concluded that partners of drug
and alcohol users would very rarely fit neatly into one of the typology of eight coping
styles which he originally proposed, with overlap between the styles more common
than not (Orford et al.,1992). Later research revealed little evidence in support of
Orford’s original eight styles of coping (Orford et al., 1998). Orford and his colleagues
(1998) concluded that there are instead three main coping styles: engagement,
tolerance and withdrawal. Orford and his colleagues have defined engagement as
the use of supportive and assertive strategies. Tolerance has been defined by Orford
et al as inaction, self-sacrifice and acceptance. Withdrawal has been described as
ignoring the problem, using distraction and independent action. Researchers are still
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rather undecided about which form of coping is desirable and likely to lead to a better
patient outcome.
Orford devised the Coping Questionnaire which is a 68 item self-report instrument
assessing coping styles in partners of drinkers by asking the partners to rate how
often in the last three months they used a particular style of coping (Orford et
al.,1998). A briefer 30 item version of this scale was later devised which assessed
the frequency of each of the proposed three coping behaviours in the previous 3
months. Participants are required to rate if and how often they have used certain
coping behaviours on a scale from “No” (scored 0) to “Often” (scored 3). Partner
coping style, as assessed by a short version of the original Coping Questionnaire,
has been found to be influenced by the duration of coping with the partner’s
substance use problem, degree of hardship caused and the amount of available
support the partner has access to (Hurcom et al., 1999). Results from research
conducted using the Coping Questionnaire has found that engaged and tolerant
coping in partners is unhelpful and less coping of all types is linked with poor health
in family members (Orford et al., 2005). However more research needs to be
conducted using the Coping Questionnaire given the failure to replicate the original
factor structure of the scale and its inadequate reliability data (Orford et al., 1998).
Another instrument used to specifically assess partner coping style in partners of
alcoholics is the Spouse Situation Inventory (SSI;  Rychtarik, Carstensen, Alford,
Schlundt & Scott, 1988). The SSI asks partners of alcoholics to report how they
would react in 48 typical problem situations as described in case vignettes in a self-
report questionnaire. Partners are required to write down exactly how they would
deal with the problem if it happened today. For instance, one of the items on the SSI
asks partners to describe what they would do if their partner passes out at the dinner
table in front of family. The main problem with such a scale is it is difficult to score the
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data from open-ended questions and scoring is estimated to take 50 minutes alone.
Give that the scale takes 40 minutes to administer to each participant and a further
50 minutes is needed to score each participant’s responses, this may deter clinicians
and researchers from actually using this scale. Furthermore, the scale requires
partners to have adequate written communication skills. The SSI’s full psychometric
properties such as its factor structure have not been examined. In addition to this,
further work needs to be conducted on the scale’s external validity as it is not clear if
scores on the scale are reflective of actual coping behaviour used in one’s natural
environment.
A number of older studies have assessed coping style in partners of drug and alcohol
users without using standardized scales. Schaffer & Tyler (1979) examined the
coping styles of wives of alcoholics and found that non-threatening criticism from
wives decreased one’s chance of relapse. Similarly, perceived criticism from partners
of substance abusing patients has been found to significantly contribute to relapse
(Fals-Stewart, O’Farrell & Hooley, 2001). Orford & his colleagues (1975) found that
patients whose partner displayed avoidance when coping with their partner’s drinking
had a poorer prognosis. Billings & Moos (1983) found that those partners of alcohol
users reporting using problem-solving techniques and who were also less reliant on
avoidance coping strategies tended to report fewer symptoms of distress and had
higher self-esteem and their partners were more likely to maintain post-treatment
gains.
Jung (1986) found that most significant others of problem drinkers tended to ignore
the patient’s drinking problem or talk to others about the problem. Other commonly
reported coping responses were criticizing and confronting the drinker. The least
frequently used coping strategies were to seek counselling and withdrawing from the
drinker. The research was based on a sample of 100 college students who were
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asked open-ended questions about how they felt about their significant other’s
drinking and how they coped with their drinking in a survey-format. However, the
results of this study may not be generalizable to partners of problem drinkers given
that none of the 100 subjects identified their partner as the “significant other”.
Furthermore it is not clear if the subjects were in fact in a close relationship with or
even residing with their identified problem drinker. The vast majority of subjects who
were identified as “significant others” were in fact friends of the subject or the child of
a drinking parent.
The identification of maladaptive coping styles in the partners of drinkers has
important implications for treatment. It has been found that use of coping strategies
that are of benefit to the patient increases the patient’s chances of recovering
naturally without requiring treatment (Sobell et al.,1993). Furthermore, the use of
such adaptive coping strategies by partners leads to better patient outcomes in that
the patient is less likely to relapse (Fals-Stewart et al., 2001). In addition to this it
appears that use of adaptive coping styles improves the partner’s functioning and
reported level of life satisfaction (Orford et al., 1998). Overall, the research conducted
on coping styles of partners of drug and alcohol patients is consistent with the
findings obtained by research examining how partners cope with other disorders,
such as dementia and other chronic medical conditions (E.g. Matson, 1994 ; Rivera,
Rose, Futterman, Lovett & Gallagher-Thompson, 1991).
Purpose of this Study and Research Questions
The primary purpose of this study was to develop and validate a scale which
assesses partner coping self-efficacy in partners of people with a drug or alcohol
problem (The Partner Coping Self-Efficacy Scale, PCSES). Given that there are
approximately one million partners of people with a drug and alcohol problem in
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Australia alone it was considered necessary to devise a scale to assess their
confidence in being able to assist their partner in a variety of challenging situations.
Given the absence of such an important scale in the addictions field it was
considered to be potentially useful in treatment planning and in better understanding
the role of the partner. Although some research has been conducted on the self-
efficacy and coping in patients with a drug or alcohol use problem, almost none has
been conducted on the partners of the patients. A number of coping self-efficacy
scales have been developed for partners of patients with other conditions, such as
dementia and cancer, though to date none exist for partners of drug and alcohol
patients.
The present study will also examine the role of perceived partner support and its
relationship with partner coping self-efficacy and patient relapse. Furthermore, coping
style used by partners to manage the stress associated with having a substance
misusing partner will also be examined. This will be the first study to examine coping
style in partners of drug and alcohol patients using the Ways of Coping
Questionnaire.
The following research questions are being addressed in the present study :
1. What is the underlying factor structure of the PCSES?
2. Is the PCSES assessing confidence ratings which are related to measures on
other constructs?
3. Can the PCSES predict relapse in patients following treatment?
4. Is the PCSES a valid instrument with adequate internal consistency?
5. Can the original factor structure of the PCSES be replicated in a different
sample of partners of drug and alcohol users?
The first four research questions will be addressed in Study 1. Study 2 will address
research question 5.
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Study 1 Methodology
Study 1 Design
The study design included both a qualitative and quantitative methodology.
Qualitative data were gathered through feedback from an expert review panel and
from individual focus sessions with partners of substance users in order to assist with
item review and review of the draft scale. Quantitative data were obtained from the
administration of the PCSES to a sample of 83 partners of patients.
The study was completed in three separate phases. Phase 1 consisted of concept
clarification and item generation for the PCSES. The time taken to complete Phase 1
was approximately 6 months. Phase 2 consisted of a review of the PCSES by an
expert panel and pilot testing of the PCSES. Phase 2 took approximately 6 months to
complete. Phase 3 consisted of obtaining ethical approval from the Western Sydney
Area Health Service (WSAHS) Ethics Committee and the Sydney University Ethics
Committee and administering the scale to a sample of 83 subjects from the WSAHS
Drug & Alcohol Service. Ethical approval alone took 8 months to be obtained from
both ethics committees. Following receiving ethical clearance the researcher
collected data from the WSAHS Drug & Alcohol Service for a period of approximately
2 years.
Hypotheses
The primary purpose of this study was to devise and determine the psychometric
properties of  a scale for assessing partner coping self-efficacy in partners of people
with drug or alcohol problems. Overall it was expected that the PCSES would display
adequate psychometric properties as assessed by the following hypotheses :
1. Expect the scale to have acceptable and clear factor structure.
36
2. Expect the scale to have adequate test-retest reliability and internal
consistency.
3. Expect the scale to have adequate face validity and construct validity. A
number of predictions about the relationship between partner coping self-
efficacy and psychosocial factors can be made :
(a) Expect to see a positive relationship between partner coping self-efficacy (as
assessed by the PCSES) and general positive coping strategies (Problem-
Focused Coping) as assessed by the Ways of Coping Questionnaire.
(b) Expect to see a negative relationship between partner coping self-efficacy (as
assessed by the PCSES) and self-reported anxiety and depression, as
assessed by the Hospital Anxiety & Depression Scale.
(c) Expect to see a positive relationship between partner coping self-efficacy (as
assessed by the PCSES) and patient drug and alcohol self-efficacy.
4. Expect the scale to have adequate predictive validity in that it will be able to
predict relapse in patients 6 months following treatment.
Scale Development Process
Construction of the PCSES was based upon a review of the partner coping literature
in the addictions field and in various health conditions. Unfortunately there are no
published partner coping self-efficacy scales in the addictions field to date. As a
consequence of this lack of empirical data, examination of published and validated
partner coping self-efficacy scales in the fields of cardiology, dementia, cancer care
and palliative care was conducted for identification of common issues and themes
surrounding partner coping self-efficacy. Items on the PCSES were also based upon
a qualitative assessment of challenging behavioural and emotional situations that
partners of drug and alcohol users often find themselves confronted with. More
specifically, a pool of situations commonly encountered by partners of drug and/or
alcohol users was developed after asking partners of patients attending treatment at
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the Western Sydney Area Health Service (WSAHS) Drug & Alcohol Service and from
agreed upon clinical experiences among specialists in the addictions field. Situations
obtained were grouped into a variety of challenging care giving domains including :
the patient lying about their substance use, the patient not taking on their usual
responsibilities (e.g. going to work) due to the effects of their substance use, the
patient embarrassing the patient whilst intoxicated, the patient not being sufficiently
motivated to change their drug and / or alcohol use, and perceived criticism between
the patient and his/her partner. Given one criticism of most self-efficacy scales is that
they often produce ceiling effects due to the items being rated as rather ‘easy’ the
current study wanted to prevent this by selecting items considered most challenging
for partners.
The draft PCSES described common “high risk” coping situations for partners of drug
and/or alcohol users for which participants must assess their coping confidence.
Responses on the PCSES ranged from 0% to 100% confidence in 10% unit
increments, as per Bandura’s (2005) recommendations on response item formats for
self-efficacy scales. Participants were required to rate their confidence “today or right
now” rather than in the future as self-efficacy is not static and also because Bandura
(2005) argues that people tend to be more efficacious and tend to overestimate their
self-efficacy when asked about a situation in the future compared to when asked to
rate a situation right now. In order to enhance the PCSES’s clinical applicability items
on the scale were worded so that responses could be obtained regardless of the
patient’s specific goal, that is abstinence or harm minimisation. Filler items were not
included in the final scale as they would increase the scale’s length unnecessarily
and in turn increase response time and possibly lead to non-completions. When
developing the PCSES the author wanted to create a scale which was short in length
to make administration easier in both a clinical and a research setting. Scales which
are lengthy could reduce the chance of participants completing all items.
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Items on the 26 item draft PCSES were generated based upon the above-mentioned
challenging care giving situations. A panel of experts in the field of drug and alcohol
were then provided with a copy of the draft PCSES to individually review. The panel
consisted of 4 clinical psychologists, 2 medical officers, 1 social worker, 2 drug and
alcohol counsellors and 1 research psychologist. Each panel member had at least 2
years experience working in the addictions field, with the average number of years
work experience being 5 years. The panel of experts reviewed the draft PCSES and
provided feedback on the face validity of the scale, clarity, content validity, wording,
ordering of the items in the scale and the experts were also asked to consider
whether any of the items had any potential to cause distress in participants. The
expert panel also rated items in terms of the frequency of occurrence from their
experience working with partners of substance users. Items which represented
situations which the panel rated as occurring infrequently were removed from the
draft scale. The expert panel recommended that two items from the draft PCSES be
removed due to the fact that they appeared to be measuring the same situation as
another item already on the scale. These two items which were subsequently
removed asked how confident partners were in being able to seek counselling for
themselves and how confident they were in being able to assist their partner if he/she
was not ready to change their alcohol/drug use. The panel also recommended minor
modifications regarding the wording of two items and the order in which some items
should be presented.
The 24 item PCSES was then administered to partners of substance users in
individual focus interviews in order to gather opinions and feedback prior to
administration on a large sample. A total of 8 partners of patients attending treatment
at the WSAHS Drug & Alcohol Service were approached and all agreed to review the
PCSES in an individual session. Individual sessions, as opposed to group focus
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interviews, were conducted as they were considered the safest and most comfortable
situation for partners to openly discuss confidential and sensitive issues pertaining to
their partner’s substance use problem. During the interview the author read aloud
each item whilst the participant followed on their paper and pencil version of the
scale. Participants answered verbally to each item and the author then recorded their
response on a scoring sheet. Participants were then asked if they felt that the
question was an important one to ask partners of substance users and whether they
felt comfortable being asked such a question. After completing all items of the draft
PCSES participants were then asked if any additional items should be included in the
scale which are considered to be important to them in terms of “challenging coping
situations”. Participants were then asked if any of the PCSES items did not apply to
them or whether they found it difficult to put themselves in the situation described in
the PCSES items. Participants were also asked about the length of the scale and the
clarity of the wording of items. Any feedback provided was recorded verbatim by the
author on a scoring sheet. Feedback obtained from the individual focus interviews
supported the face and content validity of the PCSES. Minor grammatical
modifications and one word substitution was made to the draft PCSES based upon
feedback from the individual focus interviews.
In summary, the draft PCSES was piloted on eight partners of substance users
attending treatment and reviewed by a panel of ten experts. The PCSES can be
found in Appendix A.
Ethical Approval & Ethical Issues
The 24 item draft PCSES was then submitted initially to the WSAHS Ethics
Committee followed by the Sydney University Ethics Committee for ethical approval
before being field tested. The WSAHS Ethics Committee stated that it was a
condition of ethical approval that the author ask participants about “willingness” after
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each of the 24 items of the PCSES. The author responded to the WSAHS Ethics
Committee’s concerns and explained to them that “willingness” and “self-efficacy” are
unrelated constructs however the WSAHS Ethics Committee still required the author
to ask about “willingness” after every item of the PCSES. Bandura (2005)
recommends that when one is constructing a self-efficacy scale they should phrase
individual scale items “ in terms of can do, rather than will do”. Bandura (2005) also
states that “Can is a judgment of capability ; will is a statement of intention. Perceived
self-efficacy is a major determinant of intention, but the two constructs are
conceptually and empirically separable” (p. 308). Therefore each of the 24 items was
added to a separate scale, the “willingness PCSES”, which essentially included every
item of the draft PCSES with the word “confident” being replaced with “willing” (e.g.
“How willing are you to assist your partner change their mood when they are feeling
low or depressed?”). No other ethical issues were raised by the two ethics
committees.
Perceived risks to participants from taking part in this study were anticipated to be
minimal. Some of the items and responses from the PCSES may have had the
potential to elicit anxiety in some participants.
Participants were expected to obtain some benefit from participation by increasing
their awareness of their confidence in being able to assist their partner in a variety of
challenging situations. Furthermore, it was anticipated that the findings of the present
study could assist in future treatment planning, particularly if the scale was able to
predict relapse in patients.
The present study did not receive any funding.
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Participant Selection and Recruitment
Participants were recruited from the Western Sydney Area Health Service (WSAHS)
Drug & Alcohol Service which is a government-funded free treatment service for
residents of Western Sydney, New South Wales, Australia. Participants were not
paid to participate nor did they receive any inducements to participate in the study.
All patients referred to the Western Sydney Area Health Service (WSAHS) Drug &
Alcohol Service were first assessed either on the telephone or in a face-to-face
interview by an intake officer. The intake officer asked basic information about
quantity and frequency of their drug and/or alcohol use, obtained demographic
details, and assessed suicide risk. Patients were told that a clinical psychologist from
the WSAHS Drug & Alcohol Psychology Service would contact them for an outpatient
counselling appointment. If from the intake interview the intake officer suspected the
patient may have been at risk of alcohol and/or drug withdrawals and/or they may be
interested in pharmacotherapy to assist them with their treatment goal they were
referred to a medical officer from the WSAHS Drug & Alcohol Service prior to
commencing counselling. All participants were seen by the author in an outpatient
clinic of the WSAHS Drug & Alcohol Service, known as the Centre for Addiction
Medicine, located in the grounds of Cumberland Hospital, North Parramatta, NSW for
a face-to-face interview. Patients who reported being in a relationship at the time of
assessment and who reported that they lived with their partner for at least the last 12
months were then provided with written information about the study (i.e. the
Participant Information Statement and Consent Form – see Appendix B). Patients
were included only if they agreed to their partner filling out questionnaires about their
coping. All patients were required to bring their partner in to the WSAHS Drug &
Alcohol Service for him/her to participate in the study in a face-to-face interview with
the author.
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Participants (both patients and their partners) had to meet the inclusion criteria prior
to commencement of the study. Patients and their partners were excluded if they
were at the time of testing experiencing alcohol/drug withdrawals which were
assessed at the initial appointment. Patients and their partners were also excluded if
there was any evidence of organic brain disease or severe psychiatric problems
(such as schizophrenia or manic-depression) or severe intellectual impairment, as
assessed at the initial clinical interview. Participants were also excluded if they could
not read or write English or if they were not aged between 18 and 65 years.
All participants who were approached about the study agreed to participate. A total of
6 patients were excluded from the study due to evidence of severe psychiatric
problems (four had schizophrenia, one had bipolar disorder and one had
schizoaffective disorder). Three more patients were excluded due to the presence of
strong suicidal ideation at assessment requiring immediate admission to a psychiatric
facility. A further 16 patients had to be excluded due to the presence of alcohol
and/or drug withdrawals at the time of assessment which required medical
management. Most patients who agreed to participate at their assessment session
would usually arrange with the researcher to bring their partner in to the next
scheduled appointment for the measures to be completed (usually in the 7 to 10 days
following initial assessment). However, 30 patients agreed to bring their partner in at
the next appointment though they failed to attend any further appointments and were
unable to be contacted in order to participate in the study.
Partners and patients were tested separately in order not to bias or influence each
other’s responses. Anonymity and confidentiality was emphasized to all participants.
Individual participant’s names were not recorded on any protocols/questionnaires.
Instead, a number was assigned to each participant. Patients took approximately 60
to 90 minutes to complete their assessment measures and for almost 10% of
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patients this was completed over two separate testing sessions which were no more
than one week apart. Partners took on average 30 to 40 minutes to complete their
assessment measures and none of the partners needed an additional testing session
to complete the measures. From this sample of patients and their partners, 39
partners had to be excluded from the study due to the partner’s reported excessive
use of alcohol and/or drugs, as assessed by either one of the two drug and alcohol
screeners (the AUDIT-C and the DAST-10). Therefore the final sample consisted of
83 partners and patients. The response rate for the present sample was 77%. The
author conducted all of the data collection for this study, including collecting data
from subjects who were subsequently excluded from participation.
It was a requirement of inclusion that participants agreed to be contacted by
telephone 1 month and 6 months following the last treatment session by the
researcher in order to review their progress. All patients attending WSAHS Drug &
Alcohol Psychology Services are routinely contacted at 1 month and 6 months
following treatment completion by telephone to assess their progress and also to
assess their satisfaction with the treatment provided by the service. At the 1 month
and 6 month follow-up phone call to patients they were asked if they felt they had met
their treatment goal of drug or alcohol abstinence/reduced use (“yes” or “no”),  and
they were also asked about the quantity and frequency of their drug/alcohol use in
the last 2 weeks. Patients were also asked if they felt they had relapsed back to
heavy use (“yes” or “no”),  and if so, they were asked what date they had started
drinking or using drugs regularly again. The timeline follow back method was
employed in order to identify relapse dates and frequency of substance use.
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Measures Used
Questionnaires / Interviews conducted:
Partners of patients were required to complete the following instruments :
-Partner Coping Self Efficacy Scale (Giannopoulos, 2003) a self-report measure of
partner coping self-efficacy.
-Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) a measure of
symptoms of depression & anxiety.
-Ways of Coping Questionnaire (Folkman & Lazarus, 1988) a self-report measure of
cognitive and behavioural coping processes.
-Alcohol Use Disorders Identification Test – Consumption (AUDIT-C) (Saunders et
al., 1993) a 3 item screener for alcohol problems.
-Drug Abuse Screening Test -10 (DAST-10) (Skinner, 1982) a 10 item screener for
drug problems.
Patients were required to complete the following instruments :
-Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) a measure of
symptoms of depression & anxiety.
-Beck Scale for Suicidal Ideation (Beck & Steer, 1991) a self-report measure of the
severity of suicidal ideation .
-Ways of Coping Questionnaire (Folkman & Lazarus, 1988) a self-report measure of
cognitive and behavioural coping processes.
-Drug & Alcohol Self-Efficacy Scales (Sitharthan, 1999 ; Sitharthan et al., 2003) used
to identify high risk situations and assess confidence in such situations.
45
-Alcohol Helplessness Scale (Sitharthan et al., 2001) a self-report measure of
alcohol-specific helplessness beliefs.
-Comprehensive Drug & Alcohol Evaluation Form (CDAEF) (Sitharthan, 1996) a
structured clinical interview assessing past and current drug and alcohol use,
adverse consequences of substance use, dependence, readiness to change, social
support, demographic information and includes a timeline follow back interview.
-Support Scale (SS) (Sitharthan, 1993) a self-report measure of both general and
drug and alcohol-specific perceived support.
A copy of all of the above scales can be found in Appendix C.
Hospital Anxiety and Depression Scale (HADS)  (Zigmond & Snaith, 1983)
This self-report questionnaire was developed by Zigmond and Snaith (1983) to
identify possible cases of anxiety disorders and depression among patients of non-
psychiatric hospitals. The HADS was used in the present study in order to assess
symptoms of anxiety and depression in both partners and patients. This
questionnaire consists of 7 items which assess anxiety and 7 which assess
depression. Subjects are asked to answer items to reflect how they have been
feeling during the past week. All items are scored on a 4 point Likert scale from zero
(not present) to 3 (considerable). Total scores on the HADS range from 0 to 42 with
higher scores reflecting greater levels of emotional distress. Subscale scores for
anxiety and depression are each out of 21 with higher scores indicating greater levels
of anxiety and depression symptom frequency respectively. Scores for both the
anxiety and depression subscales are typically categorized as follows : “normal” (0 to
7), “mild” (8 to 10), “moderate” (11 to 14), and “severe” (15 to 21) (Snaith & Zigmond,
1994). The HADS is free of charge and no formal training is required to administer or
score the scale. Administration time is approximately 2 to 5 minutes. A computerized
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version of the HADS using a touch-screen has been found to be as valid as the
paper and pencil version (McDowell, 2006).
Although the HADS was originally devised to be used with hospital inpatients it has
also been found to perform adequately with non-hospital populations as well
(McDowell, 2006). Although not originally intended to be used a diagnostic tool the
HADS has repeatedly been found to display high sensitivity and high specificity (E.g.
Olsonn, Mykletun & Dahl, 2005). A review of 24 studies reporting sensitivity and
specificity published prior to the year 2000 by Bjelland and his colleagues (2002)
suggest using an optimal cut-off score of at least 8 on both the anxiety and
depression subscales, as originally suggested by Zigmond and Snaith (1983). More
specifically, a threshold of at least 8 produced sensitivity and specificity between 0.70
and 0.90 for both the HADS anxiety and depression subscales for a wide range of
clinical populations including cancer and non-cancer medical groups, community and
primary care groups (Bjelland et al., 2002).
The HADS has adequate concurrent validity with numerous studies reporting high
correlations with other established measures such as the Beck Depression Inventory
and the HADS depression subscale (r=0.62) (Beck et al., 1997), Speilberger’s State-
Trait Anxiety Inventory and the HADS anxiety subscale (r=0.64 to 0.81) (Bjelland et
al., 2002), Symptom Checklist 90 anxiety subscale and the HADS anxiety subscale
(r=0.73) and the Symptom Checklist 90 depression subscale and the HADS
depression subscale (r=0.69) (Bjelland et al ., 2002).
Internal consistency, as assessed by Cronbach’s alpha coefficient, was reported in
15 of the 747 studies reviewed by Bjelland et al (2002) and was found to be
adequately high in all cited studies. More specifically, internal consistency ranged
from 0.68 to 0.93 for the anxiety subscale and from 0.67 to 0.90 for the depression
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subscale. Of the 21 studies reviewed by Bjelland et al (2002) reporting Pearson
correlation coefficients between the anxiety and depression subscales of the HADS,
the correlations ranged from 0.40 to 0.74.
More than half of the 19 studies reviewed by Bjelland et al (2002) provide support for
a 2 factor model with depression and anxiety subscales independent of each other,
as originally specified by Zigmond and Snaith (1983), although 42% of studies
reviewed found evidence of either a 3 or 4 factor model. A recent meta-analysis of a
further 28 studies published between 2002 and 2010 examining the factor structure
of the HADS also lend strong support to the 2 factor model (Norton et al., 2013).
The HADS is often used with patients with somatic disease (e.g. general medical
problems, cancer, cardiovascular disease) because it has the advantage of excluding
somatic symptoms of emotional distress (such as weight loss, headaches) which
could be a product of a somatic illness rather than a product of emotional distress per
se. Given that patients with substance use problems often report somatic symptoms
which are a product of their drug and alcohol use, dependence and/or withdrawal, the
HADS was considered to be an ideal tool to use in the present study to assess pure
anxiety and depression without being confounded by drug and alcohol-related
somatic complaints.
Ways of Coping Questionnaire (WOCQ)  (Folkman & Lazarus, 1988)
The WOCQ is one of the most widely used measures of coping with internally or
externally stressful situations in clinical research. The WOCQ was administered to
both partners and patients in the present study in order to assess coping style. This
66 item self-report scale asks subjects to rate the frequency of using a number of
different strategies for coping with stressful situations. The instructions were modified
in the present study to state: “take a few moments to think about the most stressful
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situations that you have experienced in the past month” as opposed to the “last
week”. Furthermore patients were asked to respond to items on the WOCQ while
considering stressful situations in the last month relating to “coping with your drug or
alcohol problem”. Partners were asked to respond to items on the WOCQ while
considering stressful situations in the last month relating to “coping with your
partner’s drug or alcohol problem”. Participants are required to rate each coping
strategy on a 4 point Likert-type scale from “does not apply and/or not used” (scored
0), “used somewhat” (scored 1), “used quite a bit” (scored 2), and “used a great deal”
(scored 3). Only 50 of the 66 items are used to create a total of 8 empirically derived
coping scales with the remaining 16 items being filler items. The eight coping scales
of the WOCQ are : confrontive coping, distancing, self-controlling, seeking social
support, accepting responsibility, escape-avoidance, planful problem-solving and
positive reappraisal. Relative scores and raw sum scores for each of the items that
compose the eight scales are calculated by a computer program available from the
scale’s publisher. Many studies have looked at 2 coping types in particular, “Emotion-
Focused Coping” and “Problem-Focused Coping”, which are each composed of 4 of
the eight subscales of the WOCQ. The present study only assessed these two
coping styles as they appeared to be the most widely examined in the literature on
partner coping. Emotion-Focused Coping is comprised of the following 4 subscales :
positive reappraisal, escape avoidance, distancing and self-controlling. Emotion-
Focused Coping scores range from 0 to 84 and are comprised of 28 items from the
WOCQ. Problem-Focused Coping consists of scores from the following 4 subscales :
planful problem-solving, seeking social support, accepting responsibility and
confrontive coping. Scores on the Problem-Focused Coping score are made up of 22
items and range from 0 to 66. Higher scores reflect more frequent use of each
particular coping style. The WOCQ takes approximately 10 minutes to complete.
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Internal consistency for the eight coping scales ranges from 0.61 (distancing) to 0.79
(positive reappraisal) (Folkman & Lazarus, 1985) and 0.86 for the WOCQ total score
(Lundqvist & Ahlstrom, 2006). The authors do not report test-retest reliability for the
WOCQ claiming it is not theoretically appropriate to do so as one would not want or
expect coping strategies employed to be stable over time. There are also no agreed
upon norms for the WOCQ given it has been used in a variety of different study
populations. A meta-analysis of 130 published studies using the WOCQ found the
scale’s “generalized reliability” (that is coefficient alpha, KR-20 or split-half reliability)
ranged from a rather low score of 0.21 on the Distancing subscale to a high of 0.93
on the Confrontive Coping subscale (Kieffer & MacDonald, 2011). Mean
generalizability coefficients for each of the 8 subscales of the WOCQ as well as the
total WOCQ score were all above 0.69 and were thus considered acceptable from
Keiffer & MacDonald’s (2011) meta-analysis. Many have failed to replicate the
original eight factor structure of the WOCQ (E.g. Edwards & O’Neill, 1998) though it
is still the most widely used factor structure in the literature.
Alcohol Use Disorders Identification Test – Consumption (AUDIT-C)  (Bush,
Kivlahan, McDonell, Fihn & Bradley, 1998)
The AUDIT was developed by the World Health Organization’s Collaborative Project
on the Detection and Management of Alcohol-Related Problems in Primary Health
Care to be used as an alcohol screener to identify hazardous drinkers or those who
have an alcohol use disorder, that is alcohol abuse or dependence (Saunders et al.,
1993). The AUDIT-C was used in the present study as a screener to identify possible
cases of alcohol use disorders in partners. The original ten item scale asks about
quantity and frequency of alcohol use, alcohol-related dependence symptoms and
alcohol-related problems. The AUDIT-Consumption (AUDIT-C) consists of the first
three items of the AUDIT which ask about quantity and frequency of alcohol use. Six
shorter forms of the original ten item AUDIT have been developed as many
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researchers found the original version to be too lengthy and patients often became
defensive when answering questions about alcohol-related problems and alcohol
dependence. The AUDIT can be administered either as an oral interview or a self-
administered paper-and pencil questionnaire. Higher scores suggest that the
person’s drinking is affecting his/her health and safety. The AUDIT has been found to
outperform most other alcohol screeners, such as the CAGE, especially in female
patients (Bradley et al., 1998).
The items on the AUDIT-C are scored from 0 to 4, with total scores ranging from 0 to
12. Questions are based on the subject’s drinking in the last year and a diagram of
standard drink sizes is included with the scale to ensure accurate responses are
obtained. Despite its shorter length the AUDIT-C has been found to be equally as
effective as the original ten item AUDIT in detecting alcohol abuse or dependence
(Bush et al., 1998). One study even found the AUDIT-C significantly outperformed
the AUDIT in detecting risky drinking, especially in women (DeMartini & Carey,
2012). The AUDIT-C has been found to have slightly greater sensitivity when
screening for severe alcohol use disorders when using DSM 5 criteria compared to
DSM-IV criteria (Dawson et al., 2012).
The suggested optimal cut-off score for risky drinking in men is greater than or equal
to 5 (sensitivity 92%, specificity 74%) and for women the optimal cut-off score for
risky drinking is greater than or equal to 4 (sensitivity 91%, specificity 68%) (Gual et
al., 2002). Others have used more stringent cut-off scores, such as Frank et al (2008)
who have suggested a cut-off score of greater than or equal to 4 in men and greater
than or equal to 3 in women. The lower cut-off for women was set to take into
consideration that women have lower thresholds for risky drinking. Lower
recommended cut-off scores have been criticized by many as patients can easily
screen positive with a score of 4 or 5 while still drinking within recommended safe
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limits, thus inflating the false positive rate to 40% in some cases (E.g. Bush et al.,
1998). In the present study the cut-off score for exclusion from the study was greater
than or equal to 5 for men and greater than or equal to 4 for women.
The AUDIT-C has been found to be highly sensitive and specific in identifying alcohol
use disorders in a large population of people with a history of mental illness (mood
disorders and personality disorders) (Dawson, Grant & Stinson, 2005). Although
originally devised as a paper-and-pencil questionnaire numerous studies have used
the AUDIT-C to identify hazardous drinkers online when screening for computer-
based interventions (E.g. Murray et al., 2007). When compared to pencil-and-paper
administration the online version of the AUDIT-C was found to be twice as likely to
identify hazardous drinkers (Graham, Goss, Xu, Magid & Diguiseppi, 2007). This
finding is probably due to the fact that online assessment of drinking eliminates social
desirability bias given it is socially undesirable to report excessive drinking in a face-
to-face setting.
Internal consistency of the AUDIT-C has been found to be adequate (coefficient
alpha=0.69) and test-retest reliability over a 3-4 week period was found to be high
0.98 (Bergman & Kallmen, 2002). One study reported a rather low internal
consistency of 0.57 for females on the AUDIT-C though it was adequate for males
(coefficient alpha=0.66) (Neumann et al., 2012).
No studies examining the factor structure of the AUDIT-C have been conducted,
though this is not surprising given that a comprehensive review of studies examining
the factor structure of the full AUDIT have almost consistently revealed a 2 factor
structure, with one factor labelled “consumption” (items 1-3) and the second factor
labelled “adverse consequences of drinking” (items 4-10) (Reinert & Allen, 2007).
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Drug Abuse Screening Test Short Form -10 (DAST-10)   (Skinner & Allen, 1982)
The DAST-10 is the shortest version of the original 28 item Drug Abuse Screening
Test (Skinner, 1982). This 10 item self-report scale has been used extensively in the
literature to screen for lifetime drug abuse or dependence across a number of
substances including prescription drug misuse. The DAST-10 was administered to
partners in the present study in order to screen for possible cases of drug
dependence and/or abuse in partners. Subjects are required to answer ‘yes’ or ‘no’ to
ten items which ask about possible substance misuse and dependence in the last 12
months. The DAST-10 takes less than 8 minutes to complete and scores range from
0 to 10 on this scale with higher scores indicating substance abuse or dependence
may be present. A score between 1 and 2 suggests “low level problems associated
with substance misuse”, a score between 3 and 5 suggests “a moderate level of
problems with substance misuse”, and scores over 6 suggest “substantial to severe
problems which may indicate substance dependence”. Skinner (1982) has
recommended a cut-off score of 3 when screening for possible substance abuse or
dependence. The present study utilized a cut-off score of 3 for inclusion/exclusion in
the study. The DAST-10 has been criticized because it cannot distinguish between
past or present substance use or dependence though one study found that it can
accurately discriminate between current and past drug abusers (Cocco & Carey,
1998).
All versions of the DAST, including the DAST-10 have been found to be reliable and
valid (Yudko, Lozhkina & Fouts, 2007). Internal consistency has been found to be
high (α = 0.94) (Bohn et al, 1991) and as low as α =0.86 in a sample of psychiatric
outpatients (Cocco & Carey, 1998). Adequate test-retest reliability (r=0.71) was found
in a sample of 45 psychiatric outpatients (Cocco & Carey, 1998).
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Most published studies have examined the factor structure of the DAST-20 rather
than the DAST-10. The strongest support for a unidimensional model was from
Carey, Carey & Chandra’s (2003) study of the DAST-10 in a sample of psychiatric
inpatients with substance use problems. The only other published study to examine
the factor structure of the DAST-10 found evidence of a 3 factor model which
accounted for 64% of the total variance (Cocco & Carey, 1998). However this
particular analysis consisted of two factors which comprised only one item each,
suggesting that a unifactorial model is more likely to be present. The DAST-10’s
discriminative validity has been reported to have a sensitivity ranging from 94% to
41% and a specificity from 68% to 99% using cut-off scores of 1 to 2 and 3 to 4
respectively (Carey et al., 2003). Maisto et al (2000) found the DAST-10 to have an
overall predictive accuracy for current diagnosis of drug abuse or dependence at
over 70%.
Due to the scale’s high face validity it is susceptible to subjects faking good their
responses in order to appear more socially desirable, that is there is a tendency for
subjects to under-report their substance use. However this tendency to minimize
one’s substance use is more likely to be a problem when the DAST-10 is
administered in a workplace setting, forensic setting or clinical setting as opposed to
when used in an anonymous voluntary study.
Many have found significant relationships between the DAST and other measures of
drug and alcohol use, such as the Addiction Severity Index, The Michigan Alcohol
Screen Test, even reports of days since last drug use, number of previous treatments
and the number of different drugs used in the recent past (Cocco & Carey, 1998).
Significant correlations between the DAST-10 and various subscales of the Symptom
Checklist-90, such as depression, anxiety, somatization, obsessive-compulsive and
paranoia, have also been reported (Cocco & Carey, 1998).
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Beck Scale for Suicidal Ideation (BSS)  (Beck & Steer, 1991)
The BSS was developed by Beck and Steer (1991) and is one of the most widely
used instruments for assessing suicidal ideation. The BSS was used in the current
study in order to identify suicidality in patients and assess its severity if present. It is a
rating scale which assesses suicidal ideation in a self-report format. This 21 item
scale consists of 5 screening items. If subjects score zero on both items 4 and 5 of
the screener they skip most questions and only complete items 20 and 21. Items ask
about suicide risk factors such as previous suicide attempts, current desire to kill
oneself, means, plans, preparation for suicide and willingness to notify others about
one’s suicidality. The BSS measures suicidal ideation in the last week on a 3 point
Likert-type scale which is scored 0,1 or 2. Total scores on the BSS range from 0 to
38, with higher scores indicating greater severity of suicidal ideation. The last 2 items
of the scale assess past suicide attempts and their scores are not calculated in the
total, only scores from items 1 to 19 are summed in the total. The BSS does not have
a formal cut-off score for suicidality. The authors of the BSS recommend rather than
using a formal cut-off to instead visually inspect answers to all items on the scale and
if any items are scored positively then to investigate further. The BSS takes
approximately 5 to 10 minutes to complete.
Internal consistency of the scale has been reported to be high, with coefficient alphas
reported to be between 0.87 and 0.91 (Beck & Steer, 1991). Test-retest reliability
coefficients over a one week period have been found to be moderately high (r=0.54)
(Steer et al., 1993). Concurrent validity with an earlier version of the BSS has been
reported to be high (r=0.90 to 0.94) (Beck & Steer, 1991). Scores on the BSS have
also been significantly associated with scores on the Beck Depression Inventory and
the Hamilton Rating Scale for Depression (Beck, Brown, & Steer, 1997). The BSS is
one of the few suicide assessment tools to assess predictive validity for completed
suicide. More specifically, in a large sample of psychiatric outpatients Brown et al
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(2000) found that patients who scored greater than or equal to 3 on the BSS were 7
times more likely to commit suicide than those who scored less than 3 on the BSS.
Factor analysis of the BSS using a sample of psychiatric inpatients found evidence of
a 3 factor model (Steer, Rissmiller, Ranieri & Beck, 1993).
The Controlled Drinking Self-Efficacy Scale (CDSES) (Sitharthan et al., 1996 ;
Sitharthan et al., 1997)
The CDSES is a 20 item self-report self-efficacy measure used to identify high risk
situations for patients with a controlled drinking treatment goal. In the present study
the CDSES was administered to patients endorsing a controlled drinking goal in
order to assess their self-efficacy for reducing their alcohol intake. Items from the
CDSES are based upon the Problem Drinking Self-Efficacy Scale (Sitharthan &
Kavanagh, 1990). Subjects are required to rate their confidence in being able to
control their drinking in a variety of difficult situations in the next 6 months on a scale
from 0% to 100% in 10% increments, with 0% suggesting “not at all confident” and
100% suggesting they are “very confident”. For example, one item from the CDSES
asks subjects how confident they are that they will not drink more than six standard
drinks when at a party with friends in the next 6 months. The scale takes
approximately 5 to 10 minutes to complete. Total confidence scores on the CDSES
prior to commencing alcohol treatment have been found to predict alcohol use 12
months later (Kavanagh et al., 1996). Internal consistency of the CDSES has been
found to be excellent (coefficient alpha=0.95) (Sitharthan et al., 2003). Factor
analysis of the CDSES has found evidence of a four factor model with the following
four factors identified : negative affect, positive mood/social context, frequency of
drinking and consumption quantity (Sitharthan et al., 2003). Test-retest reliability was
high (r=0.90) in a sample of 40 patients tested 2 weeks apart (Sitharthan et al.,
2003).
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Alcohol Abstinence Self-Efficacy Scale (AASES)  (Sitharthan, 1996)
The AASES is similar to the CDSES however it is asks participants how confident
they are in being able to refrain from drinking at all in a variety of difficult high risk
situations. The AASES was administered to patients endorsing an alcohol abstinence
goal in order to assess their confidence in being able to refrain from drinking. The
same 20 items used in the CDSES are used in the AASES except the instructions
differ in their wording to state “how confident are you that you will not drink any
alcohol”. Subjects are required to rate their confidence in being able to refrain from
drinking in a variety of difficult situations in the next 6 months on a scale from 0% to
100% in 10% increments, with 0% suggesting “not at all confident” and 100%
suggesting they are “very confident”. For example, one item from the CDSES asks
subjects how confident they are that they will not drink any alcohol when they are
depressed in the next 6 months. The AASES takes 5 to 10 minutes to complete.
Although no validity or reliability data has been published from the AASES it is
expected to have similar psychometric properties to the CDSES.
Drug Abstinence Self-Efficacy Scale (DASES)  (Sitharthan, 1996)
This 18 item self-report scale assesses how confident drug users are in being able to
refrain from using drugs in a variety of high risk situations, such as when they are
experiencing drug withdrawal symptoms. The DASES was implemented in the
present study in order to assess self-efficacy for achieving abstinence in patients
reporting drug dependence. Subjects are required to rate their confidence on a scale
from 0% (“not at all confident”) to 100% (“very confident”) in 10% increments, in the
next 6 months. The DASES takes between 5 and 10 minutes to complete and can be
used for any drug of dependence. The DASES does not have published
psychometric data available however its psychometric properties are expected to be
similar to that of the CDSES.
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Alcohol Helplessness Scale (AHS)  (Sitharthan, Hough, Sitharthan & Kavanagh,
2001)
The AHS was developed by Sitharthan and her colleagues (2001) in order to assess
alcohol-specific helplessness. The AHS was used in the present study to assess
helplessness in patients endorsing an alcohol use disorder. The AHS was only used
to assess alcohol helplessness in alcohol patients in the present study as the items
related to alcohol use only and could not be modified to be used with substance use
patients. It consists of 6 items which are scored 0, 1, 2, or 3 on a Likert-type scale
giving a total score out of 18. Items assess how much participants agree with certain
alcohol-specific beliefs, such as “alcohol is controlling my life”. Participants are
required to rate how much they agree with each of 6 statements on a scale from 0
(“strongly disagree”) to 3 (“strongly agree”). Higher scores on the AHS reflect greater
levels of helplessness.
Sitharthan and her colleagues (2001) found the AHS to have moderate internal
consistency (coefficient alpha=0.69) in a sample of 98 problem drinkers. Evidence
exists for a one factor model of alcohol helplessness for the AHS (Sitharthan et al.,
2001). Significant positive correlations have been found between scores on the AHS
and the Beck Depression Inventory as well as on a measure of alcohol dependence
(the Severity of Alcohol Dependence Questionnaire – Form C) (Sitharthan et al.,
2001). There is no data available to date on the test-retest reliability of the AHS.
Comprehensive Drug & Alcohol Evaluation Form (CDAEF) (Sitharthan, 1996)
The CDAEF is a structured clinical interview assessing past and current drug and
alcohol use, adverse consequences of substance use, dependence, readiness to
change, social support, previous drug and alcohol treatment, past and present
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suicidality, and demographic information. It also includes a timeline follow back
interview to assess quantity and frequency of use in the previous 6 months. The
CDAEF was administered to all patients in the present study in order to obtain a
thorough drug and alcohol use history. The CDAEF takes approximately 60 minutes
to complete and data collected from the CDAEF is used in treatment planning. The
CDAEF was developed by Sitharthan (1996) to be used by psychologists in both a
clinical setting and in research projects conducted by the WSAHS Drug & Alcohol
Psychology Service. In order to administer the CDAEF psychologists are required to
complete a 2 hour training session in its administration and scoring.
Support Scale (SS) (Sitharthan, 1993)
The SS is a self-report measure of both general and drug and alcohol-specific
perceived support. This scale was developed by Sitharthan (1993) to be used by
clinicians at the Centre for Addiction Medicine, WSAHS Drug & Alcohol Service to
assess perceived support from the view of the patient. This scale was selected to be
used due to its excellent face validity and due to the paucity of similar validated
scales in the literature assessing perceived support. This 20 item scale requires
patients to rate how often in the last 6 months their partner has behaved in a certain
way. Participants are required to respond on a 4 point Likert-type scale from “never
or almost never” to “nearly always”. Items ask about drug and alcohol-specific
support such as, “how often has your partner complimented you on cutting down your
drinking/drug use?”. Items also ask about general support , such as “how often has
your partner criticized you ?”. The scale takes approximately 5-10 minutes to
complete. Ten of the 20 items assess drug and alcohol specific support with the
remaining 10 items assessing general support. The SS contains both negatively
worded/scored items and positively worded/scored items. A score is obtained for
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both drug and alcohol specific support and a separate score is obtained for general
support. The psychometric properties of the SS have not been published to date.
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Study 1 Results
All data were analysed using SPSS Version 21.0 unless otherwise stated. All
statistical analyses were conducted using a level of statistical significance α=0.05
unless otherwise stated.
Missing Data
In Study 1 if a subject had any missing data from any scale all of their data were
removed from all analyses, thus only subjects with 100% completed data were
included in the analyses.
Demographic Characteristics of Participants
1. Characteristics of Partners
Eighty three partners completed the questionnaires from Study 1. A total of 153
potential participants were initially approached to take part in this study. Thirty one
subjects commenced the study though they failed to complete it due to missing
appointments/ treatment non-completion (73% response rate/completion rate). Data
from this group of 31 non-completers was removed from all analyses so that only
subjects with 100% completed data were included in the study. A further 39 potential
participants were excluded from the study at the time of data collection as their
scores on either the AUDIT-C, the DAST-10 or both exceeded the specified cut-offs
for inclusion in the study. All of the 83 partners who completed the study scored less
than 5 if male and 4 if female on the AUDIT-C and less than 3 on the DAST-10, as
this was a requirement for inclusion in the study.
Partners were on average 40.33 years of age (sd = 10.06) (range =22 to 64 years),
with 39 years of age being the median age of this group. Almost half of the partners
(44.6%) were aged between 40 and 49 years and a further 37.3% were aged
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between 30 and 39 years. The majority of partners were female (78.3%) and were
employed (28% in full-time employment, 29% in part-time employment) as opposed
to not being employed (30% were receiving government benefits, 7% were studying,
and 2% had retired). When partners were asked about highest educational level
attained almost half of the partners had completed a college/TAFE diploma (49%),
23% had completed Year 12, 8% had completed Year 10, 8% had completed a
university degree and a further 4% had postgraduate qualifications. Most partners
were living in rented accommodation (69%) as opposed to privately-owned
accommodation (31%). Ninety four percent of partners (N=78) were born in Australia.
Five partners reported being born in a country other than Australia, with three
partners born in England, one in Argentina and one in Malta.
All partners were living with their partner for at least the last 12 months as this was a
requirement of inclusion into the study. All participants were living with their partner at
the time of data collection. The majority were living in a de-facto relationship (63%)
whereas 37% were married or engaged to be married. The average number of years
they had been in a relationship with their partner was 8.49 years (sd=6.74), with the
median number of years being 8 years and the range being 1 to 30 years. When
partners were asked to specify for how long their partner had a drug and/or alcohol
problem for the average length was found to be 4.23 years (sd=4.67), with a median
length being 2 years (range= 1 to 25 years). Only 13% of partners reported a
problem had existed for greater than or equal to 10 years whereas 35% reported a
problem of up to one years duration.
Partner’s total scores on the HADS were positively skewed with a mean of 18.25
(sd=7.68), range = 6 to 40. Similarly, partner’s scores on the Depression subscale of
the HADS ranged from 2 to 20 with an average score of 9.67 (sd=4.62). Using a cut-
off score of 8 on the Depression subscale of the HADS 66% of partners (N=55) met
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criteria for “depression”, with 17% of this group (N=14) being classified as having
“severe symptoms of depression” (that is they scored more than 15 on the
Depression subscale). Scores on the Anxiety subscale of the HADS ranged from 2 to
20 with an average score of 8.61 (sd=3.84). Approximately 55% of partners (N=46)
met the criteria for “anxiety”, with 8% of all partners being classified as displaying
“severe symptoms of anxiety” (that is they scored more than 15 on the Anxiety
subscale). When compared to HADS norms from the general population published by
Crawford et al (2001) partners from this sample were very significantly more
depressed, as assessed by the HADS Depression subscale, compared to the
general population (t(1873)=16.916, p<0.0001, Cohen’s d=1.53). Partners from this
study were also significantly more anxious, as assessed by the Anxiety subscale of
the HADS, compared to norms (t(1873)=5.8453, p<0.0001, Cohen’s d= 0.65).
Furthermore, partners from Study 1 were also found to be significantly more
emotionally distressed, as assessed by HADS Total scores, compared to the general
population (t(1873)=12.3807, p<0.0001, Cohen’s d=1.22).
Partner’s scores on the Emotion-Focused Coping score of the WOCQ displayed a
mean of 32.84 (sd=16.00) with scores ranging from 12 to 82. Scores on the Problem-
Focused Coping score of the WOCQ displayed a mean of 36.45 (sd=14.08) with a
range of 8 to 65. Although there are no widely agreed upon norms for comparing
WOCQ scores due to the fact that the WOCQ has been used in a very vast range of
clinical populations, in the present study norms were used from a sample of 79
partners of women with cancer by Wagner et al (2006) for comparison purposes. No
statistically significant difference was noted in the reported frequency of use of
Emotion-Focused Coping strategies on the WOCQ compared to norms
(t(160)=1.1195, p=0.2646). In terms of reported use of Problem-Focused Coping on
the WOCQ the present sample of partners reported significantly greater use of
Problem-Focused Coping strategies (t(160)=7.576, p<0.0001, Cohen’s d=1.197)
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compared to norms. In order to determine whether partners used more Emotion-
Focused Coping or Problem-Focused Coping strategies a paired samples t-test was
conducted. Results from the paired samples t-test failed to reveal a statistically
significant difference between the mean use of Emotion- Focused Coping and the
mean use of Problem Focused Coping (t(82)= -1.214, p=0.134).
2. Characteristics of Patients
Eighty three patients made up the final sample. Initially 147 patients were
approached to participate in the study. Sixty four patients were excluded from
participation in the study. From this group of 64 patients excluded from participation,
25 were excluded for not meeting the inclusion criteria, 9 were excluded as a result of
their partner failing to meet the inclusion criteria and 30 were excluded for treatment
non-completion. Patients were on average 40.9 years old (sd= 10.68), range = 22 to
64, with 39 years being the median age for this sample. Most patients were aged
between 30 and 39 years of age (35%). The majority of patients were male (78%)
and most were employed (46% in full-time employment, 14% in part-time
employment), whereas 33% were receiving government benefits, 4% were students
and a further 4% were retired. Highest educational level reported by patients was as
follows : 42% had completed a college/TAFE diploma, 24% had completed Year 12,
12% had completed Year 10, 17% had completed a university degree and 5% had
completed postgraduate study. Most patients were living in rented accommodation
(69%) as opposed to privately-owned accommodation (31%). The majority of patients
(93%) were born in Australia, with three reporting being born in New Zealand, two in
England and one in Canada.
All patients were living with their partner for most of the last 12 months as this was a
requirement of inclusion into the study. All patients were living with their partner at
the time of data collection. The majority of patients were living in a de-facto
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relationship (63%) whereas 37% were married or engaged to be married. The
average number of years they had been in a relationship with their partner was 8.49
years (sd=6.74), with the median number of years being 8 years and the range being
1 to 30 years.
The majority of patients (82%) reported alcohol to be their substance of choice,
whereas 18% of the patients reported a drug use problem. All of the drug use
patients reported dependence on only one substance, not including dependence on
tobacco. Of the patients reporting a drug use problem 47% reported amphetamine
dependence, 40% reported cannabis dependence, and 13% reported heroin
dependence. All of the amphetamine and heroin dependent patients reported regular
intravenous use. Most of the entire sample of patients (88%) also reported regular
use of tobacco at the time of assessment.
When asked about typical quantity and frequency of alcohol use in the 6 months prior
to assessment the 68 alcohol dependent clients reported a mean use of 8 standard
drinks per drinking occasion (sd=7) and they reported drinking 5 days per week on
average. The amphetamine dependent patients reported using on average
500mg/day, on average 5 days/week. The cannabis dependent patients reported
smoking 27 cones per day on average (sd=11), seven days per week. The heroin
dependent patients reported a mean use of 0.5 gram per day, on average 5 days per
week. When patients were asked to specify how many years they had a drug and/or
alcohol problem for the mean response was 3.96 years (sd=4.78), range = 1 to 20
years with a median response of 2 years. Approximately half of the patients (49%)
reported having a drug and/or alcohol problem for one year, 12% reported having a
drug and/or alcohol problem for 2 years and 12% reported having a drug and/or
alcohol problem for at least 10 years. The majority of patients (71%) had never
attempted to change their drug and/or alcohol use without anyone’s help before
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whereas 18% had attempted to change their drug and/or alcohol use in the last 6
months. Most patients (84%) had never seen a counsellor, doctor, or any health
professional before to address their drug or alcohol problem. Similarly, 82% had
never been to Alcoholics Anonymous / Narcotics Anonymous meetings before. In
terms of patient’s self-efficacy to abstain or reduce their substance use their average
score on the Drug & Alcohol Self-efficacy scales was found to be 58.55% (sd=20.37),
with scores ranging from 10% to 100%. Such overall drug and alcohol self-efficacy
scores for this sample are largely consistent with norms cited by Sitharthan et al
(2003) (t(733)=1.216, p=0.2246). For the sample of 68 patients reporting alcohol
dependence their mean score on the Alcohol Helplessness Scale (AHS) was found
to be 8.15 (sd=4.89), range = 0 to 18. Such a score on the AHS was slightly but
significantly lower than norms reported by Sitharthan et al. (2001) (t(179)=2.228,
p=0.0271, Cohen’s d=0.22) which suggests that this sample of patients displayed
significantly less alcohol helplessness.
Almost two thirds of patients (65%) had someone express concern about their drug
and/or alcohol problem to them and suggest to them that they cut down or stop
using/drinking within the previous six months. Approximately half of the patients
referred themselves to treatment (57%), 15% were referred by other health
professionals or health care services, 12% were referred to treatment by a family
member/friend/relative, 11% were legally mandated to attend treatment and 5% were
referred by their employer. Eighty one percent of patients reported that they have
someone whom they regard to be a support person. The vast majority of patients
listed their partner as their support person (94%). Scores on the Support Scale Drug
& Alcohol Support subscale ranged from 2 to 28 with a mean score of 15.70
(sd=5.47). General Support subscale scores from the Support Scale ranged from 5 to
28 with a mean score of 15.59 (sd=4.82). No published norms are available for direct
comparison on the Support Scale.
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Coping style, as assessed by the Ways of Coping Questionnaire, produced two
scores : Emotion-Focused Coping and Problem-Focused Coping. Patient’s scores on
the Emotion-Focused Coping score ranged from 12 to 82 with a mean rating of 44.37
(sd=17.04). Such scores were found to be statistically significantly different from
control group norms published by Wagner et al (2006) (mean= 32.86, sd=9.57)
(t(160)=5.265, p<0.0001) with a large effect size evident from Cohen’s d=0.83.
Scores on the Problem-Focused Coping score ranged from 6 to 60 with a mean
rating of 28.87 (sd=13.84) and were found to be consistent with control group norms
by Wagner et al (2006), mean= 30.54, sd=7.55 (t(160)=0.947, p=0.3452). A paired
sample t-test was conducted to determine which of the two types of coping were
implemented more frequently in patients. Results from the paired sample t-test
revealed a statistically significant difference between the mean use of Emotion
Focused Coping (M=44.37, sd=17.04) and Problem Focused Coping (M=28.387,
sd=13.84) in patients, (t (82)=7.168, p=0.000), which suggested that patients
implemented Emotion-Focused strategies more often than Problem-Focused
strategies.
Scores on the HADS Depression subscale ranged from 2 to 21 with a mean of 9.23
(sd=4.96). Sixty percent of patients scored above the cut-off for depression
suggesting the presence of symptoms of depression. Sixteen percent of patients
scored in the range of “severe” depressive symptomatology. On the Anxiety subscale
of the HADS patients scored on average 7.39 (sd=3.91), with scores ranging from 1
to 21. Almost half of the patients (47%) met the criteria for the presence of anxiety
symptomatology, with 4% scoring in the “severe” range for anxiety. Patient’s Total
scores on the HADS ranged from 6 to 36 with an average score of 16.60 (sd=7.69).
In order to compare HADS scores to norms scores on the HADS subscales, scores
were compared to that of the general population from a study by Crawford et al
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(2001). On the Depression subscale of the HADS a very large statistically significant
difference was observed between patients and norms (t(1873)=15.562, p<0.0001,
Cohen’s d=1.35), with patients reporting significantly more symptoms of depression
than seen in the general population. Statistically significant differences were
observed between patient’s Anxiety scores on the HADS when compared to norms
(t(1873)=2.9557,p=0.0032, Cohen’s d=0.33). As would be expected, significantly
large differences between patients and the general population were observed in
terms of Total HADS scores suggesting that this sample was significantly more
emotionally distressed than the general population (t(1873)=9.957, p=<0.0001,
Cohen’s d=0.98).
Approximately half of the patients (51%) reported the presence of suicidal thoughts
within the previous 6 months with a further 31% of patients reporting the presence of
suicidal thoughts at some point in the past but more than 6 months ago. Only 18% of
patients reported that they had never before experienced suicidal thoughts. Although
most patients reported that they had never attempted suicide before (69%), 18%
reported an attempt within the previous 6 months and a further 13% of patients
reported a suicide attempt more than 6 months ago. Scores on the Beck Scale for
Suicidal Ideation ranged from 0 to 11 with a mean score of 2.42 (sd=2.98). Such
scores were largely consistent with norms published by Bryan et al (2013) of 77
patients accessing outpatient treatment for mood and/or substance use problems,
(t(158)=0.4997, p=0.618).
Comparison of Partner & Patient Demographics
Given that the data for patients and partners was not normally distributed for a
number of measures including age, sex, HADS scores, and WOCQ scores, it failed
to meet the assumption for a t-test. As a result non-parametric tests had to be used
to determine if statistically significant differences between partners and patients
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existed on a number of measures. More specifically the Mann-Whitney U Test
statistic was used to measure differences between the two groups. All four
assumptions for the Mann-Whitney U Test were met (i.e. ordinal responses, two
variables must not be normally distributed, all observations from both groups are
independent of each other, and the independent variable should have two categorical
independent groups). The Mann-Whitney U Test assesses the null hypothesis that a
certain population has larger values than another.
No significant difference was found between patients and partners in terms of their
age (U(1)= 3358.5, z=-0.278, p=0.781). There were significantly more female
partners than males (z=7.2958, p=0.000). In terms of differences in education level
between partners and patients a two proportion z-test was conducted. No statistically
significant difference was observed between the education levels of partners and
patients. A two proportion z-test did however find a statistically significant difference
in the employment status of partners and patients. Such results found that partners
were more likely to be employed in part-time employment compared to patients
(z=2.26, p=0.0238) and that patients were significantly more likely to be in full-time
employment than partners (z=-2.4148, p=0.015).
No significant difference was found in total HADS scores between patients and
partners (U(1)=2983, z= -1.494, p=0.135). Similarly, no significant difference in
HADS Depression subscale scores were observed between patients and their
partners (U(1)=3.113, z= -1.076, p=0.282). A statistically significant difference was
observed however in Anxiety subscale scores on the HADS (U(1)=2826.5, z= -2.01,
p=0.045) with partners displaying a higher mean rank score on the Anxiety subscale
(90.95) when compared to patients (76.05).
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In terms of coping styles employed, as assessed by the WOCQ, significant
differences were found between patients and partners. A significant difference in
reported use of Emotion- Focused Coping Strategies on the WOCQ was found
(U(1)=2054, z=-4.49, p=0.000) with patients displaying a higher mean rank on this
subscale (100.25) compared to partners (66.75). Such a result suggests that patients
tended to use Emotion-Focused coping strategies significantly more often than their
partners. Also of interest is the finding that there was a statistically significant
difference between partners and patients in their reported use of Problem-Focused
Coping strategies as assessed by the WOCQ (U(1)=2394.5, z=-3.39, p=0.005) in
that partners reported using Problem-Focused Coping strategies more often than
patients (mean rank for patients = 70.85, mean rank for partners= 96.15).
Paired samples t-tests were conducted to determine whether patients and partners
used more Emotion-Focused Coping or Problem-Focused Coping as assessed by
the WOCQ. It was found that patients showed a statistically significant difference in
their use of both reported coping types with patients reporting using Emotion-
Focused Coping (M=44.37, sd=17.04) more often than Problem-Focused Coping
(M=28.87, sd=13.84) (t(82)=7.168, p=0.00). Partners on the other hand failed to
display a statistically significant difference in their reported use of one coping style
over another (t(82)=-1.514, p=0.134), with Emotion-Focused coping (M=32.84,
sd=16.00) being used as often as Problem-Focused Coping (M=36.45, sd=14.08).
PCSES and Item Characteristics
For scoring purposed total scores on the PCSES ranged from 1 to 11 for individual
items, with a score of  “1” denoting “0% confidence” and “11” denoting “100%
confidence”, thus producing a total possible score of 264 on the PCSES. Skewness
scores for the Total PCSES score were found to lie within normal limits
(skewness=0.315, CI= -0.528 to 0.528) suggesting that the distribution for Total
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PCSES scores is not significantly skewed. This was further verified by examination of
the histogram as well as the normal Q-Q plot (see Appendix D) and given that the
mean, median and trimmed mean scores on the PCSES were almost identical.
However when considering the individual items of the PCSES as seen in Table 1,
skewness was found to be within the expected standard error of skewness
confidence interval for all but four items of the PCSES. More specifically, Item 17
(“not criticise”), Item 22 (“quality time”), Item 23 (“support”) and Item 24 (“u d and a
free”) all displayed significantly negative skew. Skewness scores on the PCSES
ranged from -1.462 (Item 24) to 0.013 (Item 10) .
The level of kurtosis for the Total PCSES score was found to lie outside of the
confidence range (kurtosis=1.383, CI = -1.046 to 1.046) suggesting a slightly
significant degree of positive kurtosis. Given that the kurtosis value was above zero
this may suggest a distribution which is too peaked with long tails. Examination of the
level of kurtosis for individual items of the PCSES revealed that 5 items displayed
significant negative kurtosis. These items were : Item 5 (“embarrassed”), Item 11
(“stress worry”), Item 12 (“bored”), Item 21 (“intoxicated”), and Item 24 (“u d and a
free”). Kurtosis scores on the PCSES ranged from  -0.261 (Item 17) to 1.938 (Item
24).
It has been recommended by West, Finch & Curran (1995) that data which is
severely non-normally distributed be transformed prior to conducting statistical
analysis only if the data is significantly skewed (>2) and/or significantly kurtopic (>7).
Given that the data from this study did not deviate severely from normality towards
the levels recommended by West et al (1995) it was not deemed necessary to
transform the data.
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Table 1. PCSES Item Mean, Standard Deviation, Skew & Kurtosis.
Item Mean Standard
Deviation
Skew
(SE=0.264)
Kurtosis
(SE= 0.523)
1. mood change 6.30 2.90 -0.243 -0.865
2. suicidal 6.27 2.89 -0.650 -0.900
3. medication 6.46 2.81 -0.129 -0.857
4. not interact 6.40 2.53 -0.092 -0.429
5. embarrassed 6.10 2.78 -0.095 -1.124
6. blames u 6.18 2.66 -0.304 -0.585
7. not understand 6.20 2.73 -0.210 -0.877
8. criticise 5.72 2.53 -0.049 -0.737
9. practical tips 5.72 2.79 0.003 -0.918
10. low mood 5.55 2.95 0.013 -1.024
11. stress worry 5.58 3.03 -0.034 -1.168
12. bored 5.65 3.09 -0.008 -1.219
13. no effort 5.81 2.91 -0.181 -1.008
14. lies 6.25 2.71 -0.311 -0.765
15. unappreciative 6.00 3.02 -0.092 -1.027
16. responsibilities 6.19 2.95 -0.254 -0.989
17. not criticise 6.58 2.60 -0.533 -0.261
18. the past 6.29 2.84 -0.314 -0.890
19. buy d and a 6.47 2.73 -0.315 -0.703
20. sick 6.73 2.89 -0.432 -0.842
21. intoxicated 6.19 3.09 -0.175 -1.052
22. quality time 7.11 2.78 -0.598 -0.335
23. support 7.23 3.25 -0.672 -0.814
24. u d and a free 9.83 1.39 -1.462 1.938
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Floor and Ceiling Effects on the PCSES
Floor and ceiling effects were calculated for each of the 24 items of the PCSES.
Floor and ceiling effects were calculated as percentages of subjects rating at the
lowest level (scoring 0%) and the highest level (scoring 100%) on each item. Results
are displayed in Table 2.
Only one item of the PCSES displayed a moderately large ceiling effect “u d and a
free” with 40% of the sample rating it at 100% confidence suggesting that almost half
of the sample of partners were extremely confident in being able to refrain from
drinking/using drugs in the presence of their partner. Other than this particular finding
the PCSES failed to display large ceiling or floor effects in the current sample.
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Table 2. Floor & Ceiling Effects on the PCSES.
Item Floor Effect Ceiling
Effect
n % n %
1. mood change 5 6% 5 6%
2. suicidal 6 7% 2 2%
3. medication 3 4% 7 8%
4. not interact 2 2% 6 7%
5. embarrassed 1 1% 3 4%
6. blames u 6 7% 3 4%
7. not understand 4 5% 4 5%
8. criticise 4 5% 2 2%
9. practical tips 5 6% 4 5%
10. low mood 9 11% 4 5%
11. stress worry 11 13% 3 4%
12. bored 10 12% 4 5%
13. no effort 9 11% 1 1%
14. lies 6 7% 2 2%
15. unappreciative 8 10% 5 6%
16. responsibilities 7 8% 4 5%
17. not criticise 5 6% 4 5%
18. the past 6 7% 3 4%
19. buy d and a 6 7% 3 4%
20. sick 5 6% 4 5%
21. intoxicated 9 11% 6 7%
22. quality time 4 5% 9 11%
23. support 7 8% 11 13%
24. u d and a free 1 1% 33 40%
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Factor  Structure of the PCSES
Determining the factorability of the dataset
In order to determine whether the dataset from Study 1 was appropriate for factor
analysis three aspects of the dataset where examined. The first aspect was Bartlett’s
Test of Sphericity which tests the null hypothesis that the correlation matrix is an
identity matrix. An identity matrix is a matrix in which the diagonal elements are one
and all off-diagonal elements are zero. A result which is significant, that is p<0.05,
suggests that the matrix is not an identity matrix. In order to run a factor analysis
ideally one would like some relationship between the variables. In other words, one
would not want an identity matrix which has virtually no relationship between the
variables (i.e. all the correlation coefficients are zero). Bartlett’s Test of Sphericity
yielded a result of χ 2 =827.557, df=276, significance=0.00, p<0.001 (see Appendix
D). This significant result suggests that the variables do relate to one another enough
to run a meaningful exploratory factor analysis (EFA).
The second aspect of the dataset to be examined was the Kaiser-Meyer-Olkin
measure of sampling adequacy which compares partial correlations of variables and
their original correlations. Results of the Kaiser-Meyer-Olkin measure of sampling
adequacy produced a result of 0.726 which is above Tabachnick and Fidell’s (1996)
recommended minimum of 0.6 which is required for a factor analysis (see Appendix
D). A result of 0.726 has been described as “middling” by Kaiser (1970). Such a
result suggests that factor analysis will be able to produce distinct and reliable
factors.
The third aspect of the dataset to be considered prior to conducting factor analysis
was the inter-item correlation matrix for evidence of communalities between the
items. A communality is the degree to which an item correlates with all other items
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from the same scale. As can be seen from the inter-item correlation table in Appendix
D there are numerous inter-item correlations above 0.30, further strengthening the
evidence that the data is suitable for factor analysis. More than half of the inter-item
correlations were at least 0.30 suggesting that the scale can be meaningfully factor
analyzed.
The data was also examined for evidence of multicollinearity and singularity which
tends to occur with items which are highly correlated. Evidence of multicollinearity
would mean that items may need to be amalgamated or removed as they may be
redundant. DeVellis (1991) recommends removing items prior to factor analysis if
their inter-item correlations are above 0.75. In the present study the highest inter-item
correlation obtained was between ‘mood change’ and ‘medication’ (r=0.736). This
particular correlation was not considered problematic as the two items appear to be
measuring two distinct constructs, namely enhancing medication compliance and
mood management, which did not support an amalgamation of items. Thus both
items were retained in the PCSES as they are important clinically and they are
unable to be amalgamated in a meaningful way. The second highest inter-item
correlation was r=0.574 between ‘responsibilities’ and ‘unappreciative’ which was not
deemed problematic as it was well below the recommended correlation cut-off of
0.75. Evidence of multicollinearity can also been obtained from the determinant value
from the inter-item correlation table (see Appendix D). The determinant value was
found to be 0.00001224 which is greater than 0.00001 suggesting there is no
evidence of multicollinearity. In summary all of the items of the PCSES correlate fairly
well and none of the correlation coefficients are particularly large. As a consequence
there is no need to consider eliminating any items of the PCSES at this stage.
Although factor analysis is usually conducted on large samples, as few as 100 cases
can often be sufficient when the number of variables is not excessive (Arrindell & van
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der Ende, 1985). Some argue that sample sizes as low as 50 can be adequate for
exploratory factor analysis (Sapnas & Zeller, 2002). The participants per item ratio
was approximately 3.5 : 1 in the present study. A large review of psychology scale
development studies over a ten year period (1995 to 2004) found the modal
participants to item ratio to be 3 : 1 (Worthington & Whittaker, 2006). Participant to
items ratios less than 3 : 1 are generally considered too small to produce accurate
results from exploratory factor analysis (Velicer & Fava, 1998). In the present study
the number of variables was not excessive and given the support from the various
tests reported above factor analysis was considered appropriate.
Another data requirement before factor analysis can be considered is data normality.
More specifically, severe deviations from normality tend to be detrimental to the
results of factor analysis. Examination of skewness and kurtosis for both the
individual items of the PCSES as well as subject’s total scores on the PCSES
suggest that the scale may in fact violate normality. The Shapiro-Wilks statistics for
each of the PCSES items and the Total PCSES score also suggested that the data
from the PCSES were not normally distributed (see Appendix D). It has been
recommended that data which are severely non-normally distributed be transformed
prior to conducting factor analysis only if the data are significantly skewed (>2) and/or
significantly kurtopic (>7) (West, Finch & Curran, 1995). Given that the data from this
study did not deviate severely from normality towards the levels recommended by
West et al (1995), it was not deemed necessary to transform the data prior to
commencing factor analysis. Deviations from normality are not usually significantly
detrimental to the results of factor analysis unless deviations are severe.
The presence of outliers also requires attention prior to conducting factor analysis.
Inspection of the box plot identified four outliers (three of which were for high Total
PCSES scores and one for a low Total PCSES score) (see Appendix D). The scores
77
were examined closely and they appeared to be genuine and not a coding or scoring
error, particularly since the PCSES was administered in a face-to-face setting by the
author. Furthermore, self-efficacy scores in general do tend to display ceiling and
floor effects given the nature of the variable being assessed. Given that the mean of
the PCSES and the 5% trimmed mean were almost identical (152.82  & 152.21) this
suggests that the four outliers which were identified were not having a significant
influence on the mean of the PCSES. The standardized PCSES scores were also
examined using z-scores of total scores on the PCSES. Using a cut-off off of z=3.5
none of the cases were identified as outliers, further suggesting that the four outliers
identified originally from the box plot did not need to be removed prior to commencing
factor analysis.
Prior to conducting exploratory factor analysis the communalities of all the items on
the PCSES were examined, that is the corrected item-total correlations. The
corrected item-total correlations determine if any of the PCSES items fail to have
responses that vary in line with those for the overall PCSES score. Any item which
does not correlate well with the scale overall is usually removed from the scale. All
item-total correlations for each item of the PCSES were positive and all were above
0.20. Three items had low correlations of 0.220 (u and a free), 0.221 (support) and
0.227 (buy d and a). Given that the Cronbach alpha of the scale was virtually the
same if these items were to be deleted it was not considered necessary to remove
these items from the PCSES (see Appendix D).
In summary, the results from the above tests suggest that the data from Study 1 were
suitable for factor analysis and that the results from factor analysis are likely to
produce meaningful results.
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Exploratory Factor Analysis
Exploratory factor analysis (EFA) was chosen over confirmatory factor analysis
(CFA) as CFA requires the researcher to specify the number of factors which are
based on previous research and theory prior to the analysis. Where no a priori
common factors have been identified Fabrigar et al (1999) have recommended that
EFA be used instead of CFA. Given that there has not been any prior research in the
area of partner coping self-efficacy in the addictions field and that there is no strong
theoretical basis for making assumptions about the type of common factors which
may exist, EFA was considered to be the most appropriate option for analysis of the
data in the present study. Fabrigar and his colleagues (1999) have suggested using
EFA in the first instance in order to make initial assumptions about the model and
then follow this up over multiple different data sets using CFA to see if the same
number of factors can be replicated.
EFA does not discriminate between variables in terms of whether they are
independent or not. EFA allows one to find the underlying dimensions or factors that
exist in a set of data. EFA examines the inter-correlations between the variables and
then reduces the data into a smaller number of factors.
Given the evidence presented above suggesting that the distribution of data were
unlikely to be normally distributed, principal axis factoring was considered the most
appropriate factor extraction method for the data. EFA with principal axis factoring
was selected as opposed to maximum likelihood as this approach does not require
the data to be normally distributed and it is commonly used in the literature. Fabrigar
et al (1999) have suggested that when the assumption of normality is “severely
violated” the optimal factor extraction technique one should use is principal axis
factoring. Principal axis factoring using oblique rotation was chosen in the present
study due to the fact that oblique rotations, as opposed to orthogonal rotations,
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permit correlations among the factors whereas orthogonal rotation requires the
factors to be uncorrelated. Despite the lack of previous research examining partner
coping self-efficacy in the addictions field it was likely that the factors of the PCSES
would be in some way correlated. From oblique rotation the meaning of the factors is
determined from the pattern matrix, which displays the relationship between each
factor and each scale item. The pattern matrix is not affected by factor overlap and
uses partial correlations whereas the structure matrix uses zero-order correlations
and is not as useful when interpreting which variables load onto which factors
(Tabachnick & Fidell, 2001). Principal axis factoring is preferred to principal
components analysis as it only analyses common variance which is essential for
theory development. Oblique rotation using oblimin (delta = 0) rotation was
performed given one would expect to see relationships between the factors.
When determining the number of factors to retain from EFA the following seven
recommended criteria were followed:
1. The first criterion was the Kaiser criterion which states that the eigenvalues must
be greater than or equal to one in order to be retained in the factor extraction
process.
2. The second criterion for factor retention was that factor loadings greater than or
equal to 0.30 were only retained for interpretation. It has been recommended that if
items load less than 0.30 on any factor they should be deleted from the scale and
another factor analysis be performed on the remaining items (Tabachnick & Fidell,
1996). Ideally items should only load on one factor however when there is evidence
of strong cross-loadings across factors, that is loadings above 0.50 on more than one
factor, it has been recommended that such items be removed from the scale
(Costello & Osborne, 2005).
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3. Visual inspection of the scree plot was the third criterion considered when
determining the number of factors to retain. The scree plot is a graphical
representation of the eigenvalues in descending order linked with a line. The scree
plot test requires one to look at the scree plot and locate the point at which the slope
of the plot “breaks” and approaches zero in order to determine the optimal number of
factors to retain. Unfortunately the scree test has been criticized by many as it is a
subjective test and it is often ambiguous especially when there are more than one
clear breaks in a plot (Hayton, Allen & Scarpello, 2004). As a result the least weight
was placed on this particular criterion compared to the other criteria for factor
retention.
4. The fourth criterion for factor retention was Horn’s parallel analysis which was
conducted in order to confirm the final number of factors given the exploratory nature
of this study and that the results of most scree plots are often rather subjective and
thus inaccurate. A parallel analysis is considered by most in the literature as the most
optimal and most accurate factor retention method available (E.g. Ford, MacCallum &
Tait, 1986 ; Hayton, Allen & Scarpello, 2004). Despite this, parallel analysis appears
to be the least utilized factor extraction method as seen from published studies
(Fabrigar et al., 1999), possibly because it is not included in common statistical
programs, such as SPSS. Parallel analysis involves generating a random data matrix
(also known as a Monte-Carlo simulation) with the same parameters as the actual
data from Study 1 which if factor analyzed produce randomly generated eigenvalues.
These randomly generated eigenvalues are then compared to those from the
eigenvalues obtained in the original dataset in order to determine an upper limit on
the number of factors which should be extracted (Horn, 1965). In the present study
parallel analysis was conducted after entering O’Connor’s (2000) “rawpar” syntax into
SPSS.
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5. The fifth criterion for model selection was the total percentage of variance
explained by each model with larger percentages of variability accounted suggestive
of a more ideal model.
6. The sixth criterion to be considered was the number of items per factor. Ideally
each factor should contain at least three items (Fabrigar et al., 1999).
7. The last criterion to be considered in the model selection process was that the
factors must be meaningfully interpreted and they must make theoretical sense.
In terms of meeting the seven criteria for the initial factor analysis  :
1. All 24 items of PCSES were factor analysed using EFA direct oblimin oblique
rotation (delta=0) using principal axis factoring. The initial factor analysis provided
evidence for a 7 factor model based on the number of eigenvalues greater than or
equal to one criterion (see Appendix D). The first factor had an eigenvalue of 6.711,
the second factor had an eigenvalue of 2.311, the third factor had an eigenvalue of
1.696, the fourth factor had an eigenvalue of 1.579, the fifth factor had an eigenvalue
of 1.332, the sixth factor had an eigenvalue of 1.180 and the seventh factor had an
eigenvalue of 1.084.
2. From this initial seven factor model, items were examined to see if they loaded
more than 0.3 on a particular factor from the generated pattern matrix. All items
loaded at least 0.30 on one of the seven factors except for one item (Item 9 “practical
tips” ) which loaded only slightly less than the recommended 0.30 cut-off at  -0.289
on the seventh factor. This item was retained due to its clinical significance. The
highest item loading was 0.94 for Item 11 (“stress worry”) on factor 4, followed by
Item 1 (“mood change”) which produced a loading of 0.840 on factor 1. The average
loading for the 24 items on the PCSES was 0.540.
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The pattern matrix of the initial factor solution was also examined for the presence of
cross-loadings, that is items which load heavily (with a cut-off of 0.30) on more than
one factor. In the present study eight items cross-loaded across two factors (Item 2
“suicidal”, Item 5 “embarrassed”, Item 6 “blames u”, Item 7 “not understand”, Item 10
“low mood”, Item 12 “bored”, Item 13 “no effort”, and  Item 14 “lies”). However none
of these items displayed strong cross loadings above 0.50 across two factors. It has
been recommended that cross-loadings should not be deleted from a scale until the
final factor solution of the scale is finalized because a cross-loaded item could be
retained if the factor on which it is cross-loaded is later deleted or collapsed into
another existing factor during the factor analysis process (Worthington & Whittaker,
2006). As a result it was decided that these items would be retained given it is early
in the factor extraction process and the fact that they only displayed weak cross-
loadings.
3. Examination of the scree plot indicated either a 2 or 3 factor solution (see
Appendix D).
4. Parallel analysis was run on two different randomly generated datasets, one with
N=100 datasets and the other with N=1000 datasets to further verify the results. The
confidence level was set at  the 95th percentile. Given that the data from study one
were not normally distributed as shown from Shapiro-Wilks test results and item
normality testing, (see Appendix D) the parallel analysis was to set to generate
random data based on permutations of the original Study 1 (n=83) raw data set,
which is apparently the most robust approach to use with data that are not normally
distributed (O’Connor, 2000). When entering the syntax the following information was
specified : both 100 datasets and 1000 datasets to be computed, both at the 95th
percentile alpha level. The results obtained for both randomly generated parallel
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analyses were consistent in that the results of both suggest the presence of no more
than 4 statistically significant eigenvalues (see Appendix D) suggesting that a
maximum of 4 factors be retained.
5. This initial seven factor model accounted for a total of 66.221% of the total
variance. The first factor accounted for 27.96% of the total variance, the second
factor accounted for a further 9.629% of the total variance, the third factor accounted
for a further 7.068% of the total variance, the fourth accounted for a further 6.578% of
total variance, the fifth accounted for a further 5.551% of total variance, the sixth
accounted for a further 4.916% of variance and the seventh eigenvalue accounted for
a further 4.515% of the total variance.
6. The seven factors consisted of 5,2,2,4,2,6 and 3 items respectively.
7. Some of the seven factors did not make theoretical sense and were not easily
interpretable.
Given the results from the above criteria the seven factor model was not considered
optimal. As a consequence factor analyses were performed to determine whether a 2
factor, 3 factor or 4 factor solution were superior in structure and interpretability.
The 4 factor solution
A 4 factor solution was forced using oblique rotation, principal axis factoring (oblimin,
delta = 0) (see Appendix D & Table 3.) From this analysis four factors which
accounted for 51.239% of the total variance were obtained. Factor one accounted for
27.964% of the variance, factor two accounted for 9.629% of the variance, factor
three accounted for 7.068% of the variance and the fourth factor accounted for
6.578% of the variance. Eigenvalues ranged from 6.711 to 1.579. Factor one
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consisted of 6 items, Factor 2 was made up of 7 items, Factor 3 consisted of 7 items
and Factor 4 was made up of 4 items. Fabrigar et al (1999) recommend that each
factor should consist of at least 4 variables whereas Tabachnick & Fidell (2001)
suggest that each factor should consist of at least 3 variables.
All items had factor loadings of at least 0.3 on one factor with the lowest factor
loading being 0.313 (Item 17 “not criticise”) and the highest being 0.857 (Item 11
“stress worry”). The four factor solution provided fewer cross-loaded items when
compared to the original seven factor model in that only five items had cross-loadings
greater than 0.30 across more than one factor. These five items were:
 1. Item 4 “not interact” which cross loaded onto Factor 1 and Factor 3.
 2. Item 6 “blames u”  which cross loaded onto Factor 1 and Factor 3,
 3. Item 7 “not understand” which cross loaded onto Factor 1 and Factor 3,
 4. Item 12 “bored” which cross loaded onto Factor 1 and Factor 4,
 5. Item  19 “buy d and a” which cross loaded onto Factor 1, Factor 2 and Factor 3.
None of the cross-loaded items displayed strong cross-loadings greater than 0.50
across more than one factor. Each item displaying cross-loadings in this model and
all subsequent models examined in the present study was assigned to the factor on
which it had the highest factor loading.
Factor 1 consisted of 6 items with high positive loadings on items relating to
comprehensive patient care, such as assisting the patient with mood management,
management of suicidality, medication compliance, and avoiding interaction when
intoxicated. Two items from Factor 1 appeared to tap into the partner not getting
angry with the patient’s challenging alcohol/drug-related behavior. As a result Factor
1 was labelled “Comprehensive Care”.
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Factor 2 was made up of 7 items which loaded positively on items associated with
encouraging and supporting abstinence in the patient. More specifically Factor 2
consisted of items relating to spending quality time with one’s partner when he/she is
abstinent, not using/drinking in front of the patient, not arguing with the patient or
taking care of them when they are intoxicated/drug-affected, not purchasing
drugs/alcohol for the patient and not bringing up past upsetting drug and alcohol-
related incidents. Factor 2 also consisted of one item which appeared to tap into a
different construct, namely partner self-care, that is the partner getting support for
themselves if needed. Factor 2 was thus labelled “Reinforcing Abstinence”.
Factor 3 consisted of 7 items all of which had high negative loadings on situations
which partners consider challenging situations and not responding negatively (such
as by getting angry or criticizing the patient) but instead continuing to display
commitment to helping their partner by offering positive support and assistance even
when faced with such challenging situations. This factor consisted of items which
included the partner feeling blamed, being accused of not understanding the patient,
their efforts not being appreciated by the patient and being lied to by the patient. The
emphasis in Factor 3 was on the partner feeling “challenged” and yet still continuing
to offer positive support. As a result Factor 3 was labelled “Resilience”.
Four items with large positive loadings comprised Factor 4. All of the items in this
factor related to high risk situations for patients which produced negative mood states
(depression, stress and worry, boredom, decreased motivation to change their
alcohol/drug use). As a consequence Factor 4 was labelled “Negative Affect”.
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Table 3. Four factor pattern matrix for the PCSES.
Pattern Matrix
Item Factor
1 2 3 4
3. medication 0.684
1. mood change 0.650
4. not interact 0.634 .
5. embarrassed 0.617
2. suicidal 0.605 .
8. criticise 0.476
20. sick 0.554
22. quality time 0.489
21. intoxicated 0.478
19. buy d and a 0.442
23. support 0.411
24. u d and a free 0.378
18. the past 0.366
16. responsibilities -0.701
15. unappreciative
14. lies
7. not understand
6. blames u
9. practical tips
17. not criticise
-0.666
-0.518
-0.496
-0.420
-0.325
-0.313
11. stress worry 0.857
10. low mood
12. bored
14. lies
0.562
0.509
0.313
Coefficient Alpha 0.839 0.634 0.818 0.755
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Internal consistency for each of the four factors was examined and found to be high
for most of the factors. Internal consistency for Factor 1 was high (coefficient alpha
=0.839). Internal consistency for Factor 1 was not enhanced by deleting any items.
Correlations between each item and the sum of all remaining items on the PCSES if
that item were to be removed within each factor were examined from the corrected
item-total correlations statistic (see Appendix D). This statistic provided further
information about each item’s internal consistency. Kline (2002) has recommended
deleting items with corrected item-total correlations less than 0.30. All corrected item-
total correlations were high, ranging from 0.531 (“embarrassed”) to 0.707 (“mood
change”), suggesting that Factor 1 had excellent internal consistency. Internal
consistency for Factor 2 was adequate for a newly developed scale though not
exceptional (Coefficient alpha = 0.634). Corrected item-total correlations ranged from
0.226 (“buy d and a”) to 0.532 (“sick”) which are considered acceptable. Internal
consistency was not enhanced by removing any of the seven items of which it was
comprised which led the author to retain the item “buy d and a” in the scale. Factor 3
displayed excellent internal consistency (coefficient alpha=0.818) which was not
improved by deleting any items from this factor. Corrected item-total correlations for
Factor 3 were all high, ranging from 0.408 (“not criticize”) to 0.659 (“lies”). Factor 4
also displayed good internal consistency (coefficient alpha=0.755) with only marginal
improvement in internal consistency (coefficient alpha = 0.766) if one item
(“no effort”) were to be deleted. Given the fact that item removal would not have a
great impact on an already high internal consistency coefficient it was decided that
the item “no effort” be retained in the scale.
Examination of the factor correlation matrix revealed the presence of low correlations
between the four factors (see Appendix D). The smallest correlation was 0.110
between Factor 2 and Factor 4 whereas the largest correlation was found to be 0.282
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which was between Factor 1 and Factor 4. Given such low correlations this suggests
that the four factors are distinct and independent from each other and the PCSES
does not fit into a single factor model.
The 3 factor solution
When a 3 factor model was forced using principal axis factoring with oblique rotation
(oblimin, delta=0), it produced a model with the least amount of total variance
explained when compared to the previous factor analyses. The total amount of
variance explained by the 3 Factor model was 44.661% with the first factor
accounting for 27.964 % of  the variance, the second factor accounting for 9.629% of
the variance and the third factor accounting for 7.068 % of the variance.
As can been seen from the pattern matrix in Table 4 all items had factor loadings of
at least 0.3 on one factor with the lowest factor loading being 0.32 (“not criticize”) and
the highest being 0.777 (“mood change”). Factor 1 consisted of 13 items, Factor 2
consisted of 7 items and Factor 3 was made up of 4 items. Five items significantly
cross-loaded across factors although only slightly. These cross loaded items were:
1. Item 7 (“not understand”) which cross loaded onto Factor 1 and Factor 3.
2. Item 14 (“lies”)  which cross loaded onto Factor 1 and Factor 3.
3. Item 15 (“unappreciative”) which cross loaded onto Factor 2 and Factor 3.
4. Item 16 (“responsibilities”) which cross loaded onto Factor 2 and Factor 3.
5. Item 19 (“buy d and a”) which cross loaded onto Factor 2 and Factor 3.
None of the cross-loaded items displayed strong cross-loadings greater than 0.50
across more than one factor.
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Table 4.  Three factor pattern matrix for the PCSES.
Pattern Matrix
Item Factor
1 2 3
1. mood change 0.777
3. medication 0.724
4. not interact 0.715
12. bored 0.703
2. suicidal 0.631
10. low mood 0.616
7. not understand 0.553
11. stress worry 0.538
5. embarrassed 0.528
8. criticise 0.522
9. practical tips 0.506
6. blames u 0.413
13. no effort 0.383
20. sick
21. intoxicated
0.583
          0.516
18. the past . 0.469
22. quality time 0.454
24. u d and a free 0.398
23. support 0.352
16. responsibilities
15. unappreciative
19. buy d and a
14. lies
-0.572
-0.527
0.449
-0.433
Coefficient Alpha 0.880 0.639 0.578
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Internal consistency for Factor 1 was excellent (coefficient alpha = 0.880) and no
items had to be removed from the scale in order to improve its internal consistency
(see Appendix D). Examination of the corrected item-total correlations revealed that
all of the items comprising Factor 1 had adequate correlations between 0.409 to
0.692 suggesting that this particular factor is reliable. Factor 2 produced an internal
consistency coefficient which was almost acceptable (coefficient alpha = 0.639) and
item removal did not make the factor more reliable which resulted in all items being
retained in this factor. The lowest corrected item-total correlation was for “not
criticize” (r = 0.239) and the highest correlation was found to be r = 0.479 for “sick”.
Factor 3 had a coefficient alpha level which was poor to questionable (coefficient
alpha=0.578). One item from Factor 3 “buy d and a” produced a rather low corrected
item-total correlation of -0.025 suggesting that this item was problematic. Internal
consistency for Factor 3 improved dramatically from coefficient alpha= 0.578 to 0.761
if this particular item were to be removed from the factor. The remaining three items
which comprised Factor 3 all had very good corrected item-total correlations all
above 0.456. The item “buy d and a” was not removed at this exploratory stage of
factor analysis however its progress needs to be reviewed at the confirmatory factor
analysis level in order to determine whether it continues to perform poorly. Factor 3
comprised 4 items of which all but one (Item 19 “buy d and a”) loaded negatively on
this factor. Item 19 cross loaded highly on both Factor 2 (0.411) and Factor 3 (0.449)
and despite showing a slightly higher loading for Factor 3 the item appeared to
conceptually fit better into Factor 2 which assessed supporting abstinence which this
item appeared to assess directly. Given this it was considered a better option to
place Item 19 into Factor 2. Internal consistency for Factor 2 increased from 0.639 to
0.648 by adding this item to this factor. Also the corrected item-total correlation for
Item 19 improved from a negative value of -0.025 to an acceptable level of 0.255. By
removing Item 19 from Factor 3 internal consistency for this factor increased
dramatically from 0.578 to 0.761.
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Factor 1 consisted of 13 items with high positive loadings which shared a theme of
negative affect. More specifically, the items from Factor 1 assessed confidence in a
variety of high risk situations which were negative mood states for both the partner
and the patient. For instance it included items in which the partner was asked how
confident he/she was in being able to refrain from getting angry when the patient has
embarrassed them, when the patient blames them for their substance use problem or
claims they do not understand or claims they nag them too much. Similarly this factor
comprised items which assessed confidence to assist their partner change their
substance use when the patient was experiencing a number of negative affect states
such as depression, stress/worry, and boredom. Consequently Factor 1 was labelled
Negative Affect.
Seven items made up Factor 2, all of which loaded positively on what appeared to be
a common theme of supporting abstinence and not criticizing the patient. More
specifically items from Factor 2 assessed self-efficacy for not criticizing or bringing up
past incidents as well as avoiding the patient when intoxicated or recovering from
intoxication, refraining from supplying drugs/alcohol or using drugs/alcohol in front of
the patient and spending quality time together when the patient was abstinent.
Supporting Abstinence was the label assigned to Factor 2 of this particular model.
The remaining three items from Factor 3 appeared to share a common theme of
assisting one’s partner when he/she does not appear to be truthful about their
substance use or appreciative of assistance, and neglecting their usual
responsibilities due to continued substance use which are common occurrences
when a patient’s readiness to change their substance use problem is questionable or
low to begin with. As a result Factor 3 was labelled Readiness to Change.
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Support for the discriminant validity of the 3 factors was obtained from the factor
correlation matrix which found all of the factor correlations were low. More specifically
Factor 1 and Factor 2 produced a correlation of r = 0.343, Factor 1 with Factor 3
produced a correlation of r = -0.198, and Factor 2 with Factor 3 produced a
correlation of r = -0.166.
Two of the three factors from this model displayed inadequate internal consistency.
More specifically, Factor 3 of this model displayed poor internal consistency (coeff
alpha=0.578) and in addition to this Factor 2 was only just acceptable in terms of
internal consistence (coeff alpha=0.639). Given this and the fact that this model
accounted for less than half of the total variance (44.66%) it was rejected.
The 2 factor solution
When a 2 factor solution was forced using Principal Axis Factoring, direct oblimin
rotation the model produced accounted for 37.593% of the variance (see Appendix
D). When considering extracted components with factor loadings greater than or
equal to 0.30 the first 13 items of the PCSES comprised Factor 1, as can be seen in
Table 5. Factor 2 consisted of 9 items. Two items (Item 19 “buy d and a” and Item 22
“quality time”) did not load above 0.30 on either factor. Item 22  “quality time”
produced a maximum loading of 0.296 which just fell below the 0.30 cut off and it
was thus retained into Factor 2. On the other hand Item 19 “buy d and a” produced a
maximum loading of 0.177 which was well below the cut off of 0.30 for factor loading.
Although most researchers tend to discard items which load less than 0.30 on any
factor this item was retained as it is a clinically useful item in that it provides valuable
information about which partners are not confident in being able to refrain from
buying drugs/alcohol for their partner. This item was grouped into Factor 2 because
conceptually it related to maintaining abstinence.
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From the 2 Factor model only produced two items with cross loadings across both
factors. These items were Item 6 (“blames u”) and Item 14 (“lies”). None of the cross-
loaded items displayed strong cross-loadings greater than 0.50 across more than
one factor.
Factor 1 consisted of 13 items with positive loadings. Internal consistency for Factor
1 was excellent (coefficient alpha=0.880). Internal consistency did not improve with
item deletion, thus all items from Factor 1 were retained. Corrected item-total
correlations were all adequate, ranging from 0.409 (“no effort”) to a high of 0.692
(“not interact”) (see Appendix D). Factor 2 consisted of 11 items and produced
evidence of good internal consistency (coefficient alpha = 0.744). Item 19 (“buy d and
a”) produced a low corrected item-total correlation of 0.165, however this item was
not removed as internal consistency did not increase drastically enough to warrant
item removal. Also this item was retained due to the item’s clinical significance. The
remaining items from Factor 2 produced adequate corrected item-total correlations
which ranged from 0.329 to 0.515.
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Table 5. Two factor pattern matrix for the PCSES.
Pattern Matrix
Item
Factor
1 2
1. mood change 0.787
3. medication 0.733
4. not interact 0.711
12. bored 0.701
2. suicidal 0.632
10. low mood 0.620
11. stress worry 0.537
7. not understand 0.535
5. embarrassed 0.529
8. criticise 0.511
9. practical tips
6. blames u
0.495
0.401
13. no effort 0.377
16. responsibilities 0.660
15. unappreciative 0.619
20. sick
21. intoxicated
0.502
0.500
 14. lies 0.446
18. the past 0.439
17. not criticise 0.411
23. support 0.360
24. u d and a free
22. quality time
0.327
        0.296
19. buy d and a 0.177 0.078
Coefficient Alpha 0.880 0.744
95
All 13 items from Factor 1 had positive loadings and they shared a common theme
surrounding mood management, medication management, and negative mood states
which were high risk situations for patients. The items comprising Factor 1 were
identical to those comprising Factor 1 from the 3 Factor model and consequently
Factor 1 was labelled Negative Affect. Factor 2 on the other hand consisted of all of
the items which made up Factor 2 (Supporting Abstinence) and Factor 3 (Readiness
to Change) from the 3 Factor model and was thus labelled Change – Abstinence.
Factor 2 was not comprehensible theoretically, instead it appeared to consist of two
distinct factors which happened to be grouped together as a result of the factor
analysis.
The correlation between Factor 1 and Factor 2 in this 2 Factor model was moderately
high at r = 0.401 which suggests that the two factors may not be distinct and
independent from each other, indicating the possibility of the presence of another
factor. Furthermore such a result confirms that the PCSES does not fit into a single
factor model.
Given the fact that there appeared to be evidence of a third factor and that the 2
Factor model was not comprehensible and that this model accounted for the least
amount of total variance (37%) out of all models examined thus far it was rejected.
Model Selection
Given the results from the EFA and the fact that results from the parallel analysis
revealed a maximum of 4 factors be retained and the fact that the 4 Factor model
was the most comprehensible of all models examined, the 4 Factor model was
selected. Characteristics of the 4 Factor model are presented in Table 6.
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Table 6. Characteristics of the 4 Factor model.
Factor 1 Factor 2 Factor 3 Factor 4
Mean 40.12 49.85 42.25 22.51
Std. Error of Mean 1.29 1.19 1.43 .99
Median 39.00 50.00 42.00 23.00
Mode 36.00 43.00a 40.00a 26.00
Std. Deviation 11.79 10.84 13.07 9.07
Variance 138.91 117.47 170.70 82.30
Skewness .24 -.11 .13 .04
Std. Error of
Skewness
.26 .26 .26 .26
Kurtosis -.42 -.16 -.14 -.52
Std. Error of
Kurtosis
.52 .52 .52 .52
Minimum 14.00 21.00 9.00 4.00
Maximum 65.00 77.00 77.00 44.00
Coefficient Alpha 0.839 0.634 0.818 0.755
a. Multiple modes exist. The smallest value is shown
Reliability of the PCSES
Test-retest reliability is used to measure the consistency of scores on a test from one
testing time to another. Test-retest reliability was assessed on a subset of 15
partners who completed the PCSES again 2 weeks after the initial administration.
Test-retest reliability was found to be high (r = 0.89) for Total PCSES scores. For
Factor 1 test-retest reliability was 0.91, for Factor 2 it was 0.86, for Factor 3 it was
0.89 and for Factor 4 it was 0.88.
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Internal consistency for the Total PCSES score was excellent (coeff alpha=0.882).
Examination of each of the 24 items of the PCSES individually suggested that
removal of any of the items would not result in significant improvements in internal
consistency (see Appendix D). Coefficient alpha for each of the four factors of the
PCSES as seen in Table 6 was 0.839 for Factor 1, 0.634 for Factor 2 , 0.818 for
Factor 3 and 0.755 for Factor 4. Another measure of a scale’s internal consistency
can be obtained from item-total correlations. Items displaying low correlations below
0.2 are usually removed from scales. All the corrected item-total correlations were
positive. The lowest corrected item-total correlation was found for two items from
Factor 2 of the PCSES, namely “buy d and a” (r = 0.226), and “support” (r = 0.276).
Given that Cronbach alpha for Factor 2 did not improve at all if these two items were
to be removed from the scale they were subsequently retained.
Comparison of Male & Female Partner’s Scores on the PCSES
In order to compare females and males on their Total PCSES scores a non-
parametric test had to be used given that the measurement variable, that is PCSES
scores, do not meet the normality assumption. The Kruskal-Wallis H Test was used
to determine if there is a statistically significant difference between females and
males on their PCSES scores. The null hypothesis for the Kruskal-Wallis H Test
states that the two samples come from populations such that a random observation
from one group is greater than a random observation from another group using a
probability of 0.5. Results from the Kruskal-Wallis H Test suggest that there is no
statistically significant difference between females and males on Total PCSES scores
(H(1)=0.540, p=0.462), with females displaying a mean rank of 40.98 and males
displaying a mean rank of 45.69. Although female partners were more likely to report
lower Total PCSES scores compared to male partners there was no significant
gender difference observed.
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In order to determine whether gender differences exist for the PCSES’s 4 Factors an
independent samples t-test was conducted given that the 4 factor scores were found
to be normally distributed. Means and standard deviations for the 4 factors for
females and males are presented in Table 7 below. From the independent samples t-
test equal variances for all 4 Factors can be assumed. Overall, no statistically
significant difference between males and females was observed on any of the 4
factor scores of the PCSES. More specifically, no significant gender difference in
Factor 1 scores was observed (t(81)=-0.19, p=0.985), nor in Factor 2 scores (t(81)=-
0.553, p=0.582). Similarly, no significant gender difference was found in Factor 3
scores (t(81)=-1.195, p=0.236) or in Factor 4 scores (t(81)=0.588, p=0.558).
Table 7. Mean & standard deviation for males & females
 for the PCSES 4 Factor model.
Females
 mean (sd)
Males
mean (sd)
Factor 1 40.11 (12.195) 40.17  (10.5)
Factor 2 49.51 (11.03) 51.11 (10.32)
Factor 3 41.35 (13.09) 45.5 (12.81)
Factor 4    22.82 (9.25) 21.39 (8.54)
Construct Validity
Given that there is no published scale which assesses partner coping self-efficacy in
the addictions field available the PCSES cannot be compared to any other similar
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test, let alone a “gold standard” which is usually required to provide evidence for
construct validity. As a consequence construct validity was supported by a number of
significant correlations between the PCSES and other variables such as anxiety and
depression. Pearson product moment correlations could not be used to identify
potential correlations as this test is inaccurate when used on samples with
distributions displaying kurtosis and/or skew. Kendall’s Tau – b rank correlation
coefficient was chosen to assess correlations instead of Spearman’s Rho as
Spearman’s Rho requires a monotonic relationship between the two variables being
examined which was not always present with some of the variables as evident from
scatter plots of the variables. Kendall’s Tau statistic does not rely on any
assumptions about the distribution of the two variables and it measures the strength
of the relationship between the two variables, unlike Spearman’s rank correlation
coefficient. Kendall’s Tau statistic measures the number of concordances and
discordances in a paired observation to provide a measure of the orderings of the
data. A number of relationships between the PCSES and partner variables as well as
patient variables were examined.
Patient Variables & PCSES
No significant relationship was found between the PCSES and any of the three
HADS scores (Anxiety subscale, Depression subscale & Total score) as can be seen
from Table 8. A significant negative small association (r=-0.164) was found between
Total PCSES and total number of years in current relationship which suggests that
patients who had been in their current relationship for longer were significantly more
likely to have a partner with lower overall coping self-efficacy. A significant negative
relationship was also observed between total number of years in current relationship
and Factor 2 and Factor 3 of the PCSES. However a significant positive relationship
between Factor 1 “Comprehensive Care” and total number of years in current
relationship was found which suggests that those who had been together for longer
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tended to have partners who were more confident at providing comprehensive care
but less confident coping with reinforcing abstinence situations (Factor 2) and less
confident with more challenging situations grouped under Factor 3 “Resilience”.
Despite these findings there was no significant relationship observed between total
number of years patients reported that they had a drug and alcohol problem and
Total PCSES scores. A significant positive relationship was found only between total
number of years drug and alcohol problem and Factor 1 “Comprehensive Care”. No
significant relationship between PCSES and average patient drug and alcohol self-
efficacy scores were observed. The results also failed to find a significant relationship
between patient’s helplessness, as assessed by the Alcohol Helplessness Scale, and
their partner’s scores on the PCSES. There was also no significant relationship
observed between partner’s scores on the PCSES and patient’s scores on both the
Emotion-Focused Coping score of the WOCQ and the Problem-Focused Coping
score of the WOCQ.
A small positive though statistically significant association was found between
partner’s Total scores on the PCSES and patient’s reported suicidal ideation, as
assessed by the Beck Scale for Suicidal Ideation (r= 0.175, p=0.034). Such a result
suggests that in the present sample partner’s high in self-efficacy were more likely to
have a partner who was reporting more suicidality than those whose partners were
low in coping self-efficacy. The only significant association which was observed
between PCSES and patient’s reports of drug and alcohol-specific support or general
support, as assessed by the Support Scale (SSS), was between Factor 3
“Resilience” and Drug and Alcohol Specific Support (r=0.174). This finding suggests
that partners who were high on Resilience coping self-efficacy, that is more confident
coping with more challenging situations, were more likely to be rated by the patient
as providing more helpful drug and alcohol-specific support.
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Table 8. Patient variables & the PCSES.
PCSES Total PCSES
Factor 1
PCSES
Factor 2
PCSES
Factor 3
PCSES
Factor 4
HADS Total r = -0.045
p = 0.562
r=0.022
p=0.776
r=-0.139
p=0.073
r=0.042
p=0.589
r=-0.04
p=0.605
HADS
Depression
r = 0.006
p = 0.937
r=0.040
p=0.612
r=-0.110
p=0.161
r=0.083
p=0.285
r=0.025
p=0.751
HADS
Anxiety
r = -0.079
p = 0.309
r=0.014
p=0.862
r=-0.150
p=0.056
r=0.005
p=0.946
r=-0.123
p=0.119
Total Years
Relationship
r = -0.164
p = 0.034  *
r=0.327
p=0.000 *
r=-0.159
p=0.040 *
r=-0.158
p=0.041 *
r=-0.101
p=0.192
Total Years
D&A
Problem
r = -0.06
p = 0.464
r=0.259
p=0.002 *
r=-0.025
p=0.762
r=-0.033
p=0.692
r=-0.145
p=0.079
Controlled
Drinking
Self-Efficacy
r = 0.071
p = 0.398
r=0.045
p=0.546
r=-0.065
p=0.513
r=0.185
p=0.092
r=0.044
p=0.869
Alcohol
Helplessness
Scale
r = 0.006
p = 0.949
r=-0.066
p=0.449
r=-0.027
p=0.753
r=-0.053
p=0.540
r=-0.089
p=0.306
Emotion
Focused
Coping
WOCQ
r = -0.065
p = 0.391
r=-0.116
p=0.128
r=0.093
p=0.223
r=-0.093
p=0.221
r=-0.142
p=0.064
Problem
Focused
Coping
WOCQ
r = 0.018
p = 0.81
r=-0.69
p=0.369
r=0.061
p=0.428
r=-0.011
p=0.890
r=-0.110
p=0.152
Beck Scale
for Suicidal
Ideation
r = 0.175
p = 0.034*
r=0.077
p=0.357
r=0.114
p=0.170
r=0.149
p=0.073
r=0.146
p=0.08
D&A Support
Scale of SS
r = 0.124
p = 0.107
r=0.057
p=0.460
r=0.038
p=0.622
r=0.174
p=0.024 *
r=0.081
p=0.294
General
Support
Scale of SS
r = - 0.011
p = 0.884
r=-0.03
p=0.699
r=-0.056
p=0.472
r=0.046
p=0.554
r=0.085
p=0.277
*= significant difference at p <0.05
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Partner Variables & PCSES
No significant association was found between partner’s age and their PCSES Total
score, as seen in Table 9. Despite this a significant and moderate relationship was
found between Factor 1 and age (r = 0.304) suggesting that older partners scored
higher on Factor 1 “Comprehensive Care” of the PCSES. The analysis also failed to
find a significant association between gender and PCSES Total score and any factor
scores. A statistically significant relationship was observed between number of years
in current relationship and Total PCSES score (r=-0.164) suggesting that partners
who had been in their current relationship for longer were less confident overall as
assessed by the PCSES. A statistically significant relationship was also observed
between number of years in current relationship and two of the factors of the PCSES,
that is Factor 2 (r=-0.159) and Factor 3 (r=-0.158). The strongest relationship
between years in current relationship and PCSES was on Factor 1 of the PCSES
“Comprehensive Care” (r=0.327), however the direction of this relationship was in the
opposite direction suggesting that those who had been in their relationship for longer
were more likely to be confident in providing more general care but less confident in
providing more specialized assistance to their partner.
Partner’s total scores on the HADS showed mild to moderate statistically significant
negative associations with Total PCSES scores and all four factor scores. This
suggests that partners who were more emotionally distressed as classified by the
HADS were more likely to display lower coping self-efficacy. Weak to moderate
negative associations which were statistically significant were also found between
partner’s Total scores on the PCSES and most of the four factor scores with scores
on both the Depression subscale of the HADS and the Anxiety subscale of the
HADS. These results indicate that partners who were low in coping self-efficacy were
more likely to display symptoms of depression and anxiety. Weak and significant
relationships were observed between partner’s Total PCSES scores and scores on
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Factor 1 “Comprehensive Care” and Factor 3 “Resilience” with the Emotion-Focused
Coping score of the WOCQ. These results suggest that partners high in coping self-
efficacy were less likely to implement Emotion-Focused coping strategies when
compared to partners low in coping self-efficacy. Weak and significant relationships
were also observed between Total PCSES scores and Factor 4 “Negative Affect” and
the Problem-Focused Coping score of the WOCQ. Such findings demonstrate that
partners high in coping self-efficacy were more likely to implement Problem-Focused
Coping strategies than partners displaying low coping self-efficacy.
Table 9. Partner variables and the PCSES.
PCSES
Total
PCSES
Factor 1
PCSES
Factor 2
PCSES
Factor 3
PCSES
Factor 4
Age r=-0.054
p=0.478
r=0.304
p=0.000 *
r=-0059
p=0.444
r=-0.112
p=0.143
r=0.053
p=0.488
Gender r=0.067
p=0.462
r=0.14
p=0.881
r=0.055
p=0.550
r=0.107
p=0.241
r=-0.063
p=0.496
Years Together r=-0.164
p=0.034 *
r=0.327
p=0.000 *
r=-0.159
p=0.040 *
r=-0.158
p=0.041 *
r=-0.101
p=0.192
HADS total r=-0.379
p=0.000 *
r=-0.183
p=0.018 *
r=-0.188
p=0.015 *
r=-0.394
P=0.000 *
r=-0.184
p=0.018 *
HADS Depression r=-0.405
p=0.000 *
r=-0.167
p=0.034 *
r=-0.237
p=0.003 *
r=-0.410
p=0.000 *
r=-0.123
p=0.116
HADS Anxiety r=-0.270
p=0.001*
r=-0.155
p=0.049 *
r=-0.133
p=0.090
r=-0.273
p=0.001 *
r=-0.220
p=0.005 *
Emotion-Focused
Coping WOCQ
r=-0.215
p=0.005*
r=-0.190
p=0.013 *
r=-0.088
p=0.248
r=-0.286
p=0.000 *
r=-0.101
p=0.188
Problem-Focused
Coping WOCQ
r=0.195
p=0.01*
r=0.131
p=0.086
r=0.125
p=0.102
r=0.104
p=0.171
r=0.160
p=0.036 *
*= significant difference at p <0.05
Face Validity, Content Validity & Reading Ease
Evidence for the PCSES’s face validity was obtained from participant’s responses
and subjective feedback obtained. Participants did not report difficulties answering
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questions on the PCSES due to items not being relevant to them. Furthermore the
expert panel along with the individual focus sessions with partners only
recommended minor grammatical changes be made to the scale. The average time
taken to complete the PCSES was 5 minutes. The readability statistics for the scale
were calculated and the Flesch Reading Ease Score was found to be 49.9 which is
considered acceptable and the Flesch-Kincaid Grade Level was found to be 11.7
(Microsoft Word readability statistic), suggesting that the PCSES is expected to be
understandable by an average student in Year 11.
Results for the Partner Coping Willingness Scale
All 83 partners taking part in the study completed the Partner Coping Willingness
Scale as it was a requirement for ethical approval. Highly skewed results were
obtained for total scores on the Partner Coping Willingness Scale, with the average
total score for the sample being 2160 out of a possible 2400. More specifically,
average total willingness expressed as a percentage was 90%, with 100% being
rated as “very willing”. Minimum willingness was rated at 80% and a maximum was
found to be 100%, with 100% being the modal response. The results from this scale
will not be examined further as they are not theoretically related to the research topic
of self-efficacy and were only examined in this study as it was a requirement for
ethical approval as directed by the Western Sydney Area Health Service’s Ethics
Committee.
Predictive Validity of the PCSES
Of the 83 subjects who completed treatment for their drug or alcohol use problem
only half (N=42) were able to be located 6 months post-treatment for a telephone
follow-up interview. Thirty six of the 42 patients able to be contacted at 6 month
follow-up had received treatment for an alcohol problem, with most of this group
105
having a controlled drinking goal (N=28) as opposed to an abstinence goal (N=8). Six
patients contacted at the 6 month follow-up had been receiving treatment for drug
dependence and all six patients reported a drug abstinence treatment goal. In this
study the term “relapsed” was used to define any subject who had not met their drug
and alcohol treatment goal rather than to define continued alcohol use, given that a
large proportion of patients had a controlled drinking goal. For those patients with a
controlled drinking goal a “relapse” was defined as a period of at least 2 weeks of
excessive alcohol use above the safe drinking levels recommended by the National
Health and Medical Research Council. For patients with an alcohol abstinence goal a
“relapse” was defined as a period of two weeks minimum regular use of alcohol of
any quantity. For the small number of drug users who were able to be contacted at
follow-up (N=6) “relapse” was defined as regular use of the patient’s drug of choice
for a 2 week period. The date of commencement of relapse was calculated from the
number of days since treatment had ended.
Of the 42 subjects who were followed-up 6 months post-treatment, 19% (N=8) were
female patients and 81% (N=34) were male. Of this group of 42 patients 38%
reported relapsing (N=16) and 62% (N=26) reported having met their treatment
goals. Of the group of patients who reported relapsing at the follow-up, the vast
majority (62.5%) reported relapsing in the first month following completion of
treatment. A further 31.25% of this group reported relapsing between 4 and 8 weeks
post-treatment and a further 6.25% reported relapsing 9 to 12 weeks post-treatment.
Interestingly none of the follow-up group reported relapsing during the period 4 to 6
months post-treatment.
The majority of subjects (87.5%) who had reported relapsing at follow-up tended to
be aged less than 49 years of age and only 12.5% of this group were aged over 50
years. Of the 26 subjects who reported at follow-up as having met their treatment
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goals 65% were aged under 30 years of age, 19% were aged between 40 and 49
years, and a further 19% were over the age of 50 years.
In order to assess the PCSES’s predictive validity scores on the PCSES were
dichotomized into two distinct groups, namely “High” and “Low” partner coping self-
efficacy. “Low” scores on the PCSES were defined as a total score less than 132 out
of a possible 264 on the PCSES, that is a mean score on the PCSES less than 50%
but not including 50%. “High” scores on the PCSES were defined as scoring greater
than or equal to 132 out of a possible 264 on the PCSES, that is a mean rating of
greater than or equal to 50%. The selected cut-off score of 132 out of 264 used to
separate the High and Low groups on the PCSES was arbitrary and selected
because it fell midway on the PCSES between the two extremes of the confidence
rating responses on the scale. The “High” group consisted of 32 participants whereas
the “Low” group was comprised of 10 participants. To illustrate the patterns of
prediction graphically, survival functions based on dichotomized
(“High” versus ”Low”) PCSES ratings were plotted using Kaplan-Meier curves of
survival (Figure 1.). From this plot the prognostic value of PCSES scores appear
comparable for both those with “Low” and those with “High” confidence ratings on the
PCSES.
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Figure 1.  Survival curve for “High” versus “Low” PCSES scores.
In order to assess the predictive validity of the PCSES the author had planned a
priori to conduct analyses using the Cox proportional hazards regression model. The
Cox regression test is a non-parametric test which requires two assumptions to be
met before the model can be applied to the data. One of the assumptions is known
as the “proportional hazards” assumption and it specifies that the survival curves for
the two groups must have hazard functions which are proportional over time. This
assumption can be tested graphically by examining a log-minus-log survival function
plot. For this assumption to be met the lines from the two groups on this log-minus-
log plot must be approximately parallel without any lines intersecting. As can be seen
from the log-minus-log plot (see Appendix D) the lines for the two groups (“Low”
PCSES and “High” PCSES) intersected a number of times. As a result, the
proportional hazards assumption was violated which prevented the use of the Cox
regression model to analyze the data.
An alternative non-parametric test to assess equality of survival functions which can
be used when the proportional hazards assumption has been violated is the Gehan-
Breslow-Wilcoxon test. This particular test was selected as it has been found to be a
more sensitive test to use when the ratio of hazards (that is relapses) is higher at
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earlier survival times than at later times (Martinez & Naranjo, 2010). With the present
findings the majority of hazards, that is relapses, (62.5%) occurred in the first month
of the 6 month follow-up period suggesting that this particular test would be the most
appropriate one to use given this data trend. The only assumption made by this
particular test is that one of the sample groups must consistently display a higher risk
of relapse than the other. The mean survival time for the Low PCSES group was
122.3 days (sd=23.75) whereas for the High PCSES group it was marginally longer
at 125.7 days (sd=13.2) .
Results from the Gehan- Breslow -Wilcoxon chi-squared test of equality of survival
distributions suggests that there is no statistically significant difference between the
two PCSES confidence groups (“High” and “Low”) in terms of survival (χ2 = 0.005,
df=1, p=0.946). This failure to find a significant difference between the two
confidence groups is further highlighted by the fact that both groups had almost
identical rates of relapse, that is 40% of the “Low” confidence group relapsed and
similarly 37.5% of the “High” confidence group relapsed.
Given the failure of PCSES to predict relapse from the above results a number of
patient variables were considered to see if they instead could significantly predict
relapse. Such variables included a number of patient demographic variables,
addiction-specific variables, and psychosocial variables. Log-minus-log survival
function plots were produced for each of the variables and all met the criteria for the
use of the Cox proportional hazards regression model. Initially a number of patient
demographic variables were assessed univariately to determine if they could predict
relapse on their own prior to conducting simultaneous entry Cox proportional hazards
regression analysis. None of the patient demographic variables assessed were able
to significantly predict relapse. Some of these patient variables are displayed in Table
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10. Given the lack of significant univariate predictors of relapse the proportional
hazard model with simultaneous entry was not employed.
Table 10. Predictors of relapse.
Patient Variable
No
Relapse
(n)
Relapse
(n)
%
Relapsed
Wald df p
Sex
Male (N=33)
Female (N=9)
20
6
13
3
39%
33%
3.300 1 0.069
Age
≤39 years (N=21)
40– 49 years (N=13)
≥40 years (N=8)
14
6
6
7
7
2
50%
54%
25%
3.001 2 0.223
Primary Substance
Used
Alcohol (N=36)
Heroin (N=2)
Cannabis (N=2)
Amphetamine (N=2)
23
2
1
0
13
0
1
2
50%
0%
50%
100%
6.382 3 0.094
Patient Average D&A
Self-Efficacy
Low (N=20)
High (N=22)
4
12
16
10
80%
45%
0.234 1 0.629
Years D&A Problem
1 year (N=25)
2-5 years (N=19)
6-10 years (N=6)
10-20 years (N=2)
14
10
4
1
9
9
2
1
36%
47%
33%
50%
5.455 3 0.463
Self-Change Attempt
No (N=30)
Yes (N=12)
20
6
10
6
33%
50%
2.327 1 0.136
Prior Treatment
No (N=36)
Yes (N=6)
21
5
15
1
42%
17%
0.213 1 0.899
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Study 1 Discussion
The aim of the present study was to develop, refine and provide initial psychometric
evaluation of a scale created to assess coping self-efficacy in partners of drug and
alcohol users. There is a pressing need both in a clinical and research setting for a
validated standardized scale to assess self-efficacy in partners of substance users
given the current absence of such a scale. Despite the absence of such a scale in
the addictions field, partner coping self-efficacy scales are available in the literature
for a variety of other clinical presentations, such as dementia and cancer. Given that
there are approximately one million partners of drug and alcohol users in Australia
alone, a partner coping self-efficacy scale with adequate psychometric properties
would greatly assist in treatment planning.
Scale Development Process
Given the lack of published partner coping self-efficacy scales in the addictions field
an assessment of published and well-validated scales in the fields of dementia,
cardiology and cancer were examined for common self-efficacy issues and themes.
Emphasis was placed upon selecting items for the scale which assessed a wide
range of care giving domains. Furthermore items considered most challenging for
partners were only included in the scale in order to prevent ceiling effects. It was also
considered important when devising the PCSES to include items which focused on
the partner managing unpleasant emotions/thoughts associated with care giving. As
a consequence a number of items assessing the partner’s self-efficacy for managing
his/her anger when confronted with challenging patient drug and alcohol use
behaviours were also included in the PCSES.
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A panel of ten experts working in the addictions field from a variety of professional
backgrounds agreed to review the draft PCSES. From this review two items were
removed from the draft PCSES as they seemed to duplicate items already on the
scale. A number of minor grammatical and ordering recommendations were also
made by the expert panel. The 24 item PCSES was then administered to eight
partners attending treatment at the WSAHS Drug & Alcohol Psychology Service to
further assess the scale’s face and content validity. This review by partners resulted
in minor modifications being made to the wording of one item and the grammar used
in another item of the PCSES.
Scale Administration Study 1
A total of 147 patients attending treatment at WSAHS Drug & Alcohol Service were
approached to participate in Study 1 with their partners. From this sample 39
partners and 25 patients had to be excluded due to not meeting the entry criteria for
the study. One surprising finding was that a large number of partners had to be
excluded from participation due to evidence of excessive use of either drugs and /or
alcohol, as evident from their results on the DAST-10 and AUDIT screeners. This
finding that approximately 25% of partners approached displayed evidence of
themselves having a drug and/or alcohol problem, even after the patient and partner
initially denied excessive substance use in their partner, was largely unexpected. A
study by Orford & Dalton (2005) found almost identical rates of co-occurring heavy
drinking in partners of untreated drinkers in England, with 24% of drinkers in their
sample reporting having a partner who drank above the ‘heavy drinking’ threshold.
One possible explanation for this finding in the present study is that the patients
presenting to this treatment facility may have been rather ‘severe’ cases in terms of
substance dependency and in comparison the partners may have seen their own
drug and alcohol use as non-problematic as it may not have appeared as excessive
or problematic as the patients. Another possible explanation for this high rate of
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substance dependence in patient-partner dyads is that the majority of partners were
female and it is easier for females to produce false positive scores on the AUDIT-C,
the alcohol screener used in the present study (Bush et al., 1998). It is unlikely that
the large number of partner-patient dyads was due to the instructions or information
about the exclusion criteria for the study being unclear.
A total of 83 patients and 83 partners took part in this study. Partners in the present
sample were on average 40 years of age and the majority were female (78%). Most
partners had been in a de-facto relationship with the patient (63%) for an average of
8 years. According to partner’s reports the patient had been experiencing problems
with either drugs or alcohol for an average of 4 years (minimum = 1 year, maximum=
25 years).
Patients in the present sample were on average 41 years of age and were more
likely to be male (78% male). The majority of patients reported a problem with alcohol
alone (82%), with the remaining 18% reporting problems with either amphetamines,
cannabis or heroin dependence. Most of the patients had never received drug and
alcohol treatment before (84%). Similarly high proportions of patients reported that
they had never tried to change their drug or alcohol use on their own before (71%).
Despite this, almost one in three patients (65%) had someone suggest to them that
they reduce or stop using/drinking in the recent past.
PCSES Descriptive Analysis
One advantage of the PCSES is its failure to display floor and ceiling effects. Ceiling
effects in particular are a commonly cited problem with self-efficacy scales (E.g.
Zeiss et al., 1999). Usually the presence of ceiling effects may indicate that the scale
items are too simple or easy for partners in that they do not assess care giving
situations perceived to be challenging. Only one item of the PCSES (Item 24: “u d
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and a free”) displayed a ceiling effect. This particular item assessed the partner’s
confidence in being able to refrain from drinking or using drugs in front of the patient.
It was to be expected that a large proportion of partners would report feeling very
confident in being able to refrain from drinking/using drugs in front of the patient
given that only partners without a drug or alcohol use problem were included in the
study. Therefore the ceiling effect observed on this item of the PCSES does not
indicate a problem with the scale, rather it reflects that the sample of partners
included in this study did not themselves have a problem with drugs and/or alcohol.
This particular item which assesses confidence in being able to refrain from
drinking/using drugs in front of the patient may be more useful in a clinical setting
rather than in a controlled research setting, especially if the clinician suspects that
the partner may also have a drug or alcohol use problem.
The highest mean confidence rating reported by partners in the present study was for
Item 24 (“u d and a free”). The second highest mean rating was for Item 23
(“support”) which suggests that partners were very confident in being able to get
support for themselves from other people when finding it difficult to deal with their
partner’s substance use problem. Given that the sample in Study 1 consisted of
partners who were already attending a treatment facility to seek assistance with their
partner’s drug and alcohol problem it is not surprising that they rated this item of the
PCSES with high confidence. This particular item may be more clinically relevant for
populations of partners not currently seeking treatment for a variety of reasons, such
as those unable to attend a treatment facility due to cost or work/child care
commitments for instance.
Items on the PCSES rated with the least confidence by partners in Study 1 included
Item 10 (“low mood”), Item 11 (“stress worry”) and Item 12 (“bored”). These three
items all assessed confidence in being able to help the patient reduce or abstain
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when the patient was feeling low or depressed, stressed or worried, and bored.
Partners in the present study were not very confident in their ability to help their
partner reduce/abstain when experiencing these negative mood states. This may be
due to the common finding that negative mood states are usually triggers to
substance use. Patients themselves often cite extreme difficulty controlling their
substance use when they are feeling low, stressed or bored (E.g. Sitharthan et al.,
2003) and negative emotional states have often been found to be the most common
relapse precipitant (E.g. Marlatt & Gordon, 1985).
Research Question 1  - Factor Structure : Expect the PCSES to have a clear
and acceptable factor structure.
The first research question aimed to identify the underlying factor structure of the
PCSES by subjecting the scale to factor analysis. Exploratory factor analysis was
conducted given that there has not been any previous research conducted examining
partner self-efficacy in the addictions field and consequently there are no strong
theoretical assumptions available to base the factor structure of the PCSES on.
Exploratory factor analysis with principal axis factoring using oblique rotation was
conducted on the initial sample of 83 partners. Results from the factor analysis
produced evidence in support of a four factor model for the PCSES which accounted
for 51% of the variance. The four factors appeared to assess “Comprehensive Care”,
“Reinforcing Abstinence”, “Resilience” and “Negative Affect” respectively.
Comprehensive care consisted of items assessing self-efficacy in being able to
manage a range of patient drug and alcohol behaviours such as medication
compliance, assisting with mood management, and management of suicidal ideation.
Comprehensive Care accounted for the greatest amount of variance of all the four
factors in that it accounted for 27.96% of the variance. Factor 2 “Reinforcing
Abstinence” was comprised of items assessing the partner’s self-efficacy for
encouraging abstinence behaviour, such as by not purchasing drugs/alcohol for the
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patient, avoiding the patient when he/she is intoxicated, and spending quality time
with their partner when he/she is abstinent. Reinforcing Abstinence accounted for
9.63% of the total variance in PCSES scores. The third factor which was labelled
“Resilience” was composed of items relating to self-efficacy for continuing to provide
support to the patient and not getting angry with them even when faced with
challenging situations, such as care giving efforts not being appreciated by the
partner or being lied to by the patient. Resilience contributed to 7.07% of the total
variance in PCSES scores. The fourth factor was labelled “Negative Affect” as it
related to items assessing self-efficacy in which the patient was experiencing a range
of negative mood states, such as depression, boredom and stress/worry. Negative
Affect accounted for 6.58% of total variance in PCSES scores.
Although no partner self-efficacy scales exist in the addictions literature to allow for
direct comparison of the observed factor components some analogies can be drawn
with the many patient self-efficacy scales available in the addictions field and from
partner self-efficacy scales from other areas of clinical research. The Negative Affect
factor bears close resemblance to a similar factor found by most patient self-efficacy
scales assessing negative mood states in patients, including sadness, loneliness,
feeling upset, and worry to name a few. More specifically, validated patient self-
efficacy scales by McKiernan et al., (2011), Parr et al., (2009), Sitharthan et al.,
(2003), and Young et al., (2012) are just a few studies citing a factor assessing
negative affect in drug and alcohol patients.
The factor “Resilience” however appears to tap into a quality which is associated with
a partner care giving quality, rather than a patient variable. Bandura has proposed
that resilience is an important component of successful care giving and it is often
found in partners or carers who are high in care giving self-efficacy (Bandura, 1997).
A self-efficacy scale for caregivers of cancer patients developed by Ugalde,
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Krishnasamy and Schofield (2013) also found evidence of a factor which they
labelled “Resilience” which appeared to assess a common theme of the care giver
continuing to provide assistance to the patient even when challenged and even after
experiencing strong negative feelings associated with their care giving role. Items
from this Resilience factor in Ugalde et al’s study (2013) assessed confidence in
being able to continue providing care to the patient when the care giver was feeling
frustrated, exhausted, scared, angry and sad. Such items appear to be assessing
very similar constructs to those of the PCSES’s Resilience factor.
Also bearing a striking resemblance to the Resilience factor of the PCSES was a
factor labelled “Controlling Upsetting Thoughts About Care Giving” by Steffen and
her colleagues (2002) in their Care Giving Self-Efficacy Scale for carers of cognitively
impaired elderly adults. Items from the “Controlling Upsetting Thoughts About Care
Giving” factor assessed self-efficacy in being able to respond to challenging patient
behaviours without the care giver raising his/her voice, without arguing back with the
patient and by saying things to calm oneself down. A similar factor labelled “Stop
Unpleasant Emotions and Thoughts” was also found from factor analysis of the
Coping Self-Efficacy Scale, a scale which assesses confidence in coping with life’s
challenges in general rather than in specific situations (Chesney, Neilands,
Chambers, Taylor & Folkman, 2006).
Results from factor analysis of the PCSES revealed that all of the 24 items of the
PCSES clearly loaded on one of the four factors. However, 5 of the 24 items of the
PCSES displayed slightly complex relationships between two factors, most of which
were between Factor 1 (Comprehensive Care) and Factor 3 (Resilience). These
cross-loaded items did not display large cross-loadings above 0.50 across factors
which suggests that they may not be overly problematic. The items displaying cross-
loadings across more than one factor were : “not interact” (Item 4), “blames you”
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(Item 6), “not understand” (Item 7), “bored” (Item 12), and “buy d and a” (Item 19).
Many researchers have cautioned against making changes to new scales as a result
of exploratory factor analysis, such as deleting cross-loaded items, without first
conducting a confirmatory factor analysis (E.g. Worthington & Whittaker, 2006).
Furthermore, removal of these items from the PCSES did not result in any significant
improvement in the scale’s internal consistency. In addition, the correlations between
all four factors were all low (between 0.110 and 0.282) lending support to the notion
that the four factors are distinct from each other and that there do not appear to be
more than four factors present. As a consequence, these five cross-loaded items
were not removed from the PSCES.
Although the four factor model accounted for 51% of the variance, which just
exceeds the recommended minimum of 50% for an ideal model (Streiner, 1994), the
four factor model provided the most comprehensible and interpretable factor
structure. There are many well validated and widely implemented psychological
scales available which frequently report  factor structures which account for less than
50% of the total variance, such as the Drug Abuse Screening Test which has been
found to account for only 45% of the total variance (Skinner, 1982).
Overall the four factor model appeared to be the most optimal model from the results
of the exploratory factor analysis and such results are promising considering this is
the first attempt to develop a self-efficacy scale in this particular field.
Demographic differences
No statistically significant gender differences were observed in Total PCSES scores
or in any of the four factors of the PCSES. Despite this there was a tendency for
female partners to report lower self-efficacy on the PCSES compared to male
partners, however this difference was not statistically significant.
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A significant moderate positive relationship was observed between partner’s age and
Factor 1 “Comprehensive Care” scores on the PCSES (r=0.304, p=0.000). This
suggests that older partners were more likely to report greater confidence in being
able to provide comprehensive care to patients, such as assisting them with mood
and suicide risk management, and medication compliance. Similarly, moderately
strong relationships were also observed between Factor 1 “Comprehensive Care”
scores and length of relationship (r=0.327, p=0.000) and total years the patient had a
drug and alcohol problem for (r=0.259, p=0.002). Similar findings were cited by Zeiss
et al (1999) who found that those who had been care givers to elderly frail adults for
longer displayed higher self-efficacy scores. In contrast to these findings, total
number of years in current relationship and Total scores on the PCSES displayed a
weak though significant negative relationship (r=-0.164, p=0.034). This suggests that
the although Comprehensive Care self-efficacy increased with length of relationship,
overall self-efficacy as assessed by Total PCSES scores decreased with relationship
length.
Given that Factor 1 “Comprehensive Care” tends to capture more basic care giving
skills in comparison to the other three factors of the PCSES, which tend to instead
assess more challenging situations, one would expect greater self-efficacy in
partners for the more basic situations than the more challenging ones. This was
evident from the finding that total years in current relationship and Factor 2
“Reinforcing Abstinence” displayed a significant negative relationship (r=-0.159,
p=0.040). This result suggests that those who had been in their current relationship
for longer displayed overall lower self-efficacy for encouraging abstinence-promoting
behaviours. Given that the patients in this study required treatment to assist them
with achieving abstinence or reduced drinking and that most had never attempted to
change their drug and alcohol problem before, it is likely that their partner’s attempts
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to assist them with achieving abstinence/reduced use, as assessed by “Reinforcing
Abstinence” factor, had failed in the past otherwise they would not be presenting to
treatment requesting assistance. This tendency to have lower self-efficacy in partners
with a history of failed attempts at assisting the patient ties in with Bandura’s (1986)
self-efficacy theory which states that repeated failures lower one’s self-efficacy and
this will in turn lead the partner to continue to expect to fail. Similarly, successful past
performance in a care giving situation is likely to influence future self-efficacy, with
past success resulting in higher self-efficacy over time (Bandura, 1986).
Furthermore, a significant negative relationship was observed between years in
current relationship and Factor 3 “Resilience” (r=-0.158, p=0.041). Given that
“Resilience” tends to capture the most challenging care giving situations it may be
that this particular sample of partners found basic care giving situations easier than
more complex care giving situations.
Research Question 2 – Reliability : Expect the PCSES to have adequate test-
retest reliability and internal consistency.
The second main research question assessed the reliability of the PCSES by
examining it’s internal consistency and test-retest reliability. The Cronbach alpha
coefficient for the PCSES was 0.882 which demonstrates a high degree of internal
consistency. Three of the factors of the PCSES displayed good to excellent internal
consistency scores which ranged from a coefficient alpha of 0.755 to 0.839 which are
more than acceptable for a newly developed scale (Nunnally & Bernstein, 1994).
Factor 2  “Reinforcing Abstinence” displayed the lowest internal consistency score
(Coefficient alpha=0.634) however such a score is still considered acceptable for a
new self-report scale (Nunnally & Bernstein, 1994). Internal consistency did not
improve if items from Factor 2 were to be removed from the scale which suggests
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that future research needs to consider making improvements to this factor perhaps
by including more items to this particular factor.
Test-retest reliability of the PCSES was determined by administering the scale to a
sample of 15 partners two weeks apart. Test-retest reliability was found to be high
(r=0.89) for Total PCSES scores. For Factor 1 test-retest reliability was 0.91, for
Factor 2 it was 0.86, for Factor 3 it was 0.89 and for Factor 4 it was 0.88. Such
results demonstrate good to excellent stability in PCSES scores including the four
factor scores across time.
Research Question 3 – Validity  :
· Expect to see a positive relationship between partner coping self-
efficacy (as assessed by the PCSES) and general positive coping
strategies (Problem-Focused Coping) as assessed by the Ways
of Coping Questionnaire.
· Expect to see a negative relationship between partner coping
self-efficacy (as assessed by the PCSES) and self-reported
anxiety and depression, as assessed by the Hospital Anxiety &
Depression Scale.
· Expect to see a positive relationship between partner coping self-
efficacy (as assessed by the PCSES) and patient drug and
alcohol self-efficacy.
The third research question assessed the concurrent validity and face validity of the
PCSES. Only one published study by Hurcom, Costello & Orford (1999) has
previously examined partner self-efficacy in partners of alcoholics, albeit without
providing information about the scale’s items or conducting an adequate
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psychometric analysis of the scale. Given this and the complete absence of validated
partner self-efficacy scales in this field, there is no scale available to assess the
PCSES’s concurrent validity. As a consequence, the validity of the PCSES was
examined from associations between the PCSES and its factors with a number of
partner and patient variables.
As predicted, partners low in self-efficacy displayed high levels of anxiety, depression
and emotional distress as assessed by the HADS. Approximately 2 out of 3 partners
met criteria for depression in the current sample using the HADS. Partners in this
study appeared to have been very significantly more depressed compared to norms
from the general population (t(19873)=16.916, p<0.0001, Cohen’s d=1.53), with 17%
classified as having ‘severe symptoms of depression’ from their HADS scores.
Partners in this sample also displayed high levels of anxiety compared to the general
population (t(1873)=5.8453, p<0.0001, Cohen’s d=0.65) with over half of partners
meeting criteria for anxiety from their scores on the HADS. Such high rates of
depression and anxiety are consistent with previous research with partners of drug
and alcohol users (E.g. Kishor et al., 2013 ; Rognmo et al., 2013).
Symptoms of depression, as assessed by the HADS, showed a strong negative
association with Total PCSES scores (r=-0.405, p=0.000) and significant
associations with three of the four factors of the PCSES. This suggests that partners
who were low in self-efficacy were more likely to be depressed. Almost identical
results have been found in previous research with carers of dementia patients from
correlations between depression scores in carers and their coping self-efficacy
scores. For example, a correlation of r=-0.43 between depression scores and coping
self-efficacy was cited by Gilliam & Steffen (2006), and r=-0.34 was reported by
Steffen and her colleagues (2002). It should be noted however that these two studies
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used a different measure to assess symptoms of depression to that used in the
present study.
High partner coping self-efficacy was also significantly associated with fewer
symptoms of anxiety in partners in the present study. A moderate though significant
association between anxiety scores on the HADS and Total PCSES scores (r=-0.27,
p=0.001) and scores on three of the four factors of the PCSES was observed.
Emotional distress in general was found to be negatively associated with PCSES
scores, with higher HADS scores negatively associated with Total PCSES scores
(r=-0.379, p=0.000) including scores on all four factors of the PCSES.
Overall, the present study’s findings that partner coping self-efficacy was significantly
negatively associated with anxiety, depression and emotional distress in partners is
largely consistent with Bandura’s social cognitive theory (Bandura, 1997). More
specifically, Bandura’s (1997) theory states that partners high in self-efficacy are
expected to have more time to engage in positive stress-buffering activities, such as
obtaining social support, which in turn may reduce the partner’s levels of depression
and stress.
One interesting finding obtained was that partners in the present study displayed
significantly greater levels of anxiety compared to the patients (U(1)=2826.5, z=-2.01,
p=0.045). One possible reason for this finding may be that patients began to feel at
ease as a result of seeking and commencing treatment whereas partners did not
have this effect. It may be that anxiety levels may have been higher in partners due
to the stigma and embarrassment associated with seeking treatment and the
uncertainty that follows with regard to the patient’s chances of recovery. Another
reason for lower anxiety symptoms in patients is the possibility that the patient’s
substance use was buffering the symptoms of anxiety. Despite this finding similarly
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high levels of depression and emotional distress, as examined by the HADS, were
found between partners and patients.
Evidence for the PCSES’s construct validity was also found from its association with
partner coping style, as evident from scores obtained on the WOCQ. It was
hypothesized that a positive relationship would be found between PCSES and
Problem-Focused coping scores on the WOCQ. This hypothesis was supported in
that partner’s use of Problem-Focused coping strategies was significantly associated
with Total PCSES scores (r=0.195, p=0.01) which implies that those high in self-
efficacy were more likely to report implementing more Problem Focused strategies to
deal with their partner’s substance use problem. Conversely, those low in self-
efficacy were more likely to report implementing less effective forms of coping, that is
Emotion-Focused Coping, when dealing with their partner’s substance use problem
(r=-0.215, p=0.005).
No significant relationship was observed between partner PCSES scores and
patient’s scores on the WOCQ. Patients in the present sample did however report
significantly more use of Emotion-Focused coping strategies compared to Problem-
Focused coping strategies (t(82)=7.168, p=0.000) when dealing with their substance
use problem. Furthermore, patients in this study reported using Emotion-Focused
coping strategies significantly more often than control group norms (t(160)=5.265,
p<0.0001, Cohen’s d=0.83). This finding has also been frequently cited in the
literature from studies using the WOCQ to assess coping style in drug and alcohol
patients (E.g. Garrity et al., 2006 ; Simons et al., 2003) and in studies using scales
other than the WOCQ to assess coping (E.g. Moos et al., 1981 ; Moos et al., 1990).
One could argue that patients requiring drug and alcohol treatment are more likely to
use Emotion-Focused coping as they are unable to change their substance use
problem on their own without assistance, given that the main tenet of Emotion-
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Focused coping is that this form of coping prevents the person from finding solutions
to their problem. Patients that are more likely to implement more effective coping
strategies, such as Problem-Focused coping, are likely to have already changed their
substance use problem on their own and therefore may not need to attend a
treatment facility to address their addiction problem.
Findings from the present study are the first to my knowledge to assess the results of
the WOCQ in partners of drug and alcohol users. Compared to norms, partners in the
present study reported significantly greater use of Problem-Focused coping
strategies when dealing with their partner’s substance use problem (t(160)=7.576,
p<0.0001, Cohen’s d=1.197). Wagner et al (2006) found that Emotion-Focused
coping was used more often than Problem-Focused coping in husbands of breast
cancer patients. These results differ possibly due to sampling and patient disease
differences. When compared to patients the partners in the present study used
Problem-Focused Coping strategies significantly more often than patients did
(U(1)=2394.5, z=-3.39, p=0.005). Similarly, it was found that patients used Emotion-
Focused Coping strategies significantly more often than partners did (U(1)=2054, z=-
4.49, p=0.000). Partners however failed to display significantly more use of Emotion-
Focused Coping strategies compared to Problem-Focused Coping strategies when
managing the patient’s substance use behaviour, with results suggesting that both
strategies were used equally often in this particular sample of partners (t(82)=-1.214,
p=0.134). One could argue that the sample of partners used in the present study
consisted of partners attending a treatment facility with the patient and therefore may
be a biased sample in that it consisted of partners who may be better at coping
effectively with the patient’s drug and alcohol problem. Partners who are not coping
as effectively would be unlikely to present to a treatment facility or even consider
taking steps to manage the patient’s problem and may be more likely to use
maladaptive coping strategies instead, such as ignoring the patient’s drug and
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alcohol problem. Further research needs to be conducted using the WOCQ with
partners as this is the first study to examine the WOCQ in partners of drug and
alcohol patients. Future research in this field should consider examining the WOCQ
in partners who are not actively seeking treatment with their partner in order to
eliminate any possible sampling biases.
The third hypothesis proposed regarding the construct validity of the PCSES
expected that a positive relationship would be found between PCSES and patient’s
drug and alcohol self-efficacy scores. This hypothesis was not supported in that no
significant relationship was observed between Total PCSES scores and patient’s
average drug and alcohol self-efficacy scores (r=0.124, p=0.107). Furthermore none
of the four factors of the PCSES displayed a significant relationship with the patient’s
average drug and alcohol self-efficacy scores. These findings suggest that in the
present sample there is no relationship between partner self-efficacy and patient self-
efficacy. Such findings do not lend support to Bandura’s theory which implies that
partners can serve as coping models for the patient (Bandura, 1992). More
specifically, highly efficacious partners could serve as positive role models for the
patient, thus increasing the patient’s own coping self-efficacy and optimism through
vicarious learning which in time may improve the patient’s chances of meeting their
treatment goal. One of the few studies in the self-efficacy literature to examine self-
efficacy in partners and patients simultaneously was conducted by Schroder et al
(1997). This particular study found evidence to support Bandura’s theory in a sample
of cardiac patients whose long-term health outcomes were largely related to the
degree of concordance between patient and partner self-efficacy ratings. It is
possible that a positive relationship between patient and partner self-efficacy ratings
may have been observed in the present study if self-efficacy ratings were obtained at
the completion of treatment rather than at the commencement of treatment.
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A number of other possible relationships between patient variables and PCSES were
considered to determine if there was any further evidence of construct validity for the
PCSES. A significant though weak association between Total PCSES scores and
scores on the Beck Scale for Suicidal Ideation was found (r=0.175, p=0.034). This
unusual finding suggests that partners who were high in self-efficacy were more likely
to have a partner who reported greater levels of suicidal ideation. Given this finding
one would anticipate to find a significant result between patient levels of depression
from the HADS and PCSES, however, this was not the case. Approximately half of
the patients in this study (51%) reported suicidal ideation within the previous six
months, with only 18% reporting that they had never thought about suicide before.
Almost one in three patients (31%) had attempted suicide at some point in the past,
with 18% reporting an attempt in the previous six months. Despite this, patient’s
scores on the Beck Scale for Suicidal Ideation were consistent with norms from a
sample of outpatients accessing treatment for substance use issues (Bryan et al.,
2013).
The only other patient variable to be significantly associated with PCSES scores was
perceived drug and alcohol-specific support, as assessed by the Support Scale (SS).
More specifically Factor 3 of the PCSES (“Resilience”) was significantly positively
associated with perceived drug and alcohol-specific support from one’s partner
(r=0.174, p=0.024) as assessed by the SS. This suggests that partners high in self-
efficacy for more challenging situations were more likely to have a partner describe
them as providing a lot of drug and alcohol specific support. These results are
consistent with Bandura’s (1997) theory which states that partners who are more
resilient are able to provide more effective care to the patient compared to those
partners who are not as resilient in providing care. Furthermore, partners low in self-
efficacy may know what type of support is effective but they will not have the drive to
offer this type of support. According to Bandura’s (1997) social cognitive theory a
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bidirectional relationship between perceived coping self-efficacy and social support
exists. However, not all patients in the present sample were able to nominate a
support person at assessment despite presenting to treatment with their partner.
Eighty one percent of patients stated that they had a support person, of which almost
all patients assigned this role to their partner (94%).
Further evidence supporting the validity of the PCSES was obtained from it’s
reported face validity based on participant’s responses and verbal feedback obtained
from study participants. None of the participants in this study reported during scale
administration that they could not comprehend any questions from the PCSES.
Furthermore none of the 83 participants failed to answer items of the PCSES
because they could not relate to the situation described in the scale item. The
PCSES’s reading ease was found to be favourable from the Flesch Reading Ease
Score (Microsoft Word readability statistic) and its Flesch-Kincaid grade level was
found to be 11.7 which suggests that most students in Year 11 (approximate age 16
¾ years) are expected to understand the scale. Given that the PCSES is intended to
be completed by adults only such findings are acceptable. The PCSES took on
average 5 minutes for participants to complete.
Research Question 4 – Predictive Validity : Expect the PCSES to have adequate
predictive validity in that it will be able to predict relapse in patients 6 months
following treatment.
The present study failed to find partner coping self-efficacy to be a significant
predictor of relapse. More specifically no significant difference was observed
between partners reporting low PCSES scores and those reporting high PCSES
scores in terms of relapse (χ2=0.005, df=1, p=0.946). In actual fact the two different
PCSES groups displayed almost identical rates of relapse, that is 40% of the “Low”
PCSES group relapsed compared to 38% of the “High” PCSES group.
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A number of patient variables were examined to determine if they could instead
predict relapse. These variables included patient gender, patient age, patient
employment and education level, primary substance used by the patient, total
number of years they reported a drug and alcohol problem for, patient drug and
alcohol self-efficacy scores, previous self-change attempts and prior drug and alcohol
treatment. None of these variables were able to predict relapse in this particular
sample. Many researchers have also failed to find predictors of relapse in drug and
alcohol patients. Project MATCH (Project MATCH Research Group, 1997) is a
classic example of the largest multi-site study and the most expensive trial of
psychotherapy ever conducted which failed to find evidence of any predictors of
relapse in a large sample of patients receiving treatment for their alcohol problem.
Furthermore, results from the Project MATCH study failed to find evidence that
subjects low in self-efficacy would have better treatment outcomes if treated with
cognitive-behavioural therapy. Some claim that relapses are too unpredictable to
adequately predict and given the complex nature of relapse, standard statistical
procedures are unable to adequately capture predictors of relapse (Witkiewitz et al.,
2007). Another possible reason for the lack of predictive effect of partner coping self-
efficacy is that partner self-efficacy was only assessed at the commencement of
treatment. If, however, it was also assessed at the completion of treatment in the
present study different results may have been obtained. Predictive validity of the
PCSES needs to be assessed further using a larger sample size as it is possible that
the low number of “relapsers” identified at follow-up (N=16) may have prevented
finding a significant effect due to limited power.
One unexpected finding was that only half of the patents could be traced at 6 month
follow-up in order to review their progress. This was problematic even after each
patient had provided a trace contact person at assessment in case they could not be
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reached at the follow-up, who almost always was their partner. Although one cannot
make conclusions about the outcome of the 50% of patients who were “lost to follow-
up” 6 months following treatment, consequently these subjects were not included in
the predictive validity analysis. The rate of relapse in those patients who could be
contacted at follow-up was 38% which is largely consistent with previous research
(E.g. Penick et al., 2010).
Also unexpected was the high rate of relapse reported in the first 4 weeks following
treatment completion. More specifically, it was found that 63% of those who relapsed
did so in the first 4 weeks following treatment completion. A further 31% of relapsers
reported relapsing between 4 and 8 weeks post-treatment. Surprisingly none of the
patients reported relapsing between 4 and 6 months post-treatment, suggesting that
the vast majority relapsed almost immediately after completing treatment. These
findings are consistent with results from a large international review of the alcohol
treatment literature which included a total sample of over 8000 patients, labelled the
“Mesa Grande Project”, which found that most relapses occur in the first 3 months
following treatment completion (Miller & Wilbourne, 2002). However there is a wide
variation in how researchers define “relapse”, thus limiting the ability to compare
findings between studies. One possible reason for this high rate of relapse so soon
after completing treatment may be that the treatment provided may have been too
brief for the patients. The average number of treatment sessions provided to the
entire sample of patients in the current study (N=83) was 4 treatment sessions, not
including the assessment session. Despite this all patients who reported relapsing at
any point in the follow-up period were offered extra treatment sessions which most
agreed to attend.
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Implications of the Research Findings from Study 1
Given the results obtained from Study 1 the PCSES appears to be a useful scale for
clinicians as well as researchers to use as it provides a thorough assessment of the
coping self-efficacy in partners of drug and alcohol users. Given there is a total
absence of published well-validated partner coping self-efficacy scales in the
addictions field this study fills a large gap in the literature. Given the increasing
prevalence of drug and alcohol problems and the fact that they are a major public
health and social problem, the present research is important as it looks beyond the
patient and focuses on the role of the partner and how she/he copes with this chronic
and relapsing condition.
The findings from the PCSES in the current sample has important implications for the
development and implementation of treatment programs which include partners of
drug and alcohol users. The PCSES can be used in treatment planning given its
ability to assess self-efficacy in a variety of specific ‘high risk’ situations for partners
which then could become the focus of treatment. Specific high risk situations which
the partner endorses with low self-efficacy on the PCSES could become the focus of
coping skills training exercises in treatment. Currently there is no scale available in
the literature for clinicians or researchers to use in order to identify challenging
coping situations for partners of substance users. The PCSES can also be used to
assess changes in self-efficacy over time and to determine if partner and patient
treatments have been effective in increasing one’s self-efficacy. Future research may
wish to examine whether PCSES scores change as a result of coping skills training in
partners.
Results from the present study also confirmed the negative impact substance abuse
has on partners of patients, with strong evidence of high levels of anxiety and
depression in partners. This has important implications for treatment in that mood
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management in partners should also be a main focus of treatment in addition to
coping skills training. Future research may be interested in determining whether the
symptoms of depression and anxiety in partners change as a result of treatment or
as a function of the patient’s progress. However, one cannot firmly conclude that the
partners in the present study were depressed and anxious as a direct result of their
partner’s substance abuse problem. Future research may wish to assess the
proximal and distal factors which may be causing anxiety and depression in partners
of substance abusers.
The high rate of drug and alcohol dependence found in partners was also a largely
unexpected finding in the present study. Such a finding highlights the need for
clinicians and other health providers to routinely screen partners of drug and alcohol
patients to identify possible cases of drug and alcohol misuse in partners.
Study 1 Limitations
This study has several limitations which need to be considered prior to interpreting
the findings. The first limitation applies to the generalizability of the findings to all
partners of substance users as those included in the present study were all attending
treatment with the patient. Furthermore, although consistent with the literature, there
was an under-representation of male partners with the majority of partners in the
present study being female. Despite this the results from the PCSES do not seem to
indicate that there are gender differences operating. In addition to this partners of
drug-users were grossly under-represented in this sample given that most patients
presented with an alcohol problem. The sample of partners and patients from Study 1
may have under-represented many other groups of partners and patients including :
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-Those who had a drug and alcohol-using partner who was not able to attend
outpatient treatment for a variety of reasons (e.g. not ready to change their
substance use, work commitments, transport problems).
-Those whose partner does not want to be involved in the drug and alcohol-using
patient’s treatment for any reason (e.g. stigma, relationship discord, fear of domestic
violence).
-Those whose partner may be unable to attend treatment with the patient for a
number of logistical reasons (e.g. work or child care commitments, transport
problems).
-Those persons with a drug or alcohol problem who are able to change their drug and
alcohol use on their own without requiring treatment (“self-changers”).
-Those patients and partners who did not reside in the Western Sydney Area
geographic region and therefore lived under different socioeconomic levels.
-Those patients and partners who are unable to read or speak English or those who
suffer from comorbid psychiatric disorders.
The selection bias evident in this study may therefore limit the generalizability of the
findings. Given that patients were recruited from a public health service treatment
facility it is possible that patients from this sample may have been more dependent
on drugs and alcohol than community samples. Also, given that it was a requirement
of the study that patients consent to their partner attending treatment with them to
complete the assessment measures, the sample captured may have only included
patients with supportive partners or those in more harmonious relationships with their
partner. Furthermore, it is also possible that those partners who are not coping at all
well with the patient’s problem may be unable to find the motivation or time to
participate in a study whereas those who are coping better may well have more time
and better resources to attend a treatment facility to volunteer in a study.
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The final sample size of 83 partners was not very large for conducting factor analysis,
despite the data meeting all other prerequisites for factor analysis, such as Bartlett’s
Test of Sphericity results, results of the Kaiser-Meyer-Olkin measure of sampling
adequacy, lack of multicollinearity and singularity and absence of severely non-
normally distributed data. It would have been more ideal to have a larger sample of
partners to base the initial exploratory factor analysis on however recruiting
participants was rather difficult in the present study. This was in part due to the large
number of partners who themselves displayed a drug and/or alcohol problem, and
also due to patients missing scheduled appointments. This difficulty in recruiting drug
and alcohol patients with their partners in research studies has been often cited, with
Hurcom, Costello & Orford (1999) citing similar recruitment problems resulting in a
final sample of only 29 female partners of patients in order to assess partner coping
in their study. The sample size for the predictive validity section of the study was also
rather low (N=42). Also problematic is the fact that reported drug or alcohol use in the
follow-up telephone interview was not verified with the partner or another informant
due to practical issues and time constraints. The failure to find evidence of the
PCSES’s predictive validity from relapse rates may be due to the fact that relapse is
likely to be due to a number of different factors other than partner self-efficacy. A
more direct test of predictive validity would have been the prediction of subsequent
coping behaviours that were directly measured by the PCSES rather than relapse per
se, however, this was beyond the scope of the present study.
A number of measures used in Study 1, such as the Alcohol Abstinence Self-Efficacy
Scale, the Drug Abstinence Self-Efficacy Scale and the Support Scale, have not
themselves been published nor have their psychometric properties been studied in
depth. The internal consistency, as assessed by the Cronbach alpha for each of
these scales, was found to be acceptable for all three scales which lends further
support for their use in this clinical population. More specifically, the Alcohol
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Abstinence Self-Efficacy Scale produced a coefficient alpha value of 0.81, the Drug
Abstinence Self-Efficacy Scale  produced a coefficient alpha value of 0.77 and the
Support Scale produced a coefficient alpha value of 0.79. These particular scales
were included in the present study due to their clinical utility and due to the often
notable absence of alternative validated published scales which appear to measure
similar constructs. However, future studies should be conducted to test their
usefulness in other settings and with other populations.
Evidence of the PCSES’s construct validity was based on correlational data therefore
one cannot draw solid conclusions about causality. Although these variables appear
to be closely related to partner self-efficacy one cannot firmly conclude how and why
they are related from the correlational nature of the results. Future longitudinal
studies and treatment outcome studies may provide more information about why
partner self-efficacy and variables such as depression and anxiety for instance are
related. Furthermore, the relationship between anxiety and depression and the
PCSES is only one indication of construct validity. Future research needs to focus on
gathering stronger evidence in support of the PCSES’s construct validity.
The present study failed to assess the PCSES’s discriminative validity, that is its
ability to discriminate between partners of substance users and partners who do not
have a substance using partner. Future research may wish to examine whether the
PCSES has adequate discriminative validity. The present study did not directly
examine the clinical utility of the scale.
Although most of the psychometric properties of the PCSES were good to excellent,
internal consistency for Factor 2 “Reinforcing Abstinence” produced the worst results
out of all the factors of the PCSES. The internal consistency Cronbach alpha
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coefficient was found to be 0.634 for Factor 2 of the PCSES which is just considered
acceptable. One possible way of improving a scale factor’s reliability and validity is by
increasing the number of items that the scale assesses. Currently Factor 2 consists
of 7 items which is not considered minimal, thus it may be that the items which make
up this factor are not very applicable to most of the partners in the present sample.
As a consequence future research may wish to consider including different items to
this factor and ensuring that they are personally relevant to most partners of
substance users.
There is evidence to suggest that the PCSES has good face validity however
participants are more likely to fake good their responses on scales which have good
face validity. In the present study it is possible that partners may have faked good
their answers as the scale was administered in a face-to-face setting. However the
fact that very few respondents endorsed extremely high levels of confidence on the
PCSES in this study suggests that social desirability bias may not have been a major
issue with this particular sample. For research purposes it would have been ideal to
administer a social desirability scale to determine if this particular sample of partners
tended to respond in a socially desirable way on the PCSES. Unfortunately due to
time constraints a social desirability scale was not added to the assessment package
as it would have greatly increased the already lengthy testing session time.
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Study 1 Conclusion
Results from the present study provide strong evidence that the PCSES has sound
psychometric properties. Furthermore the PCSES’s test-retest reliability and internal
consistency were found to be good. There was also strong evidence for the PCSES’s
construct validity. The factor structure of the PCSES suggests the presence of 4
distinct and reliable factors : “Comprehensive Care”, “Reinforcing Abstinence”,
“Resilience” and “Negative Affect”. Given that the PCSES failed to predict relapse in
patients 6 months following treatment completion, predictive validity of the PCSES
needs to be assessed further using a larger sample of subjects. Overall the findings
from this study suggest that the PCSES has acceptable psychometric properties and
it is likely to be clinically useful in treatment planning and assessment of partners of
drug and alcohol users.
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Introduction  Study 2
The main purpose of Study 2 is to subject the PCSES to confirmatory factor analysis
using a separate sample of partners of drug and alcohol users. Given the high
prevalence of substance use disorders and the fact that relatively few people with a
drug and alcohol problem and their significant other actually ever seek treatment
(Cunningham & Breslin, 2004), data was obtained using a sample of partners
accessing information about addictions on the internet.
Australia boasts one of the highest rates of  internet usage in the world with 73% of
households (6.2 million households) having broadband internet connection in 2010-
2011 (Australian Bureau of Statistics, Household Use of Information Technology,
2010-2011). Home internet usage was found to be very high in households with
higher incomes whereas only 55% of households in the lowest income bracket had
internet access at home (Australian Bureau of Statistics, Household Use of
Information Technology, 2010-2011). Given the growing popularity of mobile devices
such as smart phones and tablet PCs equipped with internet browsers, the internet is
able to reach a larger audience in a shorter period of time than that would be
obtained from attendance to a treatment facility.
There are numerous advantages of using the internet to recruit partners of drug and
alcohol patients. The internet is private and there is less stigma especially if the study
is anonymous. Participants can access internet studies at any time around the clock
or at any place convenient to them without disrupting their routine compared to being
required to attend a face-to-face appointment. The internet is more likely to capture
participants who traditionally do not attend drug and alcohol treatment facilities, such
as women, those with higher educational levels, those in stable employment and
those in stable relationships (Riper et al., 2009). One study found that almost all
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participants of an online treatment for drinking had never seen a health professional
before to address their drinking (Cloud & Peacock, 2001) which suggests that online
studies may help capture patients who would not otherwise seek help. Although
many might argue that internet samples may be too dissimilar from treatment
samples to draw direct comparisons, research has found this is actually not the case.
Internet samples have been found to report drinking as much as outpatient treatment
samples however, they do not report as many adverse consequences associated
with their drinking compared to outpatient populations (Hester & Squires, 2008).
There are also numerous benefits to researchers and treatment providers by
conducting online studies and online interventions in terms of reductions in the cost
and time spent providing treatment compared to that in a face-to-face setting.
Only in the last ten years have internet-based treatments for drug and alcohol
problems become available. Despite this field still being in its infancy there are
numerous randomized controlled trials available evaluating the efficacy of internet-
based treatments for drug and alcohol problems. A review of internet-based
treatments found that all reviewed studies showed that the internet-based treatments
significantly reduced alcohol use regardless of the length of the internet treatment
and its specific components (Vernon, 2010). Self-efficacy in patients has also been
found to increase as a result of internet-based treatment (E.g. Tossmann et al.,
2011). In a review of the internet treatment literature, male drug and alcohol users
were more likely to utilize internet assessment sites (65% male) (Vernon, 2010). It
has also been found that men are more likely to drop-out of internet-based
treatments than women, and participants without a partner were also more likely to
drop-out of online treatments (Linke et al., 2007).
Although the majority of internet studies have focused on the effectiveness of
treatments rather than assessment alone, there are many studies which have cited
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the efficacy of web-based assessments with personalized feedback for patients with
an alcohol problem (E.g. Cunningham et al., 2005 ; Koski-Jannes, Cunningham, &
Tolonen, 2009 ; Kypri et al., 2008). Most researchers recommend that assessment
measures be kept brief in order not to discourage potential subjects from completing
the online assessment measures (E.g. Cloud & Peacock, 2001).
Although there is an abundance of research examining the efficacy of online
assessments and treatments for patients with a drug or alcohol use problem only one
internet study to date has focused on the partners of drug and alcohol users. This
study by Ibanga (2010) describes a “5 Step Method” treatment program for family
members of drug and alcohol users. This particular intervention originally devised by
Copello et al (2010) consisted of :
-education about how drugs and alcohol affects the family and how it leads to stress
and strain in family members.
-an assessment of how the family member has reacted to past drug and alcohol
behaviour, encouraging partners to use more positive ways of approaching these
behaviours in future.
-ways of increasing social support for the family member and how family members
can access further treatment if necessary.
The Ibanga (2010) study recruited 67 participants, 85% of which were female, with a
mean age of 45 years. Half of the family members who took part in this study were
partners of the patient, with half of the partners reporting having been in a
relationship with the patient for over 10 years. Most of the family members had a
significant other with an alcohol problem (63%). This particular sample of family
members was more likely to be employed compared to those recruited from face-to-
face treatment studies. Baseline assessment measures administered to family
members examined coping style using the Coping Questionnaire and the Family
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Impact Scale (Orford et al., 2005). The results from these assessment measures
were largely consistent with those obtained from previous face-to-face treatment
studies using the same scales. Although the efficacy of this particular online
treatment has not yet been evaluated, this study is the first to describe an online
treatment program for family members of drug and alcohol patients. Furthermore it is
the only online program available which assesses family member’s coping with the
patient’s drug and alcohol problem.
Rychatrik, McGillicuddy & Barrick have recently received US $994,778 in funding
from the National Institute on Alcohol Abuse and Alcoholism to conduct a web-
delivered coping skills training program for female partners of alcoholics. This
program is due to commence in mid- 2014. This particular program, along with the
online program offered by Ibanga (2010) are pivotal in shifting the focus to the needs
of the partners of drug and alcohol users instead of ignoring them as has been the
case in the past. There are to date no other published studies other than that by
Ibanga (2010) which assess coping or the functioning in partners of drug and alcohol
patients using an internet sample.
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Study 2   Methodology
Study Design
The study design for Study 2 included only quantitative methodology. Quantitative
data were obtained from the administration of the PCSES to a sample of 183
partners of people with a drug or alcohol problem via the internet.
Study 2 was completed in two separate phases. Phase 1 consisted of obtaining
ethical approval from the Sydney University Ethics Committee. The time taken to
complete Phase 1 was approximately 4 months. Phase 2 consisted of administering
the scale to a sample of 183 partners who replied to an online advertisement for
volunteers to participate in the study which was placed on a number of drug and
alcohol websites. It took approximately 2 to 3 months for the websites to place the
study advertisement on their web pages. Data was collected by the researcher from
the internet for a period of approximately 18 months.
Research Questions
The primary purpose of Study 2 was to further validate the PCSES through
confirmatory factor analysis on a separate larger sample of partners of drug and
alcohol users. The following research questions are being addressed in the present
study :
1. Can the original 4 Factor model of the PCSES be confirmed in a separate
sample of partners?
2. Is the PCSES assessing confidence ratings which are related to measures on
other constructs?
3. Is there further evidence to support the initial findings that the PCSES is a
valid instrument with adequate internal consistency?
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Hypotheses
It was expected that the PCSES would display adequate psychometric properties as
assessed by the following hypotheses:
1. Expect the PCSES to display a clear 4 factor structure as a result of confirmatory
factor analysis.
2. Expect the PCSES to have adequate construct validity from which the following
prediction about the PCSES and psychosocial factors can be made :
· Expect to see a negative relationship between partner coping self-efficacy
(as assessed by the PCSES) and self-reported depression and anxiety
symptoms in partners (as assessed by the Hospital Anxiety and Depression
Scale).
3. Expect the PCSES to have adequate internal consistency.
Ethical Approval & Ethical Issues
Perceived risk to participants from taking part in this online study were expected to
be minimal. Participants names and internet provider addresses were not collected
and confidentiality was emphasized. Participants were informed that they could
discontinue participation at any time. The Patient Information Sheet stated : “Being in
this study is completely voluntary - you are not under any obligation to participate in
the study and you can leave questions unanswered if you feel uncomfortable” (see
Appendix B for Consent Form & Participant Information Sheet). It is highly unlikely
that completing the questionnaires per se would have induced psychological distress
in participants or potentially placed participants in danger. However it was possible
that some participants may already have been experiencing some degree of stress or
distress associated with caring for a partner with a substance use problem. Some of
the questionnaires asked participants about their experience of negative moods. It
was anticipated that some participants may feel anxious or distressed as a result of
answering some of the items on the PCSES and other assessment measures such
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as the Hospital Anxiety and Depression Scale. As a result it was recommended by
the Sydney University Ethics Committee that participants be provided with advice to
contact emergency mental health services if they felt distressed. The following
statement was added to the online assessment package : “If you have experienced
low mood/sadness/depression or thoughts about harming yourself recently please
contact Lifeline on 131 114 or your GP or your local mental health service
immediately (Contact details can be found in your local white pages).” Furthermore, a
forward was included at the commencement of the study stating that “each
participant should fill out the questionnaires alone without assistance from their
partner or any other person to ensure honest responses and privacy.” Once items
had been completed online by the participant they could not go back to edit or view
their responses again in order to further ensure privacy.
Participants did not receive any inducements as a result of participating in this study.
It was expected that participants would receive some benefit from participating in this
study by increasing their awareness of their confidence in being able to cope with
their partner’s problem in a range of challenging situations. The present study did not
receive any funding.
Participant Recruitment
Participants for Study 2 were recruited via a number of specialist drug and alcohol
websites. A total of 15 different websites were approached by letter requesting
permission to place the following online advertisement for the study on their web
page :
O Are you aged between 18 and 65 years, and currently in a relationship with someone
who has a problem with drugs and/or alcohol?
If so, and if you do not have a problem with drugs and/or alcohol you may be
interested in a study we are conducting . This study looks at ways in which partners of
people who use drugs and/or alcohol cope with their partner’s substance use
problem. The study requires you to complete a number of brief questionnaires online
that take approximately 10 minutes and is completely confidential. If you are
interested in finding out more about this study click here
https://www.surveymonkey.com/s/PartnerCoping
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Three websites agreed to place the above advertisement on their webpage. These
websites were The Australian Centre for Addiction Research (www.acar.net.au),
Family Drug Support (www.fds.org.au) and Bottled Up (www.bottled-
up.memberlodge.com). The Australian Centre for Addiction Research website
provides specialist treatment programs and clinical research on the management of
addictive behaviours. The Family Drug Support website provides support and advice
to family members of those with a drug or alcohol use problem. The Bottled Up
website provides information and advice for people who live with an alcoholic. The
advertisement was placed on the Australian Centre for Addiction Research and the
Family Drug Support websites for approximately 18 months whereas the
advertisement was sent in a e-newsletter to approximately 400 members of Bottled
Up in August 2013. No financial incentive was offered to each website’s organization
nor was an advertising fee paid to the websites in order to advertise this study on
their site.
 After clicking on the link specified in the advertisement participants were linked to a
secure site hosted by Surveymonkey. This site initially displayed the Participant
Information Statement for the study (see Appendix B). If participants agreed to
participate they clicked on a “I Consent” icon which took them directly to the
assessment package.
Measures Used
The assessment package took approximately ten minutes to complete and consisted
of most of the same scales administered to partners in Study 1. The following
scales/questionnaires were administered in the following order :
1. Demographics Form : which was devised specifically for this study which
asked participants their date of birth, gender, length of current relationship (in
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years and/or months), and asked if participants were living with their partner
in the last 12 months. (see Appendix C)
2. Partner Coping Self-Efficacy Scale (PCSES) (Giannopoulos, 2003): a 24 item
scale which assesses partner coping self-efficacy.
3. Alcohol Use Disorders Identification Test – Consumption (AUDIT-C) (Bush,
Kivlahan, McDonell, Fihn & Bradley, 1998): a 3 item screener for identifying
alcohol problems.
4. Drug Abuse Screening Test Short Form – 10 (DAST-10) (Skinner & Allen,
1982): a 10 item screener for identifying drug problems.
5. Hospital Anxiety & Depression Scale (HADS) (Zigmond & Snaith, 1983): a
measure of the symptoms of anxiety and depression.
A description of the measures used above has already been provided under Study 1
Methodology section. The Partner Willingness Scale which had to be used in Study 1
was not included in the present study because “willingness” is not the topic of interest
in this study and it was not a requirement of ethical approval in Study 2.
Participants were prompted by Surveymonkey if they skipped any question in the
package. For ethical purposes already mentioned participants could not go back and
edit their responses on the online version of the PCSES.
Participant Selection
Participants with any missing data were excluded from all analyses in Study 2.
Participants were excluded if they were aged less than 18 years or greater than 65
years at the time they completed the study. Participants were also excluded if they
reported that they were not living with their partner in the last 12 months. Two
hundred and ninety eight partners took part in the online study. From this group, a
total of 47 subjects commenced the study though they failed to complete all of the
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scales in the online assessment package (84% completion rate). This group of 47
“non-completers” consisted of 3 participants who reported being aged more than 65
years (specifically aged 66, 68 and 72 years). Data from this group of 47 subjects
with missing data was removed from all analyses so that only subjects with 100%
completed data were included in the study. A further 68 partners had to be excluded
from participation in the study as their scores on the AUDIT-C and / or the DAST-10
exceeded the specified cut-offs for inclusion in the present study which was
suggestive of the presence of a drug or alcohol use problem. All participants reported
that they had been living with their partner in the last 12 months. Therefore a total of
one hundred and eighty three partners completed the questionnaires and were
eligible for inclusion in the study. All of the 183 partners included in the final analysis
scored less than 5 if male and less than 4 if female on the AUDIT-C and less than 3
on the DAST-10, as this was a requirement for inclusion in the study. The researcher
planned to obtain a final sample of approximately 120 partners from the internet
sample in order to have adequate statistical power to conduct the necessary
statistical analyses to answer the abovementioned research questions of interest.
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Study 2   Results
Missing Data
In Study 2 if a subject had any missing data from any scale all of their data were
removed from the analyses, thus only subjects with 100% completed data were
included in the analyses. All analyses were conducted using SPSS Version 21.0
unless otherwise stated. A statistical significance level of α=0.05 was selected for all
statistical analyses.
Demographic Characteristics of Partners
A total of 298 participants completed at least some of the scales in the assessment
package. From this sample 47 participants were excluded due to missing data and a
further 11 participants were excluded due to being aged over 65 years. A total of 57
participants were excluded due to having either high DAST and/or AUDIT-C scores
leaving a final sample of 183 eligible participants. Participants were on average 46.11
years of age (sd = 10.38) (range =18 - 65 years), with 47 years of age being the
median age of this group. Approximately one third of the partners (33%) were aged
between 41 and 50 years and a further one third were aged between 51 and 60
years (30%). Less than 10% were aged between 18 years and 30 years (9%) and
less than 10 % were aged between 60 and 65 years (8%). The majority of partners
were female (75%). All participants reported living with their partner at the time of
data collection. The average number of years they had been in a relationship with
their partner was 11.84 years (sd=9.58), with the median number of years being 8
years and the range being 1 to 40 years. Over half of the sample (57%) had been in
their current relationship for over 10 years with 20% reporting being in their current
relationship for over 20 years.
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Partner’s Total scores on the HADS displayed a mean of 16.13 (sd=5.88), range = 0
to 32. Partner’s scores on the Depression subscale of the HADS ranged from 0 to 18
with an average score of 6.72 (sd=3.83). Using a cut-off score of 8 on the Depression
subscale of the HADS 43% of partners (N=79) met criteria for “depression”, with 3%
of this group (N=5) being classified as having “severe symptoms of depression” (that
is they scored more than 15 on the Depression subscale). Scores on the Anxiety
subscale of the HADS ranged from 0 to 20 with an average score of 9.44 (sd=4.39).
Approximately 51% of partners (N=94) met the criteria for “anxiety”, with 14% of all
partners (N=26) being classified as displaying “severe symptoms of anxiety” (that is
they scored more than 15 on the Anxiety subscale).
An unpaired t-test was conducted to compare HADS scores from the Study 2 internet
sample to that of norms by Crawford et al (2001). There was a statistically significant
difference in Total HADS scores for the Study 2 sample compared to norms
(t(1873)=9.3989, p=<0.0001, Cohen’s d=1.06) with the Study 2 sample of partners
displaying significantly greater levels of emotional distress, as assessed by the
HADS Total score, compared to norms. A statistically significant difference in HADS
Anxiety scores was observed between the Study 2 sample and norms with the Study
2 sample displaying greater levels of anxiety when compared to norms
(t(1873)=7.7629, p<0.0001, Cohen’s d=0.809). A statistically significant difference in
HADS Depression scores was also observed between the Study 2 sample and the
normative sample, with the Study 2 sample displaying significantly greater levels of
depression compared to the normative sample (t(1873)=8.7138, p<0.0001, Cohen’s
d=0.88).
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PCSES and Item Characteristics
For scoring purposes Total scores on the PCSES ranged from 1 to 11 for individual
items, with a score of  “1” denoting “0% confidence” and “11” denoting “100%
confidence”, thus producing a total possible score of 264 on the PCSES. The mean
Total PCSES for Study 2 partners was found to be 131.0492 out of a possible score
of 264 (which equates to an average confidence rating of 49.62% out of 100%), (sd =
30.11613). The minimum score reported was 51 out of a possible 264 (equating to an
average confidence rating of 19%) and the maximum was found to be 213 out of a
possible 264 (equating to an average confidence rating of 81%). Total PCSES scores
were found to be normally distributed with a skew score of 0.054 (se=0.180) and
kurtosis score of 0.204 (se=0.357). Characteristics of the 24 individual items of the
PCSES are presented in Table 11. Scores on each of the 24 items of the PCSES
ranged from 1 to 11, that is 0% to 100%.
Analysis of each item of the PCSES suggests that all of the 24 items of the PCSES
displayed either mild to moderate skew or mild kurtosis. Thirteen of the 24 items of
the PCSES displayed either positive or negative skew which was outside of the
normal range. The greatest skew was found on Item 24 (“u drug and a free”) with a
skew value of -1.734 (SE=0.18). Fifteen of the 24 PCSES items displayed either
positive or negative kurtosis with Item 24 (“u drug and a free”) displaying the largest
kurtosis value (kurtosis=2.387, SE=0.357). It has been suggested that when the data
deviates significantly from normality the data needs to be transformed prior to
conducting factor analysis, with ‘substantial departures from normality’ defined as
datasets with skew greater than 2 and kurtosis values greater than 7 (West, Finch &
Curran, 1995). In the present sample none of the PCSES items displayed skew
scores greater than 2 or kurtosis scores above 7 which suggests that the data only
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slightly deviated from normality, therefore data transformation was not deemed
necessary.
Table 11. Mean, Standard Deviation, Skew & Kurtosis for PCSES items.
Item Mean Standard
Deviation
Skew
(SE=0.18)
Kurtosis
(SE= 0.357)
1. mood change 4.57 2.37 0.365 -0.668
2. suicidal 6.42 3.16 -0.162 -1.062
3. medication 5.02 3.15 0.291 -1.060
4. not interact 4.72 2.71 0.437 -0.602
5. embarrassed 4.74 2.91 0.428 -0.796
6. blames u 5.09 3.15 0.262 -1.112
7. not understand 5.93 2.88 -0.095 -0.911
8. criticise 5.38 2.87 0.141 -0.988
9. practical tips 4.85 3.04 0.413 -1.019
10. low mood 3.31 2.44 0.996 0.281
11. stress worry 3.31 2.43 1.090 0.575
12. bored 3.98 2.57 .644 -0.442
13. no effort 3.06 2.34 1.078 0.371
14. lies 3.00 2.58 1.460 1.433
15. unappreciative 3.52 2.72 1.053 0.181
16. responsibilities 5.16 3.15 0.347 -1.046
17. not criticise 5.27 2.83 0.217 -0.818
18. the past 5.25 2.98 0.213 -1.071
19. buy d and a 8.21 3.28 -0.917 -0.487
20. sick 5.91 3.34 0.059 -1.229
21. intoxicated 5.38 3.04 0.26 -.0.926
22. quality time 7.77 2.80 -0.611 -0.507
23. support 6.25 3.32 -0.113 -1.226
24. u d and a free 9.47 2.49 -1.734 2.387
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Floor and Ceiling Effects on the PCSES
Floor and ceiling effects were calculated for each of the 24 items of the PCSES.
Floor and ceiling effects were calculated as percentages of patients rating at the
lowest level (scoring 0%) and the highest level (scoring 100%) on each item. Results
are displayed in Table 12.
Only one item of the PCSES displayed a moderately large ceiling effect “u d and a
free” with 42% of the sample rating it at 100% confidence suggesting that almost half
of the sample were extremely confident in being to refrain from drinking/using drugs
in the presence of their partner. Other than this finding the PCSES failed to display
large ceiling or floor effects in the current sample.
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Table 12. Floor & Ceiling Effects on the PCSES
Item Floor Effect
n
% of
Sample
Ceiling
Effect
 n
% of
Sample
1. mood change 10 6% 11 6%
2. suicidal 13 7% 13 7%
3. medication 8 4% 18 10%
4. not interact 5 3% 14 8%
5. embarrassed 2 1% 8 4%
6. blames u 12 7% 9 5%
7. not understand 8 4% 12 7%
8. criticise 8 4% 7 4%
9. practical tips 10 6% 11 6%
10. low mood 19 10% 9 5%
11. stress worry 23 13% 7 4%
12. bored 21 12% 9 5%
13. no effort 18 10% 3 2%
14. lies 13 7% 5 3%
15. unappreciative 17 9% 11 6%
16. responsibilities 15 8% 11 6%
17. not criticise 10 6% 9 5%
18. the past 12 7% 8 4%
19. buy d and a 12 7% 15 8%
20. sick 12 7% 9 5%
21. intoxicated 18 10% 17 9%
22. quality time 8 4% 23 13%
23. support 14 8% 27 15%
24. u d and a free 2 1% 77 42%
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Gender Differences in Total PCSES for Study 2
Given that the Total PCSES scores were found to be normally distributed an
independent samples t-test was conducted to examine for the presence of possible
gender differences in Total PCSES scores. The mean Total PCSES score for
females was found to be 130.10 (sd=30.19) and for males it was found to be 133.87
(sd=30.05). No statistically significant difference was observed between males and
females on their Total PCSES scores (t(181)=  -0.733, p=0.464).
Comparison of Study 1 and Study 2 Partner Demographics
Almost identical proportions of females were observed in both Study 1 and Study 2
partner samples, that is 78% of partners in Study 1 were female compared to 75% of
partners from Study 2.  A  z–test of two proportions across two samples revealed no
statistically significant difference in the proportion of females in Study 1 compared to
Study 2 (z=0.6099, p=0.54186). Given that the data for partners in both Study 1 and
Study 2 were normally distributed on some measures including age and HADS they
met the assumption for a t-test. As a result, independent samples t- tests were used
to determine if statistically significant differences between partners from Study 1 and
Study 2 existed on a number of these measures. An independent samples t-test was
conducted to assess age differences between the two samples, with Levene’s test
revealing equal variances. A statistically significant difference was found between
partners from Study 1 compared to Study 2 in terms of their age (t(264)= -4.252,
p=0.000). The mean age of partners in Study 1 was 40.33 years (sd=10.06) and the
mean age for partners from Study 2 was 46.11 years (sd=10.38) which suggests that
partners from Study 2 were significantly older. An independent samples t-test was
also conducted to assess potential differences in the number of years partners had
been in their current relationship for between the two samples. Equal variances
between the two samples was not assumed from Levene’s test. Partners from Study
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2 had been on average in their current relationship for 11.84 years (sd=9.58)
compared to partners from Study 1 (mean =8.49, sd=6.74). This difference was
found to be statistically significant (t(218)=-3.265, p=0.001) and suggests that the
Study 2 internet sample reported being in their current relationship for longer
compared to Study 1 partners.
A statistically significant difference was found in Total HADS scores between
partners from Study 1 compared to Study 2 (t(264)=2.475, p=0.014) with Study 1
partners displaying significantly higher mean Total HADS scores (M=18.25, sd=7.68)
compared to Study 2 partners (M=16.13, sd=5.58). Similarly, a significant difference
in HADS Depression subscale scores were observed between partners from Study 1
and Study 2 (t(264)=5.103, p=0.000) with Study 1 partners displaying greater levels
of depressive symptoms (M=9.69, sd=4.62) when compared to Study 1 partners
(M=6.72, sd=3.831). No statistically significant difference was observed however in
Anxiety Subscale scores of the HADS between Study 1 and Study 2 partners
(t(264)=-1.481, p=0.14).
Comparison of Study 1 with Study 2 PCSES Results
A comparison of Total scores on the PCSES between the two samples was
conducted using the Mann-Whitney U Test statistic given that Total scores on the
PCSES were not normally distributed for the Study 1 sample. With the mean rank for
Study 1 partners found to be 169.16 and the mean rank for Study 2 partners found to
be 117.33, a statistically significant difference between the two samples was
observed on Total PCSES scores (U(1)=4634.5, z=-5.092, p=0.000). Such findings
suggest that partners from Study 2 displayed significantly lower confidence rating as
assessed by the PCSES Total score when compared to Study 1 partners.
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Examination of comparisons between the two study samples on their scores on the
24 individual items of the PCSES are displayed in Table 13. Once again the Mann-
Whitney U Test statistic was implemented given that the item scores displayed
evidence of skew and kurtosis in both samples.
As seen in Table 13, 18 of the 24 items of the PCSES displayed statistically
significant differences from Study 1 to Study 2. In all but two of these 16 items the
size of the difference was such that the Study 1 sample reported being more
confident than the Study 2 sample. The two items in which the Study 2 sample
reported significantly greater confidence compared to the Study 1 sample were for
the items “buy d and a” and “quality time”.
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Table 13. Comparison of Study 1 and Study 2 PCSES Scores
PCSES Item U z p Direction of
difference
1. mood change 4897.5 -4.685 0.000 Study 1 > 2
2. suicidal 7289 -0.531 0.595
3. medication 5542.5 -3.551 0.000 Study 1 > 2
4. not interact 4896 -4.681 0.000 Study 1 > 2
5. embarrassed 5526.5 -3.588 0.000 Study 1 > 2
6. blames u 6012 -2.744 0.006 Study 1 > 2
7. not understand 7202.5 -0.679 0.497
8. criticise 7061 -0.925 0.355
9. practical tips 6232 -2.358 0.018 Study 1 > 2
10. low mood 4252.5 -5.825 0.000 Study 1 > 2
11. stress worry 4327 -5.691 0.000 Study 1 > 2
12. bored 5241 -4.081 0.000 Study 1 > 2
13. no effort 3621.5 -6.951 0.000 Study 1 > 2
14. lies 2936 -8.156 0.000 Study 1 > 2
15. unappreciative 4140 -6.01 0.000 Study 1 > 2
16. responsibilities 6148.5 -2.505 0.012 Study 1 > 2
17. not criticise 5494.5 -3.647 0.000 Study 1 > 2
18. the past 6082.5 -2.618 0.009 Study 1 > 2
19. buy d and a 4650 -5.147 0.000 Study 2 >1 **
20. sick 6566 -1.779 0.075
21. intoxicated 6466.5 -1.954 0.051
22. quality time 6439.5 -2.008 0.045 Study 2 >1 **
23. support 6321 -2.203 0.028 Study 1 > 2
24. u d and a free 6848.5 -1.406 0.16
*= note direction of significant difference
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Research Question 1 - Confirmatory Factor Analysis :  Expect the PCSES to
display a clear 4 factor structure as a result of confirmatory factor analysis.
Exploratory Factor Analysis prior to Conducting Confirmatory Factor Analysis
In order to determine if the data from Study 2 were indeed appropriate for factor
analysis before commencing confirmatory factor analysis (CFA) the factorability of
the dataset was examined. Bartlett’s Test of Sphericity produced a significant result
(χ2=1889.201, df=276, significance=0.00, p<0.001) (see Appendix E). Such a result
suggests that the variables do related to each other enough to conduct a meaningful
exploratory factor analysis (EFA). The second aspect of this particular dataset to be
examined was the Kaiser-Meyer-Olkin measure of sampling adequacy. Results from
the Kaiser-Meyer-Olkin measure of sampling adequacy was found to be 0.744 (see
Appendix E) which Kaiser (1970) would describe as “middling” as it is well above the
recommended minimum level required for factor analysis to produce distinct and
reliable factors.
Prior to conducting EFA evidence of communalities between the items were
examined by looking at the inter-item correlation matrix for this sample (see Appendix
E). Examination of the corrected item-total correlations revealed that all items of the
PCSES had a positive correlation score. The vast majority of the corrected item-total
correlations were above 0.30 with only 3 items displaying correlations below 0.2
(“buy d and a” = 0.173 , “sick” = 0.121 , “u d and a free” = 0.041). Given that the
Cronbach’s alpha level did not improve a great deal if these items were to be
removed from the PCSES they were subsequently retained. In actual fact none of the
items of the PCSES would result in a substantially higher Cronbach alpha if they
were to be removed from the scale. Furthermore none of the items of the PCSES
produced inter-item correlations which were above DeVellis’ (1991) recommended
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limit of 0.75. The largest inter-item correlation was observed between “mood change”
and “medication” (r=0.691) which did not warrant removal from the scale as it did not
exceed 0.75. Further evidence for lack of multicollinearity was obtained from the
determinant value found from the inter-item correlation matrix. The determinant value
was found to be 0.0000183 and given that this value is greater than 0.00001 this
suggests that there is no evidence of multicollinearity.
Prior to conducting EFA one outlier was identified from a box plot of the data. This
particular participant (number 178) scored 237 out of 264 on the Total PCSES which
produced a z-score of 3.16 from examination of the standardized z-scores for Total
PCSES scores. As data was not collected in a face-to-face manner to allow for
checking of item responses it is unclear if this participant’s high score is legitimate or
not. As a result, this participant’s data was removed from all analyses in Study 2
including the CFA. Furthermore all participants with any missing data in Study 2 were
removed from all analyses, including CFA. The final sample size for EFA and CFA in
Study 2 was 183. The participants to items ratio for Study 2 was 7.6 to 1 which is well
above the recommended minimum ratio of 3 to 1 which is required for factor analysis
(Velicer & Fava, 1998).
Another requirement of factor analysis is that the data be approximately normally
distributed. Total PCSES scores for the Study 2 sample were found to lie within the
normal range without evidence of skew or kurtosis. However, analysis of each item of
the PCSES suggests that all of the 24 PCSES items displayed either mild to
moderate skew or mild kurtosis. Further evidence of non-normality was also found
from the Shapiro–Wilks test of normality. Despite this none of the items from the
PCSES displayed a great deal of skew or kurtosis in that their standardized
skewness and kurtosis scores did not exceed 3.75. Furthermore, it has been
suggested that ‘substantial departures from normality’ are those in which skew is
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greater than 2 and kurtosis values are greater than 7 (West, Finch & Curran, 1995).
In the present sample none of the PCSES items displayed skew scores greater than
2 or kurtosis scores above 7 which suggests that the data only slightly deviated from
normality. Given this it was not considered necessary to transform the data prior to
conducting EFA and CFA.
Exploratory Factor Analysis Study 2
The results above suggest that the data from Study 2 were indeed factorable. Firstly
an exploratory factor analysis was conducted without specifying a number of fixed
factors using principal axis factoring given that the data from Study 2 were not
normally distributed. Principal axis factoring with oblique rotation (delta=0) was
selected as it permits correlations between the factors. When determining the
number of factors to retain the same criteria for factor extractions as in Study 1 were
followed (for more detail refer to page 80). More specifically, seven criteria were
examined when deciding on the number of factors to retain :
1. Kaiser criterion which specifies that eigenvalues must be greater than or equal to
one to be retained.
2. Factor loadings greater than 0.30 are only to be retained.
3. Examination of the scree plot.
4. Parallel analysis to determine the maximum number of factors to retain.
5. The total amount of variance accounted for by each model, with models
accounting for greater percentages of variability considered more ideal.
6. Each factor should contain at least three items.
7. Factors must be able to be meaningfully interpreted and they should make
theoretical sense.
The results from the seven above criteria were as follows :
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1. Based on the Kaiser criteria the initial factor analysis revealed the presence of 6
factors with eigenvalues above 1. This initial 6 factor model accounted for 61% of the
total variance. The results of this model can be observed in Table 14.
Table 14. Initial 6 Factor Model
2. All items on the PCSES produced factor loadings of at least 0.30 on one factor
with the lowest factor loading for “criticise” (0.323 on Factor 1) and the highest factor
loading for “stress worry” on Factor 3 (0.756) (see Appendix E).
3. Examination of the scree plot revealed the possibility of 4 factors (see Appendix
E).
4. Parallel analysis was conducted after entering  O’Connor’s (2000) “rawpar” syntax
into SPSS. Parallel analysis was run on one randomly generated dataset, with
N=1000, in order to further verify the results. The confidence level was set at the 95th
percentile. Given that the data from Study 2 were not normally distributed as shown
from normality test results, (see Appendix E) the parallel analysis was to set to
generate random data based on permutations of the original Study 2 (n=183) raw
data set, which is apparently the most robust approach to use with data that are not
normally distributed (O’Connor, 2000). The results obtained from the randomly
Factor Eigenvalue % of
Variance
Accounted
For
1 6.892 28.715
2 2.210 9.207
3 1.633 6.802
4 1.530 6.376
5 1.268 5.282
6 1.164 4.849
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generated parallel analyses indicated the presence of no more than 7 statistically
significant eigenvalues suggesting that at most 7 factors be retained.
5. Models with the most factors accounted for the greatest percentage of total
variance.
6. None of the factors from the 4 Factor model contained fewer than 4 items per
factor. However the 6 factor model did not contain the minimum recommended
number of items per factor.
7. The 6 factor and 5 factor models did not make theoretical sense and were not
readily interpretable. A factor structure which was almost identical to that found from
the 4 Factor model in Study 1 was obtained in the present study from the 4 Factor
model, suggesting that the 4 Factor model was optimal.
4 Factor Model
A 4 factor solution was forced given that the results from Study 1 EFA suggested that
the 4 Factor model produced optimal fit for the data and was superior in terms of
interpretability. Principal axis factoring using direct oblimin rotation (delta=0) was
conducted with a forced 4 factor model (see Appendix E). The four factor solution
accounted for 51.1% of the total variance. Factor 1 consisted of 6 items and
accounted for 28.715% of total variance, Factor 2 consisted of 7 items and
accounted for 9.207%, Factor 3 consisted of 7 items and accounted for 6.802% and
Factor 4 consisted of 4 items and accounted for 6.376% of the total variance.
Eigenvalues ranged from 6.892 to 1.530.
When a 4 factor solution was forced all items loaded at least 0.30 on one factor. The
lowest factor loading was 0.352 for Item 17 (“not criticise”) on Factor 3 and the
highest factor loading was 0.888 for Item 11 (“stress worry”) on Factor 4. Five items
cross-loaded on more than one factor by at least 0.30. These five items were :
1. Item 6 (“blames u”) which cross loaded onto Factor 1 and Factor 3.
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2. Item 7 (“not understand”) which cross loaded onto Factor 1 and Factor 3.
3. Item 12 (“bored”) which cross loaded onto Factor 1 and Factor 4.
4. Item 14 (“lies”) which cross loaded onto Factor 3 and Factor 4.
5. Item 19 (“buy d and a”) which cross loaded onto Factor 1 and Factor 2.
Overall a very similar factor structure was produced to that obtained from the Study 1
factor analysis. Table 15 displays the factor loadings for each of the PCSES items
from both Study 1 and Study 2. The same items of the PCSES loaded on the same
factors in both Study 1 and Study 2. The main difference observed between the two
samples was in terms of the different cross loadings between PCSES items.
Table 15. Four Factor Model Factor Loadings : Study 1 & Study 2.
Factor Item Loading
Study 1
Loading
Study 2
1 Item 1  mood change
Item 2  suicidal
Item 3  medication
Item 4  not interact
Item 5  embarrassed
Item 8  criticize
0.650
0.605
0.684
0.634
0.617
0.476
0.579
0.660
0.619
0.580
0.594
0.504
2 Item 18  the past
Item 19  buy d and a
Item 20  sick
Item 21  intoxicated
Item 22  quality time
Item 23  support
Item 24  u d and a free
0.366
0.442
0.554
0.478
0.489
0.411
0.378
0.392
0.432
0.464
0.501
0.520
0.433
0.377
3 Item 6  blames u
Item 7  not understand
Item 9  practical tips
Item 14  lies
Item 15  unappreciative
Item 16  responsibilities
Item 17  not criticize
0.420
0.496
0.325
0.518
0.666
0.701
0.313
0.397
0.456
0.316
0.564
0.775
0.649
0.412
4 Item 10  low mood
Item 11  stress worry
Item 12  bored
Item 13  no effort
0.562
0.857
0.509
0.313
0.606
0.888
0.466
0.369
Characteristics of the 4 Factor model in the Study 2 population are presented in
Table 16.
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Table 16. Characteristics of the 4 Factor Model.
Factor 1 Factor 2 Factor 3 Factor 4
Mean 38.1967 50.7322 44.0984 23.0219
Std. Error of Mean .90395 .81140 .99356 .67715
Median 38.0000 50.0000 45.0000 24.0000
Mode 36.00a 43.00a 47.00 26.00
Std. Deviation 12.22835 10.97647 13.44060 9.16033
Variance 149.533 120.483 180.650 83.912
Skewness .037 -.128 -.193 .003
Std. Error of Skewness .180 .180 .180 .180
Kurtosis -.151 -.214 .119 -.525
Std. Error of Kurtosis .357 .357 .357 .357
Minimum 9.00 21.00 12.00 4.00
Maximum 65.00 77.00 77.00 44.00
a. Multiple modes exist. The smallest value is shown
Examination of the factor correlation matrix in Table 17 revealed low correlations
between the 4 factors which ranged from r=0.120 (between Factor 2 and Factor 4)
and a high of r=0.331 between Factor 1 and Factor 4. Such low correlations seem to
suggest that the 4 factors are distinct from each other and independent.
Table 17. 4 Factor Correlation Matrix
Factor 1 2 3 4
1 *
2 .232 *
3 -.299 -.280 *
4 .331 .120 -.245       *
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Model Estimation and Evaluation
The main purpose behind Study 2 was to confirm the factor structure of the 24 item
PCSES on an independent sample of partners who were recruited from the internet.
Confirmatory factor analysis (CFA) was used to determine which factor model
explained this second data set most fully. In CFA the relationships amongst the
factors are examined and they are free of measurement error, leaving only common
variance, thus only covariance matrices rather than correlations are used in CFA.
CFA aims to determine whether the proposed model produces an estimated
population covariance matrix that is similar to the sample’s covariance matrix.
Closeness of fit is assessed by chi-squared tests and fit indices. Regression
coefficients, variances and covariances are estimated using CFA with each model
producing its own covariance matrix.
CFA was conducted using Lisrel 9.10 (Joreskog & Sorbom, March 2013), using
maximum likelihood estimation (“robust estimation”). This particular type of
estimation technique was selected as it is designed specifically for data which are not
normally distributed. Given that the data from both Study 1 and Study 2 were not
normally distributed this particular estimation technique was expected to produce the
most accurate CFA findings. The maximum likelihood method using robust
estimation in Lisrel provides a scaled chi-squared value and “robust” standard errors
on the basis of Satorra and Bentler’s (1988) recommendations for dealing with non-
normally distributed data when conducting CFA. Furthermore the advantage of the
Lisrel program is that not only is the chi-squared statistic adjusted for non-normal
data but all fit indices reported by Lisrel have also been adjusted to deal with
violations of normality.
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Prior to conducting CFA a number of requirements about the data need to be fulfilled.
The first requirement is that one needs more data points than parameters in order to
conduct a meaningful CFA. The number of data points can be calculated using the
following formula :
Number of data points = p (p+1)
                                             2
Where  p= number of observed variables
The number of data points in the present study was found to be 300.
The number of parameters can be calculated by summing the number of regression
coefficients with the number of variances and covariances for each model. In the
present study three different  models were being examined : a 1 Factor model, 3
Factor model and 4 Factor model. The  number of parameters was 49, 51 and 52 for
each model respectively. Therefore there were a great deal more data points than
parameters in each of the three hypothesized models which suggests that each of
the models was over-identified, thus one can proceed with CFA.
A second prerequisite condition for CFA is that one must have an adequate sample
size. The ratio of cases to observed variables in Study 2 was 7.6 : 1. The final
sample for CFA consisted of 183 participants. The minimum recommended sample
size for CFA is between 100 and 200 subjects (Kline, 2005). Another requirement
prior to conducting CFA is that the data does not deviate significantly from normality
and that the variables are linearly related. As previously mentioned when examining
the factorability of the data set the data from Study 2 does not deviate significantly
from normality. Examination of scatter plots of some of the variables suggests the
variables of the PCSES are linearly related.
Another prerequisite for CFA is that the data must not have a singular covariance
matrix and there must not be evidence of multicollinearity (see covariance matrix in
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Table 18). In the present study the Lisrel program did not fail to converge which
suggests that the covariance matrix was not singular. Multicollinearity was assessed
using the determinant of the correlation matrix  from the item-item correlation matrix,
which was found to be slightly above 0.00001 at 0.00001828. Examination of the
correlation matrix revealed that the largest correlation was 0.736 between “mood
change” and “medication” and given that such a value is not considered to be very
high this further proves the absence of multicollinearity. This suggests that there was
no evidence of  multicollinearity or singularity in the data. In summary the data from
Study 2 met all of the necessary requirements for CFA.
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The following chi-squared tests and fit indices were selected by the researcher to
assist with selecting the most optimally fitting model for the data. Chi-squared
statistics measure the degree of misfit between the data and the model, with larger
chi-squared values suggesting worse fit. Chi-squared scores are known to be biased
by sample size and non-normal data distribution (Tabachnick & Fidell, 1996). For this
reason the Satorra-Bentler scaled chi-squared was reported in the following CFA
because it is adjusted for data which is not normally distributed. The Relative Chi-
Squared Fit Index, that is the Satorra-Bentler scaled chi-squared divided by the
degrees of freedom, was also examined to assess goodness of fit, with values
between 1 and 3 suggesting “good fit”, and values up to 5 considered “acceptable fit”
(Kline, 2005). Given that the sample size in the present study was not very large the
following fit indices were selected because they are not grossly affected by small to
medium sample sizes : SRMR (Standardized Root Mean-Square Residual), CFI
(Comparative Fit Index), IFI (Incremental Fit Index), NNFI (Nonnormed Fit Index),
and RFI (Relative Fit Index). The SRMR was selected because it is based on the
average differences between sample and population variances and covariances.
Values of SRMR less than 0.08 are indicative of good fit and values less than 0.1
suggest adequate fit (Hu & Bentler, 1999). The CFI, IFI and RFI represent how much
better the model fits as compared to the null model (independence model) with
values above 0.90 indicating excellent fit (Bentler, 1990). The NNFI has been found
to be least affected by sample size when compared to most commonly used fit
indices as it includes an adjustment for the degrees of freedom (Marsh, Balla &
McDonald, 1988). Values above 0.90 on the NNFI suggest excellent model fit (Hu &
Bentler, 1999). Although the RMSEA is often cited in studies it was not used in the
present study due to its tendency to produce large values and consequently to reject
valid models which have low sample sizes (less than or equal to 100) (Chen et al.,
2008).
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The Akaike Information Criterion (AIC; Akaike, 1987) was also implemented to assist
with model comparison. Although the AIC has no formal cut-off, smaller values
suggest better fit and greater parsimony when comparing different models. The
model with the smallest AIC value was in the present study considered to be the
most parsimonious and best fitting model. In addition to fit indices and chi-squared
results the standardized residuals produced from the CFA were also examined to
assist with deciding which model produced the best fit for the data. The Lagrange
Modification Index was also examined to consider suggestions to improve the model
fit.
Based upon the results from EFA of the PCSES conducted in Study 1 the
hypothesized measurement model consisted of a four factor model. This model
consisted of Factor 1 “Comprehensive Care” as a latent variable with 6 items as
indicators, Factor 2 “Reinforcing Abstinence” as a latent variable with 7 items as
indicators, Factor 3 “Resilience” as a latent variable with 7 items as indicators, and
Factor 4 “Negative Affect” as a latent variable with 4 items as indicators. The four
latent variables from this model were hypothesized to serve as indicators of a higher-
order PCSES latent factor. This hypothesized 4 Factor model was for comparison
purposes compared to a 3 Factor model as well as a single factor model. A 3 Factor
model was selected for comparison purposes instead of the 2 Factor model as it was
more theoretically comprehensible and it accounted for a greater degree of variance
when compared to the 2 Factor model in the Study 1 EFA. Results from the CFA are
presented in Table 19.
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Table 19. Confirmatory Factor Analysis Results
Satorra-
Bentler
χ 2
χ 2/df CFI NNFI IFI RFI SRMR AIC ∆
AIC
4
Factor
Model
739.844
p=0.0000
df=246
3.007 0.889 0.875 0.89 0.824 0.0932 10,834
3
Factor
Model
812.107
p=0.0000
df=249
3.26 0.873 0.859 0.874 0.809 0.101 10,945 111*
1
Factor
Model
937.648
p=0.0000
df=252
3.721 0.846 0.831 0.846 0.782 0.112 11,126 292*
*= statistically significant difference p<0.05
The Satorra-Bentler Chi-Squared statistic for the 4 Factor model was 739.844 based
on 246 degrees of freedom, p=0.0000 suggesting that the estimated population
covariance matrix and the sample covariance matrix differ significantly and thus the 4
Factor model does not fit the data. The 3 Factor model also produced a significant
Satorra-Bentler Chi-Squared statistic (chi squared= 812.107, df=249, p=0.0000)
suggesting this model also failed to provide adequate fit. The 1 Factor model also
produced significant results (chi-squared=937.648, df=252, p=0.0000) also
suggesting poor model fit. Overall when the Satorra-Bentler Chi-Squared statistic
was used on its own all three models produced results suggesting all models had
poor fit with a large amount of covariance unexplained by all three models.
Given that model fit is not usually based on chi-squared results alone examination of
the fit indices was also conducted. Overall the results from the fit indices indicated
that the 4 Factor model performed best compared to the 1 and 3 Factor models.
Although the Satorra-Bentler Chi- Squared statistic was significant for all models a
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comparison of the Relative Chi-Squared Fit Index for each of the three models
revealed that the 4 Factor model produced the best fitting model in that it produced
the lowest value (3.007). Examination of the SRMR index for each of the three
models revealed that none of the models were below 0.8 which would suggest
excellent fit. Despite this, the 4 Factor model produced the most superior results on
the SRMR index (0.0932) which suggested that the 4 Factor model produced the
most adequate model fit of all the models examined. Results from the CFI, NNFI, IFI
and RFI also provided evidence of the 4 Factor model producing the best fitting
model compared to the other two models. Although none of the models examined
exceeded the recommended cut-off of 0.90 on any of these four indexes the 4 Factor
model very closely approached the 0.90 cut-off on the IFI (0.89), CFI (0.889) and the
NNFI (0.875) suggesting almost excellent model fit. Although the fit indices were
acceptable to almost excellent for the 4 Factor model there was still a fair amount of
covariance not explained by this particular model. More specifically the NNFI result
suggested that approximately 88% of the covariance between items is explained by
the 4 Factor model.
The 4 Factor model produced the lowest AIC value of all the models tested
suggesting superior fit. The ∆ AIC values were tested to determine whether the
difference in AIC scores was statistically significant using the chi-squared test. The ∆
AIC between the 4 Factor model and the 1 Factor model was chi-square of 292, with
a difference of 6 degrees of freedom. This ∆ AIC was found to be statistically
significant (p=0.00) and suggests that the 4 factor model was a better fit to the data
than the 1 Factor model. Similarly the change in AIC from the 4 Factor model to the 3
Factor model was also statistically significant (chi-squared = 111, df=3, p=0.00). This
also suggests that the 4 Factor model provided a better fit to the data than the 3
Factor model.
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Examination of the R² statistics, that is the squared multiple correlations (SMC),
revealed how much of the variance in PCSES is accounted for by each factor of the
PCSES as well as which items of the PCSES account for most of the variance. The
SMCs revealed that the p-values of all the variables/items were significant
suggesting that all of the items were significantly associated with their respective
factors. As a consequence none of the items of the PCSES needed to be removed
from the PCSES as a result of the CFA. SMC values were greater than 0.40 for 15 of
the 24 items of the PCSES which suggests that the fit of each item on each factor
was acceptable (Table 20). The SMC values for the 4 Factor model ranged from
0.668 (“mood change”) to a low of 0.170 ( “buy d and a”).
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Table 20. Squared Multiple Correlations for the 4 Factor Model
Factor Squared Multiple
Correlation (R²)
Factor 1
Item 1  mood change
Item 2  suicidal
Item 3  medication
Item 4  not interact
Item 5  embarrassed
Item 8  criticize
0.668
0.502
0.580
0.492
0.332
0.442
Factor 2
Item 18  the past
Item 19  buy d and a
Item 20  sick
Item 21  intoxicated
Item 22  quality time
Item 23  support
Item 24  u d and a free
0.232
0.170
0.333
0.435
0.246
0.208
0.241
Factor 3
Item 6  blames u
Item 7  not understand
Item 9  practical tips
Item 14  lies
Item 15  unappreciative
Item 16  responsibilities
Item 17  not criticize
0.451
0.539
0.429
0.510
0.478
0.429
0.201
Factor 4
Item 10  low mood
Item 11  stress worry
Item 12  bored
Item 13  no effort
0.550
0.662
0.567
0.332
Examination of the standardized residual covariances was also conducted to further
assess model fit. For ideal model fit residuals need to lie between +2 and - 2, and be
centred around zero with a symmetric distribution as evident from a frequency
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distribution graph. Large residuals suggest that the model does not adequately
estimate the relationship between those particular two variables. From the 4 Factor
model 30 residuals were found to lie above 2 or less than -2. The smallest
standardized residual was between “embarrassed” and “medication” (-7.107) and the
largest standardized residual was between “blames u” and “medication” (11.561).
The median for the residuals was zero and examination of the stem and leaf plot
revealed a normal distribution with scores centred around zero. The 3 Factor model
produced similar results with a total of 32 residuals below -2 or above 2, with a
normal distribution observed from the stem and leaf plot. The 1 Factor model on the
other hand produced more residual pairs which were outside the range of -2 to +2,
that is 36 residuals were outside the recommended range. The stem and leaf plot of
the residuals closely approximated a normal distribution for the 1 Factor model.
Therefore, from examination of the standardized residual covariances it can be
concluded that the 4 Factor model was superior to the 1 Factor model, with the 3
Factor model producing almost similar results to that of the 4 Factor model.
The correlations between each of the factors from the final path diagram of the 4
Factor model revealed that all of the correlations between the factors were
significant. Correlations between factors ranged from 0.28 to 0.71 (Table 21.).
Table 21. Correlations Between Factors of the 4 Factor Model
Factor 1 Factor 2 Factor 3 Factor 4
Factor 1 *
Factor 2 0.35 *
Factor 3 0.71 0.49 *
Factor 4 0.66 0.28 0.61 *
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Lagrange Multiplier (LM) Test
The LM test in Lisrel 9.10 makes suggestions for decreasing the chi-squared value
for the model by adding covariances between items and/or by adding parameters to
the model. The LM test in Lisrel 9.10 does not make suggestions about removing
parameters, only about adding them.
Examination of the LM test results suggested that chi-squared could have been
improved by creating complex items, that is items which load on more than one factor
(e.g. “criticize” to load on Factors 2 and 3 when it is theorized to load on only Factor
1) or by adding new error covariances between PCSES items. The LM test for the 4
Factor model suggested to add 4 different parameters for 3 of the PCSES items
which was expected to result in a total decrease in chi-square of 39.2. This decrease
in chi-square was rather small given that the Maximum Likelihood chi-square value
for the model was quite large to begin with (chi-squared=1053.511). Thus the
recommended parameter changes would have resulted in only a 3.7 % drop in
Maximum Likelihood chi-square. Such a minimal drop would have been very unlikely
to have made a substantial difference to the significance of the Maximum Likelihood
chi-square value or to the fit indices. These modifications however would lead to a
change in the basic factor structure of the PCSES and complicate its interpretation.
The LM test also suggested that 41 different error covariances be added to various
items of the PCSES in the 4 Factor model. To add a covariance as suggested by the
LM test makes sense when the two items  are strongly related to each other, that is
they have something in common. The majority of the recommended error covariance
additions suggested by the LM test did not make any sense theoretically. For
instance, error covariances were suggested between the following pairs of items :
- “blames you” and “medication”
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- “buy d and a” and “bored”
- “buy d and a” and “criticize”
- “quality time” and “suicidal”
- “support” and “stress/worry”
- “u d and a free” and “blames u”
- “u d and a free” and “embarrassed”
- “u d and a free” and “medication”.
Furthermore, the largest expected change in chi-square as suggested by the LM test
was from adding an error covariance between “buy d and a” and “bored” which was
expected to lead to only a 3% drop in the Maximum Likelihood Chi-square value.
Given this no modifications were made to the 4 Factor model based on the LM test
as they did not appear to be theoretically justifiable and because the predicted
changes to the model would not have resulted in a significant change in the
Maximum Likelihood Chi-square value.
In conclusion, results from the CFA suggest that the 4 Factor model performed best
compared to the 1 and 3 Factor models leading one to reject the 1 and 3 Factor
models in favour of the 4 Factor model. The path diagram of the final 4 Factor model
is presented in Figure 2.
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Figure 2.  Final Path Diagram of the PCSES 4 Factor Model
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Research Question 2 –  Construct Validity  : Expect to see a negative
relationship between partner coping self-efficacy (as assessed by the PCSES)
and self-reported depression and anxiety symptoms in partners (as assessed
by the Hospital Anxiety and Depression Scale).
The PCSES could not be compared against a similar scale assessing partner coping
self-efficacy as none currently exists in the literature. As a result construct validity
was assessed by examining the relationship between the PCSES data from Study 2
to a number of partner variables such as depression and anxiety.
Study 2 Partner Variables & PCSES
A number of relationships between the PCSES and partner variables were examined.
Kendall’s Tau – b rank correlation coefficient was selected to assess correlations
instead of Spearman’s Rho as Spearman’s Rho requires a monotonic relationship
between the two variables being examined which was not always present with some
of the variables as evident from scatter plots of the variables. Kendall’s Tau statistic
does not rely on any assumptions about the distribution of the two variables and it
measures the strength of the relationship between the two variables, like Spearman’s
rank correlation coefficient. Kendall’s Tau statistic measures the number of
concordances and discordances in a paired observation to provide a measure of the
orderings of the data.
No statistically significant relationships were observed between Total PCSES scores
and a number of partner variables including age, gender, number of years in current
relationship and all scores on the HADS. The results also failed to reveal a
statistically significant relationship between each of the 4 factor scores of the PCSES
and partner variables such as age, gender, number of years in current relationship
and HADS scores.
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Table 22. Correlations Between Partner Variables & the PCSES
PCSES
Total
PCSES
Factor 1
PCSES
Factor 2
PCSES
Factor 3
PCSES
Factor 4
Age r=0.047
p=0.352
r=0.042
p=0.407
r=0.050
p=0.331
r=0.073
p=0.154
r=0.032
p=0.531
Gender r=0.49
p=0.426
r=-0.021
p=0.733
r=0.060
p=0.326
r=0.027
p=0.657
r=-0.048
p=0.443
Years
Together
r=0.043
p=0.398
r=-0.027
p=0.594
r=-0.030
p=0.554
r=-0.037
p=0.476
r=-0.054
p=0.298
HADS Total r=0.065
p=0.202
r=-0.013
p=0.801
r=0.004
p=0.933
r=0.023
p=0.654
r=0.032
p=0.537
HADS
Depression
r=0.032
p=0.535
r=0.056
p=0.285
r=0.088
p=0.094
r=0.049
p=0.347
r=0.088
p=0.097
HADS
Anxiety
r=0.078
p=0.129
r=-0.036
p=0.492
r=-0.064
p=0.222
r=0.008
p=0.876
r=0.007
p=0.897
*=  significant difference at p <0.05
Research Question 3 – Internal Consistency   : Expect the PCSES to have
adequate internal consistency.
Internal consistency (coefficient alpha) for Total PCSES scores for Study 2 was
found to be excellent (coeff alpha=0.893). Factor 1 produced an excellent level of
internal consistency (coeff alpha=0.820), as did Factor 3 (coeff alpha=0.835). Internal
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consistency for Factor 4 was acceptable (coeff alpha=0.778) and it was almost
acceptable for Factor 2 (coeff alpha=0.692).
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Discussion  Study 2
The purpose of Study 2 was to further assess the psychometric properties of the
PCSES. The main aim of this study was to validate the PCSES in a second larger
independent sample of partners of people with drug and alcohol problems in order to
determine if the original factor structure of the scale could be replicated. Confirmatory
factor analytic techniques were intended to be used in order to evaluate the optimal
fit for the items of the PCSES to the predetermined model from Study 1.
Scale Administration Study 2
Given that the PCSES has already been validated in a face-to-face setting it was
considered necessary to validate this self-report scale in a completely different
setting. More specifically, it was considered necessary to administer the scale
anonymously to partners accessing the internet from a variety of websites providing
information about drugs and alcohol. A total of fifteen websites were approached by
the author in order to place an advertisement for this study on their website to recruit
participants. Only the following three websites agreed to do so : The Australian
Centre for Addiction Research (www.acar.net.au), Family Drug Support
(www.fds.org.au), and Bottled Up (www.bottled-up.memberlodge.com). The
advertisement for the present study was advertised for a maximum period of 18
months.
A total of 298 participants completed some of the scales in the online assessment
package. From this group, 47 participants were excluded as they failed to complete
all of the assessment package, therefore their data was excluded from all statistical
analyses. A relatively low non-completion rate was observed in the present study
(16%) which is inconsistent with other internet research studies some of which report
that 30% fail to complete brief drug screeners during an internet trial (Sinadinovic,
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Wennberg & Berman, 2012). The fact that the assessment package was kept brief in
the present study may have helped keep the non-completion rate low. Twenty three
percent of partners who completed the entire assessment package had to be
excluded as their scores on the alcohol and/or drug screener, that is the AUDIT-C
and/or DAST-10, suggested the presence of a substance use problem. This
proportion of partners with a possible substance use problem is identical to that
obtained in Study 1 and research from others (E.g. Orford & Dalton, 2005),
suggesting that co-occurring substance use in partners may be more prevalent than
we think. It is unlikely that this high rate of substance use in partners was due to the
instructions for study inclusion/exclusion criteria being unclear as in the internet study
this particular exclusion criterion was specified twice, that is in the online
advertisement and in the Participant Information Statement. It is likely that the
partners identified from the screeners as having a substance use problem probably
may not have been aware that they were drinking/using excessively. It could also be
the case that their partner’s use was more severe than their own, leading them to
believe that they did not themselves have a drug or alcohol problem.
The final sample size from the internet sample in Study 2 was N=183 and mostly
consisted of female partners (75% female). Participants were on average 46 years of
age, with approximately two thirds of the sample aged between 40 and 65 years.
Participants had been on average in their current relationship for approximately 12
years, with more than half the sample reporting being in their relationship for over 10
years.
Similar proportions of female partners were observed in both Study 1 and Study 2
samples. In comparison to the Study 1 clinical sample, partners in the present study
were significantly older and had been in their current relationship for longer. The
average age of Study 2 participants was consistent with that of participants from
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online treatment studies such as one study by Hester, Delaney & Campbell (2011). It
is also possible that the volunteers from this study, when compared to Study 1
partners, belonged to a higher socioeconomic group and possessed higher levels of
computer literacy and had more access to a computer with internet facilities.
PCSES Descriptive Analysis Study 2
The lack of significant ceiling effects found in this sample of partners suggests that
the PCSES items are assessing situations which are not too easy or unchallenging
for partners. The same single item which displayed a ceiling effect in the Study 1
sample also displayed a similar ceiling effect in the present study. More specifically,
42% of partners endorsed 100% confidence in being able to refrain from
drinking/using in front of the patient (Item 24  “u d and a free”) in the present study.
Rather than indicating a weakness with this particular PCSES item, it suggests
instead that almost half of the participants in this sample were very easily able to
abstain from using drugs/alcohol which verifies that they were unlikely to themselves
have a substance use problem.
Partners from this internet sample reported the highest self-efficacy for items
assessing their ability to refrain from drinking/using in front of the patient (Item 24  “u
d and a free”), followed by their ability to refrain from buying alcohol/drugs for the
patient (Item 19  “buy d and a”). This particular sample also reported high self-
efficacy for being able to make an effort to spend quality time with their partner when
he/she was abstinent (Item 22 “quality time”). These findings suggest that this
sample of partners were most confident in situations pertaining to assisting and
encouraging abstinence behaviour in the patient. Conversely, the lowest self-efficacy
(approximately 30%) was reported for situations relating to assisting their partner to
abstain/reduce their substance use when the patient was experiencing a number of
negative mood states such as stress/worry and depression (Item 10 “low mood” &
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Item 11 “stress worry”). Similarly low confidence ratings of approximately 30% were
reported for situations assessing being able to continue assisting their partner with
abstinence or reducing their substance use when he/she lies to the partner (Item 14
“lies”) and when the patient does not seem to be making an effort to change their
own drug/alcohol use (Item 13 “no effort”).
When compared directly to the Study 1 sample’s responses on the PCSES the
current sample consistently displayed less overall confidence compared to the Study
1 sample on most PCSES items. The Study 2 internet sample only displayed
significantly greater self-efficacy for not purchasing drugs/alcohol for the patient (Item
19 “buy d and a”) and for being able to spend quality time with the patient when
he/she was abstinent (Item 22 “quality time”). One could speculate that the internet
Study 2 sample may have consisted of partners whose substance misusing partner
was not using/drinking as frequently to allow for more abstinence time. Furthermore
one could imply that the patient’s problem was either not as severe or the partners in
this sample were more confident in being able to assertively refuse to assist the
patients with obtaining their substance of choice. One interesting observation was
that that the present sample of partners, when compared to the Study 1 partners,
were less confident in being able to obtain support for themselves when finding it
difficult to deal with the patient’s drug and alcohol use behaviour.
Research Question 1 Confirmatory Factor Analysis  : Expect the PCSES to
display a clear 4 factor structure as a result of confirmatory factor analysis.
Although exploratory factor analysis provided important information regarding the
patterns of intercorrelations between the PCSES’s items, confirmatory factor analysis
(CFA) is the ideal method for evaluating optimal fit of the PCSES items to a particular
model. Results from Study 1 suggested that the 4 Factor model produced the best fit
for the data and exploratory factor analysis of the Study 2 dataset also confirmed that
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the 4 Factor model was optimal. CFA of the Study 2 sample using Lisrel 9.10
software (Jorskog & Sorbom, 2013) was conducted employing a maximum likelihood
estimation with “robust estimation” given that data from both samples were not
normally distributed. The Satorra-Bentler Scaled Chi-squared statistic was used, as it
is adjusted for non-normally distributed data, along with a number of fit indices in
order to determine whether the 4 Factor model did indeed provide the most optimal fit
to the data. The Chi-squared statistic is rarely used on its own in CFA studies due to
its tendency to produce misleading results (Hu & Bentler, 1999), thus the Akaike
Information Criterion was also implemented along with the Relative Chi-Squared Fit
Index.
Although none of the three different models examined produced evidence of good fit
based upon the Satorra-Bentler Scaled Chi-squared statistic alone, the Relative Chi-
Squared Fit Index (RCSFI) suggested that the 4 Factor model produced the most
superior fit of all models examined (4 Factor model  RCSFI=3.007, 3 Factor model
RCSFI= 3.26, 1 Factor model RCSFI= 3.721). Results from the four fit indices
(Comparative Fit Index, Nonnormed Fit Index, Incremental Fit Index & Relative Fit
Index) also provided support for the 4 Factor Model over the other two models.
However, none of the models examined produced results above 0.90 on any of the
four fit indices for any of the three models examined, which is the recommended
minimum value for optimal model fit. Despite this, the 4 Factor model produced fit
index values that very closely approached the 0.90 threshold, that is the Incremental
Fit Index value was found to be 0.89 and Comparative Fit Index produced a value of
0.889. Many have argued that the use of a minimum cut-off score for fit indices in
CFA is arbitrary and can result in a model being discarded when it has a fit index
score of 0.89, as was the case in the present study, and a model with a fit index
value of 0.90 being declared optimal (Hu & Bentler, 1999). Despite this, one of the
absolute fit indices, the Standardized Root Mean-Square Residual (SRMR),
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suggested that the 4 Factor model was the only model which was examined to
produce good fit, whereas the 3 Factor model was found to have adequate fit,
suggesting that the 4 Factor model was superior using this particular criterion. When
the predictive fit index the Akaike Information Criterion (AIC) was implemented to
further assess model performance the 4 Factor model produced the smallest AIC
value which suggests that when compared to the 3 and 1 Factor models, it
outperformed them in terms of model fit. Given that the change in AIC scores was
significant between the three models, this further confirms that the 4 Factor model
produced a better fit to the data.
It has been strongly recommended that when assessing model fit one should not just
examine fit indices, but they should also assess the residuals and squared multiple
correlations in order to provide another indicator of model fit (Schreiber et al., 2006).
Residuals should be statistically significant and need to be centred around zero with
as few residuals lying outside of the range of -2 to +2  in models with optimal fit.
When all three models were examined using these criteria the 4 Factor model
produced the most superior results in that it produced fewer residuals outside of the
recommended range and a stem and leaf plot of the residuals produced the most
symmetric distribution. Squared multiple correlations provide information about which
items of the PCSES accounted for most of the variance in each model. When the 4
Factor model was examined, all items of the PCSES were found to have acceptable
fit to each respective factor except for Item 19 (“buy d and a”) which did not appear to
load heavily on Factor 2 of this particular model. However, this item along with all
other items of the PCSES did not need to be removed from the scale as a result of
the CFA given that the p-values of each item of the PCSES were found to be
significant.
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The Lagrange Multiplier Test was conducted in order to determine if significant
improvements could be made to the 4 Factor model by adding covariances between
items and/or by adding parameters to the model. A number of error covariances were
recommended between items of the PCSES as was the addition of a number of
parameters for some of the PCSES items. Unfortunately the changes recommended
by the Lagrange Multiplier Test would only have resulted in a very small drop in the
Maximum Likelihood Chi-Squared value, less than 10% in total. Given that the
Maximum Likelihood Chi-Squared value was rather large to begin with (chi-
squared=1053.511) it is unlikely that the recommended modifications would have
made any difference to the significance of the chi-squared value or to the size of the
fit indices.
Furthermore, there are a number of problems associated with using the Lagrange
Multiplier Test results. Most importantly, many argue that modifications should only
be applied when there are strong theoretical justifications for them, not just statistical
justifications based on results from the Lagrange Multiplier Test (Ullman, 2006).
Model modifications based on this test’s results tend to result in over-fitting of the
model by adding unnecessary parameters to the model which researchers often have
no solid theoretical rationale for doing so (Hox & Bechger, 1988). After modifications
have been made to a model it is an untested hypothesis which needs to be cross-
validated and subjected to CFA with a new independent sample. Given that model
modifications are post-hoc they may capitalize on chance variations in the data.
Therefore unless the results can be cross-validated they should be interpreted
cautiously. A further problem with the Lagrange Multiplier Test is that it is based on
the assumption of normality and as a result the predicted change in chi-square is
referring to Maximum Likelihood chi-squared rather than the Satorra-Bentler scaled
chi-squared. Given this many caution against the use of this test for non-normal data
(Ullman, 2006) and since the data from both samples in this study were not normally
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distributed the modification results may not be valid or accurate. Given these
problems with the Lagrange Multiplier Test the suggested modifications made to the
parameters and error covariances of the model by this test were reported though not
implemented. If the modifications recommended by the Lagrange Multiplier Test were
to be applied they would lead to a change in the basic factor structure of the PCSES
without a theoretical basis for doing so and in turn would certainly complicate its
interpretation without significantly improving model fit.
Instead of relying on the Lagrange Multiplier test results, solid evidence of a quality
measurement model was obtained from the fact that the standardized factor loadings
were all statistically significant and sizeable for the 4 Factor model. Also, evidence of
a quality model was obtained from the moderate size and statistical significance of
the estimated correlations among error terms and among latent factors in the 4
Factor model. In addition to this, the strength of the residuals was considered of
much importance when evaluating the different models and the 4 Factor model
proved to be superior. Also, given that the Relative Chi-Squared Fit Index, the
Standardized Root Mean-Square Residual and the Akaike Information Criterion all
produced evidence in favour of the 4 Factor model it was thus considered to provide
optimal fit for the data. However, external validity of any scale, let alone a newly
developed scale, needs to be an ongoing process. Further research is necessary in
order to once again cross-validate the 4 Factor model of the PCSES, particularly with
a diverse sample of partners.
Research Question 2 –  Construct Validity  : Expect to see a negative
relationship between partner coping self-efficacy (as assessed by the PCSES)
and self-reported depression and anxiety symptoms in partners (as assessed
by the Hospital Anxiety and Depression Scale).
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In the present study only the HADS was administered to the internet sample. The
Ways of Coping Questionnaire was not administered to the internet sample as it
would have greatly increased the administration time for participants which may have
increased the chances of participants not completing the entire assessment package.
No significant correlational relationship between the HADS and the PCSES or any of
its factors was observed in the Study 2 sample. Although the HADS was also used in
Study 1, the lack of significant correlations between HADS scores and PCSES
scores is likely to have been due to differences in sample characteristics between
partners from Study 1 and partners from Study 2. The partners from the Study 1
sample were partners of patients attending an outpatient drug and alcohol treatment
facility who had been unable to change their substance use behaviour on their own.
Thus the partners from the Study 1 sample were probably in a state of crisis and
experiencing high levels of stress as they were likely to be desperately awaiting help
for their partner’s substance use problem. In comparison, the Study 2 partners may
have not been in such a crisis or urgent situation compared to the Study 1 sample of
partners. The Study 2 sample may not have had such a pressing need to get
treatment for their partner and they therefore had more time to use the internet,
gather information about addictions and volunteer their time to take part in this study.
As a consequence, the partners from the Study 1 sample were probably more likely
to display greater levels of anxiety and depression compared to the Study 2 internet
sample. This finding was confirmed by the data in that the Study 1 partners displayed
significantly higher Total HADS scores (t(264)=2.475, p=0.014) and significantly
higher symptoms of depression as evident from their HADS Depression subscale
scores (t(264)=5.103, p=0.000) when compared to the Study 2 sample partners. This
finding may have weakened the association between mood and partner coping self-
efficacy leading to a lack of significant correlation between HADS scores and the
PCSES in the Study 2 sample. Despite this finding, no significant difference in
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anxiety levels was observed between the two different sample of partners (t(264)= -
1.481, p=0.14).
Although the Study 2 partners were significantly less depressed and less emotionally
distressed based on their scores on the HADS compared to Study 1 partners, their
HADS scores were still significantly higher than norms. Furthermore, half of the
partners from Study 2 (51%) met the criteria for anxiety from their HADS Anxiety
subscale score and almost half (43%) met the criteria for depression based on their
HADS Depression subscale score. These findings suggest that although the Study 2
sample of partners were not as severely distressed or depressed as Study 1
partners, they still were significantly more distressed, anxious and depressed than
the general population. Such findings are consistent with previous research citing
high levels of anxiety and depression and general distress in partners of substance
users (E.g. Dawson et al., 2007 ; Kishor, Pandit & Raguram, 2013).
No significant relationships between PCSES and any partner demographic variables
(age, gender, and length of current relationship) were observed in this sample.
Although no evidence for the PCSES’s construct validity was obtained from this
particular sample of partners this could be due to sampling differences.
Research Question 3 – Internal Consistency  : Expect the PCSES to have
adequate internal consistency.
Results from the internal consistency of the PCSES using this particular sample of
partners suggests that the PCSES is a highly reliable instrument. Total PCSES
scores were found to have excellent internal consistency (Cronbach alpha= 0.893).
Cronbach alpha values for 2 of the 4 factors of the PCSES were equally high in
internal consistency (Factor 1 Cronbach alpha=0.820, Factor 3 Cronbach
alpha=0.835). Factor 4 produced acceptable internal consistency (Cronbach
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alpha=0.778) and Factor 2 produced an almost acceptable Cronbach alpha value of
0.692. Similar internal consistency scores were obtained from Study 1, further
providing support for the stability of the PCSES across two distinct samples.
Study 2 Implications of the Research Findings
Given the paucity of well-validated self-efficacy scales for partners of drug and
alcohol users, the present study provided preliminary evidence that the PCSES has
adequate psychometric properties. There is currently no published validated scale
available for assessing coping self-efficacy in partners of drug and alcohol users. The
PCSES can be administered using the internet to gather information on the partner’s
perceived self-efficacy for managing the patient’s drug and alcohol behaviour. The
low non-completion rate along with the lack of floor and ceiling effects in this internet
sample of partners suggests that the PCSES can be administered using the internet
to obtain accurate information about partner self-efficacy. Treatment programs can
focus on the partner’s specific high risk coping situations for which they endorse low
self-efficacy on the PCSES, regardless if the scale and treatment are delivered in a
face-to-face setting or over the internet. Treatment for the partner can then be
tailored to the partner’s high risk situations with the least reported self-efficacy and
the partner can be taught effective coping skills to manage these problematic
situations.
Although the results of the present study provide evidence for the sound
psychometric properties of the PCSES in a different sample of partners and using a
different administration method compared to Study 1 (i.e. face-to-face versus online
administration), adequate scale development requires ongoing multiple validation
studies. Therefore, future studies need to examine the psychometric properties of the
PCSES in even more diverse partner samples. Future research should also focus on
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longitudinal changes in PCSES over time, particularly in response to partner and
patient interventions.
Results from Study 2 also highlighted the negative impact drug and alcohol problems
have on the partner. Strong evidence of high levels of anxiety and depression which
were much greater than those seen in the general population was also found in this
non-clinical sample of partners. This finding has important implications for the
screening and treatment of mood disturbances in partners. Emphasis needs to be
placed on assessing for the presence of mood disturbances in partners and providing
them with treatment if necessary given that most drug and alcohol treatment facilities
do not tend to include partners in treatment let alone assess the partner’s mood.
Given that most drug and alcohol patients do not tend to even access addiction
treatments (E.g. Cunningham & Breslin, 2004) it may be more beneficial if non-
specialist agencies, such as general practitioners for instance, who tend to have
more contact with drug and alcohol patients and their partners, implement policies for
screening and treating partners of drug and alcohol users. This would capture more
partners of drug and alcohol users and ensure that they receive the treatment that
they obviously require.
Study 2 also found evidence of high rates of partners of drug and alcohol users who
themselves also displayed evidence of a drug and/or alcohol use problem. Patient
drug and alcohol treatment programs and general health providers need to consider
assessing the partner’s substance use more thoroughly given the high prevalence of
concordant drug and alcohol use.
Study 2 Limitations
There are a number of limitations with the present study which need to be taken into
consideration prior to interpreting the results. The first limitation is associated with the
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method of data collection employed in the present study. Although there are a
number of benefits associated with using the internet to gather data, there are also a
number of possible problems associated with this method of data collection. One
such problem is the fact that the anonymous nature of internet studies leads some
participants who are not genuine to deliberately damage the data. One online study
assessing drinking using the AUDIT and SOCRATES found that 18% of participants
reported deliberately providing false responses on these scales as they claimed to be
curious about the scales and the personalized online feedback such results would
produce (Cloud & Peacock, 2001). One internet study in which the participants were
actually instructed by the researchers to respond carelessly and randomly to items
on a addiction scale found that this group of subjects produced elevated mean
scores when compared to those who were not instructed to respond carelessly and
randomly (Meyer, Faust, Faust, Baker & Cook, 2013). Given these findings one
would expect to see higher mean PCSES scores in the Study 2 sample compared to
the Study 1 sample if respondents from the Study 2 sample were indeed not
responding to the PCSES genuinely. Given that Study 2 partners tended to display
lower levels of overall self-efficacy on the PCSES it seems unlikely that the data was
deliberately compromised by the internet sample. Furthermore the fact that the
PCSES in this study failed to displayed large ceiling effects also provides further
evidence to suggest that a large proportion of the participants were responding
honestly to PCSES items. Raw data in the present study were periodically filtered
during the data collection phase in order to identify repeat or unusual responses and
very few instances of this were observed.
In the present study no information was obtained from partners regarding the quantity
and frequency of substance use in the patients or whether or not they had received
treatment before. Also no information was gathered regarding the patient’s primary
substance of use. This was not done as it would have been very difficult to assess
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this information accurately without having the patient also complete assessment
measures over the internet. It was not considered practical as there were huge
logistical problems associated with requiring both the partner and the patient to
complete online measures at the same time. Also there were ethical issues
surrounding confidentiality and item responses if both the partner and the patient
were required to complete an online assessment package simultaneously. There is a
small possibility that partners who volunteered in the present study may have had a
partner who did not actually have a drug or alcohol problem. However this is unlikely
given that the advertisement for this study was placed only on websites for people
with drug or alcohol problems and their family members. Partners who participated in
the study acknowledged that their partner did have a drug or alcohol use problem.
Research has found that partners who live with their heavy drinking partner are very
accurate at reporting their partner’s quantity and frequency of alcohol use (Sobell,
Agrawal & Sobell, 1997).
Another limitation of the present study is that only three of the fit indices examined
using confirmatory factor analytic techniques actually met the conservative criteria for
the 4 Factor model providing “good” fit for the data (i.e. The Chi-Squared Relative Fit
Index, Standardized Root Mean Square Residual, Akaike Information Criterion). The
majority of the other fit indices examined only provided evidence of “adequate to
poor” rather than “good” model fit for the 4 Factor Model.
Selection bias in the present study may also have limited the generalizability of the
results. This sample of partners may have consisted of a biased sample comprised
only of partners who have access to a computer with internet facilities, partners who
are technologically literate and comfortable using the internet to answer questions
about sensitive issues such as their partner’s addiction.
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A further limitation of the present study was difficulty recruiting participants. A large
number of websites were approached as possible sites for advertising the study.
Unfortunately most websites failed to respond to the author’s written request to
advertise the study on their website. Those few websites that did respond declined to
advertise the study because it was apparently their organization’s policy to advertise
studies conducted only by employees of their organization.
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Overall Conclusion
In Australia alone there are approximately one million people who are the partners of
a person with a drug or alcohol use problem. In the last 10 years there has been a
rise in popularity in treatments teaching partners coping skills to manage the patient’s
drug and alcohol problem. A thorough assessment of partner coping self-efficacy
needs to be undertaken before coping skills can be taught to partners. It is expected
that effective coping skills will not only improve the partner’s functioning but will also
result in improvements in the patient’s condition. Despite this there is a complete
absence of standardized scales which assess the partner’s confidence in being able
to cope with the patient’s drug and alcohol use problem leaving clinicians with no way
of assessing the partner’s confidence.
The main purpose of this study was to devise a scale to assess coping self-efficacy
in partners of drug and alcohol patients and to assess the scale’s psychometric
properties. It is expected that the devised scale, the Partner Coping Self-Efficacy
Scale (PCSES), will assist clinicians with identifying specific coping situations in
which partners endorse low confidence. The 24 item PCSES was reviewed by a
panel of experts in the addictions field before being administered to a sample of 83
partners of patients attending an outpatient drug and alcohol treatment facility in
Study 1. Given that this is the first attempt to devise a partner coping self-efficacy
scale in the addictions field results from Study 1 suggest that the PCSES has
adequate psychometric properties. More specifically, the PCSES was found to have
acceptable face validity and construct validity. Furthermore, internal consistency for
the PCSES was high and the PCSES was found to be internally reliable over a two
week period. Results from Study 1, however, failed to provide evidence for the
PCSES’s predictive validity in that the PCSES did not predict treatment outcome in
patients 6 months following treatment. The PCSES was also subjected to exploratory
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factor analysis in Study 1 and a clear 4 factor structure was identified with 4 distinct
and reliable factors labelled “Comprehensive Care”, “Reinforcing Abstinence”,
“Resilience” and “Negative Affect”.
In the second phase of this research (Study 2) the PCSES was administered online
to 183 partners of drug and alcohol users who were accessing information about
addictions from three specialist addiction websites. The purpose of Study 2 was to
determine if the 4 factor structure obtained from Study 1 could be replicated in a
larger sample of partners. A confirmatory factor analysis was conducted and the
results suggested that the PCSES has a clear 4 factor structure, similar in structure
to that obtained from Study 1. From the Study 2 sample the PCSES and its factors
once again displayed evidence of acceptable to good internal consistency. Despite
this there was a lack of support for the PCSES’s construct validity in Study 2 in that
no significant relationships were observed between the PCSES and scores on the
Hospital Anxiety and Depression Scale and from a number of demographic variables.
Overall, these preliminary findings from the development and administration of the
PCSES to two distinct partner samples suggests that the PCSES has acceptable
psychometric properties and a stable factor structure. The results suggest that the
PCSES is relatively quick to administer and it can provide accurate information in
both a face-to-face clinical setting as well as in an online format in a variety of partner
samples, that is both a clinical sample and a non-clinical sample. Future research
may wish to determine whether the PCSES’s factor structure can be replicated
further using larger samples of partners and to determine whether further evidence
for the scale’s predictive validity and construct validity can be obtained. The
development of a coping self-efficacy scale for partners of drug and alcohol patients
has been long overdue. It is anticipated that the PCSES will prove to be an
invaluable tool for clinicians treating partners of drug and alcohol patients.
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APPENDIX A
Partner Coping Self-Efficacy Scale (PCSES)
Instructions
We are interested in how confident your feel in certain situations, that is how strongly you feel you can
actually do something. Think about each question and indicate how confident you are today or right
now. Rate your level of confidence anywhere on the scale from 0% to 100%.
For example, a rating of 0% to 10% confidence suggests that you are not very confident in that
situation. On the other hand, a rating of 90% to 100% confidence suggests that you are almost very
confident in that situation. A rating of 40% to 60% confidence suggests that you are moderately
confident in that situation
Please answer every question. If you have difficulty with an item choose the response that is mostly
right.
1. How confident are you that you can assist your partner change their mood when they are feeling low
or depressed?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
2.  How confident are you that you can seek professional assistance for your partner if he/she talks
about wanting to seriously harm himself/ herself (i.e. kill themselves)?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
3. If your partner is prescribed medications to help him/her with their drug/alcohol problem, how
confident are you that you can ensure that they take their medications regularly?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
4. How confident are you that you can avoid interacting with your partner when he/she is drunk/drug-
affected?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
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5.   How confident are you that you can stop yourself from getting angry with your partner when
he/she is under the influence of drugs/alcohol and has just embarrassed you in front of others?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
6.  How confident are you that you can stop yourself from getting angry with your partner when
he/she blames you for his/her drug/alcohol problem?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
7.  How confident are you that you can stop yourself from getting angry with your partner when
he/she tells you that you do not understand their drug/alcohol problem?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
8.  How confident are you that you can stop yourself from getting angry with your partner when
he/she claims that you criticize/nag them too much about their drug/alcohol use?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
9.   How confident are you that you can help your partner by thinking of practical ways in which
he/she     can reduce/abstain from using drugs/alcohol?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
10.   How confident are you that you can help your partner reduce/abstain from using drugs/alcohol
when he/she is feeling low or depressed?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
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11.  How confident are you that you can help your partner reduce/abstain from using drugs/alcohol
when he/she is feeling stressed or worried?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
12.   How confident are you that you can help your partner reduce/abstain from using drugs/alcohol
when he/she is feeling bored?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
13.   How confident are you that you can help your partner reduce/abstain from using drugs/alcohol
when he/she does not seem to be making a real effort to try and change his/her drug and alcohol
use?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
14.   How confident are you that you can help your partner reduce/abstain from using drugs/alcohol
when he/she lies about his/her drinking/drug use?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
15.  How confident are you that you can help your partner reduce/abstain from using drugs/alcohol
when he/she does not appear to appreciate your efforts to help them?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
16.   How confident are you that you can avoid taking on your partner’s usual responsibilities when
he/she is drinking/using drugs (e.g. shopping, childcare)?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
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17.  How confident are you that you can avoid criticizing your partner about their drug and alcohol
problem?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
18.   How confident are you that you can avoid bringing up past upsetting incidents which took place
due to your partner’s drinking/ drug using?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
19.   How confident are you that you will not buy or assist your partner in obtaining drugs/alcohol when
they want it?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
20.  How confident are you that you can refrain from taking care of your partner when they are sick
due to drinking/using drugs?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
21.  How confident are you that you can avoid arguing with your partner when he/she is under the
influence of drugs/alcohol?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
22.  How confident are you that you can make an effort to spend more quality time with your partner
when he/she is not using or drinking?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately Very
Confident Confident Confident
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23.    How confident are you that you can get help/support for yourself from other people (e.g. family,
friends, counseller) when you are finding it difficult to deal with your partner’s drug/alcohol
problem?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
24.  How confident are you that you can refrain from using alcohol/drugs in front of your partner when
he/she is using alcohol/drugs?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Not At All Moderately  Very
Confident Confident Confident
Version 2 19/12/03
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APPENDIX B
WESTERN SYDNEY AREA HEALTH SERVICE
WESTMEAD, NSW 2145
PATIENT INFORMATION SHEET
Title of project   The Development and Validation of the Spouse Coping Self-Efficacy
Scale.
Names of the investigators
Ms. Vicki Giannopoulos, Western Sydney Area Drug and Alcohol Services
Dr. Thiagarajan Sitharthan, Western Sydney Area Drug and Alcohol Services
Dr Glenn Hunt, Concord Hospital
Dr Jon Currie, Western Sydney Area Drug and Alcohol Services
What is the purpose of this study?   This study is looking at ways  in which spouses/partners of
people who use drugs and/or  alcohol can help their spouse to cut down or stop their drug and
alcohol use, and assist them in coping with feelings of sadness, suicide intentions and
behaviours that lead to harming oneself. This study aims to evaluate a questionnaire for
spouses of patients who use drugs and alcohol. At present we do not know how best to assess
how spouses of patients who use drugs and alcohol cope with their spouse’s problems. We
hope to use information you provide from these questionnaires to assist us in treating drug and
alcohol problems.
Who will be invited to enter the study?   You have been invited to enter the study because you
are aged between 18 and 65 years and either you or your spouse has contact with the Western
Sydney Area Drug and Alcohol Services. If you agree to participate in this study you and your
spouse will be required to fill in a number of questionnaires.
What will happen on the study? If you are a spouse of a patient of the Western Sydney Area
Drug and Alcohol Services will be required to fill in a number of questionnaires about how you
cope with your partner’s drug and alcohol use and your own drug and alcohol use. You will be
required to complete the following questionnaires : (a) Hospital Anxiety and Depression Scale,
(b) Ways of Coping Questionnaire, (c) Support Index, (d) Alcohol Use Disorders  Identification
Test, (e) Drug Abuse Screening Test, and  (f) Spouse Coping Self-Efficacy Scale. This will take
approximately 40 minutes. Some spouses will be asked to complete the Spouse Coping Self-
Efficacy Scale one week later.
If you are a patient of the Western Sydney Area Drug and Alcohol Services you will be asked
about your drug and alcohol use and your mood. You will be required to complete the following
questionnaires : (a) Hospital Anxiety And Depression Scale, (b) Beck Scale for Suicidal
Ideation, (c) Alcohol Helplessness Scale, (d) Ways of Coping Questionnaire, (e) Drug and
Alcohol Self-Efficacy Scales, and (f) Comprehensive Drug And Alcohol Evaluation Form. This
will take approximately one hour.
Some patients may be contacted 6 months later to complete the same questionnaires.
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WESTERN SYDNEY AREA HEALTH SERVICE
WESTMEAD, NSW 2145
Patient Information - The Development and Validation of the Spouse Coping Self-
Efficacy Scale. (continued)
Are there any risks?    Some spouses may feel anxious or guilty when completing the
questionnaires.
Do you have a choice?   Yes, refusal to take part in this study will not affect your usual
treatment;
and if you agree to take part in this study, you may still stop at any time. Any information you
give us will be kept in strict confidence at all times, and only those researchers conducting this
project will have access to your information. If the study results are published at a later date,
your name will not be used nor will you be identified in any way.
Complaints  If you have any concerns about the conduct of the study, you may contact the
Westmead Hospital Patient representative, Ms Jillian Gwynne Lewis, Telephone No 9845 7014
or email jillian_lewis @wsahs.nsw.gov.au
Contact details   If you have any problems while on the study, please contact Dr Thiagarajan
Sitharthan.  Working Hours Telephone: 9840 3950   After Hours telephone: 0411 286 109
Participant’s Name:___________________________________
Signature: _____________________
Date:___________________
Version 2  19/12/03
Page 2 (of 2)
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WESTERN SYDNEY AREA HEALTH SERVICE
WESTMEAD, NSW 2145
CONSENT TO PARTICIPATE IN RESEARCH
Title of project   The Development and Validation of the Spouse Coping Self-Efficacy
Scale.
Names of the investigators
Ms. Vicki Giannopoulos, Western Sydney Area Drug and Alcohol Services
Dr. Thiagarajan Sitharthan, Western Sydney Area Drug and Alcohol Services
Dr Glenn Hunt, Concord Hospital
Dr Jon Currie, Western Sydney Area Drug and Alcohol Services
1. I understand that the researchers will conduct this study in a manner conforming with
ethical and scientific principles set out by the National Health and Medical Research
Council of Australia and the Good Clinical Research Practice Guidelines of the
Therapeutic Goods Administration.
2. I acknowledge that I have read, or have read to me the Participant Information Sheet
relating to this study. I acknowledge that I understand the Participant Information Sheet.
I acknowledge that the general purposes, methods, demands and possible risks and
inconveniences which may occur to me during the study have been explained to me by
_________________________________
(“the researcher”) and I, being over the age of 16 years, acknowledge that I understand
the general purposes, methods, demands and possible risks and inconveniences that
may occur during the study.
3. I acknowledge that I have been given time to consider the information and to seek other
advice.
4. I acknowledge that refusal to take part in this study will not affect the usual treatment of
my condition.
5. I acknowledge that I am volunteering to take part in this study and I may withdraw at any
time.
6. I acknowledge that this research has been approved by the Western Sydney Area
Health Service Human Research Ethics Committee.
7. I acknowledge that I have received a copy of this form and the Participant Information
Sheet, which I have signed.
Before signing, please read the “Important Note” following.
Name of participant_______________________________ Date of Birth____________
Address of participant_____________________________________________________
Signature participant ____________________________________ Date: ______________
Signature of researcher ___________________________________ Date: _____________
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WESTERN SYDNEY AREA HEALTH SERVICE
WESTMEAD, NSW 2145
Title of project   The Development and Validation of the Spouse Coping Self-Efficacy
Scale (continued).
Important Note
This consent should be signed as follows:
1. Where a participant is over the age of 16 years, then by the participant personally.
2. Where the participant  is between the age of 14 and 16 years, it should be signed by the
participant and by a parent or guardian.
3. Where the participant is under the age of 14 years, then the parent or guardian only should
sign the consent form.
4. Where a participant is under a legal or intellectual disability, eg unconscious, then particular
consent should be sought from the Human Research Ethics committee as to whether the
person should take part in the research.
Independent Witness
I, ____________________________________________________(name of independent
witness) of
______________________________________________________hereby certify as follows:
1. I was present when ____________________________________(“the participant”)
appeared to read or had read to him / her a document entitled Participant Information
Sheet; or I was told by
_____________________________________________(“the participant”) that he / she had
read a document entitled Participant Information Sheet (*Delete as applicable)
2. I was present when _________________________________(“the researcher”) explained
the general purposes, methods, demands and the possible risks and inconveniences of
participating in the study to the participant. I asked the participant whether he / she had
understood the Participant Information Sheet and understood what he/she had been told
and he/she told me that he/she did understand.
3. I observed the participant sign the consent to participate in research and he/she appeared
to me to be signing the document freely and without duress.
4. The participant showed me a form of identification which satisfied me as to his/her identity.
5. I am not involved in any way as a researcher in this project.
Name of Independent Witness _______________________________________________
Signature of independent  witness _______________________________________________
Relationship to participant ______________________________________________________
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Discipline of Psychological Medicine
                          School of Psychiatry
                          Faculty of Medicine
ABN 15 211 513 464
Professor Thiagarajan Sitharthan, Honorary Professor of
Psychiatry,Sydney School of Medicine, University of Sydney &
Professor of Clinical Psychology, University of Western Sydney .
School of Psychology, University of Western
Sydney,
Locked Bag 1797, South Penrith 1797,
NSW 2006 AUSTRALIA
Telephone:   +61 2 97726706
Facsimile:    +61 2
97726757
Email:
R.sitharthan@uws.edu.au
PARTICIPANT INFORMATION STATEMENT
Title of Project: The Development and Validation of the Spouse
Coping Self-Efficacy Scale.
        What is the study about?
This study is looking at ways in which partners of people who use drugs and/or alcohol can help
their partner to cut down or stop their drug and alcohol use. This study aims to evaluate a
questionnaire for partners of people who use drugs and/or alcohol. At present we do not know
how best to assess how partners of people who use drugs and alcohol cope with their partner’s
problem. We hope to use information you provide from these questionnaires to assist us in
treating drug and alcohol problems.
       Who is carrying out the study
The study is being conducted by Vicki Giannopoulos and will form the basis for a doctorate
degree at The University of Sydney under the supervision of Professor Raj Sitharthan, Honorary
Professor of Psychiatry, Sydney School of Medicine, University of Sydney & Professor of Clinical
Psychology, University of Western Sydney .
        What does the study involve?
The study invites partners of substance users to complete questionnaires on-line which will take
approximately 10 minutes to complete.  The questionnaires are confidential .
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Can I withdraw from the study?
Being in this study is completely voluntary - you are not under any obligation to participate in the
study and you can leave questions unanswered if you feel uncomfortable. If you consent to
being part of this study, you will be required to click the “SUBMIT” button.  If you decide NOT to
consent do not click the “SUBMIT” button. You can withdraw any time prior to submitting your
completed questionnaire by closing the window on the web browser.  Once you have submitted
your questionnaire anonymously, your responses cannot be withdrawn.
Will anyone else know the results?
All aspects of the study, including results, will be strictly confidential and only the researchers will
have access to information on participants.  A report of the study will be submitted for publication,
but individual participants will not be identifiable in such a report.
Will the study benefit me?
Your participation in filling out the survey will raise your awareness about drug and alcohol
addiction.
Can I tell other people about the study?
We would encourage you to discuss this project with others.  Any one who is interested in this
project can access the website or can contact:  Professor Thiagarajan (Raj) Sitharthan
on   (02) 97726706 or R.Sitharthan@uws.edu.au
What if I require further information?
When you have read this information, Vicki Giannopoulos will discuss it with you further and
answer any questions you may have.  If you would like to know more at any stage, please feel
free to contact Professor Thiagarajan (Raj) Sitharthan on (02) 97726706   or
R.Sitharthan@uws.edu.au
What if I have a complaint or concerns?
Any person with concerns or complaints about the conduct of a research study can
contact the Deputy Manager, Human Ethics Administration, University of Sydney on +61 2
8627 8176 (Telephone); +61 2 8627 8177 (Facsimile) or ro.humanethics@sydney.edu.au
(Email).
                                This information sheet is for you to keep
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ABN 15 211 513 464
Professor Thiagarajan (Raj)  Sitharthan,
Honorary Professor of Psychiatry,Sydney
School of Medicine, University of Sydney .
                  Discipline of Psychological Medicine
                    School of Psychiatry
                          Faculty of Medicine
The University of Sydney
NSW 2006 AUSTRALIA
Telephone:   +61 (0)411286109
Email:thiagarajan.sitharthan@sydney
.edu.au
PARTICIPANT CONSENT FORM
I give consent to my participation in the research project
“The Development and Validation of the Partner Coping Self-Efficacy Scale”.
In giving my consent I acknowledge that:
1. The procedures required for the project and the time involved have been
explained to me, and any questions I have about the project have been answered
to my satisfaction.
2. I have read the Participant Information Statement and have been given the
opportunity to discuss the information and my involvement in the project with the
researcher/s.
3. I understand that I can withdraw from the study at any time, without affecting my
relationship with the researcher(s) or Sydney University now or in the future.
4. I understand that my involvement is strictly confidential and no information about
me will be used in any way that reveals my identity.
5. I understand that being in this study is completely voluntary – I am not under any
obligation to consent.
                                 Click SUBMIT button to proceed with the study.
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APPENDIX C
Hospital Anxiety And Depression Scale (HADS)
“The following set of questions will help us to know how you feel.  Read each item and
mark the reply that comes closest to how you have been feeling in the past week”
1. I feel tense or ‘wound up’:
                    [  ]   Most of the time [  ]   From time to time, occasionally
        [  ]   A lot of the time             [  ]  Not at all
2. I still enjoy the things I used to enjoy:
                    [  ]   Definitely as much [  ] Only a little
        [  ]  Not quite so much             [  ] Hardly at all
3. I get a sort of frightened feeling as if something awful is about to happen:
                   [  ] Very definitely and quite badly       [  ]  A little, but it doesn’t worry me
       [  ] Yes, but not too badly                     [  ]   Not at all
4. I can laugh and see the funny side of things:
                   [  ] As much as I always could         [  ]  Definitely not so much now
       [  ]  Not quite so much                     [  ] Not at all
5. Worrying thoughts go through my mind:
                   [  ] A great deal of the time                 [  ]  From time to time but not too often
       [  ]  A lot of the time                    [  ] Only occasionally
6. I feel cheerful:
                   [  ] Not at all                                [  ]  Sometimes
       [  ]  Not often                                [  ] Most of the time
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7. I can sit at ease and feel relaxed:
                   [  ]  Definitely                                      [  ]  Not often
       [  ]  Usually                                      [  ] Not at all
8. I feel as if I am slowed down:
                   [  ] Nearly all the time                         [  ]  Sometimes
       [  ]  Very often                                     [  ]  Not at all
9. I get a sort of frightened feeling like ‘butterflies’ in the stomach:
                   [  ] Not at all                                      [  ] Quite often
       [  ]  Occasionally                                      [  ] Very often
10.    I have lost interest in my appearance:
                   [  ] Definitely                                     [  ]  I may not take quite as much care
                   [  ]  I don’t take so much care                  [  ]  I take just as much care as ever
                                  as I should
11.    I feel restless as if I have to be on the move:
                   [  ] Very much indeed                       [  ]  Not very much
       [  ] Quite a lot                                   [  ] Not at all
12.    I look forward with enjoyment to things:
                     [  ] As much as ever I did          [  ] Definitely less than I used to
         [  ] Rather less than I used to          [  ]  Hardly at all
13.     I get sudden feelings of panic:
                   [  ] Very often indeed                     [  ] Not very often
                   [  ]  Quite often                                    [  ]  Not at all
14.    I can enjoy a good book or radio or TV program:
                   [  ] Often                                            [  ] Not often
                   [  ]  Sometimes                                [  ] Very seldom
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WAYS OF COPING QUESTIONNAIRE
Take a few moments and think about the most stressful situations that you have experienced in the past
month relating to coping with your drug and alcohol use problem / your partner’s drug and alcohol use
problem. By ‘stressful’ we mean a situation which was difficult or troubling for you, either because you felt
distressed about what happened or because you had to use considerable effort to deal with the situation.
Before responding to the statements, think about the details of this stressful situation, such as where it
happened, who was involved, how you acted, and why it was important to you. While you may still be
involved in the situation, or it could have already have happened, it should be the most stressful situation
that you experienced in the last month.
As you respond to each of the  statements, please keep this stressful situation in mind. Read each
statement carefully and indicate, by circling 0, 1, 2, or 3 , to what extent you used it in that situation.
Key :   0 = does not apply or not used
           1 = used somewhat
           2 = used quite a bit
           3 = used a great deal
_____ 1. I just concentrated on what I had to do next – the next step.
_____ 2. I tried to analyze the problem in order to understand it better.
_____ 3. I turned to work or substitute activity to take my mind off things.
_____ 4. I felt that time would make a difference – the only thing to do was to wait.
_____ 5. I bargained or compromised to get something positive from the situation.
_____ 6. I did something which I didn’t think would work, but at least I was doing something.
_____ 7. I tried to get the person responsible to change his or her mind.
_____ 8. I talked to someone to find out more about the situation.
_____ 9. I criticized or lectured myself.
_____ 10. I tried not to burn my bridges, but leave things open somewhat.
_____ 11. I hoped a miracle would happen.
_____ 12. I went along with fate; sometimes I just have bad luck.
_____ 13. I went on as if nothing had happened.
_____ 14. I tried to keep my feelings to myself.
_____ 15. I looked for the silver lining, so to speak; tried to look on the bright side of things.
_____ 16. I slept more than usual.
_____ 17. I expressed anger to the person(s) who caused the problem.
_____ 18. I accepted sympathy and understanding from someone.
_____ 19. I told myself things that helped me to feel better.
_____ 20. I was inspired to do something creative.
_____ 21. I tried to forget the whole thing.
_____ 22. I got professional help.
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_____ 23. I changed or grew as a person.
_____ 24. I waited to see what would happen before doing anything.
_____ 25. I apologized or did something to make up.
_____ 26. I made a plan of action and followed it.
_____ 27. I accepted the next best thing to what I wanted.
_____ 28. I let my feelings out somehow.
_____ 29. I realized I brought the problem on myself.
_____ 30. I came out of the experience better than when I went in.
_____ 31. I talked to someone who could do something concrete about the problem.
_____ 32. I got away from it for a while; tried to rest or take a vacation.
_____ 33. I tried to make myself feel better by eating, drinking, smoking, using drugs or
                 medication, etc.
_____ 34. I took a big chance or did something very risky.
_____ 35. I tried not to act too hastily or follow my first hunch.
_____ 36. I found new faith.
_____ 37. I maintained my pride and kept a stiff upper lip.
_____ 38. I rediscovered what is important in life.
_____ 39. I changed something so things would turn out all right.
_____ 40. I avoided being with people in general.
_____ 41. I didn’t let it get to me; refused to think too much about it.
_____ 42. I asked a relative or friend I respected for advice.
_____ 43. I kept others from knowing how bad things were.
_____ 44. I made light of the situation; I refused to get too serious about it.
_____ 45. I talked to someone about how I was feeling.
_____ 46. I stood my ground and fought for what I wanted.
_____ 47. I took it out on other people.
_____ 48. I drew on my past experiences; I was in a similar situation before.
_____ 49. I knew what had to be done, so I doubled my efforts to make things work.
_____ 50. I refused to believe that it had happened.
_____ 51. I made a promise to myself that things would be different next time.
_____ 52. I came up with a couple of different solutions to the problem.
_____ 53. I accepted the situation, since nothing could be done.
_____ 54. I tried to keep my feelings from interfering with other things too much.
_____ 55. I wished that I could change what had happened or how I felt.
_____ 56. I changed something about myself.
_____ 57. I daydreamed or imagined a better time or place than the one I was in.
_____ 58. I wished that the situation would go away or somehow be over with.
_____ 59. I had fantasies or wishes about how things might turn out.
_____ 60. I prayed.
_____ 61. I prepared myself for the worst.
_____ 62. I went over in my mind what I would say or do.
_____ 63. I thought about how a person I admire would handle this situation and used that
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                 as a model.
_____ 64. I tried to see things from the other person’s point of view.
_____ 65. I reminded myself how much worse things could be.
_____ 66. I jogged or exercised.
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AUDIT - C
Please circle the correct answer.
1. How often do you have a drink containing alcohol?
Never      Monthly or less   2 to 4 times            2 to 3 times       4 or more times
                                                   a month            a week            a week
2. How many standard drinks (see below) containing alcohol do you have on a typical day when you are drinking?
1 to 2 3 to 4 5 to 6 7 to 9          10 or more
3. How often do you have six or more drinks on one occasion?
Never      Less than monthly Monthly Weekly Daily or almost daily
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Drug Abuse Screening Questionnaire Test (DAST-10)
The following questions concern information about your possible involvement with
drugs not including alcoholic beverages during the past 12 months. Carefully read
each statement and decide if your answer is "Yes" or "No". Then circle the appropriate
response beside the question.
In the following statements "drug abuse" refers to:
1. the use of prescribed or over-the-counter drugs in excess of the
directions, and
2. any non medical use of drugs.
The various classes of drugs may include cannabis (marijuana, hashish), solvents
(e.g. paint thinner), tranquilizers (e.g. Valium), barbiturates, cocaine, stimulants (e.g.
speed), hallucinogens (e.g. LSD) or narcotics (e.g. heroin). Remember that the
questions do not include alcoholic beverages.
Please answer every question. If you have difficulty with a statement, then choose the
response that is mostly right.
These Questions Refer to the Past 12
Months
1. Have you used drugs other than those required for medicalreasons? Yes No
2. Do you abuse more than one drug at a time? Yes No
3. Are you unable to stop using drugs when you want to? Yes No
4. Have you ever had blackouts or flashbacks as a result of druguse? Yes No
5. Do you ever feel bad or guilty about your drug use? Yes No
6. Does your spouse (or parents) ever complain about yourinvolvement with drugs? Yes No
7. Have you neglected your family because of your use of drugs? Yes No
8. Have you engaged in illegal activities in order to obtain drugs? Yes No
9. Have you ever experienced withdrawal symptoms (felt sick)when you stopped taking drugs? Yes No
10. Have you had medical problems as a result of your drug use(e.g. memory loss, hepatitis, convulsions, bleeding)? Yes No
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Beck Scale for Suicidal Ideation (BSS)
Directions : Read carefully each group of statements below. Circle the one statement in each group that best
describes how you have been feeling for the past week, including today. Be sure to read all of the statements
in each group before making a choice.
1. 0  I have a moderate to strong wish to live
1  I have a weak wish to live
2  I have no wish to live
6.  0  I have brief periods of thinking about killing
myself which pass quickly
       1  I have periods of thinking about killing
        myself which last for moderate amounts of time
       2  I have long periods of thinking about killing
         myself
2. 0  I have no wish to die
             1  I have a weak wish to die
      2  I have a moderate to strong wish
           to die
7.  0  I  rarely or only occasionally
          think about killing myself
1 I have frequent thoughts about
           killing myself
2 I continuously think about killing
           myself
3. 0  My reasons for living outweigh my reasons
for dying
      1  My reasons for living or dying
       are about equal
 2  My reasons for dying outweigh
  my reasons for living
8.   0  I do not accept the idea of killing
          myself
      1  I neither accept nor reject the
          idea of killing myself
      2  I accept the idea of killing myself
4. 0  I have no desire to kill myself
      1   I have a weak desire to kill
          myself
 2   I have a moderate to strong
    desire to kill myself
9.  0  I can keep myself from committing
          suicide
     1  I am unsure that I can keep myself
         from committing suicide
2 I cannot keep myself from
     committing suicide
5. 0   I would try to save my life if I found myself
in a life-threatening situation
1  I would take a chance on life or death if I
found myself in a life-threatening situation
      2  I would not take the steps
         necessary to avoid death if I found myself
         in a life- threatening situation
10. 0  I would not kill myself because of my
           family, friends, religion, possible
injury from an unsuccessful attempt
            etc.
      1  I am somewhat concerned about killing
          myself because of my family, friends,
          religion, possible injury from an unsuccessful
          attempt etc
2 I am not or only a little concerned about
killing myself because of my family,
      friends, religion, possible injury from an
      unsuccessful attempt etc
If you have circled the zero statements in both
Questions 4 and 5 above, then skip down to
Question 20. If you have marked a 1 or 2 in either
Question 4 or 5, then go to Question 6
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11.      0  My reasons for wanting to commit
              suicide are primarily aimed at
              influencing other people, such as
              getting even with people, making
              people happier, making people
              pay attention to me etc.
            1  My reasons for wanting to commit
               suicide are not only aimed at
              influencing other people but also
              represent a way of solving my
              problems
      2  My reasons for wanting to commit
         suicide are primarily based upon
   escaping from my problems
17.  0  I have not written a suicide note
       1 I have thoughts about writing a suicide
          note or have started to write one, but
          have not completed it
  2  I have completed a suicide note
 12.     0  I have no specific plan about how
              to kill myself
           1  I have considered ways of killing
              myself, but have not worked out the
              details
    2  I have a specific plan for killing myself
  18.  0  I have made no arrangements for what
          will happen after I have committed
          suicide
        1 I have thought about making some
          arrangements for what will happen after
          I have committed suicide
        2  I have made definite arrangements for
          what will happen after I have committed
          suicide
 13.    0  I do not have access to a method or
              an opportunity to kill myself
          1  The method that I would use for
              committing suicide takes time, and I
              really do not have a good opportunity
              to use this method
          2   I have access or anticipate having
             access to the method that I would
             choose for killing myself and also
             have or shall have the opportunity to
             use it.
19.  0  I have not hidden my desire to kill
         myself from people
       1  I have held back telling people about
         wanting to kill myself
       2  I have attempted to hide, conceal , or
         lie about wanting to commit suicide
14.     0   I do not have the courage or ability to
               commit suicide
          1   I am unsure that I have the courage
               or the ability to commit suicide
          2   I have the courage and ability to
                commit suicide
20.  0   I have never attempted suicide
       1   I have attempted suicide once
       2   I have attempted suicide two or more
            times
15. 0  I do not expect to make a suicide
    attempt
      1  I am unsure that I shall make a suicide
          attempt
      2  I am sure that I will make a suicide
          attempt
If you have previously attempted suicide
please continue with Question 21
16.   0  I have made no preparations for
          committing suicide
        1   I have made some preparations for
           committing suicide
        2   I have almost finished or completed
           my preparations for committing
           suicide
21.  0  My wish to die during the last suicide attempt
           was low
       1  My wish to die during the last
           suicide attempt was moderate
       2  My wish to die during the last
           suicide attempt was high
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SELF EFFICACY  SCALE – ALCOHOL (Abstinence Version)
Think about the NEXT SIX MONTHS and imagine you are in the following situations.
How confident are you that you will NOT DRINK ANY ALCOHOL in each of the following
situations?
For example,  if you are not at all confident then circle 0% or 10%. If you are moderately
confident that you will not drink alcohol, in that situation, then circle 50%.
If you are very confident that you will not drink any alcohol, in that situation, then circle 90%
or 100%.
Circle only one number that best describes your confidence.
If you have some doubts or do not understand how to fill this questionnaire, please ask the
person who gave this to you.
1.  When you are ANGRY?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
2.  When you are DEPRESSED?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
3.  When your are PHYSICALLY TIRED?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
4. When you are AT A PARTY WITH FRIENDS?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
5. BEFORE A MEAL?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
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6.When you are BORED?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
7.  When you are IRRITATED?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
8.  When you are NOT RELAXED IN A SOCIAL SITUATION? Can't do it
Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
9.When you are WATCHING TV (EG. SPORTS, MOVIES)?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
10.  When you are WORRIED?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
11.  When you are in a  "SHOUT" SITUATION WITH FRIENDS?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
12.  When you are HAPPY?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
13.  When you WANT TO FEEL MORE CONFIDENT?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
14.  When you are STRESSED?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
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15.  When SOMEONE OFFERS TO BUY YOU FREE DRINKS?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
16. CAN YOU MAKE SURE THAT YOU DO NOT HAVE MORE THAN THREE DRINKS ON
ANY TIME THAT YOU HAVE A DRINK?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
17. CAN YOU MAKE SURE THAT YOU DO NOT HAVE MORE THAN ONE DRINK ON
ANY TIME THAT YOU HAVE A DRINK?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
18. CAN YOU STOP YOURSELF FROM DRINKING ALCOHOL AT LEAST ONE DAY A
WEEK?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
19. CAN YOU STOP YOURSELF FROM DRINKING ALCOHOL AT LEAST TWO DAYS A
WEEK?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
20. CAN YOU STOP YOURSELF FROM DRINKING ALCOHOL AT LEAST THREE DAYS A
WEEK?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
222
Self-Efficacy Profile – Alcohol abstinence
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Note:  For the Clinician
Plot the confidence rating for each of the 20 items eg: if the client scored 20% confidence for
anger and 30% confidence for depressed, place an (x) against 20 for item 1 and an (x) against
30 for Item 2.  The clinician may consider focusing on the situations rating 50% or less
confidence for immediate therapeutic attention.
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 SELF EFFICACY SCALE - ALCOHOL (Moderation Version)
Think about the NEXT SIX MONTHS and imagine you are in the following situations.
How confident are you that you will NOT DRINK HEAVILY (eg. For MEN more than SIX
standard drinks, for WOMEN more than THREE standard drinks) in each of the
following situations?
For example, if you are not at all confident that you can drink less than six standard drinks
(men) / 3 standard drinks (women), then circle 0% or 10%. If you are moderately confident
then circle 50%. If you are very confident then circle 90% or 100%.
Circle only one number that best describes your confidence.
If you have some doubts or do not understand how to fill this questionnaire, please ask the
person who gave this to you.
1.  When you are ANGRY?
Can't do it                Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
2.  When you are DEPRESSED?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
3.  When your are PHYSICALLY TIRED?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
4. When you are AT A PARTY WITH FRIENDS?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
5.  BEFORE A MEAL? Can't do it
Moderately sure                   Certain I can
0%    10%  20%  30%  40%  50%   60%  70%   80%   90% 100%
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6.  When you are BORED?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
7.  When you are IRRITATED?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
8.  When you are NOT RELAXED IN A SOCIAL SITUATION?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
9.  When you are WATCHING TV (EG. SPORTS, MOVIES)?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
10.  When you are WORRIED?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
11.  When you are in a  "SHOUT" SITUATION WITH FRIENDS?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
12.  When you are HAPPY?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
13.  When you WANT TO FEEL MORE CONFIDENT?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
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14.  When you are STRESSED?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
15.  When SOMEONE OFFERS TO BUY YOU FREE DRINKS?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
16. CAN YOU MAKE SURE THAT YOU DO NOT HAVE MORE THAN THREE DRINKS
ON ANY TIME THAT YOU HAVE A DRINK?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
17. CAN YOU MAKE SURE THAT YOU DO NOT HAVE MORE THAN ONE DRINK ON
ANY TIME THAT YOU HAVE A DRINK?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
18. CAN YOU STOP YOURSELF FROM DRINKING ALCOHOL AT LEAST ONE DAY A
WEEK?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
19. CAN YOU STOP YOURSELF FROM DRINKING ALCOHOL AT LEAST TWO DAYS A
WEEK?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
20. CAN YOU STOP YOURSELF FROM DRINKING ALCOHOL AT LEAST THREE
DAYS A WEEK?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
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Self-Efficacy Profile – Alcohol moderation
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Note:  For the Clinician
Plot the confidence rating for each of the 20 items eg: if the client scored 20% confidence for
anger and 30% confidence for depressed, place an (x) against 20 for item 1 and an (x) against
30 for Item 2.  The clinician may consider focusing on the situations rating 50% or less
confidence for immediate therapeutic attention.
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SELF EFFICACY SCALE – DRUGS
Think about the NEXT SIX MONTHS and answer each question by circling one response only.
How confident do you feel that YOU WILL NOT USE DRUGS in each of the following
situations?
For example, if you are not at all confident then circle 0% or 10%. If you are moderately
confident that you will not use drugs, in that situation, then circle 50%. If you are very
confident that you will not use drugs, in that situation, then circle 90% or 100%.
1.  When you are WITH PARTNERS OR MATES WHO ALSO USE.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
2.  When you are WITH PEOPLE WHO ARE USING AT THAT TIME.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
3.  When you are IN THE PLACE WHERE YOU BUY OR GET DRUGS.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
4.  When your DEALER/FRIEND GIVES YOU A DOSE ON CREDIT.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
5.  When you are IN THE PLACE WHERE YOU USUALLY TAKE DRUGS.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
6.  When SOMEONE GIVES YOU A FREE DOSE.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
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7.  When you START TO HANG OUT (IN WITHDRAWAL).
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
8.  When you GET THE CHILLS.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
9.  When you FEEL ANXIOUS OR NERVOUS.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
10.  When you have had an ARGUMENT WITH SOMEONE.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
11.  When you are in PHYSICAL PAIN.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
12.  When you are FEELING LOW OR DEPRESSED.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
13.  When you are FEELING GOOD ABOUT YOURSELF.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
14.  When you want to TEST YOURSELF and see if you can handle it by just
using once.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
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15.  When you are FEELING BORED.
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
16.  When you have just EARNED SOME MONEY.
can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
17.  How confident are you that you can stop using drugs for the next THREE
MONTHS?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
18.  How confident are you that you can stop using drugs for the next SIX
MONTHS?
Can't do it Moderately sure Certain I can
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
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Self-Efficacy Profile - Drug Use
100
%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Q 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
 Items
Note For the Clinician: Plot the confidence rating for each of the 18 items, eg: if the client scored 20%
confidence for Item 1 and 30% confidence for Item 2, place an (x) against - 20 for item 1 and an (x)
against - 30 for item 2.  The clinician may consider focusing on the situations ratings 50% or less for
immediate therapeutic attention.
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              ALCOHOL HELPLESSNESS SCALE  (AHS)
Please answer the following questions by selecting a number from 0 to 3 for each
question.
0=strongly disagree    1=disagree 2=agree 3=strongly agree
1. No matter how hard I will try, I just can’t seem to give up drinking.
0                                         1                                   2                                      3
strongly disagree            disagree agree strongly agree
2. No matter how hard I try I will not get over my drinking  problem.
0                                         1                                   2                                      3
strongly disagree            disagree agree strongly agree
3. It seems as if fate and other factors beyond my control affect my        drinking.
0                                         1                                   2                                      3
strongly disagree            disagree agree strongly agree
4. Alcohol is controlling my life.
0                                         1                                   2                                      3
strongly disagree            disagree agree strongly agree
5. When I see advertisements for alcohol, I feel I must have a drink.
0                                         1                                   2                                      3
strongly disagree            disagree agree strongly agree
6. No matter how hard I try to stop drinking, I will definitely fail.
0                                         1                                   2                                      3
strongly disagree            disagree agree strongly agree
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COMPREHENSIVE DRUG & ALCOHOL EVALUATION FORM (CDAEF)
WESTERN SYDNEY AREA DRUG AND ALCOHOL PSYCHOLOGY SERVICES
Name : ________________________________________________________________
Address:___________________________________ Female:_____   Male:___
D.O.B.  _____/_____/_____          Age in years:____________
Country of Birth:_________________________________________
Contact Phone No. (H):____________________ (W):____________________
Interpreter service needed: YES  /  NO (Please Circle)
Referred by:
(01) Self            (06)  Job-related
(02) Family/relative/friend (07)  Legal mandate
(03) Other alcohol/drug program (10) AA/NA or self-help group
(04) Other hospital (11) Advertisement
(05) Other community health care (99) Other - facility or professional
Has it been suggested to you by the police or the legal profession to seek our assistance about
your drinking or drug taking problem?
Yes / No
If Yes, please specify:____________________________________________________
Reason for referral/Presenting problem: __________________________
________________________________________________________________
CURRENT RELATIONSHIP
[  ]  (01)  Married or in a live-in relationship [  ]  (04)  Single
[  ]  (02)  Separated or divorced            [  ]  (05)  Currently in a
[  ]  (03)  Widowed               relationship but not living
                                                                                together.
233
CURRENT EMPLOYMENT STATUS
[  ]  (01)  Full-time        [  ]  (04)  Works at odd jobs [  ]  (07)  Student
[  ]  (02)  Part-time        [  ]  (05)  Not employed           [  ]  (08)  Retired
[  ]  (03)  Self-employed  [  ]  (06)  Government Benefits
[  ]  (09)  Home Duties
Type of employment
What is your major occupation or skill? (Please answer whether or not you are currently
employed)______________________________________________
ACCOMMODATION
(a) Where do you live?
[  ]  (1)  Own house           [  ]  (4)  Half-way house [  ]  (7)  Hotel room
[  ]  (2)  Rented house/unit [  ]  (5)  Boarding house [  ]  (8)  Homeless
[  ]  (3)  Parents home        [  ]  (6)  Hostel
(b) With whom are your presently living?  (check all that apply)
[  ]  (1)  Partner [  ]  (4)  Parents [  ]  (7)  Other relations
[  ]  (2)  Children [  ]  (5)  Brother/Sister
[  ]  (3)  Alone [  ]  (6)  Friends
EDUCATION STATUS
Do you have difficulties in reading/writing English? No:  [  ]  Yes:  [  ]
Have you completed:
[   ]  (1)  Primary school [  ]  (5)  College/TAFE diploma
[  ]  (2)  Some high school [  ]  (6)  University degree
[  ]  (3)  School certificate [  ]  (7)  Postgraduate study
[  ]  (4)  Higher school certificate
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WESTERN SYDNEY AREA DRUG AND ALCOHOL PSYCHOLOGY SERVICES
PERMISSION TO FOLLOW-UP CLIENTS FORM
We are interested in finding out how clients such as yourself do in the long term, after you have
received some assistance from our Services. We need your cooperation to find out about what
you think of our services and if it helped you at all.
We intend to contact all clients who have been to our Drug and Alcohol Services about 3
months after they complete treatment.
We will write to you and send you a very brief questionnaire asking you how you are going. This
questionnaire will be sent to you in a plain pre-paid envelope. You can complete the
questionnaire and send it back to us. The information you provide is completely confidential.
If we cannot send you a questionnaire, we will try to contact you by phone, and ask you a few
questions over the phone, as to how you are going. Again, all information you give is kept
confidential.
Please tick (√) the section below and return this form to your clinician.
_________________________ Yes, you can contact me by either letter or phone
_________________________ Yes, you can contact me, but I would prefer you to talk to me
by phone (ie. Do not send me any letter, just call me by phone)
_________________________ Yes, you can contact me, but I would prefer you to send me a
letter  (ie. Do not call me by phone, just send me a letter)
_________________________ No, I do not want anyone from this service to contact me by
phone or letter to find out how I am doing
If you ticked NO, please explain very briefly, your concerns as to why you do not want anyone
from this service to contact you.
_________________________________________________________________
Name:____________________________ Signature:____________________________
Date:__________
Name of clinician:_______________________________________________________
Date:__________
Thank you very much for your assistance
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Client Goals
Please look at these statements and indicate what your goals are right now. Circle “N/A” if you feel the
statement does not apply to you.  The numbers 0 to 3 are there so that you can show how important each goal
might be for you. Then list your three most important goals at the end.
My Aims Veryimportant
Moderately
important
Somewhat
important
Not at all
important
Not
applicable
1 I want to learn how to cut down mydrinking to a safer level 3 2 1 0       N / A
2 I want to stop drinking completely 3 2 1 0       N / A
3 I want to reduce my drug taking 3 2 1 0       N / A
4 I want to stop taking drugs completely 3 2 1 0       N / A
5 I want a therapist to help me understandwhy I drink / use drugs 3 2 1 0       N / A
6 I need a group programme to help mestop drinking / taking drugs
3 2 1 0       N / A
7 I want to learn to manage my drug /alcohol cravings / urges
3 2 1 0       N / A
8
I want a medically assisted treatment to
manage my drug use / drinking
problems
3 2 1 0       N / A
9 I want to stop smoking cigarettes 3 2 1 0       N / A
10 I want to stop my use of medication 3 2 1 0       N / A
11 I want to learn to manage my feelings ofsadness 3 2 1 0       N / A
12 I want to improve my relationships withmy partner / friend / family   3*   2*  1* 0       N / A
13 I want to learn how to relax in socialsituations 3 2 1 0       N / A
14 I would like to have someone availableto discuss my problems & questions 3 2 1 0       N / A
15 I just want to talk to someone who willknow my situation 3 2 1 0       N / A
16 I want help with finding a satisfying job 3 2 1 0       N / A
17 I want someone to help me with mylegal problems 3 2 1 0       N / A
18 I would like to contact AA / NA 3 2 1 0       N / A
In order, my three most important goals are (put number) (1st)_________ (2nd )_________ (3rd)_________
Please feel free to describe any other goals you might have: _______________________________________
______________________________________________________________________________
1. DRUG USE HISTORY (complete for all clients)
DRUG TYPE Last Time Used
Ever     Last 7   Last 6
Used     Days    Months
First Used &
Total Years
Used
Infrequent
use:
code=88
Most Typical Route
of Administration
1=oral 4=smoked
2=sniffed 5=inhaled
3=injected 6=other
Last
Used
**Typical Frequency of
Use in the Past 6
Months
Typical Amount Used per
Day in Past 6 Months
ALCOHOL
HEROIN
METHADONE
BENZODIAZEPINE
AMPHETAMINE
*Note: Code 1=NO 2=YES If "Ever used" is NO (1) for any given
line, the remainder of the line should be left blank
**Frequency Codes 0=no use 1=less than once per month  2=monthly
3= 1-2 days per week  4=3-6 days per week 5=daily
1. DRUG USE HISTORY CONT. (complete for all clients)
DRUG TYPE
Last Time Used
Ever     Last 7   Last 6
Used     Days    months
First Used
& Total
Years
Used
Infrequent
use:
code=88
Most Typical Route
of Administration
1=oral 4=smoked
2=sniffed 5=inhaled
3=injected 6=other
Last
Used
**Typical Frequency of
Use in the Past 6
Months
Typical Amount Used per
Day in Past 6 Months
CANNABIS:
Marijuana, hashish,
hash oil
TOBACCO
OTHER (Specify)
q HALLUCINOGENS
LSD, PCP STP, MDA,
angel dust, mescaline,
psilocybin
q ECSTASY
q COCAINE
q OTHER
MEDICATIONS
(MISUSED)
q SOLVENTS/
INHALANTS:
Glue, solvents, aerosols,
volatile nitrates
*Note: If "Ever used" is NO (1) for any given line, the remainder of the
line should be left blank
**Frequency Codes 0=no use 1=less than once per month  2=monthly
3= 1-2 days per week  4=3-6 days per week 5=daily
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2. ADVERSE CONSEQUENCES OF SUBSTANCE USE (Ask if the following adverse consequences were ever experienced by the patient)
Types of Problems Experienced: (For each, code the highest number that applies)
Alcohol Heroin Methadone Benzodi-
azepine
Amphetami-
ne
Cannabis Tobacco Other drugs
specify
Physical Health
Impairment
(Including overdose but
not neurological problems
unless neurological
damage has been
diagnosed)
0=  none
1=  doctor's health
warning
2=  medical treatment for
physical problem (illness
or accident) related to
substance use
Cognitive
Impairment
(acute or chronic)
[including blackouts;
memory problems;
forgetting; confusion;
difficulty thinking]
0=  none
1=  5 or fewer occasions
2=  more than 5 occasions
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Affective
Impairment
(Acute or chronic)
[including flashbacks,
mood changes, substance
related psychosis,
personality changes when
using]
0=  none
1=  minor (impairment had
no serious consequences
on daily functioning)
2=  major
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2. ACSU (cont.) (Ask if the following adverse consequences were ever experienced by the patient)
Types of Problems Experienced: (For each, code the highest number that applies)
Alcohol Heroin Methadone Benzodi-
azepine
Amphetami-
ne
Cannabis Tobacco Other drugs
specify
Work Problems
0=  none
1=  minor (been late, sick
leave)
2=  major (received
warnings from supervisor,
lost job)
Interpersonal
Problems
0=  none
1=  minor
2=  major (relationship lost
or about to be broken due
to substance use)
Financial Problems
0=  none
1=  minor (spending too
much)
2=  major(substance use
associated with significant
loss of income, etc)
Legal problems
(substance related
charges)
0=  none
1=  charged only (case
pending or dropped)
2=  convicted
Aggression
(when using or in
withdrawal)
0=  none
1=  verbally
2=  physically violent
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IN THE FOLLOWING SECTION WE WISH TO ASK YOU ABOUT YOUR
ALCOHOL/DRUG USE AND RELATED EXPERIENCES
A. RECENT ALCOHOL USE HISTORY
1. When was the last time you had a drink (how many days ago)?
__________________________________________________________
2. What did you drink and how much?
___________________________________________________________
3. Where did you drink?____________________________________
4. Did anyone else drink with you? No:  [  ] Yes:  [  ]
if Yes - who: [  ]  (01)  Friends [  ]  (03)  Co-workers
[  ]  (02)  Family [  ]  (04)  Other____________
5. How much money did you spend on alcohol the last time you drank?
$__________
6. When was the 2nd last time you had an alcoholic drink (how many days ago)?
______________________________________________________________
7. What did you drink and how
much?__________________________________________________________
8. Where did you drink?________________________________________
9. Did anyone else drink with you? No:  [  ] Yes:  [  ]
if Yes - who: [  ]  (01)  Friends [  ]  (03)  Co-workers
[  ]  (02)  Family [  ]  (04)  Other________________
10. How much money did you spend on alcohol? $_____________
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B. RECENT DRUG USE HISTORY
1. When was the last time you took opiates (e.g. heroin) or other drugs (how many
days ago)? ____________________________________________________________
2. What did you take and how much did you take?
______________________________________________________________________
3. Where did you take this drug?_____________________________________
4. Did anyone else use with you? No:  [  ] Yes:  [  ]
if Yes - who: [  ]  (01)  Friends [  ]  (03)  Co-workers
[  ]  (02)  Family [  ]  (04)  Other_________________________
5. How much money did you spend on this drug the last time you took it?
$_________
6. When was the 2nd last time you had this drug (how many days ago)?
______________________________________________________________________
7. What did you take and how much?____________________________________
8. Where did you take this drug the 2nd last time you had this drug?
__________________ ___________________________________________________
9. Did anyone else take it with you? No:  [  ] Yes:  [  ]
if Yes - who: [  ]  (01)  Friends [  ]  (03)  Co-workers
[  ]  (02)  Family [  ]  (04)  Other_________________________
10. How much money did you spend on this drug? (Or what was the estimated street
value?) $_________________
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“Now think about the past six months and answer these
questions”.
1. How many standard drinks (see standard drink comparison figure) containing alcohol
do you usually have when you are drinking?
[  ]  1 to 2 [  ]  10 to 15
[  ]  3 to 5 [  ]  15 or more
[  ]  6 to 9
2. Think about the past six months, how often did you have a drink containing alcohol?
[  ]  Once a month [  ]  3-4 days a week
[  ]  2-3 days a month [  ]  Nearly every day
[  ]  1-2 days a week
3. What type of drink do you usually have?
[  ]  Beer [  ]  Spirits
[  ]  Wine [  ]  Other _______________________
[  ]  Sherry/Port
4. How often would you have MORE than five standard drinks a day?
[  ]  (1)  Never [  ]  (4)  About once a week
[  ]  (2)  Less than once a month            [  ]  (5)  Daily or almost daily
[  ]  (3)  About once a month
5. How often would you have MORE than 10 standard drinks a day?
[  ]  (1)  Never [  ]  (4)  About once a week
[  ]  (2)  Less than once a month            [  ]  (5)  Daily or almost daily
[  ]  (3)  About once a month
6. How often would you have MORE than 15 standard drinks a day?
[  ]  (1)  Never [  ]  (4)  About once a week
[  ]  (2)  Less than once a month            [  ]  (5)  Daily or almost daily
[  ]  (3)  About once a month
7. In the last six months, what is the longest period of continuous drinking that you have
had (include hours of sleep if you began drinking the next morning)? Total:____ (hrs)
8. How often during the last six months have you needed a drink in the morning to get
yourself going?
[  ]  (1)  Never [  ]  (4)  About once a week
[  ]  (2)  Less than once a month            [  ]  (5)  Daily or almost daily
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[  ]  (3)  About once a month
9. How often during the last six months have you had a feeling of guilt or remorse after
drinking?
[  ]  (1)  Never [  ]  (4)  About once a week
[  ]  (2)  Less than once a month            [  ]  (5)  Daily or almost daily
[  ]  (3)  About once a month
10. How often during the last six months have you been unable to remember
what   happened the night before because you had been drinking?
[  ]  (1)  Never [  ]  (4)  About once a week
[  ]  (2)  Less than once a month            [  ]  (5)  Daily or almost daily
[  ]  (3)  About once a month
ALCOHOL/DRUG RELATED EXPERIENCES
11. When did you first think you may have a problem with alcohol/other drugs?
Rough date:_________________/ OR  (I don’t think I have a problem)
12. When did your partner, family or friend first become concerned about your
drinking/drug taking? Date:_________________/ OR (They don’t think I have
a problem)
13. Have you attempted to change your drinking/drug taking (ie.give up or cut
down) without anyone’s help?
[  ]  (1)  No
[  ]  (2)  Yes, but not in the last six months
[  ]  (3)  Yes, during the last six months (please
specify)____________________________
__________________________________
14. Have you seen a counsellor or a doctor (or any other health professional)
regarding your drinking/drug taking?
[  ]  (1)  No
[  ]  (2)  Yes, but not in the last six months
[  ]  (3)  Yes, during the last six months (please
specify)____________________________
__________________________________
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15. Have your been to an Alcoholics Anonymous (AA) group or any other self-
help   groups (eg. Narcotics Anonymous)?
[  ]  (1)  No
[  ]  (2)  Yes, but not in the last six months
[  ]  (3)  Yes, during the last six months (please
specify)____________________________
__________________________________
16. Do you have anyone whom your regard as a support person?
NO:________________ YES:________________
If yes, please
specify________________________________________________________
17. Has anyone been concerned about your drinking/drug taking and suggested
that you give up or cut down?
[  ]  (1)  No
[  ]  (2)  Yes, but not in the last six months
[  ]  (3)  Yes, during the last six months (please
specify)____________________________
__________________________________
18. Is there anyone else in you family who drinks heavily or takes drugs?
NO:________________ YES:________________
19. Is there anyone else in your family seeing a mental health professional?
NO:________________ YES:________________
20. At the place your are currently living does anyone else drink heavily or take
drugs?
NO:________________ YES:________________
21. Following discharge from this place, would you go back to live with them?
NO:_________ YES:_________ NOT APPLICABLE:_________
22. Have you seen a mental health professional for reasons other than
drinking/drug taking?
[  ]  (1)  No
[  ]  (2)  Yes, but not in the last six months
[  ]  (3)  Yes, during the last six months (please
specify)____________________________
___________________________________
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23. Have suffered from severe anxiety or depression?
[  ]  (1)  No
[  ]  (2)  Yes, but not in the last six months
[  ]  (3)  Yes, during the last six months (please
specify)____________________________
__________________________________
24. Do you sometimes feel like ending your life?
[  ]  (1)  No
[  ]  (2)  Yes, but not in the last six months
[  ]  (3)  Yes, during the last six months (please
specify)____________________________
__________________________________
25. Have you hurt yourself intentionally?  (e.g. attempted to commit suicide)
[  ]  (1)  No
[  ]  (2)  Yes, but not in the last six months
[  ]  (3)  Yes, during the last six months (please
specify)___________________________
_________________________________
26. Has any member of your family or someone else close to you attempted
to/or  committed suicide?
[  ]  (1)  No
[  ]  (2)  Yes, but not in the last six months
[  ]  (3)  Yes, during the last six months (please
specify)____________________________
__________________________________
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Support Scale (SS)
We would like to know about your recent relationship with your nominated “support person” (i.e. partner /
friend / or a family member) ……………………………. (name).
Please circle your answers to the following questions:
In the last 6 months how often has this support person :
1. Congratulated you for your decision to cut down your drinking/drug use?
Never or almost never Sometimes Often Nearly always
2. Said that you were unreliable?
Never or almost never Sometimes Often Nearly always
3. Helped you to think of ways to stop drinking/using drugs heavily?
Never or almost never Sometimes Often Nearly always
4. Complimented your achievements?
Never or almost never Sometimes Often Nearly always
5. Commented on your lack of commitment to cut down your drinking/.drug use?
Never or almost never Sometimes Often Nearly always
6. Criticized you?
Never or almost never Sometimes Often Nearly always
7. Understood the difficulties that you have?
Never or almost never Sometimes Often Nearly always
8. Said that any problems that your drinking/drug use has caused are your own fault?
Never or almost never Sometimes Often Nearly always
9. Complimented you on cutting down your drinking/drug use?
Never or almost never Sometimes Often Nearly always
10. Told you not to rely on them for any help?
Never or almost never Sometimes Often Nearly always
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11. Talked you out of drinking/using drugs?
Never or almost never Sometimes Often Nearly always
12. Supported your decisions in general?
Never or almost never Sometimes Often Nearly always
13. Said your problems are your own fault?
Never or almost never Sometimes Often Nearly always
14. Encouraged you to stick with your decision to stop/cut down your drinking/drug use?
Never or almost never Sometimes Often Nearly always
15. Critically commented that you look drunk/drug-affected?
Never or almost never Sometimes Often Nearly always
16. Interfered with your life?
Never or almost never Sometimes Often Nearly always
17. Criticized you for drinking heavily/using drugs?
Never or almost never Sometimes Often Nearly always
18. Been really helpful when it came to making decisions?
Never or almost never Sometimes Often Nearly always
19. Stated being embarrassed by your drinking/drug use?
Never or almost never Sometimes Often Nearly always
20. Given the kind of support you like?
Never or almost never  Sometimes Often Nearly always
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Study 2      Demographics Form
Sex :  Male  __   Female __
What is your date of birth :   --/--/----
How long have you been in your current relationship for ?   ________ months
  or _______   years.
Have you been living with your partner in the last 12 months?  Yes ____No ___
Version 3  31/1/11
Page 1 of 1
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APPENDIX D
PCSES & Item Characteristics
Descriptives
Statistic Std.
Error
totalpcses
Mean 152.82 3.764
95% Confidence Interval for
Mean
Lower
Bound
145.33
Upper
Bound
160.31
5% Trimmed Mean 152.21
Median 151.00
Variance 1175.833
Std. Deviation 34.290
Minimum 59
Maximum 263
Range 204
Interquartile Range 36
Skewness .315 .264
Kurtosis 1.383 .523
Factor Structure of the PCSES    Study 1
Determining the factorability of the dataset
KMO and Bartlett's Test
Kaiser-Meyer-Olkin Measure of Sampling Adequacy. .726
Bartlett's Test of Sphericity
Approx. Chi-Square 827.557
df 276
Sig. .000
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Tests of Normality
Kolmogorov-Smirnov Shapiro-Wilk
Statistic df Sig. Statistic df Sig.
moodchange .182 83 .000 .930 83 .000
suicidal .139 83 .000 .926 83 .000
medication .143 83 .000 .950 83 .003
notinteract .165 83 .000 .950 83 .003
embarrassed .139 83 .000 .932 83 .000
blamesu .148 83 .000 .944 83 .001
notunderstand .167 83 .000 .948 83 .002
criticise .143 83 .000 .955 83 .005
practicaltips .118 83 .006 .951 83 .003
lowmood .115 83 .009 .945 83 .001
stressworry .126 83 .002 .937 83 .001
bored .138 83 .001 .933 83 .000
noeffort .121 83 .004 .936 83 .000
lies .137 83 .001 .949 83 .002
unappreciative .127 83 .002 .940 83 .001
responsibilities .127 83 .002 .935 83 .000
notcriticise .159 83 .000 .937 83 .000
thepast .148 83 .000 .940 83 .001
buydanda .146 83 .000 .948 83 .002
sick .175 83 .000 .929 83 .000
intoxicated .142 83 .000 .938 83 .001
qualitytime .180 83 .000 .926 83 .000
support .184 83 .000 .881 83 .000
udandafree .271 83 .000 .790 83 .000
Tests of Normality Total PCSES score Study 1
Kolmogorov-Smirnova Shapiro-Wilk
Statistic df Sig. Statistic df Sig.
total pcses .112 83 .012 .968 83 .037
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Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance if
Item Deleted
Corrected Item-
Total Correlation
Squared Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
moodchange 146.52 1057.960 .580 .714 .867
suicidal 146.55 1069.567 .518 .615 .869
medication 146.36 1075.990 .499 .681 .869
notinteract 146.42 1066.369 .623 .632 .866
embarrassed 146.72 1078.008 .494 .585 .870
blamesu 146.64 1073.648 .547 .551 .868
notunderstand 146.61 1065.703 .577 .632 .867
criticise 147.10 1066.698 .620 .547 .867
practicaltips 147.10 1070.966 .531 .468 .869
lowmood 147.27 1070.539 .500 .557 .869
stressworry 147.24 1076.136 .456 .663 .871
bored 147.17 1067.703 .487 .670 .870
noeffort 147.01 1087.793 .414 .466 .872
lies 146.57 1064.614 .585 .641 .867
unappreciative 146.82 1063.540 .523 .611 .869
responsibilities 146.63 1070.139 .502 .604 .869
notcriticise 146.24 1106.892 .359 .437 .873
thepast 146.53 1112.203 .293 .418 .875
buydanda 146.35 1126.791 .227 .520 .877
sick 146.08 1105.493 .323 .548 .875
intoxicated 146.63 1091.017 .369 .452 .874
qualitytime 145.71 1119.013 .264 .361 .876
support 145.59 1117.342 .221 .475 .878
udandafree 142.99 1153.183 .220 .363 .876
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Boxplot Total PCSES identifying outliers
Initial Factor Analysis
Total Variance Explained
Factor Initial Eigenvalues Rotation Sums
of Squared
Loadings
Total % of Variance Cumulative % Total
1 6.711 27.964 27.964 5.089
2 2.311 9.629 37.593 4.272
3 1.696 7.068 44.661 3.224
4 1.579 6.578 51.239 1.301
5 1.332 5.551 56.790 2.261
6 1.180 4.916 61.706 1.530
7 1.084 4.515 66.221 2.736
8 .984 4.099 70.320
9 .910 3.792 74.112
10 .804 3.348 77.460
11 .762 3.176 80.635
12 .718 2.993 83.628
13 .595 2.478 86.107
14 .518 2.160 88.266
15 .437 1.821 90.087
16 .400 1.665 91.753
17 .389 1.619 93.371
18 .338 1.409 94.780
19 .293 1.220 96.000
20 .268 1.118 97.119
21 .238 .993 98.111
22 .183 .763 98.874
23 .147 .611 99.485
24 .124 .515 100.000
Extraction Method: Principal Axis Factoring.
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PARALLEL ANALYSIS  N=100 datasets
Specifications for this Run:
Ncases     83
Nvars      24
Ndatsets  100
Percent    95
Raw Data Eigenvalues, & Mean & Percentile Random Data Eigenvalues
         Root     Raw Data        Means     Prcntyle
     1.000000     6.301804     1.448580     1.654512
     2.000000     1.861584     1.226603     1.364696
     3.000000     1.235190     1.075238     1.200816
     4.000000     1.148825      .941230     1.067248
     5.000000      .832567      .829719      .925637
     6.000000      .742794      .722205      .805218
     7.000000      .592615      .619272      .720678
     8.000000      .509857      .532425      .627769
     9.000000      .404046      .446537      .535983
    10.000000      .341621      .361444      .436397
    11.000000      .329741      .288190      .359718
    12.000000      .199286      .213586      .285990
    13.000000      .132865      .149760      .229487
    14.000000      .069141      .076738      .141619
    15.000000      .012052      .015735      .087350
    16.000000     -.004076     -.044064      .003893
    17.000000     -.060741     -.097271     -.044671
    18.000000     -.098438     -.154557     -.111078
    19.000000     -.159315     -.200256     -.156305
    20.000000     -.189003     -.249661     -.214403
    21.000000     -.209405     -.295092     -.257904
    22.000000     -.211865     -.336962     -.304853
    23.000000     -.255467     -.379274     -.349559
    24.000000     -.317451     -.427580     -.400895
Scree plot from parallel analysis using N=100 datasets
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PARALLEL ANALYSIS N=1000 datasets:
Specifications for this Run:
Ncases      83
Nvars       24
Ndatsets  1000
Percent     95
Raw Data Eigenvalues, & Mean & Percentile Random Data Eigenvalues
         Root     Raw Data        Means     Prcntyle
     1.000000     6.301804     1.443703     1.676051
     2.000000     1.861584     1.233305     1.390214
     3.000000     1.235190     1.076301     1.203077
     4.000000     1.148825      .940384     1.060594
     5.000000      .832567      .825579      .928534
     6.000000      .742794      .714532      .809348
     7.000000      .592615      .617583      .712974
     8.000000      .509857      .526311      .617894
     9.000000      .404046      .440019      .530301
    10.000000      .341621      .358925      .435571
    11.000000      .329741      .284178      .358736
    12.000000      .199286      .212066      .283813
    13.000000      .132865      .144207      .208221
    14.000000      .069141      .078357      .136490
    15.000000      .012052      .018439      .078041
    16.000000     -.004076     -.042906      .008369
    17.000000     -.060741     -.098370     -.049405
    18.000000     -.098438     -.152960     -.108649
    19.000000     -.159315     -.202049     -.157462
    20.000000     -.189003     -.250099     -.210860
    21.000000     -.209405     -.295837     -.261260
    22.000000     -.211865     -.339021     -.309333
    23.000000     -.255467     -.381515     -.352721
    24.000000     -.317451     -.426518     -.397396
Scree plot from parallel analysis using N=1000 datasets
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 4 Factor Solution
Factor Correlation Matrix
Factor 1 2 3 4
1 1.000 .224 -.276 .282
2 .224 1.000 -.263 .110
3 -.276 -.263 1.000 -.218
4 .282 .110 -.218 1.000
Pattern Matrix
Factor
1 2 3 4
moodchange .650 -.051 -.044 .217
suicidal .605 .047 -.015 .093
medication .684 -.080 .010 .117
notinteract .634 -.131 -.313 .086
embarrassed .617 .065 -.109 -.083
blamesu .363 .039 -.420 -.006
notunderstand .373 -.117 -.496 .143
criticise .476 .231 -.151 .085
practicaltips .280 -.008 -.325 .256
lowmood .253 .010 -.041 .562
stressworry .004 -.005 -.046 .857
bored .460 .116 .262 .509
noeffort .158 .080 -.145 .313
lies .081 .122 -.518 .274
unappreciative .059 .160 -.666 -.001
responsibilities -.017 .178 -.701 .008
notcriticise .134 .216 -.313 -.091
thepast .111 .366 -.186 -.178
buydanda .392 .442 .330 -.126
sick -.050 .554 -.102 .010
intoxicated -.031 .478 -.171 .066
qualitytime .017 .489 .087 .087
support -.229 .411 -.076 .261
udandafree .017 .378 -.038 -.044
Extraction Method: Principal Axis Factoring.
 Rotation Method: Oblimin with Kaiser Normalization.
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Factor 1 of 4 Factor Model
Reliability Statistics
Cronbach's
Alpha
Cronbach's
Alpha Based on
Standardized
Items
N of Items
.839 .839 6
Factor 2 of 4 Factor Model
Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
moodchange 30.94 100.545 .707 .613 .793
suicidal 30.98 104.804 .624 .416 .810
medication 30.78 105.587 .634 .567 .808
notinteract 30.84 109.207 .651 .436 .806
embarrassed 31.14 111.198 .531 .314 .829
criticise 31.52 114.106 .546 .318 .825
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha
Based on
Standardized
Items
N of Items
.634 .646 7
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Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
thepast 43.57 92.005 .319 .173 .606
buydanda 43.39 97.801 .226 .122 .634
sick 43.12 81.376 .532 .294 .533
intoxicated 43.66 82.568 .451 .234 .560
qualitytime 42.75 91.460 .345 .135 .598
support 42.63 89.944 .276 .222 .626
udandafree 40.02 105.780 .342 .147 .614
Factor 3 of 4 Factor Model
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha
Based on
Standardized
Items
N of Items
.818 .817 7
Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
practicaltips 37.41 140.659 .502 .310 .803
blamesu 36.95 141.339 .528 .338 .799
notunderstand 36.93 138.068 .565 .458 .793
lies 36.88 133.010 .659 .480 .777
unappreciative 37.13 128.458 .643 .491 .778
responsibilities 36.94 132.204 .601 .416 .786
notcriticise 36.55 149.055 .408 .236 .817
Factor 4 of 4 Factor Model
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha
Based on
Standardized
Items
N of Items
.755 .754 4
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Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
lowmood 17.04 51.816 .525 .352 .713
stressworry 17.01 46.036 .673 .462 .628
bored 16.94 47.643 .600 .364 .671
noeffort 16.78 56.074 .419 .218 .766
3 Factor Model
Pattern Matrixa
Factor
1 2 3
moodchange .777 -.059 .082
 suicidal .631 .060 .121
medication .724 -.075 .139
notinteract .715 -.037 -.148
embarrassed .528 .131 .051
blamesu .413 .165 -.259
notunderstand .553 -.009 -.371
criticise .522 .276 .008
practicaltips .506 .031 -.243
lowmood .616 -.071 -.039
stressworry .538 -.102 -.105
bored .703 -.024 .265
noeffort .383 .067 -.107
lies .360 .196 -.433
unappreciative .170 .334 -.527
responsibilities .108 .360 -.572
notcriticise .111 .320 -.190
thepast -.010 .469 -.047
buydanda .187 .411 .449
sick -.054 .583 -.004
intoxicated .019 .516 -.077
qualitytime .028 .454 .145
support -.036 .352 -.072
udandafree -.030 .398 .034
Extraction Method: Principal Axis Factoring.
 Rotation Method: Oblimin with Kaiser Normalization.a
a. Rotation converged in 13 iterations.
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Factor Correlation Matrix
Factor 1 2 3
1 1.000 .343 -.198
2 .343 1.000 -.166
3 -.198 -.166 1.000
Reliability  Factor 1 of 3 Factor Model
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha
Based on
Standardized
Items
N of Items
.880 .881 13
Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
moodchange 71.64 458.234 .675 .666 .865
suicidal 71.67 470.490 .572 .508 .871
medication 71.48 468.643 .608 .629 .869
notinteract 71.54 468.178 .692 .576 .865
embarrassed 71.84 480.036 .515 .460 .874
blamesu 71.76 486.112 .489 .406 .875
notunderstand 71.73 472.173 .598 .482 .869
criticise 72.22 479.538 .581 .452 .870
practicaltips 72.22 477.977 .530 .383 .873
lowmood 72.39 468.971 .569 .477 .871
stressworry 72.36 474.160 .510 .561 .874
bored 72.29 464.696 .571 .499 .871
noeffort 72.13 489.360 .409 .431 .879
Scale Statistics
Mean Variance Std. Deviation N of Items
77.94 550.472 23.462 13
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Reliability  Factor 2 of 3 Factor Model
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha
Based on
Standardized
Items
N of Items
.639 .645 7
Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
notcriticise 43.39 97.801 .239 .103 .634
thepast 43.67 90.637 .336 .212 .607
sick 43.23 83.227 .479 .264 .558
intoxicated 43.77 84.276 .406 .234 .583
qualitytime 42.86 90.491 .353 .136 .601
support 42.73 85.002 .356 .225 .602
udandafree 40.13 105.653 .325 .128 .621
Reliability - Factor 3 of 3 Factor Model
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha
Based on
Standardized
Items
N of Items
.578 .568 4
Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
lies 18.66 33.958 .518 .312 .381
unappreciative 18.92 29.542 .580 .426 .303
responsibilities 18.72 33.471 .456 .369 .424
buydanda 18.45 51.274 -.025 .024 .761
Scale Statistics
Mean Variance Std. Deviation N of Items
49.96 116.840 10.809 7
Scale Statistics
Mean Variance Std. Deviation N of Items
24.92 57.761 7.600 4
263
Reliability Factor 3 of 3 Factor Model if Item 19 (“buy d and a”) is removed from
Factor 3
Reliability Statistics
Cronbach's
Alpha
Cronbach's
Alpha Based on
Standardized
Items
N of Items
.761 .761 3
Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
lies 12.19 28.109 .548 .308 .729
unappreciative 12.45 23.177 .651 .424 .610
responsibilities 12.25 25.240 .584 .355 .690
Reliability  Factor 2 of 3 Factor Model if Item 19 (“buy d and a”) added to Factor
2
Reliability Statistics
Cronbach's
Alpha
Cronbach's
Alpha Based on
Standardized
Items
N of Items
.648 .656 8
Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
notcriticise 49.86 117.467 .269 .139 .634
thepast 50.14 110.637 .346 .212 .615
buydanda 49.96 116.840 .255 .157 .639
sick 49.70 101.603 .505 .296 .569
intoxicated 50.24 103.697 .415 .241 .595
qualitytime 49.33 111.100 .351 .139 .614
support 49.20 108.311 .304 .261 .630
udandafree 46.60 126.925 .337 .147 .630
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Factor Correlation Matrix
Factor 1 2 3
1 1.000 .343 -.198
2 .343 1.000 -.166
3 -.198 -.166 1.000
2 Factor Model
Pattern Matrixa
Factor
1 2
moodchange .787 -.111
suicidal .632 -.024
medication .733 -.159
notinteract .711 .060
embarrassed .525 .084
blamesu .401 .312
notunderstand .535 .226
criticise .511 .241
practicaltips .495 .183
lowmood .620 -.043
stressworry .537 -.024
bored .701 -.183
noeffort .377 .128
lies .340 .446
unappreciative .150 .619
responsibilities .092 .660
notcriticise .093 .411
thepast -.020 .439
buydanda .177 .078
sick -.059 .502
intoxicated .007 .500
qualitytime .027 .296
support -.047 .360
udandafree -.037 .327
Extraction Method: Principal Axis Factoring.
 Rotation Method: Oblimin with Kaiser
Normalization.a
a. Rotation converged in 5 iterations.
Factor Correlation Matrix
Factor 1 2
1 1.000 .401
2 .401 1.000
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Reliability  Factor 1 of 2 Factor Model
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha
Based on
Standardized
Items
N of Items
 .880 .881 13
Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
moodchange 71.64 458.234 .675 .666 .865
suicidal 71.67 470.490 .572 .508 .871
medication 71.48 468.643 .608 .629 .869
notinteract 71.54 468.178 .692 .576 .865
embarrassed 71.84 480.036 .515 .460 .874
blamesu 71.76 486.112 .489 .406 .875
notunderstand 71.73 472.173 .598 .482 .869
criticise 72.22 479.538 .581 .452 .870
practicaltips 72.22 477.977 .530 .383 .873
lowmood 72.39 468.971 .569 .477 .871
stressworry 72.36 474.160 .510 .561 .874
bored 72.29 464.696 .571 .499 .871
noeffort 72.13 489.360 .409 .431 .879
Factor 2 of  2 Factor Model
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha
Based on
Standardized
Items
N of Items
.744 .746 11
Scale Statistics
Mean Variance Std. Deviation N of Items
77.94 550.472 23.462 13
Scale Statistics
Mean Variance Std. Deviation N of Items
74.88 264.180 16.254 11
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Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
lies 68.63 220.017 .456 .438 .716
unappreciative 68.88 210.449 .508 .463 .707
responsibilities 68.69 211.242 .515 .508 .707
notcriticise 68.30 226.018 .402 .320 .723
thepast 68.59 224.001 .378 .311 .726
buydanda 68.41 242.635 .165 .247 .753
sick 68.14 214.906 .483 .350 .712
intoxicated 68.69 213.023 .461 .333 .714
qualitytime 67.77 228.837 .329 .183 .733
support 67.65 224.206 .303 .269 .739
udandafree 65.05 247.900 .329 .165 .736
Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
moodchange 146.52 1057.960 .580 .714 .867
suicidal 146.55 1069.567 .518 .615 .869
medication 146.36 1075.990 .499 .681 .869
notinteract 146.42 1066.369 .623 .632 .866
embarrassed 146.72 1078.008 .494 .585 .870
blamesu 146.64 1073.648 .547 .551 .868
notunderstand 146.61 1065.703 .577 .632 .867
criticise 147.10 1066.698 .620 .547 .867
practicaltips 147.10 1070.966 .531 .468 .869
lowmood 147.27 1070.539 .500 .557 .869
stressworry 147.24 1076.136 .456 .663 .871
bored 147.17 1067.703 .487 .670 .870
noeffort 147.01 1087.793 .414 .466 .872
lies 146.57 1064.614 .585 .641 .867
unappreciative 146.82 1063.540 .523 .611 .869
responsibilities 146.63 1070.139 .502 .604 .869
notcriticise 146.24 1106.892 .359 .437 .873
thepast 146.53 1112.203 .293 .418 .875
buydanda 146.35 1126.791 .227 .520 .877
sick 146.08 1105.493 .323 .548 .875
intoxicated 146.63 1091.017 .369 .452 .874
qualitytime 145.71 1119.013 .264 .361 .876
support 145.59 1117.342 .221 .475 .878
udandafree 142.99 1153.183 .220 .363 .876
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Reliability Statistics
Cronbach's
Alpha
Cronbach's
Alpha Based
on
Standardized
Items
N of Items
.876 .876 24
Assumption of Normality of 4 Factors
Scale Statistics
Mean Variance Std. Deviation N of Items
152.82 1175.833 34.290 24
268
Cox Regression
Variables in the Equation
B SE Wald df Sig. Exp(B)
pcsegroup -2.428 2.024 1.439 1 .230 .088
agegrouppatient 3.001 2 .223
agegrouppatient(1) 7.651 24.148 .100 1 .751 2102.584
agegrouppatient(2) 9.437 24.139 .153 1 .696 12540.565
sexpatient -3.656 2.012 3.300 1 .069 .026
patientdandasegroup .682 1.410 .234 1 .629 1.977
priortreatment .213 2 .899
priortreatment(1) 16.799 147.332 .013 1 .909 19758983.079
priortreatment(2) -2.656 153.601 .000 1 .986 .070
aa .753 2 .686
aa(1) 4.850 74.020 .004 1 .948 127.751
aa(2) 6.173 74.036 .007 1 .934 479.398
pressuretostop 1.454 2 .483
pressuretostop(1) -.345 1.265 .074 1 .785 .708
pressuretostop(2) 1.061 1.008 1.108 1 .293 2.889
yearsdandaproblem 5.455 9 .890
yearsdandaproblem(1) -27.334 149.306 .034 1 .855 .000
yearsdandaproblem(2) -23.761 149.311 .025 1 .874 .000
yearsdandaproblem(3) -23.100 149.353 .024 1 .877 .000
yearsdandaproblem(4) -37.357 160.608 .054 1 .816 .000
yearsdandaproblem(5) -16.494 147.336 .013 1 .911 .000
yearsdandaproblem(6) -18.563 129.652 .021 1 .886 .000
yearsdandaproblem(7) -27.721 149.309 .034 1 .853 .000
yearsdandaproblem(8) -12.299 196.309 .004 1 .950 .000
yearsdandaproblem(9) -19.016 198.083 .009 1 .924 .000
patientsubstance 6.382 3 .094
patientsubstance(1) 8.028 127.384 .004 1 .950 3065.532
patientsubstance(2) 4.073 152.772 .001 1 .979 58.736
patientsubstance(3) 14.343 127.398 .013 1 .910 1694793.533
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Overall Comparisons
Chi-Square df Sig.
Log Rank (Mantel-Cox) .012 1 .914
Breslow (Generalized Wilcoxon) .005 1 .946
Tarone-Ware .008 1 .929
Test of equality of survival distributions for the different levels of PCSES group (High versus Low).
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APPENDIX E
EFA prior to CFA
KMO and Bartlett's Test
Kaiser-Meyer-Olkin Measure of Sampling Adequacy. .744
Bartlett's Test of Sphericity
Approx. Chi-Square 1889.201
df 276
Sig. .000
Item-Total Statistics
Scale Mean if
Item Deleted
Scale Variance
if Item Deleted
Corrected Item-
Total
Correlation
Squared
Multiple
Correlation
Cronbach's
Alpha if Item
Deleted
moodchange 120.9891 1139.286 .596 .522 .869
suicidal 119.1421 1162.079 .318 .413 .876
medication 120.5410 1146.678 .394 .398 .874
notinteract 120.8415 1148.046 .463 .362 .872
embarrassed 120.8197 1149.588 .418 .496 .873
blamesu 120.4699 1113.954 .555 .655 .869
notunderstand 119.6284 1121.433 .575 .671 .869
criticise 120.1803 1115.885 .606 .708 .868
practicaltips 120.7049 1113.297 .582 .529 .868
lowmood 122.2459 1124.978 .671 .868 .867
stressworry 122.2459 1122.879 .686 .871 .867
bored 121.5792 1125.245 .631 .645 .868
noeffort 122.4973 1132.757 .650 .786 .868
lies 122.5574 1124.622 .631 .837 .868
unappreciative 122.0383 1110.784 .674 .815 .866
responsibilities 120.3989 1157.933 .339 .229 .876
notcriticise 120.2842 1144.490 .459 .605 .872
thepast 120.3060 1144.664 .431 .582 .873
buydanda 117.3443 1190.392 .173 .367 .881
sick 119.6448 1201.351 .121 .220 .883
intoxicated 120.1749 1130.079 .495 .461 .871
qualitytime 117.7869 1186.213 .241 .329 .878
support 119.3115 1154.205 .333 .302 .876
udandafree 116.0874 1227.135 .041 .297 .882
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Initial Factor Analysis
Total Variance Explained
Factor Initial Eigenvalues Rotation Sums
of Squared
Loadingsa
Total % of Variance Cumulative % Total
1 6.892 28.715 28.715 4.683
2 2.210 9.207 37.922 2.180
3 1.633 6.802 44.724 1.795
4 1.530 6.376 51.100 3.154
5 1.268 5.282 56.383 1.169
6 1.164 4.849 61.232 4.016
7 1.028 4.283 65.515
8 .951 3.962 69.477
9 .894 3.724 73.201
10 .855 3.562 76.763
11 .762 3.175 79.938
12 .685 2.856 82.793
13 .594 2.475 85.269
14 .557 2.322 87.591
15 .467 1.946 89.537
16 .443 1.844 91.382
17 .421 1.753 93.135
18 .337 1.403 94.538
19 .300 1.248 95.786
20 .255 1.061 96.847
21 .247 1.031 97.878
22 .219 .913 98.791
23 .160 .669 99.459
24 .130 .541 100.000
Extraction Method: Principal Axis Factoring.
a. When factors are correlated, sums of squared loadings cannot be added to obtain
a total variance.
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Pattern Matrixa
Factor
1 2 3 4 5 6
moodchange .732 .061 -.043 .145 -.018 .063
suicidal .728 -.099 .109 -.033 .363 .034
medication .671 .155 .083 .170 -.231 .144
notinteract .599 .033 .031 -.023 -.080 -.193
embarrassed .314 -.232 .418 -.062 .096 -.348
blamesu .361 .225 .042 .030 -.234 -.324
notunderstand .434 .031 -.038 .061 -.072 -.404
criticise .323 .120 .287 .121 .043 -.232
practicaltips .305 -.042 -.027 .198 .111 -.336
lowmood .329 -.102 -.078 .512 .226 -.058
stressworry .137 .024 -.158 .756 .089 -.027
bored .122 -.096 .401 .689 -.020 .058
noeffort -.069 .103 .136 .483 -.230 -.256
lies -.001 .003 -.093 .314 .041 -.608
unappreciative -.043 .057 -.044 .061 .020 -.755
responsibilities .115 .245 -.129 -.075 .024 -.585
notcriticise -.035 .035 .129 -.047 .083 -.460
thepast .122 .414 .092 -.160 .054 -.121
buydanda -.004 .207 .712 .039 .065 .106
sick .007 .560 .021 -.021 .064 -.001
intoxicated .010 .621 .063 .061 -.001 -.063
qualitytime -.011 .219 .171 .118 .348 .011
support -.030 .299 -.179 .145 .397 -.015
udandafree -.031 .040 .082 -.057 .472 -.124
Extraction Method: Principal Axis Factoring.
 Rotation Method: Oblimin with Kaiser Normalization.a
a. Rotation converged in 18 iterations.
273
PARALLEL ANALYSIS:
PAF/Common Factor Analysis & Raw Data Permutation
Specifications for this Run:
Ncases     183
Nvars       24
Ndatsets  1000
Percent     95
Raw Data Eigenvalues, & Mean & Percentile Random Data Eigenvalues
         Root     Raw Data        Means     Prcntyle
     1.000000     7.269862      .869212     1.002328
     2.000000     2.160367      .741257      .836184
     3.000000     1.376272      .644967      .727651
     4.000000      .940755      .564585      .639886
     5.000000      .714848      .493311      .561349
     6.000000      .572368      .426414      .486313
     7.000000      .468759      .363935      .421055
     8.000000      .293458      .305122      .364705
     9.000000      .240830      .250573      .302696
    10.000000      .184951      .198973      .248403
    11.000000      .110131      .149224      .196607
    12.000000      .048122      .099964      .144334
    13.000000      .029364      .054643      .096713
    14.000000      .018221      .011525      .052408
    15.000000     -.042184     -.033959      .006065
    16.000000     -.053425     -.074902     -.038789
    17.000000     -.078606     -.115069     -.080994
    18.000000     -.098232     -.153787     -.120422
    19.000000     -.108419     -.194450     -.162583
    20.000000     -.139555     -.233286     -.200983
    21.000000     -.197190     -.271657     -.241860
    22.000000     -.205787     -.311879     -.282948
    23.000000     -.247251     -.353217     -.323765
    24.000000     -.290382     -.400599     -.365527
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4 Factor Model
Pattern Matrixa
Factor
1 2 3 4
moodchange .579 -.076 -.061 .261
suicidal .660 .113 .031 .132
medication .619 -.089 .012 .217
notinteract .580 -.096 -.258 .047
embarrassed .594 .047 -.125 -.066
blamesu .390 .008 -.397 .041
notunderstand .411 -.087 -.456 .120
criticise .504 .224 -.148 .106
practicaltips .274 .017 -.316 .263
lowmood .206 .026 -.041 .606
stressworry -.043 .036 -.052 .858
bored .382 .077 .201 .466
noeffort .104 .034 -.191 .369
lies .006 .044 -.564 .319
unappreciative .023 .117 -.775 .057
responsibilities .050 .187 -.649 -.038
notcriticise .107 .181 -.412 -.074
thepast .142 .392 -.177 -.162
buydanda .426 .432 .268 -.091
sick -.023 .464 -.115 -.039
intoxicated .023 .501 -.173 .022
qualitytime .041 .520 .103 .123
support -.220 .433 -.075 .214
udandafree -.009 .377 -.023 -.018
Extraction Method: Principal Axis Factoring.
 Rotation Method: Oblimin with Kaiser Normalization.a
a. Rotation converged in 19 iterations.
275
References
Akaike, H. (1987). Factor analysis and AIC. Psychometrika, 52, 317-332.
Arrindell, W.A., & van der Ende, J. (1985). An empirical test of the utility of the observations-to-
variables ration in factor and components analysis. Applied Psychosocial Measurement, 9,
165-178.
Australian Bureau of Statistics (2010-2011). Household Use of Information Technology,
Australia 2010-2011 (Cat. No. 8146.0). Retrieved from :
www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/8146.02010-11.
Australian Institute of Health and Welfare (AIHW) (2011). Drugs in Australia 2010 : tobacco,
alcohol and other drugs. Drug Statistics Series no. 27. Cat. No. PHE 154. Canberra : AIHW.
Australian Institute of Health and Welfare (AIHW) (2012). Australia’s Health 2012. Australia’s
health. no. 13. Cat. No. AUS. 156. Canberra : AIHW
Bandura, A. (1977). Self- efficacy: Toward a unifying theory of behavioral change.
Psychological Review, 84, 191-215.
Bandura, A. (1986). The explanatory and predictive scope of self-efficacy theory. Cognitive
Therapy & Research, 8, 231-255.
Bandura, A. (1992). Self-efficacy mechanism in psychobiologic functioning. In R. Schwarzer
(Ed.), Self-efficacy: Thought control of action (pp.355-394.). Washington DC: Hemisphere.
Bandura, A. (1995). Exercise of personal and collective efficacy in changing societies. In A.
Bandura (Ed.), Self-efficacy in changing societies (pp.1-45). New York : The Cambridge
University Press.
276
Bandura, A. (1997). Self-Efficacy : The exercise of control. New York : W.H. Freeman & Co.
Bandura, A. (2005). Chapter 14  - Guide for Constructing Self-Efficacy Scales. In Pajares, F.,
& Urdan, T.C. (Eds). Self-Efficacy Beliefs of Adolescents. Greenwich CT :  Information Age
Publishing.
Beck, A. T., Brown, G. K., & Steer, R. A. (1997). Psychometric characteristics of the
Scale for Suicide Ideation with psychiatric outpatients. Behavior Research and Therapy,
35(11), 1039-1046.
Beck, A. T., Guth, D., Steer, R.A., & Ball, R. (1997). Screening for major depression disorders
in medical inpatients with the BDI for primary care. Behavior Research & Therapy, 35(8), 785-
791.
Beck, A.T., &  Steer, R.A. (1991). Manual for Beck Scale for Suicidal Ideation . New York :
Pennsylvania Corporation.
Ben-Zur, H., Gilbar, O., & Lev, S. (2001). Coping with breast cancer : patient, spouse and dyad
models. Psychosomatic Medicine, 63, 32-39.
Bentler, P.M. (1990). Comparative fit indexes in structural models. Psychological Bulletin,
107(2), 238-246.
Bergman, H., & Kallmen, H. (2002). Alcohol use among Swedes and a psychometric
evaluation of the Alcohol Use Disorders Identification Test. Alcohol & Alcoholism, 37(3), 245-
251.
Best, D., Groshkova, T., Loaring, J., Ghufran, S., Day, E., & Taylor, A. (2010). Comparing the
addiction careers of heroin and alcohol users and their self-reported reasons for achieving
abstinence. Journal of Groups in Addiction & Recovery, 5, 289-305.
Billings, A.G., & Moos, R.H. (1982). Social support and functioning among community and
clinical groups: A panel model. Journal of Behavioural Medicine, 5, 295-311.
Billings, A.G., & Moos, R.H. (1983). Psychosocial processes of recovery among alcoholics and
their families : Implications for clinicians and program evaluators. Addictive Behaviors, 8, 205-
218.
277
Bingen, K., Kupst, M.J., & Himelstein, B. (2011). Development of the Palliative Care Parental
Self-Efficacy Measure. Journal of Palliative Medicine, 14(9), 1009-1016.
Bjelland, I., Dahl., A.A., Haug, T.T., & Neckelmann. (2002). The validity of the Hospital Anxiety
and Depression Scale – An updated literature review. Journal of Psychosomatic Research, 52,
69-77.
Booth, B.M., Russell, D.W., Soucek, S., & Laughlin, P.R. (1992). Social support and outcome
of alcoholism treatment : an exploratory analysis. American Journal on Drug and Alcohol
Abuse, 18, 87-101.
Bradley, K.A., Boyd-Wickizer, J., Powell, S.H., & Burman, M.L. (1998). Alcohol screening
questionnaires in women : a critical review. Journal of the American Medical Association,
280(2), 166-171.
Brennan, P.L., Moos, R.H., & Kelly, K.M. (1994). Spouses of late-life problem drinkers :
Functioning, coping responses, and family contexts. Journal of Family Psychology, 8(4), 447-
457.
Brown, G.K., Beck, A.T., Steer, R. A., & Grisham, J.R. (2000). Risk factors for suicide
in psychiatric outpatients: A 20-year prospective study. Journal of Consulting and Clinical
Psychology, 68, 371-377.
Bryan, C.J., Ray-Sannerud, B., Morrow, C.E., & Etienne, N. (2013). Shame, pride, and suicidal
ideation in military clinical sample. Journal of Affective Disorders, 147 (1-3), 212-216.
Bush, K., Kivlahan, D.R., McDonell, M. S., Fihn, S. D. & Bradley, K. A. (1998). The AUDIT
Alcohol Consumption Questions (AUDIT-C): an effective brief screening test for problem
drinking. Archives of Internal Medicine, 158, 1789–1795.
Butzlaff, R.L., & Hooley, J.M. (1998). Expressed emotion and psychiatric relapse : A meta-
analysis. Archives of General Psychiatry, 55, 547-552.
Carey, K., Carey, M., & Chandra, P. (2003). Psychometric evaluation of the Alcohol Use
Disorders Identification Test and short Drug Abuse Screening Test with psychiatric patients in
India. Journal of Clinical Psychiatry, 64, 767–774.
278
Charney, D.A., Zikos, E., & Gill, K.J. (2010). Early recovery from alcohol dependence : Factors
that promote or impede abstinence. Journal of Substance Abuse Treatment, 38(1), 42-50.
Chen, F., Curran, P.J., Bollen, K.A., Kirby, J., & Paxton, P. (2008). An empirical evaluation of
the use of fixed cut-off points in RMSEA test statistic in structural equation models.
Sociological Methods & Research, 36(4), 462-494.
Chesney, M.A., Neilands, T.B., Chambers, D.B., Taylor, J.M., & Folkman, S. (2006). A validity
and reliability study of the coping self-efficacy scale. British Journal of Health Psychology,
11(3), 421-437.
Chung, T., Langenbucher, J., Labouvie, E., Pandina, R.J., & Moos, R.H. (2001). Changes in
alcoholic patients’ coping responses predict 12 month treatment outcomes. Journal of
Consulting and Clinical Psychology, 69, 92-100.
Cloud, R.N., & Peacock, P.L. (2001). Internet screening and interventions for problem drinking.
Alcoholism Treatment Quarterly, 19(2), 23-44.
Cobb, S. (1976). The contribution of the social environment to host resistance. American
Journal of Epidemiology, 104, 107-123.
Cocco, K., & Carey, K. (1998). Psychometric properties of the Drug Abuse Screening Test in
psychiatric outpatients. Psychological Assessment, 10, 408–414.
Condiotte, M.M., & Lichtenstein, E. (1981). Self-efficacy and relapse in smoking cessation
programs. Journal of Consulting and Clinical Psychology, 49, 648-658.
Copello, A., Templeton, L., Orford, J., Velleman, R., Patel, A., Moore, L., MacLeod, J., &
Godfrey, C. (2009). The relative efficacy of two levels of a primary care intervention for family
members affected by the addiction problem of a close relative : a randomized trial. Addiction,
104, 49-58.
Copello, A., Templeton, L., & Powell, J. (2010). The impact of addiction on the family :
Estimates of prevalence and costs. Drugs : Education, Prevention & Policy, 17, 63-74.
Costello, A.B., & Osborne, J.W. (2005). Best practices in exploratory factor analysis : four
recommendations for getting the most from your analysis. Practical Assessment, Research
and Evaluation, 10(7), 9-16.
279
Crawford, J.R., Henry, J.D., Crombie, C., & Taylor, E.P. (2001). Normative data for the HADS
from a large non-clinical sample. British Journal of Clinical Psychology, 40, 429-434.
Cronkite, R., & Moos, R.H. (1980). Determinants of the posttreatment functioning of alcoholic
patients : A conceptual framework. Journal of Consulting and Clinical Psychology, 48, 305-
316.
Cunningham, J.A., & Breslin, F. (2004). Only 1 in 3 people with alcohol use or dependence
ever seek treatment. Addictive Behaviors, 29, 221-223.
Dawson, D.A., Goldstein, R.B., & Grant, B.F. (2007). Rates and correlates of relapse among
individuals in remission from DSM-IV alcohol dependence : a 3 year follow-up. Alcohol :
Clinical and Experimental Research, 31(12), 2036-2045.
Dawson, D.A., Grant, B.F., & Stinson, F.S. (2005). The AUDIT-C : screening for alcohol use
disorders and risky drinking in the presence of other psychiatric disorders. Comprehensive
Psychiatry, 46(6), 405-416.
Dawson, D.A., Smith, S.A.M., Saha, T.D., Rubinsky, A.D., & Grant, B.F. (2012). Comparative
performance of the AUDIT-C in screening for DSM-IV and DSM-5 alcohol use disorders. Drug
and Alcohol Dependence, 126, 384-388.
DeMartini, K.S. & Carey, K.B. (2012). Optimizing the use of the AUDIT for alcohol screening in
college students. Psychological Assessment, 24(4), 954-963.
Demmel, R., Nicolai, J., & Jenko, D.M. (2006). Self-efficacy and alcohol relapse : concurrent
validity of confidence measures, self-other discrepancies, and prediction of treatment outcome.
Journal of Studies on Alcohol, 67(4), 637-641.
DeVellis, R.F. (1991). Scale Development. Newbury, CA : Sage.
DiClemente, C.C., & Hughes, S.O. (1990). Stages of change profiles in alcoholism treatment.
Journal of Substance Abuse, 2, 217-235.
Dolan, S.L., Martin, R.A., & Rohsenow, D.J. (2008). Self-efficacy for cocaine abstinence :
pretreatment correlates and relationship to outcome. Addictive Behaviors, 33(5), 675-688.
Drummond, D.C., & Glautier, S. (1994). A controlled trial of cue exposure treatment in alcohol
dependence. Journal of Consulting & Clinical Psychology, 62(4), 809-817.
280
Edwards, J.R., & O’Neill, R.M. (1998). The construct validity of scores on the Ways of Coping
Questionnaire : Confirmatory analysis of alternative factor structures. Educational and
Psychological Measurement, 58(6), 955-983.
Fabrigar, L.R., Wegener, D.T., MacCallum, R.C., & Strahan, E.J. (1999). Evaluating the use of
exploratory factor analysis in psychological research. Psychological Methods, 4(3), 272-299.
Fals-Stewart, W., Birchler, G.R. & Kelley, M.L. (2006). Learning Sobriety Together : A
randomized clinical trial examining behavioral couples therapy with female alcoholic patients.
Journal of Consulting & Clinical Psychology, 74, 579-591.
Fals-Stewart, W., O’Farrell, T.J., & Hooley, J.M. (2001). Relapse among married or cohabiting
substance-abusing patients: The role of perceived criticism. Behavior Therapy, 32, 787-801.
Fals-Stewart, W., O’Farrell, T.J., & Lam, W.K.K. (2009). Behavioral couple therapy for gay and
lesbian couples with alcohol use disorders. Journal of Substance Abuse Treatment, 37, 379-
387.
Feeney, G.F.X., Connor, J.P., Young, R.McD., Tucker, J., & McPherson, A. (2006).
Improvement in measures of psychological distress amongst amphetamine misusers treated
with brief cognitive-behavioural therapy (CBT). Addictive Behaviors, 31, 1833-1843.
Fichter, M.M., Glynn, S.M., Weyerer, S., Liberman, R.P., & Frick, U. (1997). Family climate
and expressed emotion in the course of alcoholism. Family Processes, 36, 203-221.
Finney, J.W., Noyes, C.A., Coutts, A.I., & Moos, R.H. (1998). Evaluating substance abuse
treatment process models : I. changes on proximal outcome variables during 12-Step and
cognitive behavioral treatment. Journal of Studies on Alcohol, 59, 371-380.
Folkman, S., & Lazarus, R.S. (1985). If it changes it must be a process : study of emotion and
coping during three stages of a college examination. Journal of Personality & Social
Psychology, 48, 150-170.
Folkman, S., & Lazarus, R.S. (1988). Manual for the Ways of Coping Questionnaire. Palo Alto,
CA : Consulting Psychologists Press.
Ford, K.J., MacCallum, R.C., & Tait, M. (1986). The application of exploratory factor analysis in
applied psychology : A critical review and analysis. Personnel Psychology, 39, 291-314.
281
Forsyth, A.D., & Carey, M.P. (1998). Measuring self-efficacy in the context of HIV risk
reduction : Research challenges and recommendations. Health Psychology, 17(6), 559-568.
Frank, D., DeBenedetti, A.F., Volk, R.J., Williams, E.C., Kivlahan, D.R., & Bradley, K.A. (2008).
Effectiveness of the AUDIT-C as a screening test for alcohol misuse in three race/ethnic
groups. Journal of General Internal Medicine, 23(6), 781-787.
Freund, T., Gensichen, J., Goetz, K., Szecsenyi, J., & Mahler, C. (2013). Evaluating self-
efficacy for managing chronic disease : psychometric properties of the six-item Self-Efficacy
Scale in Germany. Journal of Evaluation in Clinical Practice, 19, 39-43.
Garrity, T.F., Prewitt, S.H., Joosen, M., Staton Tindall, M., Webster, J.M., Hiller, M.L., &
Leukefeld, C.G. (2006). Correlates of subjective stress among drug court clients. International
Journal of Offender Therapy and Comparative Criminology, 50, 269-279.
Giannopoulos, V. (2003). The Partner Coping Self-Efficacy Scale. Unpublished manuscript.
Western Sydney Area Health Service.
Gilliam, C.M., & Steffen, A.M. (2006). The relationship between caregiving self-efficacy and
depressive symptoms in dementia family caregivers. Aging & Mental Health, 10(2), 79-86.
Graham., A., Goss., C., Xu, S., Magid, D.J., & Diguiseppi, C. (2007). Effect of using different
modes to administer the AUDIT-C on identification of hazardous drinking and acquiescence to
trial participation among injured patients. Alcohol & Alcoholism, 42(5), 423-429.
Gual, A., Segura, L., Contel, M., Heather, N., & Colom, J. (2002). AUDIT-3 and AUDIT-4 :
Effectiveness of two short forms of the Alcohol Use Disorders Identification Test. Alcohol &
Alcoholism, 37(6), 591-596.
Halford, W.K., Price, J., Kelly, A.B., Bouma, R., & Young, R.McD. (2001). Helping the female
partners of men abusing alcohol: a comparison of three treatments. Addiction, 96, 1497-1508.
Havassy, B.E., Hall, S.M., & Wasserman, D.A. (1991). Social support and relapse :
Commonalities among alcoholics, opiate users, and cigarette smokers. Addictive Behaviors,
16, 235-246.
Hayton, J.C., Allen, D.G., & Scarpello, V. (2004). Factor retention decisions in exploratory
factor analysis : A tutorial on parallel analysis. Organizational Research Methods, 191-205.
282
Heller, M.C., & Krauss, H.H. (1991). Perceived self-efficacy as a predictor of after care
treatment entry by the detoxification patient. Psychological Reports, 68, 1047-1052.
Hester, R.K., Delaney, H.D., & Campbell, W.I. (2011). ModerateDrinking.com and Moderation
Management : Outcomes of a randomized clinical trial with non-dependent problem drinkers.
Journal of Consulting & Clinical Psychology, 79(2), 215-224.
Hester, R.K., & Squires, D.D. (2008). Web-based norms for the Drinker Inventory of
Consequences from the Drinker’s Checkup. Journal of Substance Abuse Treatment , 35, 322-
327.
Hoffman, E., Davis, A.K., Ashrafioun, L., Kraus, S.W., Rosenberg, H., Bannon, E.E., Kryszak,
E., Carhart, V., Baik, K., & Jesse, S. (2013). Evaluation of the criterion and predictive validity of
the Alcohol Reduction Strategies-Current Confidence (ARS-CC) in a natural drinking
environment. Addictive Behaviors, 38, 1940-1943.
Hooley, J.M., & Teasdale, J.D. (1989). Predictors of relapse in unipolar depressives:
Expressed emotion, marital distress and perceived criticism. Journal of Abnormal Psychology,
3, 229-235.
Horn, J.L. (1965). A rationale and test for the number of factors. Psychometrika, 30, 179-185.
Hox, J.J., & Bechger, T.M. (1998). An introduction to structural equation modeling. Family
Science Review, 11, 354-373.
Hser, Y. (2007). Predicting long-term stable recovery from heroin addiction. Journal of
Addictive Diseases, 26(1), 51-60.
Hu, L.T., & Bentler, P.M. (1999). Cutoff criteria for fit indexes in covariance structure analysis :
conventional criteria versus new alternatives. Structural Equation Modeling, 6(1), 1-55.
Hudson, C.R., Kirby, K.C., Clements, N.T., Benishek, L.A., & Nick, C.E. (2014). Social
adjustment of women with and without a substance abusing partner. Journal of Psychoactive
Drugs, 46(2), 106-113.
Hurcom, C.A., Copello, A., & Orford, J. (1999). An exploratory study of the predictors of coping
and psychological well-being in female partners of excessive drinkers. Behavioural & Cognitive
Psychotherapy, 27(4), 311-327.
283
Ibanga, A. (2010). Web-based 5 step method for affected family members. Drugs: Education,
Prevention & Policy, 17(Suppl 1), 129-153.
Ilgen, M., McKellar, J., & Tiet, Q. (2005). Abstinence self-efficacy and abstinence 1 year after
substance use disorder treatment. Journal of Consulting & Clinical Psychology, 73(6), 1175-
1180.
Joreskog, K.G., & Sorbom, D. (2013). LISREL 9.10 for Windows [computer software]. Skokie,
IL : Scientific Software Int, Inc.
Jung, J. (1986). How significant others cope with problem drinkers. International Journal of
Addictions, 21(7), 813-817.
Kaiser, H.F. (1970). A second generation Little Jiffy. Psychometrika, 35, 401-415.
Kavanagh, D.J., Sitharthan, T., & Sayer, G.P. (1996). Prediction of results from
correspondence treatment for controlled drinking. Addiction, 91(10), 1539-1545.
Kelley, M.L., & Fals-Stewart, W. (2002). Couples-versus-individual-based therapy for
alcoholism and drug abuse : Effects on children’s psychosocial functioning. Journal of
Consulting & Clinical Psychology, 70, 417-427.
Kieffer, K.M., & MacDonald, G. (2011). Exploring factors that affect score reliability and validity
in the Ways of Coping Questionnaire Reliability Coefficients : A meta-analytic reliability
generalizability study. Journal of Individual Differences, 32(1), 26-38.
Kishor, M., Pandit, L.V., & Raguram, R. (2013). Psychiatric morbidity and marital satisfaction
among spouses of men with alcohol dependence. Indian Journal of Psychiatry, 55(4), 360-365.
Kline, P. (2002). An easy guide to factor analysis. London : Routledge.
Kline, R.B. (2005). Principles and practice of structural equation modeling (2nd edition). New
York: The Guilford Press.
Klingemann, H. (1991). Research report: The motivation for change from problem alcohol and
heroin use. British Journal of Addiction, 86, 727-744.
284
Koski-Jannes, A., Cunningham, J., & Tolonen, K. (2009). Self-assessment of drinking on the
internet – 3 , 6 and 12 month follow-ups. Alcohol & Alcoholism, 44(3), 301-305.
Kraus, S.W., Rosenberg, H., Bonar, E.E., Hoffman, E., Kryszak, E., Young, K.M., Ashrafioun,
L., & Bannon, E.E. (2012). Assessing self-efficacy to reduce one’s drinking : Further evaluation
of the Alcohol Reduction Strategies- Current Confidence Questionnaire. Alcohol & Alcoholism,
47(3), 312-316.
Kuijer, R.G., Ybema, J.F., Buunk, B.P., & de Jong, G.M. (2000). Active engagement, protective
buffering and overprotection : Three ways of giving support by intimate partners of patients
with cancer. Journal of Social & Clinical Psychology, 19(2), 256-275.
Kypri, K., Langley, J.D., Saunders, J.B., Cashell-Smith, M.L., & Herbison, P. (2008).
Randomized controlled trial of web-based alcohol screening and brief intervention in primary
care. Archives of Internal Medicine, 168, 530-536.
Lazarus, R.S., & Folkman, S. (1984). Stress, appraisal, and coping. New York : Springer.
Linke, S., Murray, E., Butler, C., & Wallace, P. (2007). Internet-based interactive health for
intervention for the promotion of sensible drinking : Patterns of use and potential impact on
members of the general public. Journal of Medical Internet Research, 9(2), e10.
Love, C.T., Longabaugh, R., Clifford, P.R., Beattie, M., & Peaslee, C.F. (1993). The
Significant-Other Behaviour Questionnaire (SBQ): an instrument for measuring the behaviour
of significant others towards a person’s drinking and abstinence. Addiction, 88, 1267-1279.
Lundqvist, L., & Ahlstrom, G. (2006). Psychometric evaluation of the Ways of Coping
Questionnaire as applied to clinical and nonclinical groups. Journal of Psychosomatic
Research, 60, 485-493.
Mackenzie, C.S., & Peragine, G. (2003). Measuring and enhancing self-efficacy among
professional caregivers of individuals with dementia. American Journal of Alzheimer’s Disease
and Other Dementias, 18, 291-299.
Maisto, S.A., Carey, M., Carey, K., Gordon, C., & Gleason, J. (2000). Use of the AUDIT and
the DAST-10 to identify alcohol and drug use disorders among adults with a severe and
persistent mental illness. Psychological Assessment, 12, 186–192.
285
Maisto, S.A., McKay, J.R., &  O’Farrell, T.J. (1995). Relapse precipitants and behavioral
marital therapy. Addictive Behaviors, 20, 383-393.
Maisto, S.A., O’Farrell., T.J., Connors, G.J., McKay, J., & Pelcovits, M.A. (1988). Alcoholics’
attributions of factors affecting their relapse to drinking and reasons for terminating relapse
episodes. Addictive Behaviors, 13, 79-82.
Marlatt, G.A., & Gordon, J.R. (1985). Relapse prevention. New York : Guildford Press.
Marsh, H.W., Balla, J.R., & McDonald, R.P. (1988). Goodness of fit indexes in confirmatory
factor analysis : The effects of sample size. Psychological Bulletin, 103, 391-410.
Martin, T., LaRowe, S.D., & Malcolm, R. (2010). Progress in cue exposure therapy for the
treatment of addictive disorders : A review update. The Open Addiction Journal, 3, 92-101.
Martin, R.A., MacKinnon, S.M., Johnson, J.E., Myers, M.G., & Cook, T.A.R. (2011). The
alcohol relapse situation appraisal questionnaire : development and validation. Drug & Alcohol
Dependence, 116, 45-51.
Martinez, R.L.M.C., & Naranjo, J.D. (2010). A pretest for choosing between logrank and
Wilcoxon tests in the two-sample problem. METRON- International Journal of Statistics, 68(2),
111-125.
Matson, N. (1994). Coping, caring and stress: A study of stroke carers and carers of older
confused people. British Journal of Clinical Psychology, 33, 333-344.
Mattoo, S.K., Chakrabarti, S., & Anjaiah, M. (2009). Psychosocial factors associated with
relapse in men with alcohol or opioid dependence. Indian Journal of Medical Research, 130,
702-708.
Mausbach, B.T., Aschbacher, K., Patterson, T.L., Ancoli-Isreal, S., von Kanel, R., & Mills, P.J.
(2006). Avoidant coping mediates the relationship between care recipient problem behaviors
and depressive symptoms in spousal Alzheimer’s caregivers. American Journal of Geriatric
Psychiatry, 14, 299-306.
McDowell, I. (2006) Measuring Health . A Guide to Rating Scales and Questionnaires . 3rd
Edition. New York : Oxford University Press.
286
McKiernan, P., Cloud, R., Patterson, D.A., Golder, S., & Besel, K. (2011). Development of a
brief abstinence self-efficacy measure. Journal of Social Work Practise in the Addictions, 11,
245-253.
Meyer, J.F., Faust, K.A., Faust, D., Baker, A.M., & Cook, N.E. (2013). Careless and random
responding on clinical and research measures in the addictions : A concerning problem and
investigation of their detection. International Journal of Mental Health Addiction, 11(3), 292-
306.
Miller, W.R., & Wilbourne, P.L. (2002). Mesa Grande : A methodological analysis of clinical
trials of treatment for alcohol use disorders. Addiction, 97(3), 265-277.
Monti, P.M., Rosenhow, D.J., Rubonis, A., Niaura, R., Sirota, A., Colby, S., Goddard, P., &
Abrams, D.B. (1993). Cue exposure with coping skills training for male alcoholics : A
preliminary investigation. Journal of Consulting & Clinical Psychology, 61, 1011-1019.
Moos, R.H., Finney, J.W., & Chan, D.A. (1981). The process of recovery from alcoholism.
Comparing alcoholic patients and matched community controls. Journal of Studies on Alcohol,
42, 383-402.
Moos, R.H., Finney, J.W., & Cronkite, R.C. (1990). Alcoholism treatment : context process and
outcome. Oxford : Oxford University Press.
Murray, E., McCambridge, J., Khadjesari, Z., White, I.R., Thompson, S.G., Godfrey, C., Linke,
S., & Wallace, P. (2007). The DYD-RCT protocol : an on-line randomised controlled trial of an
interactive computer-based intervention compared with a standard information website to
reduce alcohol consumption among hazardous drinkers. BMC Public Health, 7, 306-311.
Nattala, P., Leung, K.S., Nagarajaiah, & Murthy, P. (2010). Family member involvement in
relapse prevention improves alcohol dependence outcomes : A prospective study at an
addiction treatment facility in India. Journal of Studies on Alcohol & Drugs, 71(4), 581-587.
Neumann T., Linnen, H., Kip, M., Grittner, U., Weib-Gerlach, E., Kleinwachter, R., MacGuill,
M., Mutzke, S., & Spies, C. (2012). Does the Alcohol Use Disorders Test- Consumption
identify the same patient population as the full 10 item Alcohol Identification Test ? Journal of
Substance Abuse Treatment, 43(1), 80-85.
Norton, S., Cosco, T., Doyle, F., Done, J., & Sacker, A. (2013). The HADS : A meta
confirmatory factor analysis. Journal of Psychosomatic Research, 74(1), 74-81.
287
Nunnally, J., & Bernstein, I. (1994). Psychometric Theory. 3rd Edition. New York : McGraw Hill.
O'Connor, B. P. (2000). SPSS and SAS programs for determining the number of components
using parallel analysis and Velicer's MAP test. Behavior Research Methods, Instrumentation,
and Computers, 32, 396-402.
O’Farrell, T.J., & Clements, K. (2012). Review of outcome research on marital and family
therapy in treatment for alcoholism. Journal of Marital & Family Therapy, 38(1), 122-144.
O’Farrell, T.J., & Fals-Stewart, W. (2003). Alcohol abuse. Journal of Marital & Family Therapy,
29, 97-120.
O’Farrell, T.J., Hooley,J., Fals-Stewart, W., & Cutter, H.S.G. (1998). Expressed emotion and
relapse in alcoholic patients. Journal of Consulting & Clinical Psychology, 66(5), 744-752.
Olsson, I., Mykletun, A., & Dahl, A.V. (2005). The hospital anxiety and depression rating scale
: A cross-sectional study of psychometrics and case finding abilities in general practise. BMC
Psychiatry, 5, 46-53.
Orford, J. (Ed) (1987). Coping with disorder in the family. London : Croom Helm.
Orford, J., & Dalton, S. (2005). A four-year follow-up of close family members of Birmingham
untreated heavy drinkers. Addiction Research & Theory, 13(2), 155-170.
Orford, J., Guthrie, S., Nicholls, P., Oppenheimer, E., Egert, S., & Hensman, C. (1975). Self-
reported coping behaviour of wives of alcoholics and its association with drinking outcome.
Journal of Studies on Alcohol, 36, 1254-1267.
Orford, J., Natera, G., Davies, J., Nava, A., Mora, J., Rigby, K., Bradbury, C., Bowie, N.,
Copello, A., & Velleman, R. (1998). Tolerate, engage or withdraw: a study of the structure of
families coping with alcohol and drug problems in South West England and Mexico City.
Addiction, 93(12), 1799-1813.
Orford, J., Rigby, K., Miller, T., Tod, A., Bennett, G., & Velleman, R. (1992). Ways of coping
with excessive drug use in the family : A provisional typology based on the accounts of 50
close relatives. Journal of Community & Applied Social Psychology, 2, 163-183.
Orford, J., Templeton, L., Velleman., R., & Copello, A. (2005). Family members of relatives
with alcohol, drug and gambling problems : a set of standardized questionnaires for assessing
stress, coping and strain. Addiction, 100, 1611-1624.
288
Parr, J.M., Kavanagh D.J., Young, R.McD., & Connor, J.P. (2009). Development of self-
efficacy and expectancy measures for benzodiazepines. Addictive Behaviours, 34, 751-756.
Penick, E.C., Knop, J., Nickel, E.J., Jensen, P., Manzardo, A.M., Lykke-Mortensen, E., &
Gabrielli, W.F. (2010). Do premorbid predictors of alcohol dependence also predict the failure
to recover from alcoholism ? Journal of Studies on Alcohol & Drugs, 71(5), 685-694.
Phillips, K.T., & Rosenberg, H. (2008). The development and evaluation of the Harm
Reduction Self-Efficacy Questionnaire. Journal of Addictive Behaviors, 22(1), 36-46.
Project MATCH Research Group (1997). Matching alcoholism treatment to client
heterogeneity: Project Match post-treatment drinking outcomes. Journal of Studies on Alcohol,
58, 7-29.
Rabinowitz, Y.G., Mausbach, B.T., Thompson, L.W., & Gallagher-Thompson, D. (2007). The
relationship between self-efficacy and cumulative health risk associated with heath behavior
patterns in female caregivers of elderly relatives with Alzheimer’s disease. Journal of Aging
and Health, 19, 946-964.
Raitasalo, K., & Holmila, M. (2005). The role of the partner in regulating one’s drinking.
Addiction Research & Therapy, 13(2), 137-144.
Reinert, D.F., & Allen, P. (2007). The Alcohol Use Disorders Identification Test : An update of
research findings. Alcoholism: Clinical and Experimental Research, 31, 185-199.
Rejeski, W.J., Craven, T., & Ettinger, W.H. (1996). Self-efficacy and pain in disability with
osteoarthritis of the knee. Journal of Gerontology : Psychological Sciences, 51B (1), 24-29.
Riper, H., Kramer, J., Conijin, B., Smit, F., Schippers, G., & Cuijers, P. (2009). Translating
effective web-based self-help for problem drinking into the real world. Alcoholism : Clinical and
Experimental Research, 33, 1401-1408.
Riso, L.P., Klein, D.N., Anderson, R.L., Ouimette, P.C., & Lizardi, H. (1996). Convergent and
discriminant validity of perceived criticism from spouses and family members. Behavior
Therapy, 27, 129-137.
289
Rivera, P.A., Rose, J.M., Futterman, A., Lovett, S.B., & Gallagher-Thompson, D. (1991).
Dimensions of perceived social support in clinically depressed and non depressed female
caregivers. Psychology & Aging, 6(2), 232-237.
Rognmo, K., Torvik, F.A., Roysamb, E., & Tambs, K. (2013). Alcohol use and spousal mental
distress in a population sample : The nord- trondelag health study. BMC Public Health, 13(1),
319-332.
Rohrbaugh, M.J., Shoham, V., Coyne, J.C., Cranford, J.A., Sonnega, J.S., & Nicklas, J.M.
(2004). Beyond the ‘self’ in self-efficacy : Partner confidence predicts patient survival following
heart failure. Journal of Family Psychology, 18(1), 184-193.
Rohsenhow, D.J., Monti, P.M., Rubonis, A.V., Gulliver, S.B., Colby, S.M., Binkoff, J.A.,
Abrams, D.B. (2001). Cue exposure with coping skills training and communication skills
training for alcohol dependence : six and twelve month outcomes. Addiction, 96, 1161-1174.
Rychtarik, R.G. Carstensen, L.L., Alford, G.S., Schlundt, D.G., & Scott., W.O. (1988).
Situational assessment of alcohol-related coping skills in wives of alcoholics. Psychology of
Addictive Behaviors, 2(2), 66-73.
Rychtarik, R.G., & McGillicuddy, N.B. (2005). Coping skills training and 12-Step facilitation for
women whose partner has alcoholism : Effects on depression, the partner’s drinking and
partner physical violence. Journal of Consulting and Clinical Psychology, 73(2), 249-261.
Rychtarik, R.G., & McGillicuddy, N.B. (2006). Preliminary evaluation of a coping skills training
program for those with a pathological-gambling partner. Journal of Gambling Studies, 22, 165-
178.
Rychtarik, R.G., Prue, D.M., Rapp, S.R., & King, A.C. (1992). Self-efficacy, aftercare, and
relapse in a treatment program for alcoholics. Journal of Studies on Alcohol, 11, 435-440.
Sapnas, K.G., & Zeller, R.A (2002). Minimizing sample size when using exploratory factor
analysis for measurement. Journal of Nursing Measurement, 10(2), 135-153.
Sattora, A., & Bentler, P.M. (1988). Scaling corrections for statistics in covariance structure
analysis. Los Angeles : University of California, Department of Psychology. (UCLA Statistics
Series, No. 2).
290
Saunders, J.B., Aasland, O.G., Babor, T.F., de la Fuente, J.R., & Grant, M. (1993).
Development of the Alcohol Use Disorders Identification Test (AUDIT) : WHO collaborative
project on early detection of persons with harmful alcohol consumption II. Addiction, 88, 791-
804.
Schaffer, J.B., & Tyler, J.D. (1979). Degree of sobriety in male alcoholics and coping styles
used by their wives. British Journal of Psychiatry, 135, 431-437.
Schreiber, J.B., Nora, A., Stage, F.K., Barlow, E.A., & King, J. (2006). Reporting structural
equation modeling and confirmatory factor analysis results : A review. The Journal of
Educational Research, 99(6), 323-338.
Schroder, K.E.E., Schwarzer, R., & Endler, N.S. (1997). Predicting cardiac patient’s quality of
life from the characteristics of their spouses. Journal of Health Psychology, 2(2), 231-244.
Simons, L., Ducette, J., Kirby, K.C., Stahler, G., & Shipley, T.E. (2003). Childhood trauma,
avoidance coping, and alcohol and other drug use among women in residential and outpatient
treatment programs. Alcoholism Treatment Quarterly, 21(4), 37-54.
Sinadinovic, K., Wennberg, P., & Berman, A.H. (2012). Targeting problematic users of illicit
drugs with internet-based screening and brief intervention : A randomized controlled trial. Drug
& Alcohol Dependence, 126 (1), 42-50.
Sitharthan, G., Hough, M., Sitharthan, T., & Kavanagh, D. (2001). The Alcohol Helplessness
Scale and its prediction of depression among problem drinkers. Journal of Clinical Psychology,
57(12), 1445-1457.
Sitharthan, T. (1993). Support Scale. Unpublished manuscript. Royal Prince Alfred Hospital.
Sitharthan, T. (1996). Comprehensive Drug & Alcohol Evaluation Form (CDAEF). Unpublished
manuscript. Western Sydney Area Health Drug & Alcohol Service.
Sitharthan, T., Job, R.F.S., Kavanagh, D.J., Sitharthan, G., & Hough, M. (2003). Development
of a Controlled Drinking Self-Efficacy Scale and appraising its relation to alcohol dependence.
Journal of Clinical Psychology, 59(3), 351-362.
Sitharthan, T. & Kavanagh, D.J. (1990). Role of self-efficacy in predicting outcomes from a
program for controlled drinking. Drug and Alcohol Dependence, 27, 87-94.
291
Sitharthan, T. & Kavanagh, D.J. & Sayer, G. (1996). Moderating drinking by correspondence :
An evaluation of a new method of intervention. Addiction, 91, 345-355.
Sitharthan, T., Sitharthan, G., Hough, M., & Kavanagh, D.J. (1997). Cue exposure in
moderation drinking : A comparison with cognitive behavior therapy. Journal of Consulting &
Clinical Psychology, 65, 878-882.
Skinner, H.A. (1982). The Drug Abuse Screening Test. Addictive Behaviours, 7(4), 363-371.
Skinner, H.A. & Allen, B.A. (1982). Alcohol dependence syndrome: Measurement and
validation. Journal of Abnormal Psychology, 97, 199-209.
Snaith, R.P., & Zigmond, A.S. (1994). HADS: Hospital Anxiety and Depression Scale. Windsor
: NFER Nelson.
Sobell, L.C., Agrawal, S., & Sobell, M.B. (1997). Factors affecting agreement between alcohol
abusers’ and their collaterals’ reports. Journal of Studies on Alcohol, 58, 405-413.
Sobell, L.C., Sobell, M.B., Toneatto, T., & Leo, G.I. (1993). What triggers the resolution of
alcohol problems without treatment ? Alcoholism : Clinical & Experimental Research, 17, 217-
224.
Sobell, M.B., & Sobell, L.C. (1993). Treatment for problem drinkers : A public health priority. In
J.A. Baer, G.A. Marlatt, & R.J. McMahon (Eds.), Addictive behaviours across the life span:
prevention, treatment and policy issues. Newbury Park : Sage.
Soyka, M., & Schmidt, P. (2009). Outpatient alcoholism treatment : 24-month outcome and
predictors of outcome. Substance Abuse Treatment, Prevention, and Policy,  4, 1747-1597.
Staley, D., & El-Guebaly, N. (1990). Psychometric properties of the Drug Abuse Screening
Test in a psychiatric patient population. Addictive Behaviors, 15, 257–264.
Steffen, A.M., McKibbin, C., Zeiss, A.M., Gallagher-Thompson, D., & Bandura, A. (2002) The
revised scale for caregiving self-efficacy : Reliability and validity studies. Journal of
Gerontology : Psychological Sciences, 57B(1), 74-86.
Steer, R.A., Rissmiller, D.J., Ranieri, W.F., & Beck, A.T. (1993). Dimensions of suicidal
ideation in psychiatric inpatients. Behavior Research Therapy, 31(2), 229-236.
292
Streiner, D.L. (1994). Figuring out factors : The use and misuse of factor analysis. Canadian
Journal of Psychiatry, 39, 135-140.
Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the
2011 National Survey on Drug Use and Health : Summary of National Findings. NSDUH
Services H-44, HHS Pubn No. (SMA) 12-4713 (Rockville, MD: SMAHSA Admin, 2012).
Tabachnick, B.G., &  Fidell, L.S. (1996). Using Multivariate Statistics : 3rd Edition. New York :
Harper Collins College Publishers.
Tabachnick, B.G., &  Fidell, L.S. (2001). Using Multivariate Statistics : 4th Edition. Needham
Heights, Mass. : Allyn & Bacon.
Tapert, S.F., Ozyurt, S.S., Myers, M.G., & Brown, S.A. (2004). Neurocognitive ability in adults
coping with alcohol and drug relapse temptations. The American Journal of Drug & Alcohol
Abuse, 30(2), 445-460.
Tempier, R., Boyer, R., Lambert, J., Mosier, K., & Duncan, R. (2006). Psychological distress
among female spouses of male at-risk drinkers. Alcohol, 40(1), 41-49.
Templeton, L., Velleman, R., & Russell, C. (2010). Psychological interventions with families of
alcohol misusers : A systematic review. Addiction Research & Theory, 18(6), 616-648.
Toner, P., & Velleman, R. (2014). Initial reliability and validity of a new measure of perceived
social support for family members of problem substance users. Addiction Research & Theory,
22(2), 147-157.
Tossman, H-P., Jona, B., Tensil, M-D., Lang, P., & Struber, E. (2011). A controlled trial of an
internet-based intervention program for cannabis users. Cyberpsychology, Behavior, and
Social Networking, 14(11), 673-679.
Ugalde, A., Krishnasamy, M., & Schofield, P. (2013). Development of an instrument to
measure self-efficacy in caregivers of people with advanced cancer. Psycho-Oncology, 22,
1428-1434.
Ullman, J.B. (2006). Structural equation modeling : Reviewing the basics and moving forward.
Journal of Personality Assessment, 87(1), 35-50.
293
United Nations Office on Drugs and Crime (UNODC) (2012). United Nations World Drug
Report 2012 (United Nations Publication, Scales No. E.11.X1.10).
Velicer, W.F., & Fava, J.L. (1998). Effects of variable and subject sampling on factor pattern
recovery. Psychological Methods, 3, 231-251.
Velleman, R., & Orford, J. (1993). The importance of family discord in explaining childhood
problems in the children of problem drinkers. Addiction Research, 1, 39-57.
Vernon, M.L. (2010). A review of computer-based alcohol problem services for the general
public. Journal of Substance Abuse Treatment, 38, 203-211.
Wagner, C.D., Bigatti, S.M., & Storniolo, A.M. (2006). Quality of life of husbands of women
with breast cancer. Psycho-Oncology, 15, 109-120.
West, S.G., Finch, J.F., & Curran, P.J. (1995). Structural equation models with nonnormal
variables : Problems and remedies. In R.H. Hoyle (ed.) Structural equation modeling :
Concepts, issues and applications (pp.56-75). Newbury Park, CA : Sage.
Witkiewitz, K., van der Maas, H.J., Hufford, M.R., & Marlatt, G.A. (2007). Non-normality and
divergence in post-treatment alcohol use : re-examining the Project MATCH data “Another
Way”. Journal of Abnormal Psychology, 116, 378-394.
Worthington, R.L., & Whittaker, T.A. (2006). Scale development research – A content analysis
and recommendations for best practice. The Counseling Psychologist, 34(6), 806-838.
Young, R.McD., Gullo, M.J., Feeney, G.F.X., & Connor, J.P. (2012). Development and
validation of the Cannabis Refusal Self-Efficacy Questionnaire (CRSEQ) in adult cannabis
users in treatment. Drug and Alcohol Dependence, 125, 244-251.
Yudko, E., Lozhkina, O., & Fouts, A. (2007). A comprehensive review of the psychometric
properties of the Drug Abuse Screening Test. Journal of Substance Abuse Treatment, 32, 189-
198.
Zeiss, A.M., Gallagher-Thompson, D., Lovett, S., Rose, J., & McKibbin, C. (1999). Self-efficacy
as a mediator of caregiver coping : Development and testing of an assessment model. Journal
of Clinical Geropsychology, 5(3), 221-230.
294
Zigmond, A.S., & Snaith, R.P. (1983). The Hospital Anxiety and Depression Scale. Acta
Psychiatrica Scandinavica, 67(6), 361-370.
Zywiak, W.H., Stout, R.L., Trefry, W.B., Glasser, I., Connors, G.J., Maisto, S., & Westerberg,
V.S. (2006). Alcohol relapse repetition, gender and predictive validity. Journal of Substance
Abuse Treatment, 30(4), 349-353.
295
